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ZN-DTC INTERFERENCE ON P.LIVIDUS ARS ACTIVITY .
E .E .A lia, M .A .F ighetti, F.A.P.Giannasi. Is t i tu to  di Is to log ia  ed Embriolo 
gia Generale. Facoltà di Medicina e Chirurgie. Université di Sassari. 
Viale Mancini, 5. 07100 Sassari ( I ta ly ) .
Key Words: Sea Urchin, D iffe re n tia tio n , Aryl s u ifatase.
Zinc-ethyl enebisdithiocarbamate (Zn-DTC) strongly a ffects  the 
development o f the P .liv id u s  sea urchin fe r t i l iz e d  eggs. Abnormal 
plutea formation have been observed in fe r t i l iz e d  eggs grown in  the 
presence o f 0.4 ug/ml Zn-DTC solution. To dissolve the s a lt in  the 
sea water, DMSO is  required. We preferred to  t r y  without the use 
o f DMSO, to achieve more re a lis t ic  conditions. And fo r these experiments 
we used Zn-DTC suspended in  natural sea water containing fe r t i l iz e d  
eggs. The contamination was performed 15 mins a fte r  the fe r t i l iz a t io n .  
A 99% fe r t i l iz a t io n  index was observed every time.
The contamination seems to  in h ib it  the m itosis of the blastomeres: 
the 24 ug/ml concentration blocks the segmentation at 2-16 blastomeres; 
but the s a lt seems also to  in te rfe re  with the migration of the c e lls : 
the 0.4 ug/ml concentration (solution in  presence o f DMSO) produces 
abnormal larvae. D iffe ren t experimental conditions, most o f them 
due to d iffe re n t Zn-DTC concentrations employed, induced the formation 
o f blastomeres of various number and shape. I t  is  not clear at which 
stage the in h ib it io n  takes place and which is  the more affected event.
I t  has been suggested that e x trace llu la r proteoglycans play an 
important ro le  in c e ll migration (Giudice G., 1986) and because of
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the dramatic morphological modifications observed, we went on to  study 
the eventual m odification o f the arylsu lfa tase (ARS) a c t iv ity  during 
the contamination. This enzyme is  known to  degrade glycosaminoglycans 
and su lfa tides (Kolodni E.H. e t a l . ,  1983) and i t  has been shown to 
be synthesized in a large quantity in  the sea urchin during development 
(Sasaki H. et a l. ,  1988).
Our study was done w ith  21 hour treated (w ith 24 ug/ml Zn-DTC) 
fe r t i l iz e d  eggs. In th is  case, everything is  affected: ce ll d iv is io n , 
c e ll morphology, zygote development and d if fe re n tia t io n . Strong ARS 
a c t iv i t y  inh ib ition  was expected. The ARS a c t iv ity  was visualized 
using the method of Dubois (1973), over a non-denaturating polyacrylamide 
slab gel electrophoresis, APS-polymerized as a m odification o f the 
method o f Davis (1964). The sea urchin ARS a c t iv ity  is  non-inhib ited 
by APS and shows a s ing le  band near the buffer fro n t in  control samples.
Treated samples showed a new strong reaction band above the f i r s t  
one, which is  also present (a t least p a r t ia l ly ) .  The Zn-DTC does 
not a ffe c t the ARS a c t iv i ty ;  i t  may be supposed i t  induces the formation 
o f a higher molecular weight peptide, but i t  is  not known whether 
th is  would be so i n v ivo .
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LAXATIVES ANO THE PRODUCTION OF KININS BY RAT COLON 
Autore G., Mascolo N., Capasso F.
Department of Experimental Pharmacology, via D. Montesano 49, 80131 Naples, 
I ta ly .
Keywords: laxatives, k in ins , cellulose suplhate.
Some studies have suggested that prostaglandins (PGs), histamine and sero­
ton in , are involved in  the mechanism by which castor o i l ,  senna, phenol­
phthalein and sulfosuccinate a lte r colonic f lu id  and e lectro ly te  movement 
(Beubler and Juan, 1979; Capasso et a l . ,  1986). The studies demonstrated 
that these laxatives, in  addition to th e ir  a b i l i t y  to a lte r water and elec­
tro ly te  absorption and/or secretion, also increased the release of PGs, 
histamine and serotonin in to  the colonic tissue and lumen. Recently i t  has 
been demonstrated that there is  also an increase in  kininogen content in  
the colonic mucosa of ra ts  treated with phenolphthalein (Autore et a l . ,  in  
press). These resu lts  are consistent with the hypothesis that k in ins  con­
tr ib u te  to the laxative  e ffec t of phenolphthalein. In the present study we 
have determined whether other laxatives lead to changes in the leve ls of 
kininogen in  the ra t colon and i f  a treatment which a lte rs  k in ins pro­
duction a ffec t thé response to laxative in  a corresponding manner. Male 
Wistar ra ts  (120-140 g) were deprived of food overnight but allowed free 
access to water. Bisacodyl (5 mg/kg), castor o i l  (2 m l/ra t), mannitol 
(10 mg/kg), senna (30 mg/kg), sulfosuccinate (20 mg/kg) and water (co n tro l,
2 m l/ra t) were administered by gavage. When diarrhoea was evident, the ra ts  
were k il le d  and specimens of colon were immediately removed, homogenised in  
ethanol and processed fo r kininogen assay as previously described (Autore 
et a l . ,  1989). Experiments were performed also in  ra ts pretreated w ith  ce l­
lulose sulphate (1 mg/kg in jected i . v . )  1 h before administration of laxa­
t iv e . Control ra ts were pretreated with saline solution (NaCl 0.9 %, 3 
m l/kg). Data obtained from laxative-treated ra ts  are shown in Table 1. A ll 
extracts contained kininogen, a k in in  precursor, which was activated by in ­
cubation with tryps in . However the mean amounts were s ig n ifica n tly  (P<0.01) 
higher only in  tissue extracts from cator o il- tre a te d  rats. Senna and su lfo ­
succinate had l i t t l e  e ffe c t while bisacodyl and mannitol had no e ffe c t. 
Pretreatment of the animals with cellu lose sulphate reduced d ra s tic a lly  
kininogen content both in  control and in  laxa tive -trea ted  rats.
A ll the drugs produced unformed faeces in  2-4 h, but pretreatment w ith ce l­
lulose sulphate reduced only the e ffec t of ca s tro l o i l  (-39%; P<0.05). Cel­
lulose sulphate given to control ra ts did not cause diarrhoea or modify the 
number of pe lle ts  excreted. The present re su lts  demonstrate that only castor 
o i l  stimulated colonic formation of kininogen in  ra ts , and th is  was re­
duced by cellu lose sulphate, a compound able to deplete kininogen. Cel­
lulose sulphate also reduced the laxative e ffe c t of castor o i l .  These 
findings indicate tha t castor o i l  may act in  part through kin ins release.
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Table 1. Kinin precursor levels in normal colon and in colon
of ra ts  treated with laxatives (bisacodyl, castor o i l ,  mannitol, senna,
sulfosuccinate) and pretreated or not with ce llu lose sulphate.
Treatment Kininogen content (ug/g Bk)
None Cellulose sulphate
Control 7.5+2.9 1.9+0.5
Bisacodyl 7.7+2.7 2.9+0.5
Castor o i l 16.3+3.3a 5.4+0.9
Mannitol 7.1+3.0 1.7+0.4
Senna 11.7+3.3 2.9+0.6
Sulfosuccinate 10.4+3.0 2.0+0.5
Laxatives were given o ra lly  2-4 h before the animals were k il le d . Cellulose 
sulphate 1 mg/kg was given intravenously on three occasions at 10 min in te r ­
va ls . Each resu lt is  the mean S.E. of 8 experiments. Kininogen content re­
presents the amount o f kininogen releasing measured as bradykinin (Bk) 
equivalents per g tissue wet weight, 
a P<0.01 compared w ith con tro l. Student's t - te s t .
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BIOCHEMICAL EFFECTS OF GYKI-12 743
A .B a ko n y i, Z s . Tömösközi  , Á.Heiczman, E . J .H o rvá th , P .A rá n y i 
and G y.Rabloczky
I n s t i t u t e  fo r  Drug Research, Budapest, P.O.Box 82, Hungary
86Keywords: A n t ih y p e r te n s iv e j Rb e f f l u x , o( ^ - s e le c t i v i t y s
GYKI-12 743 was dem onstra ted  to  d is p la y  a n t ih y p e r te n s iv e  and 
v a s c u la r smooth m uscle re la x in g  a c t i v i t y .  P ha rm aco log ica l tests  
suggested th a t  i t  had a n t io ^ -a d re n e rg ic  and potassium  channe l 
a c t i v i t i n g  e f f e c t s .  R e c e p to r-b in d in g  s tu d ie s  were perfo rm ed in  
o rd e r to  c o rra b o ra te  the  above f in d in g s  w ith  b io ch e m ica l d a ta . 
Human p la te le t  p re p a ra t io n  was used to  te s t  fo r  o ^ - re c e p to r  
d isp lacem en t w ith  ( ^H )-yoh im b in  as r a d io l ig a n d  (M o tu lsky  e t al.
1983). GYKI-12 743 had h igh  a f f i n i t y  fo r  the  yohim bin b in d in g  
s i te s  ( IC 50=5,8 nM and 41 nM fo r  yoh im b in  and 12 743, re sp e c ­
t i v e l y ) .  Rat m yo ca rd ia l membrane p re p a ra t io n  was used, as a 
source ofo( j-a d re n o re c e p to rs  (Glossmann e t a l . ,  1980). GYKI- 
12 743 in h ib i te d  ( ^ H )-p ra z o s in  b in d in g  in  a c o n c e n tra t io n  
dependent manner w ith  an IC^g o f 530 nM, d e m onstra tin g  the 
s e le c t i v i t y  o f GYKI-12 743 fo r  © (^ - re c e p to rs . Our compound had 
no a p p re c ia b le  a c t i v i t y  fo r  e ith e r  ve ra p a m il or d ih y d ro p y rid in e  
b in d in g  s i te s .
Potassium  channel a c t iv a t in g  c a p a c ity  can be dem onstrated by
8 6m easuring enhancement o f Rb e f f lu x ,  s in c e  membrane pe rm eab i­
l i t y  fo r  Rb+ p a r a l le ls  th a t  o f K+ (H a m ilto n  e t a l . ,  1986).
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We found th a t GYKI-12 743 opened K+-c h a n n e ls  o f r a b b i t  a r t é r ia  
p u lm o n a ris  more e f f i c i e n t l y  than p in a c id i l .  I t s  e f f ic a c y  was 
s im i la r  to  th a t o f c ro m a ka lim . Thus, b io ch e m ica l and pharma­
c o lo g ic a l  data c o n c e rn in g  the mechanism or a o rio n  o f GYKI- 
12 743 are in  good agreem ent.
R e fe rences :
H.Glossmann e t a l .  J . C a rd io v a s c . Pharmacol 2, S 303-324 (1 9 8 0 ).
T .C .H am ilton  e t a l .  B r . J . Pharmacol £8 , 103-111 (1 9 8 6 ).
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CYTOCHEMICAL EFFECTS OF BIOLOGICALLY ACTIVE SUBSTANCES ON THE HEART MUSCLE
Balogh, I . ,  Kecskeméti, V.4 Kertész, Z .*, Kereszt^/, E.
Departments of Forensic Medicine and Pharmacology’*
Semmelweis Medical School, Budapest, Hungary.
Keywords: heart muscle, trace elements, cytochemistry, PAF
Using electronmicroscopic and cytochemical methods the effects of d i f ­
ferent b io lo g ica lly  active substances (p la te le t activating fac to r: PAF, 
trace elements) were studied on Langendorff preparation of guinea p ig  and 
ra t hearts. Hypoxic, ischemic and tox ic  a lte ra tions  can be examined on the 
vessel w a ll, p e rica p illa ry  space and surrounding myocardialcells. Damages of 
endothelia l c e lls , hypoxia, ischemia, (cadmium, cobalt, vanadium, n icke l, 
zinc, selenium, mercury) (Fig. 1 .) ,  in tra lum ina l p la te le t adhesion and ag­
gregation (PAF-platelet activa ting  factor and i t s  antagonist) (F ig . 8,9) the 
membrane bound adenylate cyclase enzyme xocalised in  sarcolemma and tu b u li 
of sarcoplasmic re t ic u l i  (Fig. 2), the in tra c e llu la r  calcium pools o f myo- 
card ica l c e ll (F ig. 5, 6, 7), some special mitochondrial enzymes (cyto - 
chromoxydase, Fig. 3 .; succinic dehydrogenase Fig. 4 .) can be tested. Cyto­
chemical techniques fo r trace elements accumulation, the a lte ra tio n  o f mem­
brane permeability (lanthanium, ruthenium-red, dimethylglioxime, d ith iso n , 
s a lic y l ic ic  aldoxime, rubeanic acid) have been used. These methods can be 
used fo r investigating the e ffec t of some "cardioprotective" substances 
(prostacyclin ) on isolated heart muscle c e l l .
Fig. 1. Cadmium e ffec t on the endothelial c e l l ,  Fig. 2. Adenylate cyclase 
cytochemistry, Fig. 3. Cytochromic oxydase cytochemistry, Fig. 4. Succinic 
dehydrogenase, Fig. 5. Cacliumcytochemistry, Fig. 6, 7. Intram itochondria l 
calcium deposits, Fig. 8, 9. E ffect of p la te le t activating fac to r, thrombo- 
c y tic  adhesion and aggregation in  ca p illa ry .
22
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URINE RETENTION INDUCEO IN RATS BY INTRA-SPINAL CORD INJECTION OF 
COLCHICINE AS A TOOL TO FIND NEW PHARMACOLOGICAL TREATMENTS
M. Barald i, P. Zanoli, C. Truzzi, G. Vaccari, A. Giacobazzi, R. Avallone
Chair of Pharmacology and Pharmacognosy, School of Pharmacy,
Dept, of Pharmaceutical Sciences, Modena U n ive rs ity , I ta ly
Keywores: micturition-colchicine-Bremazocine-GM^-NGF
Available treatments fo r bladder disturbances seem to be unsatisfactory and 
the attempt to find  new drugs require a be tte r understanding of the machin­
ery which regulates m ic tu rition  and suitable animal models.
We have recently described (P. Zanoli and M. Bara ld i, 1988) that the in tra -  
spinal cord ( i . s . c . )  in je c tio n  of low doses o f colchicine (2-5 ug /ra t) in ­
duced urine retention w ith a latency period o f 24 hrs. Rats sac rified  72 
hrs a fte r  the single in je c tio n  of colchicine showed a bladder hypertrophy 
which is  associated with a retention of more than 5 ml of urine and a 
minimum output of urine due to overflow (P. Zanoli and M. Baraldi, 1989). 
Substance P has been shown to play a key ro le  in  the regulation of the 
voiding re fle x . Here we report that colchicine induces a dramatic decrease 
of the Substance P immunomaterial in  the lumbar tra c t of the spinal cord. 
However, neither i . s .c .  in jec tion  of Substance P nor systemic in je c tio n  of 
eledoisine counteracted urine retention. Hence changes in  Substance P alone 
cannot explain the observed phenomena. Indeed the i .s .c .  adm inistration of 
co lch ic ine , probably by blocking axonal transport, induced also an increase 
of Met-Enkephalin associated with a reduced a f f in i t y  constant of d e lta - 
receptors labelled by ^H-DADLE. Though. Met-Enkephalin exerts an in h ib ito ry  
a c t iv ity  on the bladder function, we tested the a b i l i ty  of naloxone to 
counteract the colchicine-induced urine re ten tion  with negative re su lts . 
Furthermore we tested whether or not Dynorphin and opioid К receptor sub- 
types were altered in  colchicine treated ra ts  w ith urine retention and we 
found an up-regulation of these receptors labe lled  by ^H-Ethylketocyclazo- 
cine. The administration of the receptor agonist Bremazocine, but not 
tha t of the agonist U-69593 was able to prevent the colchicine induced 
urine re tention  and the bladder hypertrophy. Thus the colchicine-induced 
urine re tention was a ttribu ted  to an imbalance between the d iffe re n t neuro­
peptide systems in  the spinal cord and the e ffe c t of Bremazocine to i t s  
agonist-antagonist property. Colchicine ( 2 / jg / r a t ) ,  when i.s .c .  in jec ted ,
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induces a mild urine re ten tion  lasting  fo r about two-three weeks w ith a 
slow recovery. Herein we report (Table 1) th a t the administration o f 30 
mg/kg/day of monosialoganglioside (GM1) in  combination with a s ingle i . s .c .  
adm inistration of NGF (0 .8 / jg / ra t )  improved the functional recovery o f the 
m ic tu r it io n  function judging from urine emission and content in  the bladder 
at day 3 and 7.
Table 1: Influence of Nerve Growth Factor and Monosialoganglioside (GM^)
day
adm inistration on colchicine-■induced urine re ten tion
Treatment Drugs Urine output (ml/8 hi
3 7 12
Saline Saline 2.5+0.3 3.8+0.6 3.0+0.7
Colchicine Saline 0.8+0.4* 1.6+0.2* 2.5+0.3
Colchicine NGF+GM1 2.5+0.3 4.1+0.4 2.5+0.4
Mean values C+S.D.) of 6 rats/group.
NGF (0 .8 ^ g /ra t ,  i . s . c . )  was injected once 24 h before colchicine, while 
GM. (30 mg/kg/day, i . p . )  was dosed chron ica lly  s ta rting  3 days before 
colchicine..Student's t - te s t :  x p<0.01 vs con tro l.
These findings seem to demonstrate that our knowledge on the mechanisms 
regu la ting  bladder function is  s t i l l  poor and tha t the use of su itab le  
animal model can lead to fin d  out new ra tio n a l pharmacological approaches.
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ACTIVITY OF PGT/1A, A NEW IMMUNOSTI MULATING DRUG, ON MACROPHAGES AND 
LYMPHOCYTES IN IMMUNODEPRESSED MICE.
M.Barchielli and G.Coppi
Research Centre, Poli Industrie Chimica S .p .A ., Via Volturno no 48, 20089
Rozzano (M I), I ta ly
Key words : PGT/1A; i o i u n o s t i a u l a t i n g  a c t i v i t y ;  l a c ro p h a g e s ;  lymphocytes; b a c t e r i a l  i n f e c t i o n s .
In the las t years many progress were obtained in the knowledge of 
m icrobial and mammalian peptides endowed w ith immunostimulating a c t iv it ie s .  
S ign ifican t a c tiv it ie s  on the immune system were found on peptides derived 
by thymus gland, but immunoenhancing a c t iv ity  was also present in  small 
peptides lik e  TP-5 (Arg-Lys-Asp-Val-Tyr) and tu f ts in  (Thr-Lys-Pro-Arg).
Following our researches on new immunostimulating drugs, we found a new 
in te res ting  peptide-like  compound PGT/1A (3-L-pyroglutam yl-L-th iazo lid ine-4- 
carboxylic acid) (P o li, 1989).
In th is  study we report the a c tiv ity  of th is  new immunostimulating drug 
on c e llu la r  immune system and more prec ise ly , on splenic lymphocytes and 
peritoneal macrophages in immunodepressed mice.
Mice CD-I (C.River) were depressed by prednisolone (5 mg/kg/die s .c . fo r 
two days) and o ra lly  (200-400 mg/kg/die fo r  7 days) and in tra p e rito n e a lly  
(100-200 mg/kg/die fo r 7 days) treated w ith PGT/1A. The treatment w ith  the 
new compound stimulated the number of splenic lymphocytes producing rosette 
against sheep erythrocytes (Wilson, 19871); the percent varia tions ranged 
from +25.8% to 44.6%.
In mice immunodepressed by cyclophosphamide (120 mg/kg i .p .  fo r  two 
days), PGT/1A administered o ra lly  (200 and 400 mg/kg die per 12 days) and 
in tra p e rito n e a lly  (100 and 200 mg/kg die per 12 days) increased clearance of 
co llo id a l charcoal (Biozzi et a l. ,  1953) from blood restoring to leve ls of
26
no immunodepressed mice.
The new immunostimulating drug protected the mice against many bacteria l 
in fe c tio n s . The compound was administered in trape ritonea lly  (50 to  200 
mg/kg) fo r five  times (12 hours of in te rva l)  before in fections; la s t drug 
adm inistration was 8 hours before bacteria l challenge.
Table
T r e a t m e n t
1 Dose 1 
1 mg/ к  g / d  i  e 1 E . c o l i
S u r v i v a l  
E . c o l i  P
a f t e r  i n f e c t i o n s  { % )  
m i r a b i l i s  P s . a e r u g i n o s a P . m o r g a n i i
1 X 5 t i m e s  | P1 02 P103 P 2 0 3  P279 P 1 2 0
C o n t r o l
I I
0 1 25 1 
I I
30  1 o 1
I I
10
P GT / 1 A
1 1 
1 1 00  1 70
1 1 
1 70 1
1 1 
1 0 0  1 90 1 A0
PGT/1A showed s ig n if ic a n t protections; the a c tiv ity  was evident only 
a fte r  5 treatments and was dose-related; the a c t iv ity  was s im ila r to those 
of TP-5 and thymostimulin (E .co li in fec tions ).
From these prelim inary results we can conclude that PGT/1A is  a new 
immunostimulating drug which increases the a c t iv ity  of lymphocytes and 
macrophages in immunodepressed mice and shows good protections against 
bac te ria l in fections in mice.
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EFFECTS OF CENTRAL PUTATIVE NEUROTRANSMITTERS ON DIMETHYLPHENYL- 
PIPERAZINIUM -INDUCED EMESIS: PHARMACOLOGICAL AND PHYSIOLOGICAL 
IMPLICATIONS
D .B .B e le s l in ,  S .K .K r s t i c ,  Ranka S a m a rd z ic  a n d  D a n ic a  Jo v a n o v ic -M ic ic
D e p a rtm e n t of P h a rm a c o lo g y ,M e d ic a l F a c u l ty , P .O .B o x  662 , 11000 B e o g ra d , 
Y u g o sla v ia
K ey w o rd s :  DMPP -  N e u r o tr a n s m it te r s  -  E m e s is  -  A re a  p o s tr e m a
N ic o tin ic  r e c e p to r s  in  th e  c a t 's  a r e a  p o s t r e m a  m ed ia tin g  e m e s is  h a v e  a l ­
r e a d y  b e e n  d e s c r ib e d  (B e le s l in  and K r s t i c ,  1986 ) , b u t l i t t le  is  know n o n  th e  
n e u ro n a l c i r c u i t r y  o r  t r a n s m i t t e r s  in v o lv ed  in  th i s  a s p e c t  of e m e s is  r e s p o n s e .  
H o w e v e r , th e r e  i s  a  r e p o r t  th a t  n ic o tin ic  r e c e p t o r s  m ig h t be u n d e r  c e n t r a l  
op io id  c o n tro l  (B e le s l in  e t  a l . , 1 9 8 1 ). T h e r e f o r e ,  i t  w as of in te r e s t  to  f u r th e r  
in v e s tig a te  th e  e f fe c ts  o f p u ta tiv e  n e u r o t r a n s m i t t e r s  p re s e n t  in  th e  a r e a  p o s ­
t r e m a  on th e  e m e s is  in d u c ed  by d im e th y lp h e n y lp ip e ra z in iu m  (DM PP) in je c te d  
in t r a c e r e b r o v e n t r i c u la r ly  ( i . e . v . )  to  u n a n a e s th e tiz e d  c a ts .
In an  a s e p t ic  o p e ra tio n  u n d e r p e n to b a rb ita l  so d iu m  (35-40  m g /k g , i . p .  ) 
a n a e s th e s ia ,  an  in fu s io n  c a n n u la  w as im p la n te d  in to  th e  le f t  l a t e r a l  c e r e b r a l  
v e n t r ic le  o f c a ts  of e i th e r  s e x  (2 -4  k g ) ,  so  th a t  i . e . v .  in je c tio n s  o f d r u g s  
cou ld  l a t e r  b e  m a d e  w ith o u t a n a e s th e s ia .  In o n e  g ro u p  of the  c a t s ,  th e  a r e a  
p o s tr e m a  w as  d e s tro y e d  e le c t r o ly t ic a l ly . The so lu t io n s  of d ru g s  w e r e  in je c ­
ted  m a n u a lly  f ro m  a  1 m l s y r in g e  in  a  v o lu m e  o f  0 .1  o r  0 .2  m l o v e r  a  p e r io d  
of 15-20  s e c o n d s  and  w a sh e d  w ith  0 .1  m l o f s a l in e  u n d e r the  s a m e  c o n d itio n s  
a s  fo r  th e  d r u g s .  O nly e x p u ls io n  of th e  g a s t r i c  c o n te n t w as ta k en  a s  a  p o s i ­
t iv e  e m e tic  r e s p o n s e .  S u c c e s s iv e  e x p e r im e n ts ,  c a r r i e d  out on 6 c a ts  w e r e  
s e p a r a te d  by  an  in te r v a l  o f a t  l e a s t  5 d a y s .  The r e g im e n  fo r  th e  i . e . v .  in je c ­
tio n s  of DMPP and a n ta g o n is ts  w as r a n d o m iz e d  s o  th a t  each  an im a l w a s  in c lu ­
ded  in  e a c h  of th e  e x p e r im e n ta l  c o n d itio n s . A c o e f f ic ie n t of c o r r e la t io n  ( r )  
o f l in e a r  r e g r e s s i o n  w a s  u se d  to d e te rm in e  th e  e x is te n c e  of d o s e - r e s p o n s e .
An a n a ly s is  o f v a r ia n c e  w as  u se d  to  t e s t  fo r  d i f f e r e n c e s  betw een  t r e a tm e n t  
and a p p r o p r ia te  c o n tro l  g ro u p s .
DMPP ( 0 .2 - 2 .0  m g ) g iv e n  i . e . v .  p ro d u c e d  e m e s i s ,  w hich a p p e a re d  w ith in  
15 m in u te s  a f te r  th e  i , c . v .  in je c tio n  and  l a s te d  f ro m  3 to  50 m in u te s .  The 
p e rc e n ta g e  of e m e tic  r e s p o n s e s  in d u ced  by D M PP w as d o se -d e p e n d e n t (r-=0.9 4 ; 
p  0 . 0 5 ) .  H o w e v e r , th e  p e rc e n ta g e  o f c a ts  sh o w in g  e m e s is ,  ev en  w ith  th e  
l a r g e s t  d o s e s  of DMPP ( 1 .0  -  2 .0  m g ) a m o u n te d  to  83 %, but n e v e r  r e a c h e d  
100 %.
Of g an g lio n ic  b lo ck in g  a g e n ts ,  h e x a m é th o n iu m  ( 0 .5  -  2 .0  m g ) w a s  u s e d  to  
p re v e n t th e  e m e s is  p ro d u c e d  by 1 .0  m g of D M PP. The gang lion ic  b lo c k in g  
ag e n t w as  in je c te d  i . e . v .  15-20  m in u te s  b e f o r e  DMPP w as s im i la r ly  a d m in i­
s t e r e d .  H ex a m éth o n iu m  d e p r e s s e d  o r  a b o l is h e d  (p  -iO .O l) th e  p e r c e n ta g e  of 
D M P P -induced  e m e s i s .
The c a te c h o la m in e s ,  d o p am in e  ( 0 .5  -  1 .0  m g ) ,  n o ra d re n a lin e  ( 0 .5  -  1 .0  
m g ) and  a d re n a lin e  ( 0 .5  -  l .O m g ) ,  a s  w e ll a s  GABA (0 .5  -  1 .0  m g ) ,  g ly c i­
ne ( 0 .5  -  1 .0  m g ) ,  5 -h y d ro x y try p ta m in e  ( 0 .5  -  1 .0  m g) and h is ta m in e  ( 0 . 5 -
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1 .0  m g )  w e re  in je c te d  i . c . v .  15 -  20 m in u te s  b e f o r e  th e  em e tic  c h a lle n g e  of
1 .0  m g  DM PP. By th a t  t i m e ,  th e  e m e s is  in d u c e d  by  ca te c h o la m in e s  a n d  h i s t a ­
m in e  s u b s id e d . C a te c h o la m in e s , GABA, g ly c in e ,  5 -h y d ro x y try p ta m in e  an d  h i­
s t a m in e  had v ir tu a lly  no e f f e c ts  on D M P P -induced  e m e s i s .
In  c a ts  w ith  a  le s io n  o f th e  a r e a  p o s t r e m a ,  1 .0  mg of DMPP in je c te d  i . c . v .  
d id  n o t  evoke e m e s i s .
In  c o n tro l e x p e r im e n ts ,  tw o r e p e a te d  i . c . v .  in je c tio n s  of 0 .9  % s a l in e  in  
v o lu m e s  of 0 .2  m l a t  i n t e r v a l s  of 15-20 m in u te s  d id  no t p ro d u ce  an y  v is ib le  
b e h a v io u r a l ,  au to n o m ic  o r  m o to r  p h en o m en a .
T he a r e a  p o s tre m a  of th e  c a t  co n ta in s  c a te c h o la m in e r g ic , 5 -h y d ro x y tr y p ta -  
m in e r g ic  and g a b e rg ic  n e r v o u s  e le m e n ts  (F u x e  an d  O w m an, 1965; A rm s tr o n g  
e t  a l .  , 1981; N ew ton and  M a le y ,  1 9 8 7 ). The p r e s e n t  e x p e r im e n ts  r e v e a le d  
th a t  c a te c h o la m in e s  and  h i s t a m in e ,  bu t n o t 5 -h y d ro x y try p ta m in e , GABA and 
g ly c in e  in d u ce  e m e s is  an d  th a t  n e ith e r  o f th e m  m o d ify  th e  e m e s is  p ro d u c e d  by 
D M P P . S ince  ab la tio n  of th e  a r e a  p o s tr e m a  a b o l is h e d  D M PP-induced e m e s i s ,  i t  
i s  a p p a r e n t  th a t c a te c h o la m in e r g ic , 5 -h y d ro x y try p ta m in e rg ic , h is t a m in e r g ic  
a n d  g a b e r g ic  m e c h a n ism s  d o  n o t m o d u la te  th e  e m e t ic  re s p o n s e s  in d u c e d  
th r o u g h  n ic o tin ic  r e c e p to r s  in  th e  a r e a  p o s t r e m a  of th e  c a t .  The p r e s e n t  e x ­
p e r im e n t s  fu r th e r  s u g g e s t  th a t  GABA, of n e u r o t r a n s m i t t e r s  p r e s e n t  in  th e  
l a r g e s t  am o u n ts  in  th e  a r e a  p o s tre m a (N e w to n  an d  M a ley , 1 9 8 7 ), c a n n o t b e  an  
in h ib i to r y  n e u r o tr a n s m it te r  in  th e  c o n tro l o f e m e s i s  evoked by an  a c t io n  on 
n ic o t in ic  r e c e p to r s  in  th is  a r e a  of th e  b r a in s t e m .
T h is  w o rk  w a s  s u p p o r te d  b y  a  g ra n t  f ro m  th e  S e rb ia n  Republic F u n d , Beo -  
g r a d  , Y u g o slav ia .
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THE EFFECT OF CH-38083 ON THE MOTILITY AND PASSIVE AVOIDANCE BEHAVIOR OF 
MALE SPRAGUE-DAWLEY RATS
0. Bence, K. Kuthy, M. Kurcz, P. Várkonyi and P.S. Körmöczy
CHINOIN Pharmaceutical and Chemical Works Co. L td ., Research Centre,
Budapest, Hungary
(alpha-2 adrenoreceptor antagonist, CH-38083, clonid ine, CNS)
CH-38083 (7,8-Cmethylenedioxy]-14-£ -hydroxyalloberbane-HCl) is  a se lective  
and spec ific  antagonist on alpha-2 adrenoreceptors, V iz i et a l . ,  (1986). 
However, the e ffec t of CH-38083 on the cen tra l nervous system in  mammals 
has only been p a r t ia lly  characterized. In the present work we aimed to 
examine the CNS e ffec t of CH-38083 given on i t s e l f  and also i t s  presumed 
alpha-2 adrenoreceptor antagonistic e ffe c t against the alpha-2 agonist, 
c lon id ine. A four-channel computerized Omnitech's Digiscan Animal A c tiv ity  
Monitor served to measure the m o tility  of male Sprague-Dawly ra ts , weighing 
between 100-260 g. Clonidine was administered subcutaneously 20 min before, 
while CH-38083 was given o ra lly  40 min before the begining of the 
measurements. Data were collected fo r 30 min and from the recorded 20 type 
of movements the mean i  SD of percentage difference in  TOTAL ACTIVITY 
between untreated (con tro l) and treated pa ir of rats was calculated. For 
s ta t is t ic a l evaluations the unpaired _t te s t (2 treatment groups consisting 
of d iffe re n t ind iv idua ls) and analysis of variance (more treatment groups 
consisting of d iffe re n t indiv idua ls) were used. To assess the e ffec ts  on 
learning and memory a six-channel shu ttle  box system was used. Drugs were 
applied a fte r five  days of shuttle  box tra in in g . We observed the passive 
avoidance behavior of ra ts during the tra in in g  and re testing (a fte r  
treatment) periods, and changes in  the acquired performance were 
expressed as mean i  SD percentage d ifference between periods. For 
s ta t is t ic a l evaluation the unpaired jt- te s t,  analysis of variance, and the 
paired t  tes t (before and a fte r a single treatment in the same ind iv idua ls)
were used.
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The re su lts  are summarized in  the fo llow ing tables:
THE EFFECT OF CLONIDINE, CH-38083 AND CLONIDINE + CH-38083 ON THE MOTILITY 
OF RATS
Compound N Dose (mg/kg) \  D ifference in to ta l a c t iv ity
C lonidine 22 0.1 (s .c .)  - 82 i  6. p<0.001*
12 1.0 + 8 t  25.6
CH-38083 10 5.0 ORAL + 12 t  27.9 N. S .**
19 10.0 + 31 t  42.4
Clonidine 0.1 (s .c .)
+ 5 1.0 -  80 i  7.3
CH-38083 5 5.0 ORAL - 79 i  3.5 p<0.05**
7 10.0 *(p<0.001) -  22 i  27.3
Values are meäh t  SD percentage difference in  m o tility  between contro l and 
trea ted  group of ra ts ; *unpaired t_ te s t; **  one-way ANOVA.
THE EFFECT Of CLONIDINE, CH-38083 AND CLONIDINE + CH-38083 ON THE PASSIVE
AVOIDANCE BEHAVIOR OF RATS
Compound N Dose (mg/kg) % Difference in to ta l a c t iv ity
Clonidine 15 0.1 (s .c) -  94 t  5.20 p<0.001***
11 1.0 - 0.5 i  6.40
CH-38083 6 5.0 ORAL - 3.1 ;  1.90 N.S**
21 10.0 - 4.7 + 5.6
Clonidine 0.1 (s .c .)
CH-38083 6 5.0 - 93 + 6.60
14 10.0 *p<0.001 - 33 i  30.0 p<0.05**
Values are mean i  SD percentage difference in  the acquired performance 
before and a fter drug treatment; * = unpaired t_ te s t; **one way ANOVA; * * *  
= paired t_ tes t.
Thus, 0.1 mg/kg clonid ine (s .c .)  was h igh ly e ffec tive  in decreasing the 
m o t i l i ty  of rats ( -  82 i  %). CH-38083 alone, has dose-dependent, moderate 
a c t iv i ty  increasing e ffe c t. 1 mg/kg dose of CH-38083 did not influence the 
e ffe c t of clonidine. In 5 mg/kg concentration i t  had a moderate and in  10 
mg/kg dose i t  showed submaximal antagonistic e ffe c t. CH-38083 alone was 
w ithout e ffec t on the passive avoidance behavior of ra ts , while clon id ine 
s ig n if ic a n t ly  impaired th e ir  performance. In case of coadministration of a 
10 mg/kg dose of CH-38083 greatly improved the clonidine-debased behavior. 
IN SUMMARY, CH-38083 given o ra lly , a ffec ts  CNS function of rats and th is  
e ffe c t has a special alpha-2 antagonistic component.
E.S. V iz i, L.G. Hársing Or., 0. Gaál, T. Kapocsi, S. Bernáth, G.T. Somogyi 
0. Pharmacol. Exp. Ther 238. 701-706 (1986)
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EXCITATORY AMINO ACIDS AND CARDIOVASCULAR APPARATUS: EXPERIMENTAL STUDIES 
ON CONSCIOUS RATS WITH L-GLUTAMATE, N-METHYL-D-ASPARTATE, KAINATE AND 
QUISQUALATE
L. Berrino, M.G. Matera, S. Maione, S. Vitagliano, A. Loffreda, E. Marmo
Institute of Pharmacology and Toxicology (Head: Prof. E. Marmo) - 1st 
Faculty of Medicine and Surgery - University of Naples - Italy
Key words: EAA, arterial blood pressure, AVP, catecholamines, rat
It is currently known that L-glutamate can act as an excitatory synaptic 
transmitter in the CNS. Moreover, there is little information about the 
involvement of excitatory amino acids (EAA) in the manteinance of the 
cardiovascular tone (Marmo, 1988). We evaluated the effects of icy (3rd and 
right lateral ventricles, posterior hypothalamus and striatum) EAA (L- 
glutamate, N-methyl-D-aspartate, kainate and quisqualate) on arterial blood 
pressure, on heart rate, on catecholamines and arginine vasopressin plasma 
levels, and on the behaviour of conscious normotensive rats.
All these drugs significantly increased arterial blood pressure, heart rate 
and catecholamines and arginine vasopressin plasma levels. Regarding 
behaviour, all animals presented psychomotor agitation, stereotiped 
movements and hyper-excitability.
A systemic (intravenously or subcutaneously! pretreatment with reserpine, 
propranolol, prazosin, phentolamine, clonidine, hexaméthonium, diltiazem, 
and CGP 25838 (a selective antagonist of receptor of arginine
vasopressin) reduced cardiovascular, behavioural and biochemical responses 
of icv EAA. In addition, the bisurrenectomy and the spinal transectomy (at
32
C7) considerably reduced responses caused by EAA.
On the contrary, naloxone, atropine and bivagotomy significantly enhanced 
EAA-induced responses.
Icy (3rd and right lateral ventricles, posterior hypothalamus and striatum) 
pretreatment with 2-APV, a selective antagonist for NMDA receptors, induced 
the strongest inhibition of the EAA effects.
These data show that the glutamergic transmission partecipates, through a 
central mechanism mainly mediated by specific receptors (e.g. NMDA, KA 
subtypes) in the regulation of cardiovascular function in conscious rats. 
In addition, this research point out an increase in the central sympathetic 
efferent activity and in arginine vasopressin release and an involvement of 
parasympathetic and opiod systems.
This research was supported by MPI and CNR, Rome (Italy).
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ALCOHOL WITHDRAWAL ANO PROLACTIN
A tt i la  Bezzegh, Judit Skrapits, László Nyuli x and Gábor L. Kovács,
Central Laboratory and Alcohology Unit x of the Dept, of Psychiatry, 
Markusovszky Teaching Hospital, 9700 Szombathely, Hungary
Keywords: etanol withdarawl, p ro lactin
I t  is  known that p ro lac tin  (PRL) plays important ro le (s ) in various func­
tions of central nervous system, e.g. the hormone resu lts  in a lte ra tions 
in  the paternal and maternal behavior; m igration; feeding behavior; learning 
and memory; sexual behavior, etc. The role of PRL in  drug-induced behavioral 
responses has also been suggested (Drago, 1982). There is  a large body of 
evidence ind ica ting  that a lte ra tions of PRL secretion are common in  chronic 
a lcoholic patients, (Noth and Walters, 1984) but i t  has not been analyzed 
system atically, whether altered PRL secretion might have a role in c l in ic a l 
symptoms of ethanol withdrawal or in  endocrine and clinico-chemical d is ­
turbances observed during withdrawal period. In the present investigations 
90 male chronic a lcoholics attending the Alcohology Unit of the Markusovszky 
Teaching Hospital, were investigated concerning changes in clinico-chem ical 
and endocrinological parameters during a 40 days period of alcohol w ith ­
drawal. The serum levels of PRL, LH, testosteron (TEST), ACTH and c o r t is o l 
(C0RT) were determined by radioimmunoassay. The resu lts  were analyzed with 
SAS Manova te s t (SAS In s titu te s  Inc ., USA). One group of group of a lcoho lic  
patients exhibited normal- or s lig h tly  low PRL leve ls  at the f i r s t  day of 
withdrawal. Patients in  the second group exhib ited hyperprolactinemia. 
Hypogonadism in  chronic alcoholics is  induced e ith e r by a d irec t peripheral 
e ffec t of alcohol (Legros et a l . ,  1980), or in  a secondary manner, by hyper­
prolactinemia (Thorner e t a l . ,  1980). There were no PRL-related differences 
in  the a c t iv ity  of p itu ita ry-adrena l axis, or p itu itary-gonadal axis. There 
was, on the other hand, a very marked PRL-related difference in  the incidene
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o f de lirium  tremens (7% in  normoprolacinemic patients and 39% in  hyperpro­
lactinem ic patients (p 0 .05 )). I t  is  concluded that PRL might have an im­
portan t role in  ethanol withdrawal, but changes in  the a c tiv ity  of p itu ­
ita ry -ad rena l and p itu itary-gonadal axis seem to be independent o f altered 
PRL secretion pattern.
day a ** day 2 # day 10 fi day 40 #
PRL
N 144.6+12.0 о 217.5+22.4*0 240.6+23.4xо 252.1+51.5x
H 583.6+43.1 495.1+98.8x 375.0+61.4x 314.1+58.9x
LH
N 16.0+ 4.0 12.4+ 2.0 11.8+ 1.2 9.8+ 0.7
H 19.9+ 4.7 16.7+ 2.1 16.5+ 2.2 11.1+ 1.2
TEST
N 17.5+ 2.9 14.1+1.5 16.0+2.2 22.8+ 3.0
H 14.1+ 3.2 14.8+1.8 18.3+ 2.5 26.1+4.0
ACTH
N 25.3+10.9 no data 26.1+ 7.2 no data
H 30.6+16.2 no data 45.8+31.8 no data
CORT
N 784.1+59.8 630.0+55.0 602.9+33.6 554.1+69.3x
H 673.7+74.2 639.2+77.7 532.2+44.1 557.6+60.1
Table 1. The serum hormone leve ls in  chronic male alcoholics during the 
withdrawal period. N ind icates the normoprolactinemic groups and H indicates 
the hyperprolactinemic group. »: mean _+ S.E.; x: s ig n ifica n tly  d if fe re n t 
form the f i r s t  day; ■ ; s ig n if ic a n tly  d if fe re n t from the hyperprolactinemic 
group on the same day.
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T ilt EFFEOTS OF RECEPTOR BLOCKERS ON ATRIAL NATRIURETIC 
PEPTIDE-INDUCED ACTION ON PASSIVE AVOIDANCE LEARNING IN 
RATS
A. Bid z s e ra n o v a . ,  G. Te legdy
Departm ent o f P a th o p h ys io lo g y  A lb e r t  S zen t-G yörgy i  M e d ica l 
U n iv e r s i t y ,  Szeged, Hungary
Key w ords : A t r ia l  n a t r iu r e t ic  f a c to r ,  re c e p to r b lo c k e rs  
In t ro d u c t io n
In  our p re v io u s  experim en ts  we have dem onstrated th a t  
r a t  a t r i a l  n a t r iu r e t i c  p e p tid e  (ANP) is  ab le  to  le n g th e n  
the  pass ive  avo idance response in  a dose-dependent manner. 
T h is  in d ic a te s  th a t  ANP is  ab le  to  f a c i l i t a t e  le a rn in g  in  
t h is  paradigm .
In  the p re se n t expe rim en ts  we t r i e d  to  re p ly  the  q u e s t i ­
on th a t  whether n e u ro tra n s m it te rs  a re  in v o lv e d  in  the  beha­
v io u r a l  a c tio n s  o f ANP. In  the p re s e n t re p o r t an accoun t 
is  g iven  on the  e f fe c ts  o f d i f f e r e n t  re c e p to r b lo c k e rs  on 
ANP-induced a c t io n  o f o n e - t r ia l  le a rn in g  o f the  p a ss ive  
avo idance b e h a v io u r.
Methods
The pass ive  avo idance beh a v io u r was perform ed by the 
method o f Ader e t a l .  (1 9 7 2 ). The a c t io n  o f the  p e p tid e  
and the in te r a c t io n s  w ith  the re c e p to r  b lo c k e r were s t u d i ­
ed on c o n s o lid a t io n  o f the  memory when the p e p tid e  was g i ­
ven im m e d ia te lly  a f t e r  the  le a rn in g  t r i a l .  The re c e p to r  
b lo c k e rs  were g ive n  20-30 min b e fo re  the p e p tid e  a d m in is ­
t r a t io n .  The dose o f the  p e p tid e  was s e le c te d  a c c o rd in g  to  
our e a r l ie r  e xp e rie n ce  in  th is  pa rad igm , in  which the  pep­
t id e  per se would no t in te r fe r e  w ith  the b e h a v io u r. The
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dose o f the ANF was 200 ng and i t  was g iv e n  ic v .  fo l lo w in g  
th e  le a rn in g  t r i a l .  The an im als were te s te d  24 hr la t e r .  
R e s u lts  and D iscu ss io n
The re s u lts  are p re se n te d  on Table 1.
T a b le  1. The e f fe c ts  o f  re c e p to r b lo c k e rs  on ANP-induced 
a c tio n  o f c o n s o lid a t io n  o f the  p a s s iv e  avoidance 
le a rn in g .
T re a tm e n t P a ss ive  avoidance response S ig n if ic a n c e  
( sec) versus ANP
U n tre a te d 100 + 20 -
ANP (200 ng ic v . ) 200 + 20 -
AN P+H aloperido l 
(10 u g /kg  i . p )
90 + 15 p 0,05
ANP+Phenoxybenzamide 
(2 mg/kg i . p . )
189 + 34 NS
AN P+Propranolo l 
(10 mg/kg i . p . )
156 + 31 NS
ANP+Methysergide 
(5 mg/kg i . p . )
171,» 26 NS
A N P + B icu cu llin e  
( 2 mg/kg s c . )
229,2+ 35 NS
ANP+Naloxone 
(0 .3  mg/kg s c .)
195 + 38 NS
ANP+Atropine 
(2  mg/kg i . p . )
85 .,9 + 21 p 0,05
The re c e p to r  b lo c k e rs  a lone  had no in f lu e n c e  on the con­
s o l id a t io n  in  the doses used. The m in im a l number o f a n i­
m als used in  a group was lo .
The da ta  presented here  suggest th a t  in  the  a c t io n  o f ANP 
on f a c i l i t a t i n g  the  c o n s o lid a t io n  o f the  p a ss ive  avoidance 
le a r n in g ,  dopam ine rg ic  and c h o lin e rg ic  m e d ia tio n s  are in ­
v o lv e d . B lo ck in g  the  re c e p to rs ,  the  ANP a c t io n  w i l l  be d i ­
m in is h e d . O ther re c e p to rs  such as a lp h a - ,  o r b e ta -re c e p ­
t o r s ,  GABA re c e p to rs , endogenous o p ia te s ,  o r s e ro to n e rg ic  
re c e p to rs  are not in v o lv e d  in  th is  m e d ia tio n .
R e fe rence
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INHIBITORY AND STIMULANT EFFECTS OF BACLOFEN ON GASTRIC ACID SECRETION
C. B landizzi, M.C. Bernardini and M. Del Tacca - In s titu te  of Medical 
Pharmacology, University of Pisa, Via Roma 55, 1-56100 Pisa, I ta ly
Key words: Baclofen, phaclofen, GABA-B receptors, gastric acid secretion
Introduction - The parenteral adm inistration o f the GABA-B receptor agonist
baclofen in anaesthetized rats increased gas tric  acid secretion (a .s .)  with
a p a ra lle l increase in a tropine-sensitive vagal efferent a c t iv i ty ,
suggesting that baclofen activates parasympathetic outflow to the stomach
ce n tra lly  (Goto et a l . ,  1985). However the putative central GABA receptors
which might mediate tne effects of baclofen on a.s. remain to  be
characterized. The present study investigates the nature of central GABA
receptors involved in the secretory e ffects o f baclofen.
Materials and methods - Experiments were carried out in conscious
pylorus-ligated ra ts (200-220 g, 24 h fa s tin g ) . In a group of animals a
cnronic cannula was implanted into the la te ra l ven tric le  of the brain.
Results - Baclofen 1-9 pg/rat i.c .v .  induced a phaclofen-sensitive
in h ib it io n  of a .s .. S im ilar results were obtained with 1 mg/kg i . v . ,
wnereas baclofen 9 and 27 mg/kg i.v .  induced a non phaclofen-sensitive
increase in a .s .. Muscimol was without e ffe c t (F ig. 1)
Discussion - The present in h ib ito ry effects of i .c .v .  or i ■V. baclofen on
hypersecretion evoked by pylorus lig a tio n  indicate the involvement of
GABA-B receptors,, On the basis of these re su lts , the decrease in a . s.
fo llow ing i.c .v . GABA in conscious rats (Bnargava et a l . ;, 1985) may be
explained by central GABA-B receptor a c tiva tio n . Since acid hypersecretion 
by pylorus lig a tio n  is mediated by central cho linerg ic  pathways (Sharma et
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a l . ,  1963), the present antisecretory e ffec ts  o f baclofen may be mediated 
by cen tra l phaclofen-sensitive GABA-B receptors in h ib itin g  vagal a c t iv ity .  
Furthermore, i .v .  baclofen at high doses increased a .s ., as observed by 
Goto et a l.  (1985) in anaesthetized ra ts . However, although baclofen may 
behave as a p a rtia l GABA-A agonist (Del Tacca et a l. ,  1989), the lack of 
secretory effects of the GABA-A agonist muscimol suggests that neither 
cen tra l GABA-A nor GABA-B receptors pa rtic ip a te  in the present stim ulant 
e ffe c t o f i .v .  baclofen.
Figure 1 - Effects of baclofen (BA), muscimol (MU), and phaclofen (PF) on 
g a s tr ic  acid output (p£qH /4h). Values represent the mean o f 8
experim ents^.E. Student's t - te s t  fo r unpaired data, *p<0.05.
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THE EFFECT OF CIMETIDINE ON THE RAT SCIATIC NERVE - GASTROCNEMIUS MUSCLE
PREPARATION IN  V I V O
R. BOSSA, G. EFSTATHIU, I .  GALATULAS, M.A. NINCI
Dipartimento d i Farmacologia de ll'U n ive rs ita , v ia  V a n v ite lli 32, 20129 
Milano, I ta l ia .
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In vivo.
We have reported that cimetidine and ra n itid in e  produced neuromuscular 
blockade in  the isolated phrenic nerve - diaphragm preparation of the ra t 
and increased the neuromuscular blockade induced by non depolarizing re la ­
xants and aminoglycoside a n tib io tic s . Neuromuscular blockade produced by 
the two H2 antagonists was reversed by CaC^ and 4-aminopyridine and not by 
neostigmine or d im parit; on d ire c tly  stimulated preparations the two drugs 
did not produce any block. (Bossa et a l. 1981, 1982, 1988).
These resu lts  are obtained in  v i t r o  at high concentrations, fa r above 
plasmatic levels required fo r antisecretory a c t iv i ty .  For th is  reason we 
investigated the e ffec ts  of cimetidine on neuromuscular transmission in  
vivo. Male ra ts  of 250-350 g were anesthetized w ith urethane (1.5 g/kg i . p . )  
and kept under a r t i f ic ia l  resp ira tion ; in d ire c tly  e lic ite d  muscle contrac­
tions were obtained by using the sc ia tic  nerve -  gastrocnemius muscle pre­
paration; the parameters of stim ulation of the nerve were: frequency 0.2 Hz, 
duration 1 msec, at supramaximal voltage. As the te tan ic stim ulation, a 
frequency of 50 Hz was applied for 20 sec. Drugs were administrated in  the 
jugular vein.
Single intravenous in jec tion  of cimetidine (20 mg/kg) did not a lte r 
tw itch tension; single intravenous in je c tio n  of d-tubocurarine (45 AJg/kg) 
produced a reduction of tw itch tension that was potentiated by successive 
treatment with cimetidine (Table I ) .  We obtained s im ila r results when we 
substituted d-tubocurarine with pancuronium (150 /jg /kg ), sisomicin
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(20 mg/kg) and n e tilm ic in  (20 mg/kg).
Tetanic contraction and post-tetanic po ten tia tion  were reduced a fte r  
cim etid ine administration (60 mg/kg). Continuous infusion of cim etidine 
(30 mg/kg/min) provoked a reduction of tw itch  tension (50% of basal value 
a fte r  12 min): there is  a complete recovery a fte r  treatment with 4-amino- 
p ir id in e  (2 mg/kg i . v . )  (Lund, H., 1978).
Our i n  v i t r o  and i n  v i v o  resu lts  suggest that neuromuscular e f­
fe c ts  o f cimetidine are not related to i t s  sp e c ific  a c tiv ity  on histamine 
H2 receptors, but to an in h ib it io n  of transm itte r release at the nerve 
ending through a reduction of calcium in f lu x  at presynaptic le ve l.
The importance of th is  action is  the p o s s ib il ity  of respiratory depres­
sion or prolonged apnoea induced by in te rac tion  with curare or other muscle 
re laxants (Argov Z. et a l . ,  1979).
Table I :  Effect of d-tubocurarine and cim etid ine on the neuromuscular 
transmission (s c ia tic  nerve - gastrocnemius preparation of ra t)
CONTROLS d-TUBOCURARINE CIMETIDINE X
DOSE 45 jjg/kg 20 mg/kg
TWITCH TENSION 100
(56.3+18.7 g)
61.45+23.70 18.11+14.56xx
X = Cimetidine was administrated 60 sec a fte r treatment w ith  d- 
tubocurarine;
xx= p<0.01 versus d-tubocurarine value
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CHARACTERIZATION OF THE ALPHA-2-ADRENOCEPTOR LABELLING SPECIFICITY OF 
C3HXH-38083
K. Botos, J. Gaál and E. Fejér
CHINOIN Pharmaceutical and Chemical Works Co. L td ., Budapest, Hungary 
(alpha-2-adrenergic receptors, C3HXH-38083, ra t brain)
We previously reported the alpha-2-adrenoreceptor s e le c tiv ity  and 
s p e c if ic ity  of CH-38083, a berbane deriva tive  (7 ,8-methylene-dioxy-14 ot- - 
hydroxy alloberbane-HCl) in binding studies, carried  out in ra t brain crude 
membrane preparations, using E3HXrazosin and C3HIlIdazoxan as reference 
substances. The s e le c tiv ity  ra tio  of CH-38083 (K,j alpna^/K^ alpha2 ) was 
found to be 1368, V iz i et a l . ,  (1986).
The t r i t ia te d  deriva tive  of CH-38083 was synthetized by c a ta ly tic  
isotope change reaction using tr it iu m  gas (spec ific  a c t iv ity :  67.6 
Ci/mmol). The characteris tics of C3HXH-38083 were determined in 
association, d issociation and saturation studies, including pH,
temperature, incubation time, prote in, mono- and divalent cation contents 
optim ization, Gaál et a l . ,  (1988).
In the present displacement studies we aimed to establish the degree of 
s p e c if ic ity  of C3HXH-38083 as la b e llin g  ligand for alpha-2-adrenergic 
receptors. The binding of C3HXH-38083 was established in the mixture of 
500 pi crude ra t brain membrane preparation (0.7-0.9 mg/ml p ro te in ), 100 pi 
buffer and drugs, respectively and 400 pi buffe r (50 mM Tris/HCl, pH 7.4, 
25 °C) in a to ta l volume of 1.0 ml.
The concentration of C3HXH-38083 was 2 nM fo r competition assays. The 
tubes were incubated at 25 °C for 45 min and incubation was terminated by 
rapid f i l t r a t io n  under vacuum through GF/C glass fib re  f i l t e r s .  The 
ra d io a c tiv ity  was measured by liq u id  s c in t i l la t io n  spectrometry. The 
spec ific  binding was 60 \  of the to ta l a c t iv ity  determined by the
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app lica tion  of 10 |JM unlabelled CH-38083. The experiments were evaluated by 
a поп- lin e a r curve f i t t in g  program, Batke and Gaál (1986).
The results are summarized in  the fo llow ing table:
Compound Kd (nM) Compound Kd (nM)
alpha-adrenergic cho linerg ic
CH-38083 2,7 Atropine > 10000
Idazoxan 8,5 Carbamylcholine 3900
Yohimbine 30 QNB > 10000
Clonidine 59 serotoninergic
Phentolamine 30 Methysergide 1800
Prazosin 280 Spiperone > 10000
beta-adrenergic a n ti depressants
Isoprénaline 3000 Imipramine 1200
Propranolol 2800 Desipramine 3000
Dihydroalprenolol > 10000 MAG in h ib ito rs
Terbutaline > 10000 (-)-Deprenyl 1800
histam inergic
Histamine 3800
Pargyline > 10000
Cimetidine 2400
Thus, only the alpha-adrenergic substances showed s ign ifican t a c t iv ity  
on the C^HlCH-38083 labe lled  alpha-2-adrenoceptors. The order of th e ir 
re la t iv e  potencies is :  CH-38083 > Idazoxan > Yohimbine = Phentolamine >
Clonidine »  Prazosin » >  compounds with d iffe re n t receptor s p e c if it ie s . 
W ithin the group of compounds acting on alpha-adrenergic receptors 
CH-38083, Idazoxan and Yohimbine can be regarded as spec ific , i .e .  the 
receptors labelled by C^HUCH-38083 were the alpha-2 type.
J. Batke, J. Gaál
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CALCIUM-ANTAGONIST EFFECT ON PURINE RELEASE FROH DISSOCIATED PRIMARY G LIA L 
CULTURES OF RAT STRIATUM.
F. Caciagll, R. Ciccarelli, P. Di Iorlo, P. Ballenm, M. Dl Muzio. Inst, of 
Neuroscience, Chair of Pharmacolgy, University of Chietl, Via del Vestinl 
31, 66013 Chieti, Italy.
Key words: purine release, glial cultures, Ca2+-channels.
An increasing number of experimental evidences seems to give glial cells new 
functional roles in the central nervous system. As a matter of fact, besides 
exerting a trophic activity, astrocytes would be excitable and able to 
modulate the neuronal transmission through specific mechanisms of uptake and 
release. Our previous studies pointed out that dissociated primary cultures 
of glial cells are able to release labelled purines (3H-P), traced by 3H- 
adenosine used for the incubation, at rest. The 3H-P outflow nsed, under 
electrical stimulation, in a frequency-dependent and Na+-independent manner 
(Caciagll, 1966). The presence of voltage-sensitive Ca2+ channels (VSCC) in 
cultured glial cells have been shown by electrophysiological studies (Mac 
Vicar, 1964). This finding has been successively confirmed by the 
individuation of high affinity binding sites for nitrendipine, a potent and 
specific L type of VSCC antagonist, on glial cell membrane (Litzinger, 
1966). Thus, it is possible to infer that astrocytes represent a potential 
target for Ca2+ channel blockers.
The aim of the present study was to evaluate the eventual Ca2+-dependence of 
both basal and electrically evoked 3H-P release from d is s o c ia te d  p r im a r y  
cultures of rat striatum glial cells, focusing on the role played b y  VSCC in 
such a mechanism. Ю -90пМ  Nitrendipine, chosen as r e p r e s e n t a t iv e  d r u g  o f  
dihydropyndlnes, and lOOnM w-conotoxin (w-cgTx), a t o x in  a b le  to  b lo c k  b o th  
N and L types of VSCC, alone or in combination, w e re  a d d e d  to  th e
superfusion medium 60 m m  before the electrical stimulation.
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30-i20pM Verapamil was used too, even if, besides blocking VSCC, it is known 
to affect other cellular mechanisms (Hiller and Freedman, 1964). All the 
assayed Ca2+-antagonlsts significantly reduced, in a dose-dependent manner, 
the evoked 3H-P release; while the basal outflow was incresed, even if this 
latter effect was variable and not dose-dependent. Consequently, the ratio 
between evoked and basal 3H-P fractional release (rFR=Sl/Spl) resulted 
significantly reduced. The rank order was the following: w-CgTx > 
nitrendipine > verapamil. When lOOnM w-CgTx was added to the cultures 
already submitted to 90nM nitrendipine treatment, no further significant 
effect on 3H-P release, compared to that of nitrendipine or w-CgTx alone, 
was observed.
These findings, though preliminary, suggest that at glial level the L type 
of VSCC play a relevant role in the regulation of P release, whereas the N 
channels seem not to be involved in such a mechanism.
Since astrocytes have been found to be provided with Ca2+-activated K+ 
channels and K+ currents represent important events for the physiological 
glial activity, the effect of lOmM tetraethylammonium (TEA), a Ca2+- 
activated K+ channel blocker, was assayed. The drug, added to the culture 
superfusion medium 60 min before the stimulation, induced a significant 
reduction of fractional 3H-P release, increasing the basal outflow and 
decreasing the evoked one. The simultaneous culture treatment with TEA and 
nitrendipine confirmed that, at glial level, K+ and Ca2+-channels are 
functionally connected and suggested that they together participate in 
controlling 3H-P release.
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ß- CYCLODEXTRIN COMPLEXATION IMPROVES ABSORPTION AND GASTRIC TOLERABILITY 
OF PIROXICAM
S. CADEL, S. BONGRANI
Pharmacological and Toxicological Research Laboratories,
Chiesi Farmaceutici S .p .A . ,  Parma, I t a ly  
KEY WORDS: pi roxicam-ß-cyclodextrin; gastric t o le r a b i l i t y  
ß-cyclodextrin is an o ligosaccaride with a ring structure of 7 glucose mo­
nomers, which can form inclusion complexes with molecules that are pharma­
cologically  active. These complexes offer considerable improvements in wa­
ter s o lu b i l i ty ,  rate of absorption a fter oral administration and a reduc­
tion in possible i r r i t a n t  e ffects  on the mucosa of the gastro in testina l  
tract (Nambu et a l . ,  1988).
Piroxicam, a modern and p a r t ic u la r ly  effective  non-steroidal a n t i - in f la m ­
matory and analgesic drug (NSAID), is characterized by a long elimination  
h a l f - l i f e  (38-45 hours) but slow and gradual absorption: peak plasma le ­
vels are achieved 3 to 4 hours a f te r  oral administration.
In order to obtain a more rapid onset of peak plasma concentration and a 
better t o le r a b i l i t y ,  piroxicam has been complexed with ß-cyclodextrin in 
the molar ra t io  of 1 :2 .5 .  The product obtained (pi roxicam-ß-cyclodextrin;  
P-ß-CD) proved to have tne same pattern of anti-inflammatory and analgesic 
a c t iv i ty ,  but a faster appearance of e ffects . In rats the inh ib it ion  of 
paw oedema was infact 60 min. a f te r  administration considerably greater 
for P-ß-CD in respect to p la in  piroxicam (P-ß-CD 58% inh ib .;  piroxicam 39% 
in h ib i t . :  P<0.05; dose 3 mg.kg p.o. of active p r in c ip le ) .  No s ta t is t i c a l  
difference was observed in the overall anti-inflammatory a c t iv i ty  (reduc­
tion of AUC "oedema against time": P-ß-CD: 50%; piroxicam 46%).
In mice the almost maximal analgesic a c t iv i ty  was reached a fte r  5 min. 
from treatment. A quan tita t ive  assessment of gastro ir r ifancy  of P-ß-CD in 
comparison to piroxicam (4 .5  mg/kg p.o. as active pr incip le) was performed 
in Crl:CD (SD) male rats using two experimental models, namely: 
a) gastro intestinal bleeding by means of measure of erne in faeces spectro- 
photometrically a fte r  conversion to pyridine-hemochromogen (Ghanayum et
46
Ahmld, 1982). Fasted male Crl:CD (SD) rats (g. 150-175) were treated  by 
o ra l  route and faeces were collected over the successive 24 hours, 
b) Morphological assessment of hemorrhagic lesions in the gastric mucosa 
by evaluation of areas of extravasation of Monastral blue, a suspended 
blue tracer that normally crosses injured blood vessels only.
Fasted male Cri: CD (SD) rats (g. 200-250) were used. 5 hrs a f te r  t r e a t ­
ment the stomach was removed, opened along the greater curvature, pinned 
f l a t  on cork board and f ixed  in 10% buffered formaldehyde for 24 hrs and 
examined with reflected l ig h t  using a stereomicroscope (Szabo et a l . ,1985) 
Results obtained in both tests  (Table I )  show that P-ß-CD has a s i g n i f i ­
cant better gastric t o l e r a b i l i t y  in respect to plain piroxicam.
Table I :  Gastric t o le r a b i l i t y  of P-ß-CD in comparison to plain piroxicam 
in the ra t .  Mean value + S.E.
Treatment | Doses* mg/kg | Fecal blood loss jTotal area of extravasation
/ j l / 2 4  hrs
Veh i c le - 3.0 + 0.7 0 + 0
P-ß-CD 4.5 18.2 + 5.4 0.37 + 0.15
Pi roxi cam 4.5 53.2 + 15.6 1.77 + 0.70
*  dose was given as ac tive  princ ip le ; statistical difference between P-ß 
-CD and piroxicam was in both tests P < 0 .0 5  (Mann-Whitney "U" t e s t ) .
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AMILORIDE-OUABAIN INTERACTION IN CARDIAC CONTRACTION: THE ROLE 
OF Na+/Ca2+ EXCHANGE.
Gabriella Cargnelli, Patrizia Debetto, Sergio Bova and Sisto 
Luciani.Department of Pharmacology, University of Padova, L.go E. 
Meneghetti, 2, 35131 Padova, Italy.
+ 2+Key words: Na /Ca exchange, ouabain, amiloride, heart.
Most authors agree that the positive inotropic effect of
ouabain is the result of an increase of intracellular Na+ due
to inhibition of Na+/K+ATPase (Repke, 1964). The reduction of
Na+ gradient through the sarcolemmal membrane, caused by the
increase of ^Na 3 ^ » may induce a decrease of Ca exit or an
increase of Ca2+ entrance via Na+/Ca2+ exchange. These two
events may be not mutually exclusive, since in each cardiac 
+ 2+cycle the Na /Ca exchange system operates in either direct-
2 +ion across the sarcolemma, promoting Ca influx upon depola- 
2 +rization and Ca efflux upon repolarization (Sheu and Blau-
stein, 1986). The positive inotropic effect of amiloride,
+ 2 +known inhibitor of Na /Ca exchange, has been ascribed to a 
reduction of Ca2+ efflux through Na+/Ca“+ exchange (Floreani 
and Luciani, 1984). Therefore, ouabain and amiloride eventu­
ally share a common mechanism to induce positive inotropic
2+effect, i.e. an increase of intracellular Ca through a mo­
dification of Na+/Ca + exchange activity.
Since it has been reported that amiloride increases the 
inotropic effect and counteracts the toxic responses of cardi­
ac muscle to digitalis glycosides (Seller et al., 1975; Flo­
reani and Luciani, 1984), the pattern of amiloride action on 
the ouabain-induced positive inotropic effect has been stu­
died in isolated guinea-pig left atria to clarify the featu­
res of ouabain-amiloride interaction.
The addition of 0.5 mM amiloride to left atria previously 
exposed to 0.5 juM ouabain either increased, reversed or 
unaffected the fully developed positive inotropic effect of
the cardiac glycoside, depending on the experimental condi-
2 +tions. When atria driven at 1 Hz were bathed in 1.8 mM Ca , 
addition of amiloride induced a further increase of the for­
ce of contraction, whereas amiloride was uneffective at
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0.4 5 mM external Са^+. However, the positive inotropic effect
of ouabain in atria driven at 0.1 Hz was reversed by amiloride
2+ 2 + at 1.8 mM Ca , while was enhanced at 3.6 mM Ca
+ 2 +These results suggest that the relevance of Na /Ca 
exchange in promoting Ca2+ entry and efflux is different under
different experimental conditions (Cargnelli et al., 1989).
+ 2+Therefore, the action of drugs affecting Na /Ca exchange 
activity may have different consequences on cardiac contracti­
lity.
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RUFLOXACIN, A NEW FLUOROQUINOLONE IN BIOLOGICAL FLUI DS BY 
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
G. Carlucci1 , D. Fanini2 , G. C. Pantaleoni^, G. Palumbo2
1 Di parLi mentő di Chi mica, Ingegneria Chi mi ca e Materi ali
2 Dipartimento di Medicina Interna, Cattedra di Farmacologia 
Uni versi t a ’ del 1 ’ Aqui 1 a , ITALIA.
Key words: rufloxacin, biological fluids, HPLC.
Ruf'l oxaci n CI Э , 9—f 1 uoro-10-C N-methyl pi per azi nyl ~J -7-oxo-2,3
di hydro—7H—pyr i do C1,2,3—deD C1,40 benzothiazi ne-6—carboxyli c
acid is a new pyridone carboxylic acid derivative.
COOH
:■)
The last quinolone generation includes norfloxacin, 
pei'loxacin, ciprofloxacin, di fl oxaci n, fleroxacin,
temafloxacin and many others in phase I and phase II clinical 
trials. The 4-pyr i done-3-car boxylated moiety linked with an 
additional aromatic or heteroaromatic ring in position 5 and 6 
represents the fundamental structure for the hypothesized 
quinolone mechanism of action CCrumplin et al. , 
1980J.Experimental studies performed on animals demonstrated 
that the distribution of the drug in both tissues and organic 
fluids is rapid, and the reached concentration are higher than 
cor г espondi ng serum levels CSegre ©t al . , 1980}. In the rat,
the urinary recovery determined by microbiological assay was
higher than that of the unmodified drug, thus indicating the
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presence of an active indeterminate metabolite CCecchetti et 
al. » 19840. In the present communication, we describe an
extraction and quantitation procedure for measuring ruf'loxacin 
concentrations in human serum, and urine after oral 
administration of the drug. We used a Waters liquid 
chromatograph equipped with a model M6000A pump, a U6K 
injector, a model 740 Data module integrator and a 
Luminescence—LS—30 Perкin-Elmer detector . The chromatographic 
separation was achieved in a cyano column 6pm C£6cm x 4.6mm, 
I . D. Э connected by a Pern disposable Pel li guard column L C —CN 
C 40/jmD . The mobile phase used was a mixture of 
acetonitrile-phosphate buffer CpH=7.0I>. The excitation 
wavelength was set at 338nrn and the emission wavelength at 
526nm. The calibration curve for the determination of 
rufloxacin in human serum was linear over the range
О. 1 — 5. Opg/rn.l and the corresponding equation was
Y=0. 70Q6X+0. 034 Сг=Ю.9983; for urine the l inear range
O. 05-20pg/ml was described by the equation Y=0. 80X+0. Ol 46 
C r —O.9993 where Y is the peak area ratio of drug to internal 
standard and X is the rufloxacin concentration Cpg/mlO in 
serum and urine. The intra-assay CV С п ^ Ю  was 6.6% and 6.3% 
for- serum concentr ation of 0.1 and 6pg%ml and 4.6% and 1.6% 
for urine concent r at i o n , of O. 0 6 —20pg/nil respectively. The 
extraction recovery of rufloxacin from human serum was 93%
while for urine the recovery was 96,7%.
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QUANTITATION OF THE ENANTIOMERS OF FURPROFEN IN BIOLOGICAL 
FLUIDS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
G. CARLUCCI1 , D. FANINI2 , G. PALUMBO2
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2 Dl PARTIMENTŐ DI MEDICINA INTERNA - UNI VERSI T A ’ DELL’AQU1 LA 
ITALIA.
Key words: furprofen, HPLC.
Furprofen, 2- [4-phenyl -C2’ -f uroyl5] propionic acid C l ' j ,  is an 
analgesic, antipyretic and antiinflammatory drug.
Aryl propionic acids are an important class of non steroidal 
anti-inflammatory agents displaying stereoselective activity 
inhibiting of prostaglandin synthesis. The CS1-enantiorners 
being consistently more active than the CRl-enantiomers C Gund 
et al. 19773. A previously reported method for assaying plasma 
levels of furprofen has quantified the total parent drug 
CPalumbo et al.,1988J. The carboxylic group that partecipates 
in amide formation is retained by the principle oxidative 
metabolites of furprofen, therefore, we extended the above 
cited technique to allow quantitation of enantiomers in 
biological fluids. In this context it is of considerable 
significance the fact that the pharmacological activity of
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these compounds is markedly influenced by their matabolic
fate, in particular by their stereoselective biotrasformati on
CHutt et al. ,19833. The fate of furprofen enantiomers was
studied in humans dosed with the racemate;for this purpose,
the drug was deri vati zed and the di ast ereoi someri c amides
determined by high performance liquid chhromatogrphy C HPLC3.
The HPLC system consisted of a Waters model M6000A pump, a U6K
injector, a Lambda Max model 481 LC-spectr ophotometer
connected to a 740 Data Module integrator. The separation was
performed at ambient temperature and the detector set at 0.1
a. u. f . s. . A 85cm x 4. 6mml . D. column paked with LiChrosorb Si
60 ClOpirD was used. The mobile phase was
i sopropanol -cyclohexane C7:93, v/v3. The wavelength of the
detector was set at 245nm. Plasma samples were treated with
1 —1 ’carbonyldiimidazole, then acidified and derivatized with
S —C cO —methyl benzyl ami ne and the final extraction was performed
by hexane. Hexane was evaporated to dryness and the residue
was taken up with mobile phase and used for chemical analysis.
The method presented here is suitable for the simultaneous
determination of enantiomers of furprofen.
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EFFECTS OF FREE RADICALS-GENERATING SYSTEM ON VOLTAGE-GATED Na 
CHANNELS OF SINGLE MYELINATED NERVE FIBRES
M.R. Carratu, *E. Masini, *P.F. Mannaioni, D. Mitolo-Chieppa In s titu te  of 
Pharmacology, University of Bari, ^Department o f P rec lin ica l and C lin ica l 
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Key words: node of Ranvier, sodium channels, free radicals 
Active oxygen intermediates, such as superoxide and hydroxyl free rad ica ls , 
which are probably formed in a l l  liv in g  organisms, could be responsible fo r 
l ip id  peroxidation, leading to a sequence of reactions when not termined 
(Kappus, 1985). Therefore l ip id  peroxidation is  a very a ttrac tive  hypothe­
s is  fo r explaining many deseases and drug-induced to x ic ity .  I f  oxygen-deri­
ved free radicals are involved in membrane in ju ry  by d irec t attack on l i ­
pids, i t  is  important to question whether e lectrophysio logical abnormali­
t ie s  of excitable ce lls  ensue. In view of th is  p o s s ib ility , the coventional 
voltage clamp analysis (Nonner, 1969) on single myelinated nerve fib re s , 
dissected from the sc ia tic  nerve of the frog, was used to study the e ffects  
of conditions promoting l ip id  peroxidation. Since th is  issue was heavily 
biased towards voltage-gated Na channels, К current was suppressed by rep­
lacing the end pool so lu tion with 110 mM CsCl + 10 mM NaCl and adding te t -  
raethylammonium (10 mM) to the external so lu tion . At the beginning of an 
experiment the voltage-clamp was balanced in Ringer's solution to give a 
steady-state Na inac tiva tion  h of approximately 0.7. A ll the measurements 
were made before and a fte r exposure to the " in  v it ro "  free radicals genera­
tin g  system, FeCly ADP-H202- Three to five  minutes a fte r exposure to 1 / j M 
FeClj'10 yuM ADP'0.1 /uM 1 ^ 2  spontaneous action potentia ls  appeared at a 
frequency of about 100 Hz. Neither the amplitude nor the duration of action 
potentia ls  were s ig n if ic a n tly  modified. Under voltage clamp-conditions
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the main e ffect was the appearance of a maintained ( la te ) inward current 
(I|^) during long lasting  depolarizations; the inactiva tion  time course of 
Na current could s t i l l  be separated in to  two exponential phases with almost 
the same time constants and amplitude as those under control conditions. 
The peak Na current was not s ig n if ic a n tly  modified. The la te  current 
ac tiva ted  and reversed at more negative voltages than the peak cu rren t. The 
steady-state inactiva tion-vo ltage re la tionsh ip  showed that a fra c tio n  of 
the sodium current, corresponding to the la te  current described above, did 
not inac tiva te  and the curve, corresponding to the inactivable fra c tio n  of 
Na cu rren t, was shifted towards negative voltage by about 3 mV. When the 
contact between the nodal membrane and the free radicals generating system 
contain ing solution exceeded a c r i t ic a l  period of 15 minutes, spontaneous 
ac tion  potentia ls were separated by s ile n t periods of several tens of 
m illiseconds; th is  e ffec t ran p a ra lle l w ith the progressive disappearance 
o f 1^, while the peak Na current was reduced to about 40 X of i t s  contro l 
value. These in v itro  experiments on hydroxyl rad ica l formation by the 
c la s s ic a l Fenton reaction, show a two-phase e ffe c t: an early exc ita to ry
phase (due to m odification of a frac tion  of Na channels) and a la te  
depressant phase (due to blockade of membrane currents).
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DIHYDROPYRIDINO-SENSITIVE CALCIUM CHANNELS IN OPIOID-INDUCED THERMIC AND
BEHAVIORAL EFFECTS
E. Cavicchini, S. Spampinato, E. Speroni, B.- C o le tti, G. Murari, C.
Romagnoli, R. Sotgiu and S. Fern
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Dynorphin - Met-enkephal in - Verapamil - Body temperature.
In tracerebroventricu lar (ICV) adm inistration of opioids in te rac ting  w ith p 
or к receptors in the ra t e l ic i t s  d iffe re n t pharmacological e ffe c ts .
For instance p agonists induce, at lower doses, an increase in body tem­
perature and a clear hypothermia at higher doses and a dose-related a n ti­
nociception and catalepsy. On the contrary, dynorphin A (Dyn A), a pur­
ported к endogenous agonist e l ic i t s  a s ig n ifica n t hypothermia together with 
barrel ro llin g  and bizarre postures without any change on nociceptive 
threshold (Cavicchini et a l . ,  1988). I t  has been suggested a functiona l 
coupling of opioid receptors to voltage-dependent Ca++ channels and, in 
pa rt, calcium-antagonists potentia te some effects induced by op io ids. The 
aim of our research was to investigate possible involvement of d ihydropyri­
dine Ca++ antagonists on thermic and behavioral e ffects induced by ICV 
adm inistration of dyn A and FK 33-824 a synthetic stable analogue o f met- 
enkefa lin , binding p re fe re n tia lly  to p receptors.
Male Sprague-Dawley ra ts (180-200 g) were prepared with a permanent ICV 
cannula and used 7 days a fte r  surgery. Rectal temperature was measured 
before and a fte r ICV in je c tio n  and, at 15- or 30- min in te rva ls .
Nociceptive threshold was monitored by t a i l - f l i c k  test and evaluation of 
catalepsy was timed placing the ra t across twin plexiglass platforms (cu t­
o f f  time 2 min). Dyn A (10 pg) provoked a clear hypothermia (Tab. 1). The 
calcium antagonist verapamil (10 pg ICV, 15 min before opioids) did not, by 
i t s e l f ,  a ffec t basal body temperature, but s ig n if ic a n tly  reduced the 
e ffec ts  of Dyn A. Barrel ro ll in g  and bizarre postures were observed during 
15 min a fte r Dyn A and were not altered in verapamil pretreated ra ts . No 
s ig n if ic a n t change on nociceptive threshold was observed. 
Intracerebroventricu lar FK 33-824 elevated body temperature at the dose of
0.15 pg/ra t and induced a long-lasting  hypothermia at the dose o f 0.25
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мд/ r a t .  Verapamil pretreatment changed in hypothermia the hyperthermic 
response induced by the lower dose of FK 33-824 and s ig n if ic a n tly  enhanced 
the hypothermic e ffe c t o f the higher dose. Antinociception and catalepsy 
induced by FK 33-824 (0.15 pg/rat) were potentiated by verapamil 
pretreatment.
Table 1 ,- Body temperature changes 
(VER) and opioid peptides (Dyn A and
; (»C) 
FK 33
in ra ts  
-824) at
treated with 
d iffe re n t time
verapami1 
(m in).
Treatment 15' 30' 45' 60' 90' 120'
Saline +0.3 +0.2 +0.1 +0.1 0 +0.1
VER (10 pg) + 
Sali ne
0 +0.1 0 -0.1 0 +0.1
Dyn A (10 pg) -1.2 -1.4 -1.3 -0.8 -0.6 -0.5
VER (10 pg) + 
Dyn A (10 pg)
-0.5 -0.2 -0.3 -0.4 +0.2 +0.3
FK 33-824 (0.15 pg) +0.2 +0.2 +0.6 +1 +1.2 +1.2
VER (10 pg) +
FK 33-824 (0.15 p)
-1.5 -2 -2.3 -2.8 -3.2 -3.0
FK 33-824 (0.25 pg) -0.1 -0.7 -1.3 -1.9 -2.4 -2.7
VER (10 pg) +
FK 33-824 (0.25 pg)
-0.6 -1.2 -1.9 -2.5 -3.5 -4.2
I t  is  widely accepted th a t molecular events subsequent to opioid receptor 
a c tiva tio n  involve a change in in tra ce llu la r Ca d is tr ib u tio n . I t  was also 
found that к agonists, including dynorphin, are coupled to voltage 
dependent calcium channels. Analogously the calcium antagonist potentiates 
the antinociceptive e ffe c t induced by p receptor agonists.
Our findings can be explained in the line  of these resu lts . As concerns 
behavioral effects, e l ic i te d  by the к agonist Dyn A,seems that they are not 
re la ted  to d ihydropyrid ine-sensitive calcium channels. On the contrary th is  
channel seems to mediate antinociception and catalepsy induced by the p 
agonist.
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EFFECT OF D-PENICILLAMINE ON RAT BRAIN CORTEX LIPID PEROXIDATION 
INDUCED "IN VITRO" AND "IN VIVO" BY IRON-COMPOUNDS
Cluff I M., Gent 11i n i G., Franchi-Ml che Ii S. and Zi I le t t i  L.
Department of Preclinical and Clinical Pharmacology -  University of Florence 
V. le G.В. Morgagni, 65 -  50137 Firenze.
Key words: iron, lipid peroxidation, TBARS, lipid-soluble fluorescence,
D-pen ic i 1 lamine.
Penicillamine is an agent used in the treatment of a rthr it is  and as copper 
chelator in the treatment of copper over dose and Wilson’ s disease. Moreover 
this drug is reported to be an effective "in vitro" hydroxyl scavenger (Aruoma 
et a l . ,  1988), although a possible generation of thiyl and peroxy radicals by 
attack of OH on penicillamine, as well as a possible hydrogen peroxide and 
hydroxyl radical formation enhancement caused by reducing and iron-binding 
properties of penicillamine have been pointed out (Gutteridge et a l . ,  1979).
In order to study the scavenging effect of D-pen ic 1 1 lamme on CNS peroxi dative 
damage, experiments were performed both "in vitro" and "in vivo" on the brain 
cortex of Wistar rats.
Lipid peroxidation "in v itro” was stimulated in brain cortex homogenates (10X 
in phosphate buffer pH 7.4) by adding iron-chloride (20 pM) and ascorbic acid 
(100 pM). D-pemci 1 lamine HCI (50 to 1000 pM) added and the reaction mixtures 
were incubated at 37“C in b.m. for 30 min under agitation. The extent of lipid  
peroxidation in reaction mixtures and controls (mixtures without 
penicillamine) was assessed by measurement of TBARS expressed as 1/0.D. at 
532 nm.
We observed that 50 pM penicillamine slightly but significantly enhanced the 
peroxidative process, whereas higher concentrations showed clear inhibition 
(Fig. la). No variation was observed by adding penicillamine (1000 pM) at the 
end of incubation.
"In vivo" the scavenging effect of the drug was evaluated by actnimster mg
i.p. D-pen ic i I lamme HCI (50 mg/Kg) to Wistar rats in whose right brain cortex
3+
a slow lipid peroxidation was induced by iron-saccharate (200 pg Fe ) 
injection according to Ciuffi et al. (1988). The extent of lipid peroxidation
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a b
cortex cortex
Fig, 1. Inhibition by penici I lamine of rat brain cortex lipid peroxidation 
induced "in vitro" by iron chloride plus ascorbic acid (a) and "in vivo" by 
i ron-saccharate (b). * : p<0.05.
in penicillamine treated rats and controls (drug-untreated, iron-injected 
animals) was assessed by measurements of lipid-soluble fluorescence (Fletcher 
et a l . ,  1973) in samples from the iron-injected ( ipsilateral) and contra­
lateral brain cortex 7 days after operation.
Penicillamine was str ik ingly effective, causing a significant decrease in 
l ip id  soluble fluorescence values in both ipsilateral and contralateral hemi- 
cortices (Fig. 1b).
In view of our preliminary data and of the emerging role of metals and 
particularly iron in the pathogenesis of several ischemic or degenerative CNS 
diseases via a lipid peroxidation process, i t  would be interesting to 
investigate further the effect of penicillamine in the CNS.
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ENERGY OF ACTIVATION OF HETASTARCH IN A LIMITED RANGE OF THERMAL 
EXPOSITION
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C o n f o r m a t i o n a l  and s t a b i l i t y  a n a l ys e s  o f  b i o l o g i c a l  
l i n e a r ,  s i m p l e ,  complex  or  c h e m i c a l l y  m o d i f i e d  h y d r o c a r b o n  
p o l y m e r s  a p p e a r  n o t .  t o  be c o m p l e t e l y  u n d e r s t o o d ,  and 
e f f e c t i v e n e s s  of  he t as t a r ch  ( h y d r o x y e t h y l s t a r c h  6% in s a l i n e  NaCl
0.9%;  Hespan R. )  compared t o  o t h e r  p l asma s u b s t i t u t e s  i n  the 
r e s u s c i t a t i o n  t r ea tment  of  p a t i e n t s  would seem to  c a l l  a bas i c  
r e a p p r a i s a l .  Our p r e l i m i n a r y  data on the therm al s t a b i l i t y  o f  the 
p r oduc t  had been ob ta i ned  by s p e c t r op h o t o m e t r i c  measurements of  
the commercial  p r oduc t ,  and i t s  more d i l u t e d  s o l u t i o n s .  H i g h l y  
s i g n i f i c a n t  (p < 0.01)  234 vs 310 nm wavelenght  d i f f e r e n c e s  in 
d i f f e r e n t  v i a l s  o f  same or  d i f f e r e n t  ba t ches  had been f o u n d ,  
which i ncreased when submi t t ed to se t s  of  thermal e x p o s i t i o n s  
such as:  one pe r i od ,  one t ime f rom 2 5 ° to  100°C ( a ) ;  one t ° u n t i l  
960 min ( b ) ;  u n t i l  100 t i mes  a t  f i x e d  t c and p e r i o d s  ( c )  ( A1 
Sawai r  et  a l . , 1 989 ) .
The general  p r i n c i p l e  of  f i n i t e  f l u c t u a t i o n s  ( P i a n t e l l i ,
1987) had been f i t t e d  to the data,  the abundance o f the mo l ecu l es  
w i t h  g r e a t e r  e n e r g y  a s s o c i a t e d  w i t h  t h e  i n c r e a s e  o f  t he  
t e m p e r a t u r e s  d e t e r m i n e d  and the d i s c r e t e  d i s t r i b u t i o n  o f  the 
e l e m e n t s  w h i c h  a t  a t h r e s h o l d  t  and e n e r g y  l e v e l  r e a c h  an 
o b s e r v a b l e  p r o b a b i l i t y  o f  a g g r e g a t i o n  w i t h  o t h e r  s i m i l a r  
mo l ecu l es ,  being t h e i r  s t r u c t u r e  m o d i f i e d  to the po i n t  where i t  
takes on d i f f e r e n t  con f o r ma t i on ,  e s t i m a t e d .  These s t r u c t u r e s  may
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p a r t i a l l y  r ega i n  t h e i r  pr imary c o n f o r ma t i on  wi th  r e v e r s i o n  of  the 
t e m p e r a t u r e  t o  t he  i n i t i a l  v a l u e ( s ) ,  p a r t  of  the s t r u c t u r e s ,  
however ,  i n t e r a c t i n g  wi th  s i m i l a r  u n i t s ,  may give r a i s e  to new 
i r r e v e r s i b l e  complexes.
F i g u r e  1 r e p o r t s  t h e  v a l u e s  o f  t he  Д  0 . D . i n  one 
p r e p a r a t i o n  exposed  one t i me ,  6 0 min at  the i n d i c a t e d  t°. By 
a p p l y i ng  the A r r h e n i u s '  log к = Ea /  2.303 RT equa t i on ,  being к 
t h e  234-310 nm Д  O.Ds,  the v a l u e  o f  Ea equal  t o  1 . 22  ( r  = 
0 . 9 9 )  Kcal  /  M i s  es t i ma t ed .  An average energy o f a c t i v a t i o n  of  
1.34 Kcal  /  mol e ( s t a n d a r d  e r r o r  + / -  0 . 17)  had been found in t h ree  
d i f f e r e n t  p r e p a r a t i o n s  f o r  the range o f  t ° 2 5 ° t o  60°C.  The value 
i s  o f  the o r der  o f  t h a t  of  a charge r e d i s t r i b u t i o n  t r a n s f e r  and 
i t  i s  compat i b l e  w i t h  which could happen in d i f f e r e n t  c o n d i t i o n s  
o f  the p roduc t ,  a f f e c t i n g  i t s  s t a b i l i t y .
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A1 Sawai r  A. ,  Bons ignore  F. ,  M o r e t t i  V . ,  P i a n t e l l i  F . ,  Re L . ,  
Ross i n i  L . , Nuovo B o l l . F a r m a c o l . C l i n . ,  ~11~,  in p r i n t i n g ,  1989. 
P i a n t e l l i  F . ,  R . I . F .  , 1 987.
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PHARMACOKINETICS AND TISSUE DISTRIBUTION OF CYCLOSPORIN (CSA) 
IN METHYLPREDNISOLONE-TREATED RATS
A. Conforti*,, L. Cuzzolin*, M. Schinella**, G. Mazzi**, G. Benőni*
* Institute of Pharmacology, University of Verona
** Laboratory of Clinical Chemistry and Haematology, Hospital of Verona 
Key Words: Cyclosporine, Méthylprednisolone, Tissue Pharmacokinetics, Rat
We previously observed that the blood levels of cyclosporin (CsA) were modified by 
méthylprednisolone (MTP) in the rats (unpublished data). CsA was assayed by RIA methods. 
In the present study, we evaluated the role of MTP on the tissue distribution of CsA assayed 
by high pressure liquid chromatography (HPLC). Male Sprague-Dawley rats were infused 
intravenously with CsA (1.5 mg/kg) and with CsA (1.5 mg/kg) plus MTP (1.5 mg/kg) during 
3 minutes. The CsA levels in blood, lung, liver, kidney and spleen were evaluated from 0.5 to 
24 hours after injection. The elimination rate constant, the elimination half-life, the area under 
the curve of the drug concentration versus time from 0 h to infinity were determined for each 
group of rats by fitting blood and tissue profiles for each animal to a sum of exponentials by 
using an extended least-squares method. The percentage of penetration was calculated as ratio 
between tissue and blood AUC. Statistical analysis of the differences between groups was 
performed by "t" Student test. The results are shown in Table 1.
Analysis of the area under the curve of the drug concentration in the blood and different 
tissues versus time showed a higher accumulation of CsA in the méthylprednisolone infused 
rats than in the rats treated with CsA alone. Méthylprednisolone was associated with an 
increase in CsA half-life in liver, spleen (P>0.05) and kidney and lower elimination rate 
constant. The percentage of tissue CsA penetration was modified by méthylprednisolone in 
kidney (P>0.05). These results demonstrate that MTP modifies the blood and tissue 
pharmacokinetics of CsA. In our experiment, CsA accumulated in tissues 0.5 h after it was 
injected and the tissue of MTP-infused rats accumulated more CsA than did the tissues of rats 
treated with CsA alone. MTP infused in our animals enhanced the blood levels of CsA and
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then the distribution and the uptake in the tissues.
Table 1. Pharmacokinetic parameters of cyclosporin in rats treated with cyclosporin alone 
and associated with méthylprednisolone.
Rats Fluid or 
Tissues
Elimination 
half-life(h) ± SD
Percentage of 
Penetration ± SD
AUC
(ng.h/ml) ± SD
Blood 12.47 ± 1.27 21,897 ±  1,524
Liver 12.14 ± 1.71 79.0 ± 9.59 17,260 ±  1,483
CsA Spleen 9.1 ±1.64 41.2 ± 6.65 8,965 ± 1,016
Kidney 11.1 ±1.98 45.8 ± 8.64 9,930 ± 1,674
Lung 12.4 ± 3.54 31.8 ±5.81 6,939 ±  1,070
Blood 11.02 ± 1.74 _ 25,786 ± 4,273
CsA + MTP Liver 16.63 ± 4.37 80.2 ± 12.6 20,444 ±  2,836
Spleen 13.99 ± 3.35* 40.2 ± 10.73 10,181 ±2,314
Kidney 15.94 ± 4.5 51.0 ± 3.67* 13,219 ±2,257
Lung 15.94 ± 1.90 35.8 ± 12.99 8,828 ± 1,961
* P < 0.05 T  Student
Klintmaln and Sawe (1984) observed an increase of blood CsA levels in patients after MTP
treatment and explained this result with an inhibition of the CsA metabolism induced by the 
steroid since both CsA and MTP probably utilise the hepatic microsomal enzymes for their 
metabolism.
The persistence of CsA in some tissues (liver, spleen and kidney) might be the result of an 
altered tissue binding of the drug induced by MTP.
As alterations in glucose and lipid metabolism are induced in some tissue by MTP (Jensen et 
al 1987), we cannot eliminate the possibility that it could have acted directly on the tissue 
uptake of CsA.
In every case, although the mechanism by which MTP interfers with tissue pharmacokinetics 
of CsA is not clear, the increase in CsA within the tissues might be associated with an higher 
incidence of toxicity.
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MULTICENTER STUDY OF HOSPITAL ADVERSE DRUG REACTIONS
Conforti A., Leone R., Moretti U., Sartori M. and Velo G.P.
Institute of Pharmacology, University of Verona, Verona, Italy 
Key words: Hospital monitoring - Adverse drug reactions
Clinical trials carried out before licensing new drugs are designed primarily to assess efficacy 
and generally do not involve more than 3000 patients. Rare adverse drug effects are unlikely 
to be detected at this stage and there are many examples of drug withdrawn from the market 
because of serious adverse reaction not detected before (hepatotoxicity of benoxaprofen, 
epidermic necrologies of isoxicam, oculomucocutaneous syndrome of practolol). 
Postmarketing drug surveillance studies (PMS) have been developed with the aim to screen 
unknown adverse drug reactions, determine the incidence of known adverse reactions in 
patient populations, evaluate the role of factors that influence drug efficacy and toxicity. 
From some years we are carrying out PMS studies primarily addressed to adverse drug effects 
in hospitalized patients (Leone et al., 1988; Conforti et al., 1989).
The present study was performed with the cooperation of medical, geriatric and neurological 
wards of some Hospitals of Regione Veneto, and had a length of three months. The patients 
of 33 medical and geriatric wards assuming calcium antagonists, angiotensin-converting 
enzyme inhibitory and antimicrobial agents, and those of 14 neurological wards assuming 
antiparkinsonism drugs and platelet aggregation inhibitors were admitted to the study. Dat; 
were collected by doctors using a special form requiring patient informations related t< 
possible adverse drug effects, pharmacological therapy during hospitalization, suspecta 
adverse reactions and some data to assess drug imputability. The АТС classification syster 
was used. The total number of forms was 5355.
The percentage of side effects was 3.7 in the medical and geriatric ward patients and 8.3 i 
the neurologic patient group. In both groups there was a positive correlation between previot 
and present adverse drug effects (P< 0.01, Chi-square test). Figure 1 shows the incidence 
side effects of the five groups of drugs referred to the number of administrations.
6 4
Figure 1. Adverse drug reaction (ADR) incidence in hospitalized patients. On columns 
number o f drug administrations, in brackets number o f patients with ADR.
In certain cases the analysis o f the single chemical substances revealed in the some group of 
drugs differences in the incidence of side effects. For example among macrolides 
erythromycin lactobionate and among Ca-antagonists gallopamil showed the highest 
incidence of side effects. However in this last case the small number of patients requires 
further confirmations. Eight patients showed adverse effects unknown for the suspected drug. 
In two of these patients the relationship between drug and effect resulted uncertain. In 14.4% 
of medical ward patients and in 4.8% of neurologic patients the side effects were considered 
"serious" by the doctors.
W e think that the main value o f this study, beside the obtained results, is to awaken doctors 
towards the necessity of monitoring side effects of drugs and more in general towards the 
problems of pharmacoepidemiology.
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PHARMACOLOGICAL STUDIES ON NEW GASTROKINETIC DRUGS.
Coppi G ., Pinzetta A ., and Barchielli M.
Research Centre, Poli Industrie Chimica S .p.A ., Via Volturno no 48, 20089
Rozzano (M I), Ita ly
Key words: benzaaide f l u o r o - d e r i v a t i v e s ; g a s t r o k i n e t i c  a c t i v i t y ;  a n t i - d o p a i i n e r g i c  a c t i v i t y .
Metoclopramide is  in c lin ic a l use as antiemetic and gastrok ine tic  agent. 
I ts  usefulness is  lim ited  by central side e ffects such as extrapyramidal 
reactions, parkinsonism, hyperprolactinemia; these e ffects are considered a 
consequence of central dopaminergic D^-receptors antagonism. Many researches 
have been made toward the m odification of metoclopramide in order to  separa­
te gastric  therapeutic e ffec ts  from central undersiderable side e ffe c ts .
During these research we obtain three new in teresting  compounds:
P1435 { 2-methoxy-3-amino-5-fluoro-N-[(2-diethylamino)-ethyll-benzamidej ,
PI 439 { 2-methoxy-4-f 1 uoro-5-amino-N-[2-diethyl ami no)-e th y l] -benzamidej and 
PI 450 {2-methoxy-4-f1uoro-3-amino-N-[(2-methyleye 1opropyl ami no)e th y l] -benza- 
mide } .
In the ra t gastric  emptying time (Amberlite pe lle ts ) te s t (Brodie and 
Kundrats, 1965), the a c t iv it ie s ,  in decreasing order, were: metoclopramide;» 
P1450 > P1439> P1435 (ED^q were 1.16; 3.54; 5.28; 6.32 mg/kg/os respecti­
vely) .
In the central anti-dopaminergic a c t iv ity  test by using apomorphine in 
ra t (Janssen et a l . ,  1965), the a c t iv it ie s , in decreasing order, were: 
metoclopramide > PI435^P I439 > P1450 (ED^ g were 5.50; 48.74; 67.01; >80 
mg/kg/os respective ly).
In the mouse ca ta lep tic  a c t iv ity  te s t (Athee and Buncombe, 1974) the
ED of metoclopramide was 84.0 mg/kg/os whereas a ll three compounds showed 50
an EDC„>  640.0 mg/kg/os.5U
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The oral LD s in  mouse of P1435, P1439 and P1450 were>1600; ca. 1200 50
and>1600 mg/kg respective ly  whereas that of metoclopramide was ca. 350 
mg/kg.
The new compounds, in  which the 5-chloro group of metoclopramide was 
substitu ted by fluo ro  group in  position 4 or 5, show, in comparison with the 
standard, less gas trok ine tic  a c tiv ity  but very low central dopaminergic ac­
t i v i t y  and oral acute to x ic i ty .
In the reserpinized (5 mg/kg i.p . )  ra t the most in te resting  compound 
P1450, administered at 0.2 mg/kg/os 18 h a fte r reserpine, showed no 
va ria tio n  in plasma p ro la c tin  (RIA dosage) (Cocchi et a l. ,  1985) whereas
metoclopramide, at the same dosage, shows 
The table summarized the resu lts  obtained 
toclopramide as standard.
a s ig n if ic a n t increase.
with P1450, in comparison with me-
1 1 R a t  g a s t r i c  | C e n t r a l  a n t i - - |  C a t a l e p t i c 1 P l asma O r a l  a c u t e  |
1 Compound | e m p t y i n g  t i m e | d o p a m i n e r g i c 1 a c t i v i t y 1 p r o l a c t i n  1 t o x i c i t y
1 a c t i v i t y 1 1 l e v e l s  '
! ED 5 0  1 E0 so 1 EO 50 1 V a r i a t i o n s  | ED 50 1
1
1
1 ( m g / k g / o s )  | ( m g / k g / o s ) 1 ( m g / k g / o s ) 1 ( * )  1 ( m g / k g / o s )  |
1
I
P 1450 1 3 . 5 4  1 8 0 . 0  
I I
1 6 4 0 . 0  
I
1
1
+ 4 6 . 4  1
I
>  1600  1
1
1 M e t o c l o p r a m i d e
1 1 
1 1 . 1 6  1 5 . 5 0
1
1 8 4 . 0
1
1
1
+ 8 5 . 6 *  1 c a .  350  1
*  p 0 . 0 5  Du n n e t t  " t "  t e s t .
The new compound P 1450 is  s lig h tly  less active than metoclopramide as 
gastrokinetic but i t  is  also p ra tica lly  devoid of central dopaminergic 
a c t iv ity .
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SENSITIVITY TO END0THELIN-1 IN MESENTERIC BEOS AND AORTIC RINGS 
OF 4-WEEK-OLD SPONTANEOOSLY HYPERTENSIVE RATS
L. CRISCIONE, H. THOMANN AND TRI D. LOO 
C a rd io v a s c u la r Research D epartm ent, CIBA-GEIGY L im ite d , 4002 
B a s le , S w itz e r la n d .
Key words: e n d o th e lin , h y p e rte n s io n , v a s c u la r r e a c t i v i t y
E n d o th e lin  is  a very p o te n t v a s o c o n s tr ic to r  agent is o la te d  
from  the sup e rn a ta n t o f c u ltu re d  p o rc in e  e n d o th e lia l c e l ls  
( 1 ) .  The ro le  o f e n d o th e lin  in  the development a n d /o r in  the 
m aintenance o f h igh  b lood  p ressu re  is  not y e t unde rs too d . S tu ­
d ie s  from our la b o ra to r ie s  in  a d u lt  16 -w eek-o ld  spon taneous ly  
h y p e rte n s iv e  ra ts  (SHR), in d ic a te d  th a t e n d o th e lin  may no t be 
in v o lv e d  in  the m aintenance o f h yp e rte n s io n  ( 2 ) .  The o b je c t iv e  
o f these s tu d ie s  was to  in v e s t ig a te  whether p o te n t ia l  e a r ly  
fu n c t io n a l a b n o rm a lit ie s  to  e n d o th e lin -1  (ET — 1) occur in  young 
(4 -w e e k -o ld ) SHR, which may c o n tr ib u te  to  the  development o f 
h ig h  b lood p ressure  in  g e n e tic  h y p e rte n s io n .
The v a s o c o n s tr ic to r  e f fe c ts  o f ET-1 were s tu d ie d  in  p e r fu ­
sed m esen te ric  v a s c u la r beds (MVB) and a o r t ic  r in g s  o f 4-week- 
o ld  SHR and age-matched W is ta r Kyoto ra ts  (WKY).
I n i t i a l  mean b lood p re ssu re  in  SHR was s ig n i f i c a n t l y  h ig h e r 
than in  WKY r a ts ,  a lth o u g h  the  va lues are no t h y p e rte n s iv e  
(124 v s .97 mmHg re s p . ,  n=12, p< 0 .0 1 ). Compared to  WKY, r e a c t i ­
v i t y  to  ET-1 was in c re a se d  in  MVB's o f SHR, as in d ic a te d  by 
the  maximum p e rfu s io n  p re ssu re  ob ta ine d  (223 vs 155 mmHg 
re s p . ,  p<0 .001). S e n s i t i v i t y ,  however, was no t s ig n i f i c a n t l y  
d i f f e r e n t  between the two s t r a in s ,  ( s im i la r  E D ^ s : 50 and 80
pmol re s p . ,  n=10) .
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In  a o r t ic  r in g s ,  in  c o n t r a s t ,  r e a c t iv i t y  to  ET-1 was reduced 
in  SHR, whereas s e n s i t i v i t y  was s im i la r .
As w ith  ET-1, r e a c t i v i t y  to  n o ra d re n a lin e  was inc reased  in  
M VB 's, but not in  a o r t ic  r in g s  o f SHR.
The lack  o f in c re a s e d  s e n s i t i v i t y  in  both  the m esen te ric  
and a o r t ic  v a s c u la tu re ,  in d ic a te s  th a t  th e re  are no fu n c t io n a l 
a b n o rm a lit ie s  to  ET-1 in  SHR at a p re -h y p e r te n s iv e  age. The 
in c re a s e d  r e a c t iv i t y  in  the  perfused MVB are most l i k e l y  due 
to  v a s c u la r changes. These r e s u lts  in d ic a te  th a t  ET-1 may not 
be a p rim ary  h y p e r te n s iv e  mechanism in  g e n e tic  h y p e rte n s io n .
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INTESTINAL BACTERIAL FLORA AND LESIONS IN ARTHRITIC RATS: 
EFFECT OF ANTIINFLAMMATORY DRUG
Cuzzolin L.,Caliceti P.*,Conforti A.,Veronese F.M.*, Benőni G., Velo G.P. 
Institute of Pharmacology, University of Verona and *Department of 
Pharmaceutical Science, University of Padua, Italy 
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The observations concerning the presence of pathological intestinal lesions 
or the increased sensitivity of the gastrointestinal mucosa against NSAIDs 
in arthritic rats, are controversial. Bjarnason et al (1987) referred that 
patients with rheumatoid arthritis, untreated, have normal intestinal 
permeability. Schleyerbach et al. (1984) referred that the injection of 
Freund's adjuvant in rats induced not only polyarthritis but also 
histological changes of the viscera and alterations in the secretory capacity 
of gastrointestinal tract. Rainsford (1978) did not find significant 
differences between the number and occurrence of lesions in adjuvant- 
arthritic compared with normal rats given single or repeated doses of 
aspirin. Bjarnason et al (1987) found that NSAIDs caused small intestinal 
inflammation in arthritic patients, unrelated to the type and dose of drugs 
and previous or concomitant second-line drug treatment. Di Pasquale (1973) 
referred similar results in rats. Our purpose was to study whether 
complete Freund's adjuvant in rats induced intestinal lesions and alterations 
in bacterial flora pattern. Moreover we evaluated if, in presence of 
intestinal lesions, there were alterations of bacterial flora after 
indomethacin and SOD-PEG administration, antiinflammatory drugs with 
different mechanism of action, in arthritic rats.
Adjuvant arthritis was induced in male Sprague-Dawley rats, by injection 
of 0.6 mg of heat-killed Mycobacterium butyricum (Difco), suspended in 
0.1 ml of mineral oil into the plantar region of hindfoot. After 14 days rats
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received indomethacin (3 mg/kg), SOD-PEG (10 mg/kg) and indomethacin 
plus SOD-PEG (3 mg/kg and 10 mg/kg) i.m. for 14 days. Faecal samples 
were collected from all rats 24 h after the last drug administration and the 
microbiological analysis was performed using the standard techniques. Then 
animals were killed and intestinal mucosa was everted, rinsed under water 
and macroscopically examined. Arthritic rats showed no ulceration. 
Moderate inflammation was observed in indomethacin treated rats: 4 on 10 
animals showed some small ulcerations. In animals receiving SOD-PEG and 
SOD-PEG plus indomethacin, no alterations of intestinal mucosa were 
evident. No changes of intestinal aerobes and anaerobes were observed in 
arthritic rats compared to controls. Indomethacin and SOD-PEG treatments 
did not induce significant alterations in bacterial flora pattern, even if 
SOD-PEG plus indomethacin induced an increase of Escherichia coli 1, 
Bacteroides and anaerobic lactobacilli.
In conclusion, we have shown that the functional integrity of the intestinal 
barrier, in arthritic rats, was not correlated with alterations in bacterial 
flora pattern. Moreover, the moderate intestinal inflammation induced by 
indomethacin, was not correlated to bacterial flora alterations. Then, the 
mechanism of drug action, route of administration, kinetics and the changes 
of the intestinal acidity due to the alterations in the gastrointestinal 
functions during the development of adjuvant disease may be important 
factors inducing intestinal damage. Further investigations are needed to 
evaluate the influence of long-term antiinflammatory therapy on intestinal 
mucosa and bacterial flora in arthritic rats.
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ARE BACTERIAL TOXINS INVOLVED IN ARTHRITIS INDUCED IN RATS? 
Cuzzolin L.,Caliceti P.*,Conforti A., Veronese F.M.*,Velo G.P., Benőni G. 
Institute of Pharmacology, University of Verona and *Department of 
Pharmaceutical Science, University of Padua, Italy 
Key words: bacterial toxins, arthritic rats, NSAIDs
In previous works (Zaphiropoulos, 1986) it has been suggested that the 
disruption of the intestinal barrier in untreated patients with rheumatoid 
arthritis is important in the aetiology of the disease.
Bjarnason et al (1986) have also shown that non-steroidal anti-inflammatory 
drugs themselves increase intestinal permeability. This effect, combined 
with NS AID effects on chemotaxis and neutrophil function (Warne et al., 
1978) may overwhelm the local mucosal immunological defense system and 
result in the long term in the bacterial invasion of the mucosa.
Previously (Benőni et al., 1987), we observed in normal rats treated with 
high doses of indomethacin, intestinal lesions and an overgrowth of 
bacteria, particularly an increase of Clostridium perfringens enterotoxin. 
The aim of this work was to evaluate in arthritic rats treated already from 
the third day with antiinflammatory drugs, the intestinal lesions and the 
presence of Clostridium perfringens enterotoxins.
Adjuvant arthritis was induced in male Sprague-Dawley rats, by injection 
of 0.6 mg of heat-killed Mycobacterium butyricum (Difco), suspended in 
0.1 ml of mineral oil into the plantar region of hind foot. At the third day 
from inducing arthritis, a group of rats was treated with indomethacin (1.5 
mg/kg i.m.) and another group with SOD-PEG (10 mg/kg i.m.) (Veronese 
et al., 1989). The treatment was continued until the 28th day. Feces were 
collected for Clostridium perfringens enterotoxin determination at 14th, 21st 
and 28th day of drug administration. The enterotoxin was determined by 
means of the late agglutination text of Sakaguchi et al. (1973), by using a
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commercial kit (Oxoid). The results were expressed as 1-5 scores on the 
basis of concentration ranges 0-40 to 640-1280 ng/g feces. The animals 
were killed 24 h after the last drug treatment and intestine was examined 
macroscopically for the presence of lesions.
The results of enterotoxin concentrations are shown in the following table 
( values as mean 1 S. D . ) : *
Treatment
14th day Enterotoxin score 21st day 28th day
Arthritic 
untreated rats 0.7510.46 0.6310.74 0.7510.46
Indomethacin 
1.5 mg/kg
1.00± 0 0.86+0.69 1.1410.38
SOD-PEG 
10 mg/kg 0.50+1.07 1.38±0.74 * 2.88±1.13 *
*P<0.05 as compared to arthritic untreated rats
No macroscopic lesions were observed in all groups. It is known (Griffiths, 
1987) that the low iron concentration enhances the production of several 
toxins, among which Clostridium perfringens enterotoxin. It is also known 
that the metabolic reactions involving SOD-PEG are iron-mediated. The 
treatment with this drug may therefore further increase the iron 
deficiency, common in rheumatic patients, and then the overgrowth of 
toxins.
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PHENTOLAMINE ANTAGONIZES THE HYPOXIA-INDUCED SUPPRESSION OF MYOCARDIAL 
CONTRACTILITY AND SINU-ATRIAL PACEMAKER ACTIVITY 
Á. Cseppentő, A.3. Szentmiklósi and 0. Szegi. Department of Pharmacology, 
Medical University of Debrecen, Debrecen, Hungary 
Key words: adenosine, hypoxia, myocardial c o n tra c t i l i ty ,  phentolamine, sinu­
a t r i a l  pacemaker a c tiv ity
I t  has been previously shown that phentolamine antagonizes some physio log i­
cal actions of ATP (BURNSTOCK, 1976). I t  was also described that a competi­
tive  non-competitive antagonism exists between phentolamine and adenosine 
(CSEPPENTŐ et a l . ,  1983). In addition, an important role of adenosine re le ­
asing under hypoxia in  the functiona l impairment of myocardial c o n tra c t il i ty  
(SZENTMIKLÓSI et a l. ,  1979) and s in u -a tr ia l pacemaker a c tiv ity  (SZENTMIKLÓ­
SI et a l . ,  1986) was also suggested.
In the present experiments, iso la ted , e le c tr ic a lly  driven le f t  and spontane­
ously beating r ig h t a tr ia  of guinea pigs were used to analyse the action of 
phentolamine on the hypoxia-induced suppression of con trac tile  force and 
sinus ra te. A tr ia l preparations were mounted in  an organ bath containing 
Krebs so lu tion (95% O2 and 5% CO2 ; 37°C). Hypoxia were induced by gassing 
of the nu trie n t solution w ith 95% N2 and 5% CO2 . During hypoxia (16 minutes) 
the isometric tension of le f t  a tr ia  gradually declined, but th is  cardio- 
depression could has been p a r t ia l ly  antagonized by various concentrations 
of phentolamine (3,10 and 30 /jmol/1; Fig 1A). When spontaneously beating 
r ig h t a tr ia  were exposed to a long-lasting  hypoxia (80 minutes), the sinu- 
- a t r ia l rate reduced by about 80%. In the presence of phentolamine ( 30
^jmol/1) th is  hypoxia-induced sinus slowing was strongly antagonized ( Fig. 
18). The resu lts  presented here confirm the previous suggestion, according 
to which, endogenous adenosine released under hypoxia, could play an impor­
tant ro le not only in  regulation of coronary vascular tone (BERNE, 1963),
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F i g . l .  Action of 3 /jmol/1 (о----- о), 10 yumol/1 ( • -----■) and 30 ^pmol/1
( • -----■) phentolamine on the hypoxia-induced decrease of con trac tile
force ( • -----■ before exposure to hypoxia) in  e le c tr ic a lly  driven
a tr ia l preparations (F ig. 1A). E ffec t of hypoxia on the s in u -a tr ia l 
pacemaker a c t iv ity  in  the absence ( • )  and in  the presence (o) of 
30 jjmol/1 phentolamine in  spontaneously beating r ig h t a t r ia l  prepa­
rations of guinea pigs Fig. IB; means-S.E.M.)
but in  decrease of functiona l a c t iv ity  of a tr ia  (c o n tra c tility , s in u -a tr ia l 
pacemaker a c t iv ity ) ,  as w e ll. In add ition , our resu lts could serve as expe­
rim enta l basis fo r explanation of the c l in ic a l observations, according of 
which, phentolamine has a benefic ia l e ffe c t on the impaired mechanical per­
formance during acute myocardial in fa rc tio n .
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THE APHRODISIAC EFFECT OF (-)DEPRENYL IN MALE RATS 
J. Dalló, T.T. Yen, J. Knoll
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Budapest, P.O.B. 370, 1445-Hungary
Key words: (-)Deprenyl, aphrodisiac effect
The effect of (-)deprenyl, the selective inhibitor of mono­
amino oxidase (МАО) В form (for review see Knoll 1983) was tes­
ted in male rats having low and high baseline sexual activity. 
CFY male rats (body weight 400-450 g) were exposed to receptive 
females and the male copulatory patterns (mounting, intromis­
sion, ejaculation) were tested once a week (test duration 30 
min) for four weeks. At the end of the fourth week (selection 
period) male copulatory performances were categorized according 
to Dalló, Lekka and Knoll 1986 as follows): 1. males which 
failed to show any copulatory patterns as non copulators; 2 . 
males which displayed at least one mounting during the selec­
tion period as only mounting males; 3. males which displayed 
intromission at least once without ejaculation as sexually 
sluggish; 4. males which displayed full copulatory repertoire 
including ejaculation in at least two out of four weekly mating 
tests as copulators. 280 males went over this procedure and 37 
proved to be sexually inactive, 82 as sexually sluggish and 20 
males were sexually active (copulators). (-)Deprenyl treatment 
started after four weeks selection period. The males were treat­
ed with single (0.25 mg/kg s.c.) and repeated doses of (-(dep­
renyl, and the mating behavior of the males were checked weekly. 
Control non-copulators failed to reach ejaculation during the 
observation period (17 consecutive weeks) but mountings and
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intromissions were detectable during repeated testings. Single 
dose of (-)deprenyl elicited ejaculation in non-copulator males 
which effect lasted for several weeks and facilitated intro­
mission and mounting as well. Repeated doses of (-)deprenyl 
(three times a week) exerted a more pronounced stimulation of 
mating patterns in non-copulator male rats: ejaculations and 
intromissions were consistently produced during observation. 
These findings are consistent with the ones described on sexual­
ly sluggish males (Knoll, Yen and Dalló, 1983). Single dose of 
(-)deprenyl stimulated the sexual activity in copulator males, 
it decreased the number of intromissions preceding ejaculation 
and decreased the ejaculation latency, one week after the ad­
ministration. Thus (-)deprenyl proved to be a potent aphrodi­
siac in male rats both at low and'at high baseline sexual ac­
tivity. (-)Deprenyl was shown to facilitate the activity of 
the nigrostriatal dopaminergic neurons with high selectivity 
(Knoll, 1987). This might explain the aphrodisiac effect of 
the drug in male rats, as the activation of the dopaminergic 
system is known to facilitate male sexual activity.
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NON-ADRENERGIC NON-CHOLINERGIC INHIBITORY INNERVATION OF THE GASTRIC 
FUNDUS IN STREPT0Z0T0CIN-DIABETIC RATS.
M. D'Amato, D. Currö. In s t itu te  of Pharmacology, Catholic University 
School of Medicine, Largo F. V ito , 1 1-00168 Rome, ITALY.
Key words: diabetes, neuropathy, NANC innervation, stomach.
A lterations of gas tric  m o til ity  have been described in d iabetic  pa­
tie n ts  (Loo et a l . , 1984). A complexity of, progressive changes occurs in
adrenergic, serotonergic and peptidergic nerves of the gastro in testina l 
tra c t from diabetic ra ts (Bêlai et a l . , 1988). The aim of the present
study was to investigate whether d iabetic neuropathy occurs in non-adre- 
nergic non-cholinergic (NANC) in h ib ito ry  innervation of the gastric  fundus 
from streptozotocin-d iabetic (D) rats at d iffe re n t stages of disease. 
Since VIP, and possibly Peptide H istid ine Isoleucine amide (PHI), c o n tr i­
bute to the NANC in h ib ito ry  innervation in the ra t gastric  fundus (D'Amato 
et a l . , 1990), the e ffe c t o f VIP and PHI was also studied.
Diabetes was induced in adult male Wistar rats (300-400 g) by a single
i.p .  in jec tion  (65 mg/kg) of s treptozotocin . Controls (C) consisted of 
untreated animals of the same in i t ia l  weight range. Auxotonic responses 
were measured from longitud ina l muscle s tr ip s  from the gastric  fundus 12 
and 25 wk a fte r induction o f diabetes. The s tr ip s  were suspended in Krebs 
solution at 37°C, bubbled with 95% 02 and 5% C02. Atropine 1 pM, guanethi- 
dine 50 pM and Prostaglandin F2a 1 pM were present throughout the experi­
ment. A ll relaxatory responses were expressed as a percentage o f the 
re laxation induced by SNP 35 pM administered at the beginning o f the 
experiment to normalize the resu lts , expressed as mean ± S.E.M. Data from
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C and D from 12- and 25-wk groups were compared by ANOVA. A level of 
p robab ility  <0.05 was considered to be s ig n if ic a n t.
E lectrica l f ie ld  stim ulation (EFS, rectangular biphasic pulses, 1 
msec, 120 mA, supramaximal voltage), induced a frequency-dependent relaxa­
tio n  (0.25-8 Hz) in a l l  groups of preparations. The amplitude of the 
relaxation was s ig n if ic a n t ly  smaller in D than in C at each, but the 
highest frequency of stim u la tion  both in 12- and 25 wk groups. No d i f fe ­
rences were observed between 12- and 25-wk groups of D ra ts . VIP (0 .3- 
300nM) and PHI (10nM-lpM) induced a concentration-dependent re laxation. At 
equieffective concentrations, VIP was about 30 times more potent than PHI.
The present study measured the NANC re laxation of gastric  fundus at 
d iffe re n t stages of diabetes. The defective re laxation found only during 
EFS of the NANC in h ib ito ry  neurones, but not on application of th e ir  
pu tative neurotransmitters VIP and PHI, c le a rly  indicate the occurence of 
d iabe tic  autonomic neuropathy of the NANC in h ib ito ry  neurones from the ra t 
gas tric  fundus. The nerve damage is  accomplished by functional impairment 
th a t might thus account fo r  the a lte ra tions o f gastric  m o til ity  described 
in  diabetic patients. As no differences were observed between 12- and 25- 
wk groups of 0 ra ts , we might speculate tha t the functional impairment 
does not increase progressively during the course of the disease. 
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EXOCYTOSIS AND MEMBRANE RECYCLING IN ADRIAMYCIN-TREATED RAT PERITONEAL MAST 
CELLS.
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During the process of secretion by exocytosis, secretory granule 
membranes fuse with the plasma membrane of the cells; subsequently, the 
excess membrane must be retrieved from the cell surface to restore the 
normal dimension of the plasma membrane, by an endocytosis like process. 
This process is known as exocytosis-endocytosis coupling. The mast cell 
provides a cellular system in which secretion can be induced by numerous 
stimulants under controlled conditions. Recently it has been shown that the 
antineoplastic drug adriamycin is a potent noncytotoxic histamine liberator 
(Decorti et al., 1986). In addition, adriamycin exhibits a very high 
affinity for mast cells, and adriamycin uptake and histamine release are 
strictly correlated (Decorti et al., 1989).
The aim of the present study was therefore to evaluate if, during 
exocytosis, a specific adriamycin-binding site is exposed on the cell 
surface, and if this phoenomenon could be responsible for the high affinity 
of adriamycin for mast cells.
Purified rat peritoneal mast cells were used for all experiments. 
Histamine realease and adriamycin binding (0 °C) and uptake (37 °C) were 
measured by the spectrofluorimetric methods of Shore et al. (1959) and 
Bachur et al. (1970) respectively.
Incubation of mast cells at 0 °C with adriamycin 50 ug/ml for 10 min 
resulted in a limited binding of the antineoplastic drug. However, if mast 
cells were stimulated to secrete with compound 48/80 (1 ug/ml) at 37 °C for 
10 min, chilled and then treated with adriamycin (50 ug/ml) at 0 °C, more
than 5-fold greater binding of the drug could be observed. Permeabilization 
of mast cells with saponin resulted in a high binding of adriamycin, even if
the uptake was prevented (0 °C, prefixation with p-formaldehyde). Similar
results were obtained when mast cells were disrupted by sonication, and 
hence the granule membrane was exposed.
The carboxylic ionophore monensin, which mediates proton movements across 
membrane, had no effect on adriamycin binding (0 °C, sonicated cells), but 
blocked, in a time and concentration dependent fashion, receptor mediated 
uptake of the antineoplastic drug. Adriamycin uptake was an energy dependent 
process, and w$.s completely inhibited by antimycin A (1 uM); on the contrary 
antimycin A had no effect on the binding of the anthracycline.
These results indicate that the great majority of adriamycin binding 
sites in mast cells are not exposed in basal conditions, but become evident 
when these cells are stimulated to exocytate, either by adriamycin or by 
other secretagogues, permeabilized by saponin, or disrupted by sonication.
Acknowledgements: supported by grants from Ministero della Pubblica Istru- 
zione and C.N.R. Progetto Finalizzato Oncologia contract n° 88.00509.44.
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IDAZOXAN AND CH-38083 AFFECT GASTRIC SECRETION BY INHIBITING ALPHA-2 
ADRENOCEPTORS AT VAGAL AND SYMPATHETIC PATHWAYS
M. Del Tacca, C. B landizzi, M.C. Bernardini and S.E. V iz i*
In s titu te  of Medical Pharmacology, University of Pisa, Via Rorna 55, 1-56100 
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Sciences, Szigony Utca 43, H-1450 Budapest, Hungary
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Introduction - The concept that alpha-2 adrenoceptors are involved in the
regulation of acid secretion is  mainly based on the in h ib ito ry  e ffec ts  of
alpha-2 agonists (Del Tacca et a l . ,  1982). However the mechanisms by which
alpha-2 adrenoceptors influence acid secretion are s t i l l  unclear. The
present study investigates the e ffects of idazoxan and CH-38083, two
selective alpha-2 antagonists (Doxey et a l . ,  1983; V izi et a l. ,  1986), on
acid secretion during vagal and sympathetic ac tiva tion .
Materials and Methods - Experiments were carried out in stomach 
lurnen-perfused rats (200-220 g, 24 h fasting) anaesthetized with urethane 
(1.2 g/kg i . p . ) .  Under these conditions urethane potentiates basal 
sympathetic a c t iv ity  (Ernas, 1964). The vagus nerves were cut at the
cervica l level and the acid secretion was evoked by continuous e le c tr ic a l 
stim ulation of the le f t  vagus nerve (0.5 msec, 3 Hz, 10V). The same 
procedure was performed in a group of animals treated with reserpine (2 
mg/kg i.p .  20 h before the experiments). The significance of d ifferences 
between means was evaluated by Student's t - te s t  fo r unpaired data. Each 
value refers to 8-10 experiments.
Results - E lec trica l vagal stim ulation rap id ly  increased acid output (from 
5.3+1.2 to 31.4+4.2 (ufqH+/15 min; n=10; p <  0.05). Both idazoxan and
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CH-38083 (1 mg/kg i . p . ;  n=8 fo r each drug) caused a s ign ifican t increase in 
vagal hypersecretion (from 31.4+4.2 to 42 .H 3.9  and to 52.3_+5.3 fiEqH /15 
min, respectively; p < 0.05). At the dose o f 3 mg/kg i.p . both the 
antagonists gave e r ra t ic  resu lts . When a combined i .v .  infusion of prazosin 
(0.5 mg/kg/h) and propranolol (0.5 mg/kg/h) was given, both idazoxan and 
CH-38083 (3 mg/kg i . p . ;  n=10 fo r each drug) s ig n if ic a n tly  potentiated vagal 
hypersecretion (from 31.4+4.2 to 45.5+5.2 and to 56.6+5.9 |oEqH+/15 min, 
respective ly; p< 0 .05 ). In reserpinized ra ts  both idazoxan and CH-38083 (1
rug/kg i .p . ;  n=8 fo r  each drug) did not a ffe c t vagal hypersecretion. 
Discussion - The present potentiating e ffe c t of both idazoxan and CH-38083 
a t low doses on vagal hypersecretion was prevented by reserpine; th is  may 
ind icate that during a sympathetic activa tion  alpha-2 adrenoceptors play an 
in h ib ito ry  role on acid secretion at vagal peripheral s ites. Moreover, the 
resu lts  obtained in the presence of a combined treatment with prazosin and 
propranolol suggest tha t higher doses o f both idazoxan and CH-38083 might 
potentiate an in h ib ito ry  influence on acid secretion through the blockade 
o f alpha-2 adrenoceptors on sympathetic nerve pathways.
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INTERACTION OF ADENINE NUCLEOSIDES IN THE CANINE MESENTERIC CIRCULATION
István Dobi, V io le tta  Kékesi and Alexander Juhász-Nagy. Cardiovascular 
Surgical C lin ic , Semmelweis University Medical School, Budapest, Hungary
Keywords:adenosine,inosine,mesenteric blood flo w ,in te s tin a l vasodilation
Inosine (INO) in  small doses markedly potentiates the adenosine (ADO)- 
-induced coronary vasodilation(a) and "immunizes" the la tte r  e ffec t against 
methylxanthine blockade(b); larger doses of INO are capable of d ila t in g  the 
coronaries maximally(c). This t r ip le t  o f INO-actions is  thought to be cen­
t r a l  to the general nucleoside theory of vascular adaptation in  the heart 
muscle (Kékesi 1987). Presupposing d is t in c t ly  d iffe re n t in teractions in  the 
splanchnic c ircu la tion  where peptidergic neural mechanisms of adaptation 
seem more important than d irec t metabolic coupling (Rózsa and Varró 1989), 
the actions of adenine nucleosides were investigated in the mesenteric bed.
Methods In dogs anesthetized with pentobarbita l a large segment of the 
small bowel (167_+29 g) was exteriorized and a flow probe (Statham SP) was 
positioned on i ts  a rte ry . ADO and INO were infused in tra a r te r ia lly  to  5 dogs 
through a th in  (23 gauge) indwelling needle in  dose ranges of 6-200/ug min  ^
and 1.25-20.0 mg min  ^ respectively. To block purinoceptors, aminophylline 
was in jected in a single dose (6 mg kg j  i . v . ) .  Responses to drugs were cha_r 
acterized by changes of mean flow and calculated vascular conductance. The 
threshold INO dose was determined in  each dog according to the la t te r  term. 
Homogenity of vasodilation was contro lled  by computer-aided in frared th e r­
mography using an AGA 750 camera.
Results and Discussion The resting leve ls  of blood flow (0.74+0.12 
ml min  ^ g ■*■) and mean blood pressure (151+8 mmHg) remained essen tia lly  un­
changed throughout the interventions. Moreover, since systemic pressure was 
l i t t l e  affected by the nucleosides, percent changes in  flow and conductance 
were p ra c tica lly  id e n tic a l. The mesenteric vascular responses to ADO, INO, 
and ADO + the threshold dose (2.5-5.0 mg min *) of INO are shown in  F ig . 1.
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Fig. 1. Changes o f mesenteric blood flow (MBF) plotted against calculated 
nucleoside levels in  the a r te r ia l blood. Molar plasma concentrations (a r­
rowheads) are also ind ica ted . Insert: Dose response curves. INO-induced 
potentia tion  was not s ig n if ic a n t (p>0.05) at any of the points.
Ind iv idua l measurements as well as dose response curves indicated that INO 
was nearly in e ffe c tive , and that the trend fo r  INO-induced potentia tion of 
the ADO effect was s l ig h t .  This is  in sharp contrast with the coronary e f­
fec ts  of INO. At the same time, ADO, in  i t s e l f ,  e lic ite d  very great in tes­
t in a l  flow increases a t concentrations which were less, by about one order 
o f magnitude, than those obtained in the a r t i f i c ia l l y  perfused mesenteric 
bed. (Granger et a l.  1978). Thus, the e fficacy  of ADO in  the mesenteric 
c ircu la tio n  was comparable to that in the coronaries. Aminophylline was 
found to block s im ila r ly  both control and INO-backed flow responses (86^8 % 
vs 81+6 % blockade p > 0 .5 ) .  Taken together, in  sp ite  of the great potency 
o f ADO fo r inducing vasod ila tion , the lack o f sp e c ific  INO-actions renders 
h igh ly  improbable the c ru c ia l role of adenine nucleosides in  the metabolic 
autoregulation of the in te s t in a l vessels.
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CHRONOTROPIC AND INOTROPIC EFFECTS OF MILRINONE AND CONGE­
NERS: COMPARISON WITH PDE III INHIBITION.
P.Dorigo, M.Floreani, P.Belluco, R.M.Gaion and F.Carpenedo 
Department of Pharmacology, University of Padova, Italy.
Key words: milrinone analogs - guinea pig atria - PDE III.
Amrinone and milrinone are bipyridine derivatives with well established 
positive inotropic activity. An antagonism towards endogenous adenosine 
and a selective phosphodiesterase (PDE III) inhibition are part of their 
complex mechanism of action. However, the extent to which each of these 
mechanisms is involved in the cardiac effects of these drugs is still unclear. 
In the attempt to obtain a new compound with defined mechanism of action 
and with consequent more specific therapeutic indications, milrinone was 
taken as the parent drug for the synthesis of various analogs. The pre­
sent study was undertaken in order to evaluate the effects of these new 
molecules on heart preparations and on PDE III activity.
For the evaluation of inotropic and chronotropic effects, spontaneously 
beating atria obtained from reserpine-treated guinea-pigs (2 mg/Kg i.p. 
daily for 2 days) were used. The atria were suspended in organ baths 
containing 30 ml of Webb solution maintained at 29° C (pH 7.5). For the 
evaluation of drug effects on PDE, PDE III was prepared according to 
Kariya et al (1982) and assayed according to Thompson et al (1974).
Compounds I and II are esters of 2-substituted 5-cyano-l,6-dihydro-6- 
oxo-3-pyridinecarboxylic acid. Compound III is a 6-substituted of 5-aryl- 
1,2 dihydro-2-oxo-3-pyridinecarbonytrile. Compounds IV and V are a 7,8- 
dihydro-2,5(lH,6H) quinoline-dione and a 5-aryl-2(lH)-pyridinone deriva­
tive, respectively.
The results are reported in table I and can be summarized as follows :
- like milrinone, compounds I-IV increased the force and the rate of con­
traction in guinea-pig isolated atria and inhibited PDE III activity. By 
contrast compound V exerted negative inotropic and chronotropic effects 
and didn't modify PDE III activity. The relative potencies (EC5Qs) and the 
maximum activities of these molecules indicate that:
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Table I. Potency and activity of milrinone and milrinone analogues. 
Compound EC50 Emax
(% of control)
Inotropism Chronotropism PDE III Inotropism Chronotropism
milrinone 32 80 2 + 48 + 30
I 13 120 10 + 63 + 31
II 17 240 65 + 43 + 33
III 60 240 23 + 65 + 23
IV 70 320 760 + 46 + 26
V 120 200 - - 46 - 41
- milrinone and its derivatives affected cardiac inotropism more than the 
rate of contraction, as indicated by the differences in EC50S and Emax 
for the two effects;
- comounds I and II, with a -CN group in 5 position, were the most po­
tent in terms of cardiac effects, but not as inhibitors of PDE III activity;
- the order of potency as inotropic or chronotropic agents was different 
from the one as inhibitors of PDE III activity;
These data suggest that, if PDE III inhibition is related to the inotropic 
effect of these compounds, it is not the sole mechanism involved.
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CONTINUOUS MEASUREMENT OF LOCOMOTOR ACTIVITY OF SMALL L A B O R A ­
TORY ANIMALS
Gy. Dura, L.E. Csorbáné, G. Mayer, D. Polinák 
National Institute of Hygiene, Budapest, Hungary 
locomotor activity, neurotoxicity
Because of the increasing demand of continuous measurement of 
c h e m i c a 1-induced motor activity of rats and mice (Schaeppi, 
1988) a monitoring system was developed and evaluated e n ­
abling registration of experimental activity without experi- 
mentator’s intervention. The plastic r a t ’s cages are placed on 
the spring-mounted plates with vibration-sensitive detectors 
similarly to those proposed by Cizadlo and Bown (1980). The 
converted signals are accumulated by a microprocessor based on 
Intel 8085 for the preset intervals. The equipment consists of 
8 separate units. There is an option to differentiate the 
total movements from gross one. The measures were conducted in 
a conventional animal room.
Some factors influencing on motor activity were studied. It 
was found that the adaptation of experimental rats to a new 
cage lasted for 4 hours. There are more advantages of r e g i s ­
tration of motor activity of animals in group then those in 
singly held animals. The system is suitable to the circadian 
rhythm analysis of motor activity. The accumulated values for 
4 hours epochs in dark period proven to be 300-400 X higher 
than in light span. The physiological variations remained 
within 20 % during the 2 weeks continuous observation.
The reproducibility of measurements were tested by amphetamine 
and chlorpromazine treatment. The relatively small doses (1.5
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and 3 mg/kg) of amphetamine administered by i.p. injection 
enhanced the locomotor activity over 3 hours after treatment. 
6 mg/kg dose produced repetitive stereotyped behavior and in­
creased the activity up to 3.5 times. Dose-dependent d e c r e a s ­
ing was observed in chlorpromazine administered rats.
□ur aim was to demonstrate the extent to which locomotor a c ­
tivity was affected by toxic chemicals. The motor activity 
measurement was followed immediately the acute i.p. exposure 
to carbon tetrachloride (2.0 g/kg), h e x a c h 1orophene (50 mg/kg) 
and cadmium chloride (1.0 mg/kg). Continuous measurement was 
performed throughout 3 days after treatment. After transient 
enhance caused by carbon tetrachloride in the activity c o m p a r ­
ing to the baseline (pre-exposure) value a considerable d e ­
crease was observed in 3 hours time after treatment. On the 
3rd day only h e x a c h 1orophene produced significant reduction in 
the act i V i t y .
Our results emphasize the potential value of using 24-hour 
continuous home cage locomotor activity measure for studies of 
the neurobehavioral effects of toxicants. The characteristic 
daily motor activity pattern indicates that the time of t est­
ing may be important in determining the effects of chemicals 
on motor activity.
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NEGATIVE FEEDBACK MODULATION OF NORADRENALINE RELEASE FROM THE
SPLEEN
Ilia Elenkov and E. Sylvester Vizi
Institute of Experimental Medicine, Hungarian Academy of Sciences
Budapest, Hungary
Key words: noradrenaline release, spleen, alpha-2 receptors
The stimulation evoked release of noradrenaline (NA) from 
noradrenergic axon terminals is subject to presynaptic negative 
feedback modulation. (E.S.Vizi, 1979, 1984; K.Starke, 1981). It
was shown that this feedback modulation is mediated via
presynaptic alpha-2 adrenoreceptors. This fact indicates that NA, 
released from the axon terminals is able to reduce its own 
release evoked by subsequent stimulation.
The modulation of NA release from isolated rat spleen 
strips was investigated. Rat spleen strips, kept in Krebs
3
solution, were loaded with H-NA, superfused and stimulated 
electrically (8 Hz, 480 pulses). The effect of drugs on ^H-NA 
release was studied on Sg/S^ ratio. The drugs were administrated 
15 min before Sg . A computer programme was used to calculate 
fractional release. The tissue content of radioactivity was 
439431 Bq/g + 47194 (n=3). Electrical stimulation released
3.20 + 0.21 % of the total radioactivity (n=3).
The effects of different alphal and alpha2 agonists and 
antagonists on NA release were studied. Table 1 shows the data
90
obtained. CH-38083 (0.02 uM - 2 uM), a highly selective alpha-2
antagonist (E.S.Vizi et a l . 1986) enhanced the stimulation-evoked 
release of NA in a concentration dependent manner. L- 
phenylephrine, an alpha-1 agonist enhanced both resting and 
stimulated release of NA. In addition it was found that the Mg- 
muscarinic and nicotinic receptors are present on the axon 
terminals and exert an inhibitory and stimulatory effect 
respectively. Oxotremorine (Mg agonist;1 uM) reduced the release 
of NA enhanced by alpha-2 antagonist (C H - 3 8 0 8 3 ; 0.02 u M ) .
It is suggested that alpha-2 and Mg- receptors are present 
on noradrenergic neurons and located on the same nerve terminals.
Table 1 .
3Effect of different agonists and antagonists on H-NA release
Drugs (uM) n s2/s1 Signi f i cance
Control - 3 0.94 + 0.03
CH-38083 0.02 3 1.98 + 0.18 P * 0.01
CH-38083 0.1 3 2.12 + 0.18 P < 0.01
CH-38083 0.5 3 2.49 + 0.24 P < 0.01
CH-38083 0.02
+ Oxotremorine 1 . 0 1 0.80 -
Oxotremorine 1 . 0 3 0.44 + 0.02 P < 0.001
DMPP 100.0 2 3.53 + 0.85 P < 0.01
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PAPAVERINE BLOCKS THE EARLY OUTWARD CURRENTS IN HELIX NEURONS 
L. ERDÉLYI, DEPARTMENT OF COMPARATIVE PHYSIOLOGY,
ATTILA JÓZSEF UNIVERSITY OF SCIENCES, H-6726 SZEGED, KÖZÉPFASOR 52, 
HUNGARY
Key words: papaverine, fast potassium current, snail neurons
Papaverine has been reported to exert either blocking effects 
on fast Na+ and slow C a ^  currents in guinea pig heart, Schneider 
et al.,/1975/ or facilitatory actions on the c AMP-induced trans- 
membrane current in Helix neurons, Kononenko et al., /1986/.
Papaverine is structurally retated to verapamil. However, the latter 
does not possess phosphodiesterase inhibitor activity but can modulate 
the potassium currents in molluscan neurons, Kostyuk et al., /1975/.
The effects of papaverine on the resting membrane potential, 
action potertial and fast outward currents were examined in snail 
neurons under current- and voltage-clamp conditions. The detailed 
methods concerning the physiological preparation, the electrophysio- 
logical recording and the solutions were published previously,
Erdélyi and Such, /1986/.
As can be seen in Figure 1A, papaverine /1 mM,10 min/ slightly 
depolarized the neuronal membrane and prolonged the action potential 
duration. Under voltage-clamp papaverine decreased the amplitude 
of the А-currents in dose-dependent way /K^= 0.8 mM, n^= 0.6 / and 
increased the rate of the late decay component /Fig. 1B and C /. 
Papaverine did not influence the voltage-dependence of the steady-state 
activation and inactivation or 0 potential of the А-current. Other 
voltage activated membrane ionic currents, including leakage current 
were in much less extend influenced by papaverine in comparison with 
the effects found on the A-currents.
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Figure 1. Effects of papaverine on the resting membrane potential, 
action potential, membrane resistance / 1 mM, 10 min, A / and the 
early outward currents / 0.5 mM, 10 min, В /. А-currents were 
estimated by depolarizing voltage steps from a holding potential 
of —50 mV to -25 mV in incremmts of 5 mV with preceding hyper- 
polarizing pulses of 500 ms duration to -100 mV. a= control responses; 
b= test responses. Papaverine induced attenuation of the A-currents 
is a dose-dependent event / K.= 0.8 mM, C /. Calibrations: 20 mV,
10 ms and 25 nA for A; 50 mV, 100 ms and 25 nA for B.
The experimaits show that papaverine has an inhibitory action on 
the A—currents in Helix neurons which corresponds with a moderate 
prolongation of the APD and a decrease of the spike threshold voltage.
The verapamil-induced actions differ from the papaverine evoked events 
on the А-currents, Kostyuk et al., /1975/. Both drugs contain methoxyben- 
zene groups which determine the effectiveness of the verapamil 
molecule but does not the papaverine one on the А-currents, Erdélyi 
and Such, /1989/.
L.Erdélyi and Gy. Such: Comp. Biochem. Physiol., £ ÿ ;  /1986/ 319-327; 
L.Erdélyi and Gy. Such: Neurosci. Letters,102 /1989/ 44—49.
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EFFECT OF AMPRILOSE ON VARIOUS IMMUNOLOGICAL AND INFLAMMATORY
ANIMAL MODELS
F. ERDŐ, К. TÖRÖK, Z. NÉMETH, J.J. SZÉKELY, J. BORSY, E. CSÁNYI
INSTITUTE FOR DRUG RESEARCH, BUDAPEST, HUNGARY
Keywords: amprilose, macrophag function, antirheumatic action
Amprilose, a low molecular weight immunopotentiator (1,2-0- 
isopropylidine-3-O^"3 '-(N,N'-dimethylamino)-propyl^-D-glucofura- 
nose HCL) has been found effective in the treatment of rheuma­
toid arthritis without considerable side effects (Caldwell et 
al., 1987).
The aim of our experimental studies was to find out the dose 
dependent spectrum of immunological and antirheumatic effects 
of this compound on animal models.
The effect on T and В lymphocyte functions was measured in 
mice by means of the following tests: delayed type hypersensi­
tivity, SRBC induced heterohemolysin and hemagglutination ti­
ters. Amprilose failed to influence the functional responses of 
lymphocyte. Supression of macrophage functions (phagocytosis 
and chemiluminescence test) was, however, detected at 200 mg/kg 
ip. dose level of amprilose. These data are in accordance with 
those described by Hopkins (1985) in his survey.
The antiinflammatory and antirheumatic studies were performed 
using the carrageenan edema test (Winter et al., 1962) and the 
adjuvant arthritis model (Newbould, 1963) in rats. In short 
term study amprilose failed to inhibit edema formation but in 
the case of subacut treatment high, 300 and 1000 mg/kg ip. do­
ses resulted in a significant inhibition. In further studies 
amprilose produced a dose dependent inhibitory effect on the 
FCA induced adjuvant arthritis model. In a three week study 
oral doses of 30 mg/kg/day caused a stimulation while 1000 
mg/kg/day exerted a marked inhibition on the development of 
immunarthritis (Table 1.)
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Table 1.
Effect of amprilose on the paw wolume of rats on adjuvant 
arthritis test
Treatment (n) Dose
mg/kg
p.o.
Means of p^wvolume 
increase - S. E. 
(unit)
Action
(%)
Control (15) - R: 100.6 + 7.37L: 40.9 - 6.40
Amprilose (13) 30 R: 103.9 + 8.39 + 2.7L: 58.6 8.90 + 43.4 x
Control (11 ) - R: 103.9 + 8.44
L : 56.2 - 5.85
Amprilose (12) 300 R: 107.8 + 9.23 + 3.7L: 48.3 0.57 14.1
Control ( 8) - R: 112.9 + 10.86L: 49.8 - 9.24
Amprilose (10) 1 000 R: 94.5 + 7.24 - 16.3L: 23.4 8.48 53.0 X X
R = right leg: primer inflammation ; L = left leg immunoinflammation ; X :  p< 0. 1 ; XX : p< 0. 05 on Duncan's test
In conclusion the study revealed the selective macrophage 
directed as well as antirheumatic effects of amprilose wich 
failed to have any action on the T and В lymphocyte dependent 
immunological and on the prostacyclin dependent short term 
antiinflammatory tests.
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THE DOSE-RELATED HYPOTENSIVE EFFECT OF HIGHLY PURIFIED BOVINE 
LIVER ANGIOHYPOTENSIN IN NARCOTIZED NORMOTENSIVE RATS
I. Faragó, I. Miklya, J. Knoll
Department of Pharmacology, Semmelwein University of Medicine 
Budapest, P.O.B. 370, 1445 Hungary
Keywords: angiohypotensin, rat blood pressure, hypotensive 
effect
Angiohypotensin (AH) is a blood-borne selective inhibitor of 
the release of noradrenaline from the nerve terminals of resis­
tance vessels. The existence of the substance in the blood 
which inhibits the release of noradrenaline with high selecti­
vity in resistance vessels, the fact that the effect of AH is 
readily reversible, the onset and offset of the effect is ex­
tremely rapid, no tolerance to this effect develops and blood 
pressure can be decreased to a reasonable limit only, led to 
the hypothesis that AH is a continuously acting, highly speci­
fic brake in resistance vessels operating as a putative tuning 
mechanism for controlling peripheral resistance (Knoll, 1987,
1988) .
Recently highly purified AH preparations (containing 3000- 
3500 units/kg) were elaborated from bovine liver. The aim of 
the study was to measure the hypotensive effect of bovine liver 
angiohypotensin on normotensive rats anaesthetized with uretha­
ne (1 g/kg).
Animals of both sexes weighing 300-350 g were used in this 
study. AH was injected in single doses into the femoral vein. 
Blood pressure was measured in the carotic artery.
Blood pressure decreased within a few seconds after the in­
9 6
travenous injection of highly purified bovine liver AH. The mag­
nitude of the effect, as well as, its duration depended on the 
dose given. The lowest dose range which exerted a visible dec­
rease in blood pressure was found to be between 1-3 units/kg. 
After finding the lowest detectable dose we checked the effect 
of 10-50-100-250-500-1000-3000 units/kg. The initial blood 
pressure was usually betv/een 105-125 Hgmm. The blood pressure 
decreased in response to the injection of AH in a dose-depen­
dent manner between the 10-250 units/kg dose range. In response 
to the 250 units/kg dose blood pressure usually declined to 75- 
80 Hgmm, as the lowest, level and the hypotensive effect dis­
appeared within a few minutes. Normal blood pressure (105-120 
Hgmm) was reestablished after each injection of AH. The further 
rise of the dose (500, 1000 and 3000 units/kg) did not lower 
blood pressure significantly more than the 250 units/kg dose, 
though, the recovery was a bit longer lasting. Even after these 
high doses of AH, blood pressure was resumed to the initial 
level. After the reestablishment of blood pressure from the 
decrease caused by the 3000 units/kg dose, we checked again the 
effect of 10 units/kg AH and found it to be as effective as it 
was at the beginning of the experiment.
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COMPUTERIZED INTERACTIVE CONTINUOUS MONITORING OF CARDIAC 
ARRHYTHMIAS WITH THE SM 2000H SYSTEM
T. Fazekas^, I .  U n g i \  M. Rohla^
1s t Department o f M e d ic in e , S zen t-G yö rgy i  A lb e r t  U n iv e r s i ty
M ed ica l S choo l^ , Szeged; 3rd Department o f M ed ic ine ,2
Semmelweis U n iv e rs ity  M ed ica l School , Budapest/Hungary
The a rrh y th m ia -a n a ly s in g  system developed by Rohla e t a l .
(3 rd  Dept, o f M e d ic in e , Semmelweis U n iv e rs ity  M edica l S ch o o l, 
Budapest) has proved o f va lue  in  o b s e rv a tio n s  on in te n s iv e  
care p a t ie n ts  and in  c l i n i c a l  p h a rm a co lo g ica l s tu d ie s .  The 
a rrh y th m ia  program can be run on a p e rsona l computer (IBM AT 
/40  M bytes, W in c h e s te r /,  C language) and is  s u ita b le  fo r  the  
s im u ltaneous  re a l- t im e  m o n ito r in g  o f one p a t ie n t  to  s a t is f y  
s c ie n t i f i c  re q u ire m e n ts . The program is  based on r e c o g n it io n  
o f the  QRS com plexes, t h e i r  i d e n t i f i c a t io n ,  measurement o f 
the  RR in te r v a ls ,  f i l t e r i n g  o f the  T wave and o b s e rv a tio n  o f 
the  ST segment. The new program v a r ia n t  a lso  p e rm its  v is u a l ­
iz a t io n  o f the  P waves w ith  an o p t io n a l le v e l o f m a g n if ic a ­
t io n  o f the  re c a lle d  ECG. The in d iv id u a l  a rrh y th m ic  e ven ts  
can be documented in  a u to m a tic  or in te r a c t iv e  o p e ra tin g  mode, 
and the system is  a b le , a f te r  r e d e f in i t io n  o f the QRS c a te g o ­
r ie s ,  to  sepa ra te  the  ’ a b e r r a n t ly ’ conducted s u p ra v e n tr ic u la r  
beats and the  v e n t r ic u la r  e x tra s y s to le s ,  fo r  in s ta n c e . I t  is  
p o s s ib le  to  s to re  the  v a r io u s  QRS m orpho log ies , and to  ob ­
serve and c a lc u la te  a l l  o f the  a rrh y th m ia  c a te g o r ie s  o i im ­
po rtance  in  c l i n i c a l  p r a c t ic e .  From the aspect o f the  i n t e r -
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p r e ta t io n  and tre a tm e n t o f v e n t r ic u la r  a r rh y th m ia s , i t  is  
o f te n  o f d e c is iv e  im p o rta n ce  to  re co g n ize  some s y s te m a tic  
c o r r e la t io n  ( " s t r i n g " )  in  the a p p a re n tly  c h a o tic  e x tra s y s -  
t o l i c  a c t iv i t y .  The com puter program and the  m athem atica l 
model pe rm it r e c o g n it io n  o f the v e n t r ic u la r  p a ra s y s to le  and 
s im u la t io n  o f the  m odu la ted  p a ra s y s to lic  a c t i v i t y  w ith  g iven  
i n i t i a l  c o n d it io n s . The a rrh y th m ic  e ve n ts  can be s to re d  on 
th e  b a s is  o f p re v io u s ly  s p e c if ie d  c r i t e r i a  (s a v in g  on hard 
d is c s  or flo p p y  d is c s ) ,  they  may be ana lysed  r e t r o s p e c t iv e ly  
a t  w i l l ,  the s to re d  e ve n ts  may be s c r o l le d  fo rw a rds  and 
backwards in  t im e , and the  more in te r e s t in g  p e rio d s  may be 
su rveyed  aga in , w ith  p r in t in g - o u t  in  o p t io n a l s iz e .  S lid e s  
can be prepared from  th e  co lou red  m o n ito r .
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EFFECTS OF RESTACORINx (B-GYKI-38233) A NEW ANTIARRHYTHMIC AGENT IN A 
CORONARY OCCLUSION-REPERFUSION CANINE MODEL
G. Fehér, ЕЛ. Takács, XT. Seres
Dept, of Pharmacology, BIOGAL Pharmaceutical Works, xI I I r d  Internal Med. 
Debrecen Medical School, Hungary
Key words: Restacorin,B-GYKI-38233,arrhythmias,antiarrhythmic agent
Restacorin (1—(2 ,6 ,-dimethylphenyl)-4,4-dimethyl-aminoguanidine hydro­
chloride) is  a newly synthesized antiarrhythmic compound. In vivo 
studies in  ra ts , guinea pigs and dogs have demonstrated that Restacorin 
given by ora l or parenteral route has a potent and long lasting  
in h ib ito ry  action against supraventricular and ven tricu la r arrhytmias 
(Varró et a l . ,  1987; Rabloczky et a l. ,  1988; Ohmura et a l. ,  1980).
We studied the e ffec ts  of Restacorin in open chest dogs. A 15-min 
lig a tio n  of ramus descendens anterior (LAD) was applied and when no 
ven tricu la r f ib r i l la t io n  occured, the myocardium was reperfused fo r 60 
minutes. The protective e ffects of B-GYKI-38233 was evaluated by 
comparison of a contro l group I  (n:17) and two treated groups I I  (n:7) 
and I I I  (n :8).
Group I I :  0.2 mg/kg/min ra te  infusion fo r 45 minutes (from 15 min
before coronary occlusion to 15 min a fte r reperfusion)
Group I I I :  4.0 mg/kg iv .  bolus administration 5 min before occlusion.
Restacorin did not re su lt in s ig n ifica n t change in hemodynamic 
parameters: AMBP, LVSP, +dP/dtmax and HR. Regional con trac tile  function 
(measured by s tra in  gauge) was reduced s ig n if ic a n tly  by 22% and 28%, 
respectively (negativ ino trop ic  action) and myocardial oxigén demand- 
(PRP) decreased at 15 and 5 minutes, respectively a fte r  the treatment.
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There was no s ign ifican t d ifference between contro l and treated groups 
in  co n tra c tile  function a fte r  reperfusion of severe ischemic segment. 
Recovery was 50% of preischemic value a fte r 60 minutes of reperfusion in 
a l l  three groups.
Pretreatment was unable to  protect against incidence of early severe 
arrhythmias (VT-VF) induced by coronary o c c lu s io n ,(I.6/17 vs. I I . 4/7 vs. 
I I I . 4/8) but reduced ectopic a c t iv ity  and the severity of ex is ting  
arrhythmias. Reperfusion VF did not occur in  group I I I  compared to group 
I :  5/11 (45%).
Our data suggest tha t 4 mg/kg iv .  pretreatment can increase the 
s u rv iv a l, but treatment o f ex is ting  arrhythmias (ongoing study) can be 
more e ffec tive  when VT or VF does not occur immediately at 3 minutes or 
between 10-15 minutes of the occlusion period.
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THE BEHAVIOR OF CH-38083 ON PUTATIVE ALPHA-2 ADRENORECEPTOR SUBTYPES 
E. Fejér, К. Botos, P.Sz. Körmöczy, and J. Gaál
CHINOIN Pharmaceutical and Chemical Works Co. L td ., Budapest, HUNGARY 
(CH-38083,alpha-2 adrenoceptor subtypes,h. p la te le t ,neonatal ra t lung)
CH-38083 is  an antagonist with high s e le c tiv ity  and s p e c if ic ity  on 
alpha-2 adrenoreceptors, V iz i et a l . ,  (1986).
However, there are several reports on the heterogeneity of alpha-2 
receptors. I t  was shown that the displacement pattern of E^HjYohimbine by 
Prazosin can be characterized by two d issocia tion constants (K ^  = 7 nM; 
Kd2 = 273 nM) in  ra t brain, i.e .  two subtypes of alpha-2 adrenoreceptors
were id e n tif ie d . According to the Prazosin binding characteris tics these 
subtypes are present in equal ra tio  in  the ra t brain. Human p la te le ts  
contain mainly the low a f f in ity  type (°^ 2A^  anc' the neonatal ra t lung has 
only high a f f in i ty  s ites ( c^ ej), Bylund (1985).
In the present work our purpose was:
1 .  ) to id e n tify  by binding studies the putative alpha-2 adrenoreceptor 
subtypes in ra t brain, neonatal ra t lung and human p la te le t membrane 
preparations.
2 . ) to clear whether CH-38083 possesses subtype s p e c ific ity  on alpha-2 
adrenoreceptors.
Rat brain (minus cerebellum) and neonatal ra t lung membranes were 
prepared by homogenization in 20 vols of bu ffe r (50 mM Tris/HCl; 
pH = 7.7, 25 °C, used throughout), f i l t r a t io n  through cheese-cloth,
centrifugation at 1000 g for 1 min and (2x) at 12000 g for 10 min. Human 
p la te le ts  were prepared according to the method of Enyedi et a l . ,  (1986). 
The membranes (0.2-0.4 mg protein) were incubated at 25 °C w ith 0.5 nM 
C^HjRauwolscine (Amersham, 85 Ci/mmol) fo r 45 min. Phentolamine (10-  ^ M)
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was used to define the ra t io  of spec ific  binding. The bound ra d io a c tiv ity  
was trapped on Whatman GF/C f i l t e r s  and washed w ith 3x5 ml ice-cold bu ffe r. 
The compounds were tested in  a concentrations range of 10~ -10~H m.
The experiments were evaluated by a поп-lin e a r curve f i t t in g  program, Batke 
and Gaál (1986).
The resu lts  are summarized in the fo llow ing table:
TISSUE Prazosin 
(Kd , nM)
L^HJRauwolseine
CH-38083 
(Kd, nM)
HUMAN PLATELET 2000Í 86 0.8Î0.036
RAT BRAIN 250i25 2.7±0.17
RAT LUNG 90Í3.3 l.OiO.04
A ltoge the r,
in  agreement with the resu lts of Lanier et a l, (1988) we were not able to
id e n t ify  high a f f in ity  binding s ites to Prazosin in ra t brain, only the 
о(,2д type was detectable. Using human p la te le t and ra t lung preparations i t  
was possible to demonstrate binding s ites  of high and low a f f in i t y ,  
revealing a considerable (22 x) difference.
However, CH-38083 was bound to the tested tissues with equally high 
a f f in i t y .  Therefore, lik e  other alpha-2 antagonists, CH-38083 does not have 
alpha-2  adrenoceptor subtype s p e c if ic ity .
J. Batke, J. Gaál J. Biochem. Biophys. Meth. 12. 203-212 (1986)
D. B. Bylund Pharmacol. Biochem. Behav. 22. 835-843 (1985)
S.M. Lanier, C.J. Homey, C. Patenaude, R.M. Graham 
J. B io l. Chem. 263. 14491-14496 (1988)
E. S. V iz i,  L.G. Hársing J r . ,  J. Gaál, J. Kapocsi, S. Bernáth, G.T. Somogyi: 
J. Pharmacol. Exp. Ther. 238. 701-706 (1986)
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Changes of GTP binding in hormone induced opiate or 
adrenergic sub sensitivity
M.I.K. Fekete, T. Szentendrei, Do, T, Kiem.;
EGIS Pharmaceuticals, Inst. Exp. Med., Hung. Acad. Sei., 
Budapest, Hungary
First in 1783 it has been published that a prolonged 
treatment with glucocorticoids or ACTH decrease the opiate 
agonist induced pituitary hormone release (Kanyicska et al. 
1983). The glucocorticoid induced decreased sensitivity is 
also demonstrable measuring 2 adrenergic responses.
Prolonged stress situation mimiced the effects of prolonged 
gucocorticoid treatment (Fekete et al. 1984.a). Certain 
nonendocrine effects, as well as changes of dopamine 
metabolism induced by morphine were also inhibited by 
glucocorticoids (Fekete et al. 1984.b). The decreased 
effectivity of iev given opioid peptide agonists as well as 
receptor binding studies suggest g lucocorticoid induced 
changes of receptor sensitivity, which could be demonstrated 
by selective kappa, mu and delta agonists measuring 
pituitary hormone release (Kiem et al. 1987). The daily 
alterations of endocrine responses evoked by opoid peptides 
run in dependence of the presence of adrenals in case of 
prolactin and ACTH/corticosterone release (Kiem et al.
1988), while in case of growth hormone release the daily 
rhythm seemed to be related to the testosterone release in 
male rats (Fekete et al. in press). Similarly the changes of 
adrenergic sensitivity under physiological conditions were
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mainly attributable to the endogeneus testosterone (Kiem,
Do, T. et al. 1990). In heterologue binding studies the 
high affinity binding site of alphas adrenergic receptors 
was not demonstrable and the amount of low affinity binding 
increased following hydrocortisone treatment. The high 
affinity site reappeared in the presence of БТР, in contrast 
the high affinity binding was depressed by GTP in the 
control préparâtes. In case of mu opiate bindig DAGO- 
morphine competition has been measured to reveal the posible 
altered binding characteristics. The binding affinity was 
decreased by the addition of GTP to the assay medium of 
membranes derived from saline treated rats. This effect of 
GTP disappeared when measuring the opiate receptors in 
cortisol treated animals. It is suggested that the 
biochemical mechanism of hormone induced receptor 
alterations is mainly explainable by changes of GTP binding 
during the transfer of information by the certain mediators. 
Decrease of adrenocortica 1 reactivity similar to that in 
glucocorticoid treated animals were described in depressed 
patients. We suggest that further investigation of the above 
described phenomena may lead to better understanding of 
biochemical mechanisms of illnesses.
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OPIATE PEPTIDERGIC NEUROTRANSMISSION AND CARDIOVASCULAR AND RESPIRATORY 
APPARATUS: EXPERIMENTAL RESEARCH WITH ß-ENDORPHIN AND DERMORPHIN ON
NORMOTENSIVE AND HYPERTENSIVE RATS
A. Filippelli, R. Marrazzo, V. Susanna, C. Losasso, D. De Santis, V. De 
Novellis, E. Marmo
Institute of Pharmacology and Toxicology (Head: Prof. E. Marmo) - 1st
Faculty of Medicine and Surgery - University of Naples - Italy
Key words: ß-endorphin, dermorphin, cardiovascular-respiratory apparatus
ß-Endorphin and related opiod peptides are involved in both central and 
peripheral cardiovascular regulation (Donatelli and Marmo, 1981). The 
dermorphin are a class of opiods isolated from the skin of some South 
American frogs (Montecucchi et ai., 1981) and from mammalian brain (Negri 
at al., 1981). The cardiovascular and respiratory effects of ß-endorphin 
and dermorphin have been evaluated in freely moving or anaesthetized 
(natrium pentobarbital 25 mg/kg ij>) male rats which were normotensive, 
spontaneously hypertensive and rendered hypertensive by DOCA 
administration. lev injections (3rd and right lateral ventricles) of ß- 
endorphin and dermorphin induced a transient arterial hypotension with 
sinus bradycardia. This was significantly antagonized by an iv 
pretreatment with naloxone, a competitive antagonist of p and к 
receptors. ICI 174864, a selective 6- opiod receptor antagonist, did not 
reduce the cardiovascular effects of ß- endorphin and dermorphin. Atrial 
natriuretic antipeptide IgG, _iy administered 5 min before, considerably 
reduced the cardiovascular changes caused by iev ß- endorphin and 
dermorphin. In hypertensive rats (both spontaneously and DOCA-induced)
the cardiovascular effects of 2 opiate peptides were more intense and
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lasted longer than those seen in normotensive rats.
lev injections (3rd and right lateral ventricles) of ß- endorphin and 
dermorphin elicited a significant respiratory depression which was 
antagonized by naloxone. In contrast, a 5 min pretreatment with ICI 
174864 or with atrial natriuretic antipeptide IgG did not modify the 
respiratory depression triggered by ß- endorphin and dermorphin.
In conclusion, the cardiovascular and respiratory depression induced by 
ß-endorphin and dermorphin involve the activation of p and к opiod 
receptors without any significant effect on 6- receptors. Since 
naloxonazine, an antagonist of p^-receptors, does not antagonize the 
respiratory depression caused by ß- endorphin and dermorphin, it is 
likely that the respiratory effects seen in the 2 opiate peptides involve 
y- receptors different from p - receptors. In addition, the 
cardiovascular and not the respiratory effects caused by ß- endorphin 
and dermorphin are also likely due to the release of atrial natriuretic 
peptide. Our findings show that dermorphin is about 20 times stronger 
than ß- endorphin.
This research was supported by MPI and CNR, Rome (Italy).
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SOMATOSTATIN AND CO G NTIVE FU N C TIO N S: B E H A V IO R A L, NEUROCHEMICAL
AND MOLECULAR BIO LO G Y S TU D IE S
T.Florio, C.Ventra, E.Cocozza, S.Talia, G.Schettini, A.Marino 
Inst. Pharmacology, II School of Medicine, University of Naples 
Key words: somatostatin, aging, cognitive functions
Brain somatostatinergic neurotransmission has been reported to 
be greatly impaired in patients affected by the dementia of the 
Alzheimer type (Davies 1980). We evaluated the role of brain 
somatostatin in the modulation of cognitive function in the rat 
by means of behavioral, neurochemical and molecular biology 
approaches. For this purpose we used cysteamine (CSH) a thiol 
agent able to reduce the brain somatostatin content in both 
young and old rats. The administration of CSH (300mg/kg,sc) 
to a group of conditioned young rats (more than 90% of 
conditioned avoidance responses, CARS, for at least three 
consecutive days) caused a progressive reduction of CARS in 
both active and passive avoidance conditioning, showing a 
maximal efficacy after 4h from the injection. After 24h the 
deconditioning effects of CSH disappeared. The administration 
of somatostatin or its analog SMS 201-995 (5ug and 
1 0 0ng/1 0ul,icv, respectively) almost completely abolished the 
deconditioning effects of CSH at 4h. This observation strongly 
suggests that the behavioral effects of CSH are primarily due 
to the impairment of somatostatinergic neurotransmission 
(Schettini 1988). In old rats CSH also reduced the acquired 
CARs, but the icv injection of SMS 201-995 did not revert the
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CSH effect. The lack of recovery after somatostatin
administration in the old rats could be related to the
reduction in rat brain somatostatin receptors during the aging 
process, as previously reported (Sirvio 1987). We demonstrated 
that somatostatin receptors are coupled, in an inhibitory way, 
with the adenylate cycalse system in young rat brain (Schettini
1989). Here we reported an age-dependent alteration in the 
somatostatin receptor coupling with the adenylate cyclase 
enzyme. In aged rats, somatostatin inhibition of cAMP
production both in the frontal cortex and in the hippocampus 
was significantly less marked than in the young animals in 
basal or stimulated conditions. Finally, we evaluated the 
expression of pre-prosomatostatin gene expression in the
frontal cortex of 2, 6 , 12 and 25 months old rats. The
pre-prosomatostatin mRNA content increased from 2 to 6 and 12 
months of age, but was greatly reduced in the 25 months old 
rats. In conclusion, our data show that the impairment of 
somatostatin neurotransmission caused impairment of cognitive 
functions in the rat, and that both the pre-prosomatostatin 
gene expression and the coupling of the somatostatin receptor 
to the intracellular effectors are altered during the aging 
process.
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DIFFERENT CHANGES ON HEPATIC DRUG-METABOLIZING 
SYSTEM CAUSED BY NON-STEROID ANTI-INFLAMMATORY
DRUGS
Fracasso M.E., Gasperini R., Leone R.
Institute of Pharmacology, University of Verona, Verona, Italy.
Key words: NASAIDS - Hepatic metabolizing system - Cyt. P-450.
In the course of studies of side effects caused by non-steroid anti-inflammatory 
drugs (NSAIDS), in the rat, we noted different changes in the hepatic and renal 
drug-metabolizing system. In fact, the treatment of rats with indomethacin led to 
decreases in the renal and hepatic enzymatic activities cytochrome P-450 
dependent (Fracasso et al., 1987); the treatment of rats with piroxicam reduced 
the same parameters in the livers, even if in less dramatic extent, while the renal 
drug-metabolizing components were not affected (Fracasso et al., 1988). In the 
light of these results we have investigated the mechanism whereby these two 
NSAIDS induced different changes on hepatic drug-metabolizing system.
Male Sprague-Dawley rats (150-200 g) were treated for 3 days with an oral 
suspension of indomethacin (10 mg/kg) or piroxicam (50 mg/kg) or vehicle. The 
animals were killed by cervical dislocation 24 h after the third drug 
administration. The livers were homogenized with cold solutions and the hepatic 
microsomal fractions (105,000 g) were isolated by differential centrifugation 
following usual techniques. Cytochrome P-450, P-420 and bs levels in the 
microsomes were determined by the method of Omura and Sato (1964). The 
amount of complexed cytochrome P-450 was determined as the difference 
between the amounts of cyt. P-450 that were able to bind CO in microsomes 
before and after ferricyanide treatment. The total protohaeme content was 
determined by Omura and Sato (1964) as the pyridine haemochrome. 
Indomethacin caused a significant loss in the liver of cyt. P-450 and bs (69% 
and 46% respectively compared to control group), no significant loss (30%) of
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cytochrome P-450 was caused by the piroxicam treatment and b5 content did not 
change. The reduction of cyt. P-450 levels in the two treatments was not due to 
the complexed form of hemoprotein, the treatment of microsomal suspension 
with ferricyanide did not modify the concentrations СО-binding cyt. P-450. The 
loss of the total protohaeme was consistently lower (45% vs control) after 
indomethacin than after piroxicam treatment (13% vs control); and moreover, a 
P-420 peak was detected in indomethacin- and piroxicam-microsomes, while 
this peak was not observed in any of the microsomal suspension of control.
The most likely interpretation of these findings is that, at these doses, the two 
drugs cause a different change in the hepatic drug-metabolizing system, in fact, 
piroxicam treatment reduces the cyt. P-450 only while indomethacin treatment 
induces an important decrease in both cytochromes (P-450 and bs) and in the 
total protohaeme. Probably indomethacin treatment, leads in part to an inhibition 
of haemoprotein synthesis and in part to a conversion of cyt. P-450 to an 
inactive form so-called cytochrome P-420, while the piroxicam treatment causes 
dénaturation of cyt. P-450 to cyt. P-420, a derivative deprived of functional 
activity. In fact we noted that the enzymatic liver activity was greatly affected 
by indomethacin than by piroxicam treatment.
% Loss
Enzymatic
activityTreatment P-450 Tot. haem. b5
Indomethacin 69 45 46 u
Piroxicam 30 13 0 i
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"IN VITRO" CYCLOSPORIN AND METHYLPREDNISOLONE 
INTERACTION WITH CYTOCHROME P-450.
Fracasso M.E., Gasperini R., Sartori M., Leone R.
Institute of Pharmacology, University of Verona, Verona, Italy.
Key words: Cyclosporin - Méthylprednisolone - Cyt. P-450 - Interaction.
Cyclosporin (CsA) is a powerful immunodepressive agent which has been 
demonstrated useful in a wide variety of clinical situations, particularly in the 
field of organ transplantation. Moreover, post-trasplant patients rarely receive 
CsA alone but require multiple drug therapy. An important cause of side effects 
of CsA results from drug interactions. Indeed it has been demonstrated that CsA 
is extensively metabolized in the liver of both animals and man (Maurer et al.,
1984). The many potential sites for oxidation by cytochrome P-450 lead to the 
speculation that CsA could interfere with other drugs which are metabolized by 
system P-450 dependent. Particularly conflicting are the data concerning the 
interaction between CsA and glucocorticoids.
Following the observation (Fracasso et al., 1989) that "in vivo" CsA reduced the 
hepatic metabolizing system P-450 dependent and that MTP restored this 
function, we studied the "in vitro" interaction of these two drugs with cyt. P-450 
using hepatic microsomal preparations from MTP- and PB-treated rats.
Hepatic microsomal fractions (105,000 g) were isolated by differential 
centrifugation following usual techniques. Cytochrome P-450 levels in 
microsomes were determined by the method of Omura and Sato (1964). The 
binding spectra of CsA and MTP with P-450 were carried out on rat liver 
microsomes from control animals, pretreated with phénobarbital (80 mg/kg x 3 
days) or MTP (0.7 mg/kg x 3 days). The binding spectra of CsA (50 (xM) and 
MTP (100 pM) were measured in a suspension of microsomes containing 2.0 
jxM of cyt. P-450. Various amounts of drugs were added in 10 ц1 dimethyl 
sulfoxide to microsomal suspension in the sample cuvette. Binding spectra were
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recorded between 510 and 360 nm in a Perkin-Elmer Lambda 5/15 dual beam 
spectrophotometer.
The binding spectra obtained upon addition of CsA (50 pM) to PB-microsomes 
showed that CsA-cytochrome P-450 complex was located at 390 nm and the 
absorbance minimum at 420 nm. Thus, by convention, CsA can be classified as 
a type I compound. The binding spectra obtained upon addition of MTP (100 
pM) to PB-microsomes showed a reverse type I spectral change. The apparent 
Ks (spectral dissociation constant) and A ODmax (maximum spectral change) for 
CsA were 0.017 and 0.0092 mM respectively in microsomes isolated from 
MTP-rats. A double reciprocal plot of A 420-390 nm/nmol P-450/ml against 
MTP concentrations revealed a Ks= 0.053 mM and a A ODmax= 0.0186.
CsA interacts directly with ferricytochrome P-450 leading to spectral change of 
type I (Ятах= 390 nm, \ min= 420 nm), whereas MTP exhibits a reverse type I 
spectral change; hence the two drugs do not compete for the same hydrofobic 
binding site of cytochrome. CsA shows a Ks value lower with P-450-PB than 
P-450-MTP. This means that CsA "in vitro" shows higher affinity for PB- 
cytochromes P-450 (Р-450ь and P-450e of rat liver) than that shown for MTP 
inducible cyt. P-450 (glucocorticoids-inducible P-450p). "In vivo", following the 
combined treatment (CsA + MTP), CsA increases its own metabolism using the 
induced MTP-cyt. P-450. The above process accelerates the metabolism of CsA 
into products which are non-toxic to the metabolizing system P-450 dependent. 
Following these studies we could say that, "in vitro", there is a different type of 
interaction between CsA and MTP with cytochrome P-450 in the rat liver.
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40% BUT NOT 20% ETHANOL IS  AN IRRITANT ABLE TO EVOKE GASTRIC 
RELEASE OF PGE2 IN  MAN.
Franco L., Cavallini G.*, Brocco G.*, Orlandi P.G.**, Manara P. and Velo G.P.
Istituto di Farmacologia and Clinica Medica*, University of Verona, Divisione di Medicina 
Ospedaliera S. Camillo**, Trento, Italy.
Key Words: cytoprotection/prostaglandins/ 20% and 40% alcohol.
Studies in the rat have shown that gastric mucosa can be made more resistent to acute 
exposure to potent necrotizing agents e.g. 70% and 100% alcohol, if previous contact with a 
mild irritant (20% alcohol) is made (Robert 1979). This defensive phenomenon called 
"adaptative cytoprotection" seems mediated by endogenous prostaglandins (PGs) (Robert
1983). Recently, the role of prostaglandins has been questioned, since it has been 
demonstrated in the rat that the pre-administration of 20% alcohol, does not increase the 
release of PGs (Hawkey 1988). Aim of this study was to verify in healthy volunteers and in 
chronic alcoholics, if acute exposure to alcohol at two concentrations (20% and 40%) could 
modify the levels of gastric PGE2 and whether chronic prior exposure of gastric mucosa to 
alcohol could influence this response.
We studied 10 healthy volunteers (9 men and 1 woman: mean age 28.2+2 years) and 
11 chronic alcoholics (10 men and 1 woman: mean age 44.9±10.2 years) with daily alcohol 
intakes of > 160 g/day for al least two years, not affected by cirrhosis. They were submitted to 
the following experiment: collection of gastric juice (90 min) during i.v. infusion of 
pentagastrin (0.75 meg/kg/hr); sample 0-15’ not considered; 15-20’: intragastric 
administration of 100 ml of saline and collection of juice up to 45’; 45-60’: wash out; 60-65’: 
intragastric administration of 100 ml of 20% or 40% ethanol and collection of the juice up to 
90’.PGE2 was assayed in gastric juice using a highly sensitive PGE2 125I RIA kit (DuPont). 
Results of gastric PGE2 assay were expressed as nanograms per output (ng/30’). Statistical 
analysis was performed by Student’s t test.
The results indicate that acute intragastric administration of 20% alcohol was not 
able to provoke gastric release of PGE2 in healthy volunteers (after saline: 35.31110.84 
ng/30’; after 20% alcohol: 37.88112.42 ng/30’, P: N.S.). Howerver 40% alcohol was found to 
be a potent stimulant of gastric PGE2 production (after saline: 38.34110.40 ng/30’; after 40% 
alcohol: 85.18133.95 ng/30’, P<0.01). The behaviour of gastric prostaglandins in chronic 
alcoholism, both at basal levels and after acute alcohol stimulation, appears to be substantially 
different from that observed in healthy non alcoholics. Infact, PGE2 levels in the basal gastric 
juice of alcoholic subjects were 2 to 3 times higher than those found in healthy subjects and 
were not modified following acute exposure to 20 and 40% alcohol (after saline: 
112.01±70.51 ng/30’; after alcohol 20%: 106.06±83.96 ng/30’, P: N.S.; after
saline:79.94±52.89 ng/30’; after 40% alcohol: 87.84±45.83 ng/30’, P: N.S.).
Our findings suggest that while acute alcohol exposure in the human stomach can 
evoke a PGE2 response, it does so only in undamaged mucosa (healthy subjects) and in the 
presence of alcohol concentrations (40%) twice those considered mild irritants in 
experimental animals. Long term exposure to alcohol, as occurs in chronic alcoholics, 
produce elevated intragastric PGE2 levels, which are not subject to further increase. This 
could indicate a gastric mucosal functional adaptation to chronic alcoholic abuse.
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THE IMPORTANCE OF POSITION SIX IN THE RING C OF MORPHINE IN MO­
DULATION OF AGONIST/ANTAGONIST INTERACTION WITH MULTIPLE OPIATE 
RECEPTORS
S. Fürst , T. Friedmann" and S. Hosztafy , Department of 
Pharmacology, Semmelweis University of Medicine, Budapest,
P.O.B. 370, 1445-Hungary, XXALKALOIDA Chemical Works,
4440 Tiszavasvári, Hungary
Key words: opiate receptors, chemical modification, azidomorphines 
A large body of evidence has accumulated suggesting that, the 
mode of interaction with the receptor/s/ is largely the function 
of the chemical constitution and geometric disposition of gro­
ups interacting with opiate receptors of morphinomimetics. 6- 
-deoxy-6-azidodihydroisomorphine (AM) and its 14-0H derivative 
are extremely potent analgesics, as it was previously reported 
by us (Knoll,Fürst,Kelemen,1973). Analogs in this family were 
synthetized with various N-substituents: methyl, allyl, cyclo- 
propylmethyl (CPM). The results obtained show, that while the 
formal inversion of the 6-OH group of morphine to a-isomorphine 
or a-isocodeine does not unduly alter the analgesic properties, 
the 6-methyl, 6-ethyl or 6-butyl analogues are modest antinoci­
ceptive agents. The significance of the linear azido-group which 
has a fixed conformation, and that of its steric (ß ) orientation 
is well documented by the fact, that dihydroisomorphine proved 
to be much weaker analgesic than AM (hot plate ED,-q > 20 mg/kg 
and 0.023 mg/kg, resp.). The 6-azido-substitution and the sub­
sequent conformational change induced in ring C seemed to be im­
portant for the analgesic activity not only in the case of 3-0H 
derivatives, but also in 3-ethered members, since they proved to
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be 40 times and 50 times more active analgesics, than the parent 
molecules (codeine and ethylmorphine, resp.). Furthermore, our 
experiments strongly suggested, that AM interacted with mu recep­
tor, since its agonist effects are readily antagonized by naloxone 
(AD^0 estimated in algolytic test: 0.037 mg/kg) both in vivo and 
in vitro (isolated guinea pig ileum and mouse vas deferens) and 
also it was supported by the receptor binding study of Horvath 
and Wollemann (1986). Furthermore, AM appeared to us a pure ago­
nist, since we were not able to detect any antagonist activity. 
Furthermore, among the N-substituted azidomorphines we have found 
strong antagonists (Knoll,Fürst,Makiéit,1977) as N-allyl-norazido- 
morphine and its 14-0H derivative, when estimating their antago­
nist activity in oxymorphone righting test (AD^q=0.031 and 0.033 
mg/kg,resp.). When N-CPM was the substituent, we have observed a 
kappa agonist activity, which was demonstrated by diuretic action, 
by the strong antinociceptive effect in mouse acetic acid stre­
tching test, or agonist activity in rabbit vas deferens, which is 
devoid of other opiate receptors, than kappa ones etc (Fürst,
Friedmann,Knoll,1988) . Moreover, this compound showed strong mu 
receptor antagonist activity not only in analgesia (AD,-0 against 
morphine in the algolytic test: 0.035 mg/kg) but in catalepsy, 
respiratory depression as well. The simultaneous 14-OH-substitu- 
tion in this structure resulted in a marked reduction of agonist 
type actions, while retaining strong antagonist efficacy. 
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COMPARISON OF THE CARDIOPROTECTIVE EFFECT OF NITROGLYCERIN, 
MOLSIDOMINE AND SIN-1 IN RATS WITH CARDIAC HYPOXIA
D.Gaál, Cs. Vértesi, E. Knopf and P.Sz. Körmöczy 
CHINOIN Pharm. Chem. Works Co. Ltd, Budapest - HUNGARY 
(cardioprotection, hypoxia, n itrog lyce rin , molsidomine, SIN-1)
N itrog lyce rin , molsidomine and i ts  active metabolite SIN-1 have been 
widely used as antianginal agents. Molsidomine is  an e ffe c tive
long-acting, and SIN-1 is  a very strong-acting antianginal drug i . v .
We tested the re la tive  cardioprotective potencies and time course of 
n itro g lyce rin , molsidomine and SIN-1 in  the ra t isoproterenol (ISO) model 
according to Körmöczy et a l . ,  (1987).We evaluated the developed hypoxia 
quan tita tive ly  by h is to lo g ica l methods. To fo llow  the time course of 
cardioprotection n itro g lyce rin , molsidomine and SIN-1 were in jected d a ily  
i . p . ,  molsidomine 60, 120 and 240 min, and i.v .S IN -1  60 min before ISO to 
groups of ten ra ts , respectively. Cardioprotection was defined as the 
reduction of hypoxic areas, and was expressed as percentage change 
compared to the control saline treated group.
The comparative cardioprotective e ffec t of n itro g lyce rin , molsidomine and 
SIN-1:
Substance dose 
mg/kg
pretreatment
time
(hour)
mean 4 of
hypoxic
area
S.D. delta
0,
0
contro l 1 36.7 4.3 -
n itro g lyce rin 1 11.5 2.9 64.8X
1 2 14.9 3.2 59.4X
4 22.3 4.4 39.2X
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Substance dose
mg/kg
pretreatment
time
(hour)
mean % of 
hypoxic 
area
S.D. delta
'o
molsidomine 1 12.6 2.5 65.5X
2 2 8.2 5.0 11.1х
4 15.6 3.1 57.4х
SIN-1 0.25 1 1.7 1.1 95.5х
The values represent percentage change in  hypoxic areas compared 
to  con tro l: X = p < 0.001
N itrog lyce rin  and molsidomine showed nearly equipotent 
cardioprotective e ffec ts  but the e ffec t of molsidomine was more 
prolonged. Treatment w ith  SIN-1 prevented the development of 
cardiac hypoxia.
Körmöczy, Sz. P., V é rtes i, Cs., Mikus, E., Tardos, L ., Kovács, 
G.: Prostaglandins 33, 505-511 (1987).
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P O S S I B L E  I N V O L V E M E N T  OF THE A N T I S  K H O T O N 1 N K R Ü  1C AN!) 
ANT1HISTAMINERG1C ACTIVITY IN THE ANT ICATALEPTOGENIC EFFECT OF
EGYT-2509
Gacsályi István, István Gyertyán, Gabor Gigler, Eva Somogyi, 
Lujza Petboz
EGIS Pharmaceuticals, Division of Pharmacology, Budapest 
Keywords: atypical neuroleptic, EGYT-2509, noncataleptogenic
In animal experiments it was revealed that EGYT-2509 is a new 
atypical neuroleptic agent. The putative therapeutic gain of 
the compound is the abscence of extrapyramidal and endocrine 
side effects (Gacsàlyi et. al., 1988). In rodents it showed no 
cat a leptogenic activity, moreover it inhibited the catalepsy 
provoked by different neuroleptics (haloperidol, perphenazine). 
The molecule posseses moderate central ant i hi st ami nergic, and 
considerable central a n tiserо t o n inerg i c act ivity. It was found 
that drugs with marked central antihistamine a n t isо г о 1 oniti 
and/or anti c hо 1 i ne r g i c activity i. n h i b i t >• d l h с г a 1 a t e p s у
induced by neuroleptics i  Balsara et al., 1979:. These findings 
were supported by our experiments (Table).
Table. Pharmacological profile of some a n t ic a ta lepto g e n ic drugs
DHUG ANTICAT. ACT. OXOTHM.ANT. RECEPTOR BINDING
1D50 MG/KG PO. ID50 M U /KG P O. Ki < n M )
(haloperidol) Hl S2
EGYT 2509 43.8 105 18.28 156.4
CHLORPROMAZINE 4.13 195.27 15.17
C L O Z A P I N E  1 4 . 8  1 3 . 2  8 . 6 0  1 6 . 0
PROMETHAZINE 38.2 36.3 15.05 114.89
CYPROHEPTADINE 9.09 2.43 6.7 0.85
SETAST1NK 40.02 162.6 70.1 9338.0
1 2 0
The compound EGYT-2509 antagonizes the oxotremorine induced 
t r e m o r  only in h i g h e r  d o s e s  ( E D 5 0 = 1 0 5  m g / k g  p o . ), w h i c h  
indicates low anticholinergic potential. This result suggests 
t h a t  a n t i c h o l i n e r g i c  a c t i o n  m a y  n o t  p l a y  a r o l e  in the 
anticataleptogenic a c t ivity of the compound.
On the basis of our findings we s u g g e s t  that the c e n t r a l  
a n t i s e r otonin and antihistamine activity of EGYT-2509 may be 
responsible for the absence of unwanted extrapyramidal side 
ef f e c t s .
1. Balsara, J.J., Jadhav, J.H., and Chandorkar, A.G. (1979) 
Psychopharmacology 62 : 67-69
2. Gacsalyi, I., Péthez, I,., Fekete, М.1.К., Bukkfalvi, B.,
Gorgenyi, F., Arató, M. (1988)
Pol. J. Pharmacol. Pharm. 40:613-619
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COMPARISON BETWEEN THE BFFBCTS OF TETRODOTOXIN AND OF COOLING 
ON GUINEA-PIG ILEUM CONTRACTIONS INDUCED BY VARIOUS AGBNTS
Rosa M. Gaion, Barbara Scrignoli, Anna M. Grion and Paola Dorigo
Dept, of Pharmacology, University of Padova, Largo E. Meneghetti 2, 1-35131 Padova,
Italy.
Key words: tetrodotoxin, temperature, smooth muscle, intestine
INTRODUCTION
Tetrodotoxin (TTX) is widely used to identify nerve-mediated effects of drugs 
on guinea-pig ileum and other intestinal preparations. This toxin, by acting on Na+ 
channels, blocks the conduction of action potentials in nerve cells, without affecting 
the electrical and mechanical activity of smooth muscle cells (Gershon, 1967). 
Similarly low temperature, by a still unidentified mechanism, affects all nervous 
structures of the ileum, thus preventing neurotransmitter release (Innés, Kosterlitz 
and Robinson, 1964).
The aim of the present study was to make a direct comparison between the 
influence of TTX and of low temperature on the responses of guinea-pig ileum 
to various agents that are known to exert direct and/or nerve-mediated effects 
in this preparation. For this purpose acetylcholine (ACh), 5-HT, PGI2 and KC1 were 
used to contract intestinal smooth muscle.
M E T H O D S
Segments of the terminal portion of guinea-pig ileum were mounted in organ 
baths containing 10 ml of Tyrode solution of the following composition (mM): NaCl 
136, KC1 2.7 CaCl2 1.4, MgCl2 0.49, N a H 2P 0 4 0.32, N a H C 0 3 12 and glucose 5. 
The bath temperature was 37°C. In low temperature experiments concentration- 
response curves were first obtained at 37°C. The preparations were then allowed 
to equilibrate at 20°C for 60 min before repeating the same treatment. All 
concentration-response curves were obtained cumulatively, except for PGI2 that 
is very unstable in aqueous solutions. TTX was added to the bath fluid 10 min before 
treatment with the agonists. Other details of the experimental procedure have 
been previously described (Gaion and Trento, 1983; Gaion and Gambarotto, 1987).
RESULTS A N D  DISCUSSION
ACh contracts guinea-pig ileum by stimulating muscarinic receptors on smooth 
muscle cells. TTX (0.5 yuM) did not cause any significant change in the concentration- 
response curve for ACh (0.01-2 ^ iM). Similarly, in preparations maintained at 20°C, 
contractions induced by ACh were comparable to those obtained under control
1 2 2
conditions (37°C).
5-HT increases ACh and substance P release from enteric neurons. Moreover, 
at higher concentrations, it interacts also with specific smooth muscle receptors 
(Buchheit, Engel, Mutschler and Richardson, 1985). The contractile effect of 5- 
H T  (0.01-10 ^ lM) was markedly depressed both by TTX and by low temperature.
Contractions induced by submaximally effective concentrations of PGI2 (0.005-
0.1 yuM), that act by increasing ACh release from enteric neurons (Gaion and Trento, 
1983), were abolished by T T X  and by cooling. With both treatments a residual, 
quantitatively comparable response was obtained at PGI2 concentrations of 1 yuM 
and higher, that exert also a direct effect on smooth muscle (Gaion and Gambarotto, 
1987).
KC1, by depolarizing cell membranes, allows the entrance of Ca^+ into nerve 
terminals and smooth muscle cells, thus triggering neurotransmitter release and 
contraction, respectively. T T X  inhibited contractions evoked by 5-30 m M  KC1. 
The extent of this inhibition was inversely related to the KC1 concentration used 
and maximum contractions induced by 50 m M  KC1 were insensitive to TTX. By 
contrast, in preparations maintained at 20°C the effect of KC1 was potentiated 
at the lowest salt concentration (5 mM) and markedly inhibited at the higher ones. 
As a result, in these preparations the concentration-response curve for KC1 was 
flat.
These results indicate that T T X  and low temperature do not impair the ability 
of smooth muscle to contract in response to ACh and that they exert comparable 
inhibitory effects on contractions induced by agents that cause a receptor-mediated 
increase of propagated activity in neurons. When transmitter release occurs as 
a result of membrane depolarization, TTX blocks only impulse propagation along 
axonal structures, while low temperature may counteract the effect of KC1 also 
at nerve endings, possibly by reducing neuronal Ca^+ availability.
The mechanism by which low temperature potentiates contractions induced by 
5 m M  KC1 remains to be elucidated.
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ESORUBICIN CAR0I0T0XICITY IN VITRO: ANTAGONISM BV PIMOBENDAN 
I .  GALATULAS, R. BOSSA, G. EFSTATHIU, M.A. NINCI
Oipartimento d i Farmacologia d e ll'U n ive rs ita , via V anv ite lli 32, 20129 Mi­
lano, I ta l ia
Key words: Esorubicin - C ard io toxic ity -  Guinea pig atrium - Pimobendan
Most of the pathological a lte ra tions induced in  human heart by anthracy- 
cracy have been reproduced in animal models fo r anthracycline cardiac to ­
x ic ity :  myocardial a lte ra tions  have been reported to occur follow ing admi­
n is tra tio n  of single high dose of anthracyclines in  animals and in iso la ted  
heart models in v itro  (Taylor A.L. et a l . ,  1984).
In attempts to a lle v ia te  or prevent anthracyclines to x ic ity  we have re ­
cently reported that amrinone and sulmazole (Bossa R. et a l. ,  1986; 1988),
new cardiotonic agents, markedly reduced the negative inotropic e ffe c t of 
adriamycin in isolated guinea pig a tr ia  in  normodynamic and hypodynamie 
conditions.
The present study reports the effects of pimobendan, a close analogue of 
sulmazole (Wetzel B. et a l . ,  1988), on guinea pig atrium treated w ith eso­
rub ic in , a newly synthetized adriamycin de riva tive  (Cummings J. e t a l . ,  
1987).
The experiments were carried out on e le c tr ic a lly  driven (3 Hz, 5 msec, at 
supramaximal voltage) le f t  atrium of guinea pigs. Exposure for 60' to  eso­
rub ic in  (100 ug/ml) caused a depression of con trac tile  force and of maximal 
rate of tension development (d f/d t)  on normodynamic and hypodynamie prepa­
ra tions. A fter addition fo r 5' of pimobendan (30 ug/ml) the c o n tra c tile  
force and the d f/d t of atrium increased to the value of basal cond ition ; 
there is  a p a rtia l recovery in normodynamic conditions and a f u l l  recovery 
in  hypodynamie conditions (Table I ) .
Like amrinone and sulmazole, pimobendan antagonizes the cardiac to x ic ity  
of anthracyclines; since these compounds exert ino trop ic effects probably
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through calcium in f lu x , the protective a c t iv i ty  against toxic e ffec ts  of 
anthracyclines is  consistent with a mechanism involving calcium movement.
Table I :  E ffect of esorubicin on the c o n tra c tile  force and maximal rate of 
tension development of e le c tr ic a lly  driven le f t  atrium of guinea p ig : anta­
gonism by Pimobendan.
Conpound Coneug/ml
N aO'
b
O' 30' 60'
c
3imobendan 
30 ug/ml
Eso­
rub ic in
100
5
cf
1.16+Ű.12
xxd
70.6+8.8
xxxd
59.0+9.1
xxxf
82.2+10.4
5
cf
0.91+0.18 53.0+19.8
xxe
35.2+13.8
xe
31.0+9.6
xxxf
60.8+7.1
Eso­
rub ic in 100
5
d f/d t
25.60+2.68
xxd
67.8+9.2
xxxd
56.8+8.6
xxxf
80.1+10.2
5
d f/d t
20.03+3.39 55.7+18.7
xxe
36.2+11.9
xxe
30.7+9.2
xxxf
60.9+5.6
c f : con trac tile  force; d f /d t :  maximal rate o f tension development: absolute 
value (g and g/sec) at O' time in normodynamic conditions and % value of i t  
in  hypodynamie conditions and a fter drug treatment. Esorubicin was added at 
O' time in  normodynamic or hypodynamie conditions; Pimobendan was added 60 
min a fte r antitumor drug. Data are expressed as mean _+ S.D. and analyzed by 
Student's t - te s t .  N: number of preparations; a: normodynamic conditions
(Tyrode with CaC12 0.2 g /1 ); b: hypodynamie conditions (Tyrode w ith CaC12 
0.1 g /1 ); c: cf and d f/d t were measured 5' a fte r  Pimobendan adm inistration;
d: s ta t is t ic  s ignificance is  referred to O' time in  normodynamic conditions;
e: s ta t is t ic  s ign ificance is  referred to O' time in  hypodynamie cond itins ;
f :  s ta t is t ic  s ign ificance is  referred to 60' time; x p<0.05, xx p < 0 .01 ;
XXX p 0,001
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PREVENTION OF DlIS0PR0PYLFLU0R0PH0SPHATE (DFP)-INDUCED LETHALITY 
BY MEPTAZINOL AND 9-AMIN0-TETRAHYDR0ACRIDINE (THA) IN THE MOUSE.
A. G a lli,  A. Mazri, F. Mori, L. Cecchini and M. Lucherini 
Department o f Preclin ical and C lin ica l Pharmacology, University of 
Florence, 50134-Florence, I ta ly
Key words : acetylcholinesterase; meptazinol; 9-amino-tetrahydroacridine.
We have recently demonstrated tha t the opioid analgesic meptazinol 
is  endowed with considerable protective a c t iv ity  against acute DFP 
poisoning in the mouse (G a lli and Mazri 1988). In the present study we 
have extended our investiga tion  to the anticholinesterase agent THA 
and we have compared the pro tective  effects o f the two compounds with 
those, well documented, o f the carbamates physostigmine and p y ridos tig ­
mine (Gray 1984).
Table 1. Protection against DFP-induced le th a lity  in  the mouse
Pretreatment (mg/kg) Protection ra tios (95% confidence l im its )
Without atropine With atropine
Physostigmine (0 . 1) 2.2  (1.9-2.5) 9.2 (8.3-10.1)
Pyridostigmine (0 . 1) 1.3 (1.0-1.5) 8.1 (7.4-9.0)
Meptazinol (30) 4.8 (4.4-5.3) 4.7 (4.2-5.3)
Meptazinol (45) 9.7 (8.2-11.5) 8.1 (6 .8 -9 .8 )
THA (5) 3.1 (2.7-3.3) 8.1 (7.2-9.1)
Protection ra tio  = DFP LD50 (treated animals) /  DFP LD5Q (untreated 
animals). Pretreatment was carried out 15 min before poisoning. 
Atropine sulfate was 17.4 mg/kg.
The results in table 1 show tha t under our experimental conditions 
both meptazinol at high doses and THA exerts a protective action against 
DFP in tox ica tion  comparable fo r  in te n s ity  to that o f physostigmine and 
pyridostigmine. However, while meptazinol's action is  not affected by 
the co-administration o f a trop ine, that of the other protective agents
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is  c lea rly  increased by th is  drug.
In separate experiments, the time-course o f acetylcholinesterase (AChE) 
a c t iv i ty  recovery was evaluated in whole brain and diaphragm tissues of 
mice pretreated with meptazinol (30 mg/kg), THA (5 mg/kg), physostigmine 
(0.1 mg/kg) together w ith  atropine sulfate (17.4 mg/kg) 15 min before 
poisoning with DFP (8 mg/kg). At 10 min a fte r  DFP adm inistration, 
residual AChE a c t iv ity  in  whole brain tissue averaged 8, 49, 29 and 23% 
o f controls in the animals pretreated with atropine alone (unprotected 
anim als), meptazinol, THA and physostigmine, respective ly. At 24 hours 
a f te r  poisoning, brain AChE a c t iv ity  averaged 39, 56 and 53% of controls 
in  the mice protected by meptazinol, THA and physostigmine, respectively. 
The data from the diaphragm closely paralle led those from the brain.
On the whole these data point to d iffe re n t protective mechanisms fo r 
meptazinol and the carbamates physostigmine and pyridostigmine. Our 
re su lts  appear to be consistent, with meptazinol being able to exert a 
sho rt-las ting  shielding action  on AChE against DFP attack. The experiments 
ca rried  out so fa r do not permit us as yet to o ffe r  d e fin ite  in te rp re ta ­
tio n s  of THA protective ac tion .
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COMPARISON OF THE ULCER HEALING EFFECT OF OLFFERENT CYTUPRO- 
TECTIVE ANO ANTISECRETORY DRUGS IN GASTRIC ULCER PATIENTS
M. Garamszegi , A.Németh,  I . P a t t y ,  F . Tárnok,  Gy .M ózs ik ,  
Ä .V i n c z e ,  G .Sütő & T . Jávor
F i r s t  Department o f  M e d i c i n e . M e d i c a l  U n i v e r s i t y  o f  Pécs,
H-7643 Pécs, Hungary
Key-words: v e n t r i c u la r  u l c e r ,  u lc e r  p la n im e t r y ,  p r o t e c t i v e  agents
The deasease p e p t ic  u lc e r  does no t re p re s e n t  a u n i fo rm  
c l i n i c a l  e n t i t y .  Many f a c t o r s  -  known and u n id e n t i f i e d  - can 
be in c r im in a te d  in  the  development o f  p e p t ic  u lc e r .  I t  a ls o  seems 
to  be e v id e n t  th a t  the  n a tu r a l  h i s t o r y  o f  v e n t r i c u la r  and duodenal 
u lc e r  i s  d i f f e r e n t .  Caused by these f a c t s  th e re  i s  no u n i fo rm  
th e r a p e u t ic  response.
A c o n t in o u s  work has been done in  our i n s t i t u t e  to  compare the 
u lc e r  h e a l in g  e f f e c t  o f  d i f f e r e n t  a n t i s e c r e to r y  and p r o t e c t i v e  
agents  in  e x p e r im e n ta l u lc e r  models as w e l l  as in  v e n t r i c u l a r  
and duodenal u lc e r  p a t i e n t s .  The a u th o rs  summarize t h e i r  r e s u l t s  
in  the  f i e l d  o f  the t re a tm e n t  o f  v e n t r i c u l a r  u lc e r  p a t i e n t s  by 
com paring the u lc e r  h e a l in g  e f f e c t  o f  C im e t id in e  ( lOOgmg/day) , 
P i re n z e p in e  (150 m g/day ) ,  S u c r a l f a t  (1000 m g/day), v i t a m in  A 
(50 000 I .U . / d a y )  a lone  and in  co m b in a t io n  w i th  cyp rohep tad inum  
c h lo ra tu m ,  De-nol (3X5 m l/d a y )  and T is a c id  (A l-Mg an tac idum  
in  d i f f e r e n t  doses).  P a t ie n ts  were randomly a l lo c a te d  in  the  
d i f f e r e n t  t re a tm e n t  g roups . A d e t a i l e d  case r e p o r t  preceeded 
upper g a s t r o i n t e s t i n a l  endoscopy. G astroscopy w i th  b io p s y  was 
repea ted  in  every two weeks. S ize  o f  v e n t r i c u l a r  u lc e r  was 
reco rded  and a l i s t  o f  c o m p la in ts  and p o s s ib le  s ide  e f f e c t s  
were r e g is te r e d  by the  p a t i e n t s .  D i f f e r e n t  la b o r a to r y  exam i­
n a t io n s  were c a r r ie d  ou t on the day o f  endoscopy. Pharmacody­
namic e f f e c t  o f  the drugs was compared by the mentioned 
p a ra m e te rs .
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I t  has been found t h a t :
1. Among the agents  l i s t e d  above D e -no l r e s u l t e d  in  the  h ig h e s t  
com p le te  h e a l in g  r a t e  a f t e r  fo u r  weeks; 2. Pharmacodynamic 
e f f e c t  o f  d i f f e r e n t  d rugs  was compared by measurement o f  u lc e r  
s i z e  in  in c o m p le te ly  hea led  p a t ie n t s  a f t e r  two weeks: v i ta m in  
A w i t h  and w i th o u t  cyprohep tad inum  c h lo ra tu m  and De-no l t r e a t ­
ment s i g n i f i c a n t l y  in c re a s e d  the speed o f  u lc e r  h e a l in g  in  
com parison  to  the  le s s  e f f e c t i v e  a n ta c id  g roup ; 3. V i ta m in  A 
was a lso  able to  decrease  u lc e r  p a in  as w e l l  as T is a c id  which 
i s  an im p o r ta n t  a sp e c t  o f  drug t r e a tm e n t  from the c l i n i c a l  p o in t  
o f  w iew. 4. A n ta c id  consum ption was much h ig h e r  in  c im e t id in e -  
g ro u p ,  than in  o th e r  t re a tm e n t  g roups . H ighe r h e a l in g  r a te  in  
C im e t id in e  group may be a combined e f f e c t  o f  C im e t id in e  and 
a n t a c i d s .
I t  has been conc luded  t h a t  the g a s t r i c  c y to p r o te c t i v e  agents  
( D e - n o l ,  v i ta m in  A, T is a c id )  have s u p e r io r  u lc e r  h e a l in g  e f f e c t  
th a n  a n t i s e c r e to r y  compounds ( c im e t id in e  .P i re n z e p in e )
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THE ACTION OF ANGIOTENSIN I I  ON THE ARACHIDONATE CASCADE OF
BRAIN MICROVESSELS 
Á. Geese, Zs. Mezei, G. Telegdy 
Department o f  P a thoph ys io logy  A lb e r t  Szen t-G yörgy i  M ed ica l 
U n i v e r s i t y ,  Szeged, Hungary
Key words: a n g io te n s in  I I ,  a rach id o n a te  cascade, m ic ro v e s s e ls  
I n t r o d u c t io n
Evidence in d ic a te s  t h a t  v a r io u s  p ro s ta n o id s  p a r t i c i p a t e  in  the 
v a s c u la r  and re n a l  mechanisms c o n t r o l l i n g  b lood p re s s u re .  
P ro s ta g la n d in s  ( P G E 2 » PGD2 and PGI^) subsurve a n t i h i p e r t e n ­
s iv e  processes by opposing p resso r mechanisms th a t  b r in g  
about v a s o c o n s t r i c t io n  and c o n s e rv a t io n  o f  s a l t  and w a te r .  On 
the o th e r  hand, thromboxane A2 (TXA2 ) causes v a s o c o n s t r i c t i o n ,  
PGFzgifa reduces venous com p lience , and PGE2 and PGI2 s t im u la ­
te  re n in  s e c r e t io n .  Th is  dual na tu re  o f  p ro s ta n o id s  in  b lood  
p ressu re  c o n t r o l  seems to  be very  im p o r ta n t  mechanism ( M is t r y  
and N a s j l e t t i ,  1988). A ra c h id o n ic  a c id  can be m e ta b o l ize d  in  
a d d i t io n  to  the  cyc looxygenase enzyme by the l ip o xyg e n a se  
pathway r e s u l t i n g  in  the  re le a s e  o f  m e ta b o l i te s  which m igh t 
have r e g u la t in g  f u n c t io n  in  c e l l u l a r  responses. The p re s e n t  
s tudy was designed to  in v e s t ig a te  the e f f e c t  o f  a n g io te n s in  
I I  on the a rach id o n a te  cascade o f  r a t  b r a in  m ic r o v e s s e ls . 
Methods
B lo o d - f re e  c e re b ra l  c o r te x  m ic ro ve sse ls  were i s o la t e d  from  
male r a t s  o f  CFY s t r a i n ,  w e igh ing  160-180 g by a m icromethod 
o f  Hwang e t  a l .  (1980) w i th  m o d i f i c a t io n s .  An a l i q u o t  was 
examined f o r  p u r i t y  and v i a b i l i t y .
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The is o la te d  m ic ro v e s s e ls  were p re in c u b a te d  in  TC Medium 199
a t  37 °C fo r  10 min and then a n g io te n s in  I I  (10 ^^ 10  ^ M) was
added to the in c u b a t io n  m ix tu re ,  ten  m inu tes  l a t e r  the enzyme
14r e a c t io n  was s t a r t e d  by the  a d d i t io n  o f  C -a ra c h id o n ic  ac id  
( 3 . 7  kBq) as t r a c e r  s u b s t r a te  to  the  in c u b a t io n  m ix tu re .  
R a d io a c t iv e  a ra c h id o n a te  m e ta b o l i te s  were separa ted  an quan­
t i t a t i v e l y  de te rm ined  in  a Beckman LS 1800 l i q u i d  s c i n t i l l a ­
t i o n  counter.
R e s u l ts  and D is c u s s io n
The lipoxygenase pathway dominated the  a ra ch id o n a te  cascade in  
th e  m ic rovesse ls  i s o l a t e d  from the b r a in  c o r te x  o f r a t s .  The 
main cyclooxygenase p ro d u c ts  were 1 2 - h id r o x y h e p ta d e c a t r ie n o ic  
a c id  (12-HHT), PGD2 , TXB2 , fo l low ed  by PGF2 aj f a , PGE2 and 6 - 
-k e to -P G F - j^  . I t  i s  accepted, t h a t  12-HHT e le v a te s  a ra c h id o ­
n a te  re lease  from e n d o t h e l ia l  c e l l s  and s t im u la te s  p r o s ta c y c ­
l i n  syn thes is  (S a d o w itz  e t  a l .  1987). A n g io te n s in  (10  ^ and 
1 0 " é M) s i g n i f i c a n t l y  i n h ib i t e d  the fo r m a t io n  o f 12-HHT in  
b r a in  m ic ro v e s s e ls , w h ich  might r e s u l t  i n  le s s  p r o s ta c y c l in  
s y n th e s is .  S im i la r  r e s u l t s  were observed d e te rm in in g  the r e ­
le a se d  TXB2 q u a n t i t y  from  the m ic ro v e s s e ls  in  the presence 
o f  a n g io te ns in  I I  ( 1 0 and 10” ^ M). The r a t i o  o f l ipoxygenase  
and cyclooxygenase m e ta b o l i te s  was no t m o d i f ie d  by a n g io te n s in  
I I  (1 0 _ l i  and 10~ 10 M) w h i le  10~9 M c o n c e n t r a t io n  s i g n i f i ­
c a n t l y  reduced the  r a t i o .
Acknowledgement: This work was partly supported by the S c ien t i f ic  Research 
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A NEW IMMUNE-MODULATORY SUBSTANCE : CH-27584
L. Guczoghy, Cs. V é r t e s i ,  P. G erge lyx , B. Szendex x ,
P. Sz. Körmöczy
CHINGIN Pharm. Chem. Works Co. L td ,  Budapest-HUNGARY 
x 2nc' Department o f  M ed ic ine , SEMMELWEIS M e d ic ia l  U n iv e r s i t y ,  
xx Department o f  P a th o lo g y ,  SEMMELWEIS M ed ica l U n iv e r s i t y ,  
Budapest-HUNGARY
(Im m u n s t im u la t io n ,  a n t i tu m o r  a c i t v i t y ,  CH-27584)
CH-27584 e xe r ts  bo th  tumor c e l l  i n h i b i t o r y  and immunstimulant 
a c t i v i t i e s .  I t  enhances an t ibody  p ro d u c t io n ,  s t im u la te s  T, К 
and NK c e l l  a c t i v i t y  and a lso  a f f e c t s  the  fu n c t io n  o f  phagocy­
te s .  Th is complex a c t io n  may be a r e s u l t  o f  the s t im u la t io n  o f  
the e a r ly  steps o f  lymphocyte a c t i v a t i o n .  The exact mechanism 
o f the  compound has ye t to be e lu c id a te d .
We te s te d  the immune modula tory  a c t i v i t y  o f  CH-27584 in  v ivo  
in  animal exper im en ts  and a lso  in  v i t r o  on human lym phocytes. 
The compound dose -dependen tly  in c re a s e s :
1/ NK and ADCC a c t i v i t y ,  the in c re a se  i s  more s t r i k i n g  in  
cases w ith  depressed c y to to x ic  a c t i v i t y  
2 /  the m ig ra t io n  o f  leukocy tes
3 / mitogen (PHa- and ConA-) induced lym phocyte b la s to g e n e s is  
4 /  the pr im ary  and secondary IgM and IgG an t ibody  response 
5 / re s to re s  immune a c t i v i t y  suppressed by c o r t is o n e  
CH-27584 reduces the  number o f K-562 and P-388 tumor c e l l s  in  
c u l t u r e .  The e f f e c t  i s  due to d i r e c t  a n t i tu m o r  a c t i v i t y .  I t  
has on ly  s l i g h t  i n h i b i t o r y  a c t io n  on N K - ly  a s c i te s  lymphoma, 
but the immuno g e n ic  Lew is - lung  tumor i s  i n h ib i t e d  very
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s t r o n g l y .  The e f f e c t  r e f l e c t e d  in  the lover, number o f  m é ta s ta ­
sés .
The compound s t r o n g ly  i n h i b i t s  the  spontaneous mammary tumors 
o f  dogs.
The o r a l  th e ra p e u t ic  doses are ra ng ing  from 0.01-1 mg/kg, and 
th e  o r a l  acute LD^q 2380^320 mg/kg in  mice.
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REPEATED ADMINISTRATION OF (-)DEPRENYL LEAVES THE MESOLIMBIC 
DOPAMINERGIC ACTIVITY UNCHANGED
x S. Gyarmati, xx L. G. Hársing, xxx K. Tekes, x J. Knoll
Department of Pharmacology Semmelweis Univ. of Med. Budapest,
XXHungary, 1445-Hungary, ' Institute of Experimental Medicine,
X X XHungarian Academy of Science, Department of Pharmacodyn. ,
Semmelweis Univ. of Medicine, Budapest.
Key words: (-)deprenyl, dopamine uptake, dopamine turnover,
tuberculum olfactorium
(-)Deprenyl facilitates the activity of the nigrostriatal 
dopaminergic system with high selectivity (Knoll, 1987). The 
deprenyl-induced increase of the dopaminergic tone in the stri­
atum was proved by measuring several biochemical parameters of 
the activity of the nigrostriatal dopaminergic neurons. It was 
found that in the striatum taken from rats pretreated with 
0.25 mg/kg (-)deprenyl for 30 days, the dopamine content and 
the turnover rate of this biogenic amine was significantly 
higher than in saline-treated animals. It was also shown that 
in deprenyl-pretreated rats the uptake of dopamine was signifi­
cantly decreased.
We checked now the change of these parameters in the limbic 
system in (-)deprenyl-treated rats, using tuberculum olfacto­
rium as an indicator.
Rats were treated daily with 0.25 mg/kg (-)deprenyl or sali­
ne, respectively, for 30 days and the tuberculum olfactorium 
was prepared for biochemical analysis 24 hours after the last 
injection. The result of the study are summarized below:
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Treatment DA DOPAC HVA TRDA DA uPtake' _____uq/kq uq/q______uq/q____uq/q/h uq/min/mq próbáin
SALINE 10.76+0.3 2.15+0.14 0.72+0.02 0.72+0.02 7.85+0.46
H E G p s T /l
ЗСкО.25 11.88+0.75 2.37+0.15 0.79+0.05 0.79+0.05 7.39+0.26 
mg/kg
These results substantially support the suggestion that 
(-)deprenyl facilitates the activity of the nigrostriatal dop­
aminergic system with high selectivity.
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NEUROLEPTIC PROFILE IN BEHAVIORAL TOXICOLOGICAL STUDY 
Gyertyán István,
EGIS Pharmaceuticals, Department of Pharmacology, Budapest 
Keywords: behavioral toxicology, neuroleptics, profile
Behavioral toxicological studies carried out in our laboratory 
are based on the methods of Irwin (1968), Campbell and Richter 
(1967), and Alder et al. (1986) with several modifications. The 
standard procedure finally adapted by us is as follows:
Mice of both sexes are treated intraperitoneally with the test 
c o m p o u n d  30 m i n  b e f o r e  o b s e r v a t i o n  a n d  r e g i s t r a t i o n  of 
behavioral symptoms by the means of a p p r o p i a t e  c h e c k l i s t s .  
At least three consecutive doses are chosen from the . ..-3-10- 
30-100-... dose array according to the following guidelines: 1.
the maximum dose is 300 mg/kg 2. there must be found a dose 
with at least 50 X  lethality (unless it would exceed the 300 
mg/kg limit) 3. there must be found at least one non-lethal 
dose. The registration of the symptoms has a sequence of three 
phases: 1. observation in the cage 2. observation on the table
3. examination in hand.
Forty-eight behavioral variables and lethality are recorded. 
The variables are of three types: 1. present/absent parameters
(registered as 0 or 1) 2. uni- or b i d i r e c t i o n a l l y  r a t e d
parameters (maximum range is -2/+2) 3. descriptive variables
(denoted by a letter). The zero p o i n t  s c o r e  r e p r e s e n t s  the 
normal behavior. Lethality is determined one hour, 24 hours and 
7 days after drug administration. Th e  o b s e r v e d  b e h a v i o r a l  
symptoms are pooled into seven groups (Table).
Ne u r o l e p t i c  c o m p o u n d s  ( c h l o r p r o m a z i n e ,  1 e v o m e p r o m a z i  n e ,
haloperidol, clozapine, thioridazine and pimozide) showed a
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characteristic behavioral symptom-profile on the basis of whic 
t h e y  could be d i s t i n g u i s h e d  from o t h e r  p s у c h o p h a r m а с о n s .
Table. Behavioral symptoms of neuroleptic compounds
1 . SMA 2. stereotyped 
behavior
3. arousal 4. neurologic 
dysfunctions
m a r k e d none marked abnormal gait and
d e c r e a s e decrease body posture,
deer, muscle tone
5. sensory-motor 
f unctions
6. muscular 
functions
7. vegetative and 
other symptoms
impaired visual- 
m o t o r  coordination
severe
impairment
abnormal respiratior 
hypothermia, ptosis
E f f e c t s  on SMA and arousal variables can be considered as the 
"main effect" of neuroleptics. The order of potency to elicit 
these symptoms was haloperidol = clozapine = 1 evomepromazine >
chlorpromazine = thioridazine > pimozide. However, obviously 
t oxic symptoms such as neurologic dysfunctions and impairment 
of m u s cular functions and visual-motor coordination appeared in 
the same dose like in which the "main effect" symptoms did - in 
the case of all molecules.
T h e s e  findings i n d i c a t e  that in b e h a v i o r a l  t o x i c o l o g i c a l  
s t u d i e s  n e u r o l e p t i c s  c a n  be d i s t i n g u i s h e d  f r o m  o t h e r  
p s y c h o t r o p i c  d r u g s ,  b u t  the m e t h o d  is too r o b u s t  to 
differentiate between these compounds either by their potency 
or by their therapeutic range.
1. Alder, S., Candrian, R., Eisner, J. and Zbinden, G. (1986) 
Meth. and Find. Exptl. Clin. Pharmacol. 8^:279-289
2. Campbell, D.E.S. and Richter, W. (1967) Acta Pharmacol, et 
Toxicol. 25:345-363 3
3. Irwin, S. (1968) Psychopharmacologia (Berl.) 13: 222-257
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THE EFFECT OF DIFFERENT OPIATES ON ACIDIFIED ETHANOL-INDUCED 
GASTRIC LESIONS IN RATS
K. Gyires
Department of Pharmacology, Semmelweis University of Medicine, 
Budapest P.O.B. 370, 1445-Hungary
Key words: opiates, gastric damage due to ethanol
Contadictory data are pulished on the effect of morphine on
different types of gastric damage. Morphine was found partly to
protect (Arrigo-Reina and Ferri, 1980) partly to aggrevate
(Gyires et al., 1985) the different experimental mucosal lesions.
Recently we found that morphine inhibited the acidified ethanol-
-induced gastric damage (Gyires and Knoll, 1988). In the present
study we examined the effect of morphine, the relatively most
selective ligand of у-opiate receptors, bremazocine, a kappa-
2 5-opiate receptor agonist and (D-Met -Pro ) enkephalmamide 
(Bajusz et al., 1977) , which binds both to y and & receptors 
(Chang et al., 1989).
2 5Vie found that both .morphine and (D-Met -Pro ) enkephalmamide 
(DMPEA) were highly effective against acified ethanol induced 
lesions, the IDç.Q values are 0.07 and 0.04 mg/kg s.c., resp. 
Morphine was effective given both orally and s.c., while DMPEA 
was effective only in the case of s.c. administration. Bremazo­
cine (0 .0 1 - 1  mg/kg s.c. and p.o.) failed to produce any signifi­
cant, dose-dependent inhibition on gastric lesions.
In the presence of naloxone (0.5 mg/kg, s.c.) the 82% and 88% 
inhibition of the gastric lesions due to 0.5 and 1 mg/kg s.c. 
morphine was reduced to 33 and 25%. The inhibitory activity of
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DMPEA was less affected by naloxone (0.5 mg/kg, s.c.); the 97% 
and 93% inhibition induced by 0.25 and 0.5 mg/kg DMPEA was de­
creased only to 56% and 64%. When morphine (1 mg/kg s.c.) and 
bremazocine (0.5 mg/kg, s.c.) were combined, bremazocine sig­
nificantly inhibited the action of morphine. This result is in 
accordance with the findings that bremazocine exert some ц re­
ceptor antagonist activity, too (Leander, 1983).
The protective action of both morphine and DMPEA was higly 
reduced by indomethacin (1 0 mg/kg, p.o.) and the sulfhydryl 
blocking, N-ethylmaleimid (50 mg/kg, s.c.).
These results suggest that the protective action of morphine 
against ethanol-induced lesions is mediated via opiate recep­
tors. Kappa receptors seems to be not involved in the mucosal 
protection. Both protaglandin and sulfhydryl system might be
2involved m  the protective action of both morphine and (D-Met - 
-Pro^) enkephalinamide.
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MECHANICAL ACTIVITY OF THE ISCHAEMIC MYOCARDIUM AS AFFECTED BY VERAPAMIL AND
FENDILINE
Hála, 0 ., Papp, O.Dy., Szekeres, L.
Department of Pharmacology, Albert Szent-Györgyi Medical University, Szeged,
Hungary
l<e^_word_sj_ fe n d i l in e ,  verapamil, ischaemia, mechanical a c t i v i t y ,  
pap i l la ry  muscle.
Several studies have provided evidence to  prove that the negative 
in o t ro p ic  potency of some of the calcium channel blockers is  enhanced under 
' i n  v iv o '  ischaemic circumstances (Smith et a l . ,  1976; Abrahamson et a l . ,
1985). Since the ' i n  v iv o '  drug e f fe c ts  are also influenced by systemic 
changes induced by ischaemia, studies were ca r r ie d  out to establish the 
a l te ra t io n s  of the negative inotropic a c t iv i ty  of calcium antagonists under 
var ious  ' i n  v i t r o '  experimenta l cond it ions , s im u la t ing  one or severa l 
components of the ' i n  v iv o '  myocardial ischaemia (e.g. acidosis, elevated 
e x t r a c e l lu la r  potassium, hypoxia) (Boros et a l . ,  1984; Papp and Szekeres, 
1986; Robertson and Lumley, 1989). Despite the extensive investigations, the 
a v a i la b le  data have so far been obtained at some fixed preload or sarcomer 
leng th  on ly , which can not be extrapolated on any arb itrary part of the 
respective 'preload-maximum contracti le  force' re lationship.
The purpose of the present study was therefore twofold:
1 )  . To es tab l ish  the effects of 0.4 mg/1 verapamil and 2 mg/1 fendi­
l i n e  (producing a 50 \  depression in  the maximum contracti le  force under 
phys io log ic  condit ions) on the mechanical a c t iv i ty  of rabbit r ig h t  ve n tr i ­
c u la r  p a p i l la ry  muscles in  the presence of a moderate 'ischaemia' (9 % O2 
and 5 h CO2 in  nitrogen: pÛ2 = 350 mmHg; /K+/g = 7 mM; pH = 6 .8 ) at a near 
physiological preload (2 mN).
2) To examine the ' ischaemia ' -induced a lte ra tions of the inotrop ic
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e ffec ts  of verapamil and fend il ine  as a function of preload in general.
In both se r ies  o f  experiments the iso la te d  preparations were elec­
t r i c a l l y  driven by f i e ld  stimulation at a rate of 1.67 Hz.
In 'ischaemia' the  negative inotropic potency of verapamil ( i . e .  the 
e x te n t  of the drug-induced depression of the maximum contracti le  force) was 
s ig n i f ica n t ly  enhanced (means +_ S.D. = contro l:  51.43 +_ 4.78 %, 'ischaemia': 
23.51 _+ 5.18 %; n = 5) at the preload of 2 mN. However, at the same physio­
lo g ic a l  preload 'ischaemia' did not a lte r  the mechano-depressant a c t iv i ty  of 
fend i l ine  (control: 48.86 _+ 5.27 %, 'ischaemia': 50.73 +_ 6.39 Ч\ n = 5).
In 'ischaemia' the course of the control 'preload-maximum contracti le  
fo r c e '  re la t io n sh ip  ( f i t t a b le  with a modified H i l l ' s  equation) was changed 
to  bell-shaped having a maximum at 7 mN. Under these conditions the 'k ine­
t i c '  constant governing the descending arm was -0.113 +_ 0.021 mN- -*- (n = 5). 
In  the prersence of fe n d i l in e  and verapamil the constant was -0.012 _+ 0.003 
mN- -*- and -0.019 +_ 0.007 mN- *-, respectively. This re f lec ts  a remarkable anti-  
' ischaemic' action fo r  both drugs at high preload.
On the basis of these findings i t  can be suggested that both verapamil 
and fe n d i l in e  are able to  exert some anti- ' ishaem ic ' e ffect in the myocar­
dium, but they seem to  a f f e c t  inotropy a t  d i f f e r e n t  c e l lu la r  e n t i t i e s  
possessing d i f fe re n t ia l  s e n s i t iv i ty  to myocardial ischaemia.
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ACID-BASE PARAÆTERS IN MORPHINE TOLERANCE
Sándor Héber, Eleonóra Markó and Gábor L. Kovács 
Central Laboratory, Markusovszky Teaching Hospital, 8700,
Szombathely, Hungary
Keywords: acute morphine tolerance, acid base parameter
Lethal respiratory depression (RD) caused by opiate overdosing is  rather 
typ ica l among drug abusers. In some cases opiates may induce RD without 
appearent evidence of overdosing (Roerig et a l . ,  1987). The aim of our 
investigation was to study whether there is  a re la tionship between the 
pharmacological ( i . e .  analgesic) tolerance and the tolerance that developes 
in acid-base parameters. Mice were rendered to lerant to morphine (MO) by a 
dose of 60 mg/kg. The degree of tolerance was measured 24 hours la te r .  Tail 
blood was taken to measure blood gas parameters with an AVL-945 type acid- 
base analyzer. I t  has been found that acute MO treatment elevated the рС0£ 
level in a dose-dependent manner. Lower doses of MO (1 and 5 mg/kg s .c . )  
did not change the pH, while higher doses of 10 and 60 mg/kg resulted a 
s ign if ican t decrease in pH and 0^ saturation as w e ll.  A l l  changes could be 
antagonized with naloxone. One day after 60 mg/kg MO treatment, acute 
tolerance developed to the analgesic e ffect but not to changes in acid-base 
parameters (Fig. 1). I t  is  concluded that development of tolerance is  
faster to the analgesic (and supposedly to the euphoric) e ffect of MO than 
to RD and th is  difference may play a role in le th a l RD.
Reference:
S.R. Roerig, J.M. Fujimoto and D.G. Lange: Brain Res. 400 (1987) 278-284.
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Figure 1.
Legends :
C o n tro l  group
Acute MO (10 mg/kg) in  m orph ine -na ive  mice
MO to le r a n t  group (24 h a f t e r  60 mg/kg MO)
Repeated MO t re a tm e n t  (10 mg/kg) in  MO 
to le r a n t  group
x p < 0 . 0 5  ( s i g n i f i c a n t l y  d i f f e r e n t  from the c o n t r o l )
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RELATIVE SELECTIVITY OF RESPONSIVENESS TO CALCIUM ANTAGONISTS 
IN PERIPHERAL VASCULAR SMOOTH MUSCLE OF DOGS
Ágnes Horváth, J.Gy. Papp, L. Szekeres
Department of Pharmacology, Albert Szent-Györgyi Medical University, Szeged,
Hungary
j£e^wordsj_ pe r iphe ra l vascular smooth muscle, verapamil, d ilt iazem, 
fend il ine , KHL-8430, prajmaline.
I t  has been w e ll  established that there is  a v a r ia b i l i t y  in drug re­
sponsiveness of the receptor-operated calcium channels throughout the vascu­
la r  system (Cauvin et a l . ,  1983; Carmeliet, 1986; Taire, 1987). The evidence 
fo r  the existence of such a d i f fe re n t ia l  s e n s i t iv i ty  to drugs in the poten­
t ia l -o p e ra te d  calcium-channels is  ra ther scanty. The present study was 
the re fo re  undertaken to compare the e f f icacy  of f ive  calcium antagonists 
(verapamil, d ilt iazem, fend il ine , KHL-8430, prajmaline) in re liev ing potas­
sium-induced contractions of isolated carotid and femoral arteries.
The blood vessel preparations were obtained from dogs. Segments of the 
carotid and femoral a rte r ies  were cleaned of extraneous connective and fa t ty  
t is s u e ,  s p i r a l l y  cut in to  s t r ip s  and placed in  an organ bath containing 
Krebs so lu tion . Cummulative concentration-response curves for calcium anta­
gonis ts  were constructed on the basis o f the a b i l i t y  of the ind iv idua l 
agents to  i n h ib i t  the contracti le  response to potassium-rich (KC1 = 50 mM) 
n u t r ie n t  s o lu t io n ,  as described ea r l ie r  (Hof and Vuorela, 1983; Horváth et 
a l . , 1987).
The re s u l ts  are summarized in Table I ,  from which i t  is  obvious that 
although the rank order of potency (calculated from IC50) is  s im ilar fo r  the 
studied drugs in the carotid and the femoral vascular tissue (verapamil>  
d i l t ia ze m  >  other calcium an tagon is ts), KHL-8430 is  almost 4-times more 
a c t ive  on femoral and approximately 4-times less potent on carotid artery 
than fend il ine . A d i f fe re n t ia l  sens it iv i ty  to prajmaline in the two vascular
144
t i s s u e s  is  also apparent. Furthermore, the re su l ts  of our more recent 
s tu d ie s  have shown that under the same experimental conditions fend i l ine  is  
some 2-times, prajmaline is  almost 5-times more active, as a vaso-spasmoly- 
t i c ,  in  canine peripheral than coronary blood vessels.
Table I
IC50 values and re la t ive  a c t iv i t ie s  re la t ing  to fendiline fo r re laxation of 
contractions induced by potassium (50 mM KC1) in isolated peripheral
arteries of the dog
Carotid artery Femoral artery
Drug
IC50 Relative ÏC50 Relative
(mol/1) a c t iv i ty (mol/1) a c t iv i ty
VERAPAMIL 1.613 X 10~9
(n=5)
5641.42 1.033 X 10~7
(n=5)
84.38
DILTIAZEM 3.422 X 10“ 7 
(n=4)
26.60 1.223 X 10" 6 
(n=5)
7.14
FENDILINE 9.103 X 10“ 6 
(n=5)
1.00 8.717 X 10" 6
(n=5)
1.00
KHL-8430 3.726 X 10“ 5 
(n=5)
0.24 2.241 X 10" 6 
(n=5)
3.89
PRAJMALINE 3.000 X 10~5 
(n=5)
0.30 1.016 X 1 0 '5
(n=5)
0.86
Mean values are given (+_ S.D. +_ 5 per cen t) . n = number of preparations.
In  view of these re s u l ts  i t  appears th a t  there is  a v a r ia b i l i t y  of 
drug s e n s it iv i ty  of potential-operated calcium channels among vascular beds. 
Th is  may re s u l t  in  a r e la t i v e  s e le c t i v i t y  of peripheral vaso-spasmolytic 
responses to calcium antagonists.
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STUDY OF THE PREDOMINANT VASCULAR POSTSYNAPTIC ALPHA-ADRENERGIC 
BLOCKING CAPACITY OF GYKI-12 743 IN ISOLATED ORGANS AND PITHED
RATS
E.Horváth, I.Bódi, L.Jaszlits, Gy.Rabloczky
Institute for Drug Research, Budapest, P.O.Box 82, Hungary
Keywords: Postsynaptic alpha-adrenergic antagonism
It has been accepted that vascular smooth muscle was equipped 
with postsynaptic alpha^-adrenoceptors as affective as alpha^- 
adrenoceptors and both of them mediated vasoconstriction in 
the vasculature (Drew and Whithing, 1979; Docherty and McGrath 
1980; Fowler et al., 1984). Since vascular tone is controlled 
predominantly by alpha-adrenoceptors, therefore pharmacologi­
cal antagonists of alpha-adrenoceptors decrease the elevated 
blood pressure in most forms of hypertension. Selective bloc­
kade of the postjunctional alpha2~adrenoceptors (without strong 
prejunctional alpha2~adrenoceptor blockade) may offer a new 
approach to antihypertensive therapy.
The present study has been undertaken in order to characterize 
the alpha^- and alpha2-adrenoceptor antagonist properties of 
GYKI-12 743 in vitro (isolated mouse vas deferens (MVD), dog 
saphenous vein (DSV), rabbit aortic strip (RA) and in vivo 
(pithed rat). GYKI-12 743 was a competitive antagonist at both 
subclasses of postjunctional alpha-adrenoceptors. In RA GYKI- 
12 743 like prazosin produced a parallel shift to the right of 
dose-response curve to noradrenaline (pA2~values are 7.-6 and 
9.45 respectively). However in DSV using BHT-933 as agonist, 
GYKI-12 743 showed much higher (10 times more potent) antago­
nist potency at postjunctional alpha2~adrenoceptor sites 
(pA2 = 7.5) than idazoxan (pA2 = 6.3) . In MVD GYKI-12 743 was 
5 time weaker (pA2 = 7.0) while in the case of idazoxan 10 
times more potent antagonism was demonstrated in this prepara­
tion than in CSV. Studies in pithed rats provided an important 
in vivo evidence of the predominant postjunctional cardiovas-
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cular alpha2~adrenoceptor selectivity of GYKI-12 743,namely 
it did not increase the tachycardia induced by electrical 
stimulation of cardioaccelerator nerve.
The above results indicate that, besides a significant alpha^ 
antagonist activity, GYKI-12 743 induced a postsynaptically 
selective alpha2~adrenoceptor blockade in the cardiovascular 
system, thus it might be a potent antihypertensive agent with 
out significant tachycardia in human therapy.
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VASOCORTIN INHIBITS Ca2+ INFLUX AMD HISTAMINE RELEASE INDUCED 
BY CONCANAVALIN A IN RAT MAST CELLS 
A. Ialenti and M. Di Rosa
Department of Experimental Pharmacology, University of i.'aples, 
via Domenico Montesano 49, 80131 Naples, Italy.
Key words: Ca2+influx,glucocorticoids,histamine,vasocortin
Vasocortin is a glucocorticoid-induced anti-inflammatory
protein that we have recently identified in the peritoneal
cavity of dexamethasone-treated rats (Carnuccio et al., 1987).
We have recently reported that partially purified vasocortin
cells induced by dextran or concanavalin A (Con A) but does not 
modify the release induced by calcium ionophore A23187 or 
compound 48/80 (Carnuccio et al.,1989). Since the histamine 
release induced by both dextran and Con A is dependent on 
extracellular calcium we decided to investigate the effect of 
vasocortin on C a i n f l u x  into the cells. Vasocortin was 
generated, collected and partially purified from the peritoneal 
lavage fluid of dexamethasone treated rats following the 
procedure described by Carnuccio et al. (1987). Mast cells were 
purified from peritoneal cells of Wistar rats according to 
Foreman et al. (1977). Histamine release was induced, 
quantified and calculated as previouse described (Carnuccio et 
al.,1989). Ca^+ was measured spectrоfluorimetrically using the 
Ca2+ fluorescent indicator, fura 2. Results are shown in Fig.l. 
Ca2+ influx and histamine release reached a maximum at about 5 
min. and 10 min. respectively. Partially purified vasocortin
inhibits histamine release from rat peritoneal
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inhibited both the Con A induced release of histamine from mast 
cells as well as the Ca2+ influx into these cells. Since cS+
uptake is essential for histamine release it is coincevable
that vasocortin inhibition of histamine release may depend on 
its ability to prevent C a 2+ influx into the cells. However the
mechanism underlying the vasocortin inhibition of histamine
Effect of vasocortin (50 pg ml ) on the Ca and histamine
release induced by con A (5 p^g ml“l ) in rat mast cells. Purity 
of mast cell preparation w-as approximately 90%. Vasocortin was 
added to the incubation medium 10 min. before Con A challenge. 
Spontaneous histamine release from the cells (5-6%) was 
subtracted from experimental values. Each point is an avarage 
of two duplicate experiments.
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PAIN DURING INJECTION AND VENOUS SEQUELAE: THIOPENTONE VERSUS
PROPOFOL.
1 2  2 2 G. Iovinelli , D. Fanini , G. Pal umbo , G. Panialeoni > G.
Varrassi^.
1 Diparti mentő di Chirurgia, Cattedra di Anestesiologia e 
Rianimazione; 2 Dipartimento di Medicina Interna e Sanita’ 
Pubblica, Cattedra di Farmacologia, Uni versi ta’ del 1 ’Aqui1 a , 
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Many drugs used in intravenous anaesthesia may produce acute 
pain during administration and venous sequelae such as 
trombophlebi ti s . These complications are often underestimated 
whereas they can produce a sad memory of anaesthesia and can 
be harmful for patients CStarк et a l . ,1Q8S; Henriksson et 
ai. ,19873. Many factors may influence the appearance of these 
complications : first the chemical nature of the drug and the
possible presence of the vehicle, then the gauge and the 
length of the catheter, the vein’s size and the speed of 
injection CMatti la et al. ,1989; Mündele e r ,19883 . The aim of 
this study was to investigate the incidence of these 
complications occurring with two drugs commonly used for 
induction of anaesthesia in minor gynecological procedures. 
The study was performed on 40 patients aged 17-66 years of ASA 
grade I-II undergoing minor gynecological procedures. All 
patients were premedicated with Trazodone and Atropine i . m. 
and then randomly divided into two groups. The induction of 
anaesthesia was performed as follows: group A received 5 mg/Kg
of Thiopentone, group В received 2. S mg/Kg of PropofolC2-6 
diisopropylphenol 3 . The maintenance of anaesthesia was the 
same for all patients: NgO-OgC2:13 and Isoflurane. lO patients
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of each group were administered the hypnotic drug through a
vein of the back of the hand and the remaining through a 
larger size one of the forearm. A short 18 G teflon catheter 
was always employed and the time of injection was always not 
less than 20 sec. Afterwards patients were asked to score the 
intensity of injection pain by means of a 4, points evaluation 
scale Cno pain=0, mild pain=l, moderate pain=2, and severe 
pai n=33. Moreover all patients were followed up C7 days! for 
clinical signs of thrombophlebitis. The results of pain score 
showed important differences between the two groups CTab. I ai» . 
Some patients presented mild swelling and referred numbness; 
the average duration of these symptoms was 48 hours CTab. 1 Ы  .
Tab. I
C aO
Sc o t  e Gr . A
back forearm 
hand
О 8 IO
1 1  
2 1
3 -
Gr . В
back forearm 
hand
1 6
4* 2
4*  2
1
C.bO
Gr . A Gr . В 
swelling 3 5
redness 1 3
numbness 3 5
* ■ - p<0. 01
The two drugs considered in this study showed important
differences with regard to the analysed complications. Indeed
Propofol showed a greater incidence of these side effects when
compared to Thiopentone, yet it is possible to reduce them by
choosing a large vein for drugs admmini strati on , by using a
short and small catheter and finally by injecting very slowly,
at least within 20 sec.
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VARIATION IN THE POTENCY OF EPITHELIAL RELAXANT FACTOR TO MODULATE AIRWAY 
SMOOTH MJSCLE RESPONSIVENESS IN THE FUNCTION OF DIFFERENT CHOLINERGIC 
AGONISTS
O.Jackowski,W.M.Abraham J.Szeredi,and P.Sz.Körmöczy
Chinoin Pharmaceutical and Chemical Works L td . ,Budapest,Hungary,and Mt.
Sinai Medical Center,Miami Beach,FL 33140
(airway ep ithe l ia l fa c to r ,cholinergic agonists,tracheal smooth muscle)
We previously reported that removal of the airway epithelium (ep-)from 
sheep tracheal, smooth muscle (TSM) resulted in a small but s ign if ican t 
increased contractile  response to carbachol when compared to TSM with 
epithelium (ep+).This e ffect was abolished i f  a TSM (ep-) s t r ip  was studied 
in the SAME organ bath as a TSM (ep+) strip,suggesting that sheep airway 
epithelium produces a transferable relaxant fa c to r ,Abraham et a l . , (1988).
In th is  study we aimed to determine whether s im ila r responses could be 
obtained with acetylcholine (Ach).Single TSM s tr ip s  were hung under 2g
tension in organ baths containing Krebs-Henseleit solution (39*
C) ,eguilibrated with 95 4 0^ and 5 \
Isometric forces generated in response to increasing concentrations of 
carbachol and Ach were measured to determine the concentration reguired to 
produce 50 \  of maximum contraction (ED50).Mean^SE-log M ED50 values for 
carbachol (n=7) and for ACH (n=7) in TSM (ep+) tissues were !.!(>+_ 0.12 and 
5.80jf0.50, respectively. In TSM (ep-) tissues carbachol shifted the ED50 to 
the le f t  by 0.22+0.06 units (p c  0.05).This leftward sh i f t  was s l ig h t ly  
greater i f  Ach was used as the contractile agonist (0.30+0.04).
When TSM str ips  (ep+/ep-) were hung together,the increased s e n s it iv i ty  of 
the TSM (ep-) s t r ip  to carbachol was lost (delta-log M ED50 
for/(ep-)-(ep+)/=-0.03±0.08 units,n=6)
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However,the increased s e n s i t iv i ty  of the TSM (ep-) tissue was maintained i f  
Ach was used (delta-log M ED50=0.36±0.09 units , n=3).
The following Table summarizes the effect of ep ithe l ia l  removal on sheep 
tracheal smooth muscle con trac t i le  responses to cholinergic agonists:
SINGLE TISSUE STUDIES
AGENT n EC50 ep(+) EC50 ep(- ) Delta
Ach 7 5.80.10.50 6.1010.70 § 0. ЗОЮ • 04
Metacholine 5 7.33+0.18 7.6510.20 § 0.2710.02X
Carbachol 7 7.7Ő+0.12 7.9810.10 § 0.22i0.06x
PAIRED TISSUE STUDIES
AGENT EC50 ep(+) EG50 ep(- ) Delta
Ach 3 5.17+0.33 5.5410.25 § 0.3610.09
Metacholine 4 7.64+0.33 7.66i 0 .29 0.02i0.06x
Carbachol 5 7.72+0.17 7.69i0.15 0.03+0.08X
Values are mean SE for EC50(-log M);§=p П.05 vs (ep+);x=p 0.05 vs Ach
These observations suggest that in sheep TSM,the degree of increased 
s e n s i t iv i ty  attained by e p i th e l ia l  removal depends on the cholinergic agent 
used,as does the a b i l i t y  of the ep ithe lia l relaxant factor to modulate 
smooth muscle function under the present experimental conditions 
3ackowski,J. ,and Abrham,W.M. .-The Physiologist 31,A9 (1998).
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IN VITRO EFFECTS OF ANGIOTENSIN II ON THE HUMAN DISEASED AND THE 
GUINEA-PIG GALLBLADDER
S.Jankovic, Ranka Samardzic and D.B.Beleslin
Department of Pharmacology, Medical Faculty,34000 Kragujevac and Depart­
ment of Pharmacology, Medical Faculty, P.O.Box 662,11000 Beograd, Yugo­
slavia
Key words : Human gallbladder - Guinea-pig gallbladder - Angiotensin II 
receptors
The gastrointestinal effects of angiotensin II have already been studied in 
detail. On the other hand, there is little evidence on the effects of angiotensin 
II on the gallbladder isolated strips. For instance, it is reported that angio­
tensin II contracts the guinea-pig gallbladder in vitro (Jankovic and Beleslin, 
1989). Still, the site and mechanism/s of the stimulatory action of angiotensin 
II on the guinea-pig gallbladder as well as the effect of the peptide on the hu­
man diseased gallbladder are not known. In view of these findings, experi - 
ments were performed to investigate the site and mechanism/s of excitatory 
action of angiotensin II on the guinea-pig gallbladder isolated strips, as well 
as the effect of the peptide on the human diseased gallbladder isolated strips .
Human gallbladders were taken immediately after cholecystectomy of pati­
ents, mostly women. Guinea-pigs were killed and the gallbladder was remo­
ved. Strips of the gallbladder body of whole wall thickness, perpenducular on 
the longitudinal axis of the gallbladder were cut and set up in an isolated or­
gan bath of 15 ml in Tyrode solution, gassed with 95 % O 2 and 5 % CO 2 at 
37°C. Angiotensin II was cumulatively applied to the organ bath. Each strip 
was used for evaluation of the effect of only one concentration of an antago­
nist. Concentration-response curves were constructed using linear regression 
according to the method of least squares. A coefficient of correlation (r) of 
linear regression was used to determine the existence of concentration-res­
ponse dependence. The рАз value was calculated according to the method of 
Arunlakshana and Schild (1959). Antagonism was regarded as competitive 
when the slope of the Schild plot was close to unity (1.0).
In the first series of experiments the effect of angiotensin II on the human 
diseased gallbladder was investigated. Angiotensin II (3.2 x 10“'’m  - 2.6 x  
10~^M) did not contract, relax or had any effect on resting tone of the human 
diseased gallbladder isolated strips.
In the second series of experiments, the effect of angiotensin II on the gui­
nea-pig isolated gallbladder was studied. Angiotensin II (3 x 10~7M - 2 x 10“  ^
M) contracted the gallbladder isolated preparations. The contractile effect 
was concentration-dependent (r=0.99; pz_0.01).
In the third series of experiments, the interaction of the angiotensin II an­
tagonist saralasin, the antimuscarinic drug ,atropine, the alpha and beta adre­
noceptors blocking drugs phentolamine and propranolol, the H-l and H-2 his­
tamine antagonists, pyrilamine and cimetidine, and the local anaesthetic agent 
lidocaine on angiotensin II - induced contractions was investigated. Saralasin
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(6.7 X 10~1^M - 6.7 X 10~^М) depressed or abolished the contractile response 
of gallbladder strips to angiotensin II and the antagonist shifted the concentra­
tion-dependent curves of angiotensin II to the right with maximal contractions 
not significantly different from those obtained with the peptide. The antago­
nism gave рАз value of 12.5. The slope of the regression line was 0.41. On 
the other hand, atropine, (9.6 x 10“^M), phentolamine (2.1 x 10“^M), pro­
pranolol (2.3 x 10"5m ), cimetidine (2.6 x 10-^M) and lidocaine (9.2 x 10-5 
M  ) had virtually no effects on angiotensin II- induced concentration-response 
curves.
As shown in these experiments, angiotensin II contracted the guinea-pig 
gallbladder isolated strips, whereas the peptide did not contract, relax or had 
any effect on resting tone of the human diseased gallbladder isolated strips. 
This finding would be consistent with reports that angiotensin II contracts the 
gallbladder isolated strips (Jankovic and Beleslin, 1989) as well as the sphin­
cter Oddi of the guinea-pig (Harada et al. , 1986). The present experiments 
further revealed that the angiotensin II antagonist, saralasin, but not atropine, 
phentolamine, propranolol, pyrilamine, cimetidine and lidocaine, inhibited the 
peptide-induced contractions. It appears, therefore, that angiotensin II acted 
on angiotensin II receptors in the guinea-pig gallbladder smooth muscle. How­
ever , since the slope of the regression line is significantly less than unity 
(1.0) , the antagonism with saralasin cannot be competitive in nature.
This work has been supported by a grant from the Serbian Republic Fund, 
Beotjrad, Yugoslavia.
REFERENCES
Arunlakshana,О . and Schild,H.О. (1959). Br.J.Pharmac., 14,48-58.
Harada,T. ,Katsuragi,T. and Furukawa,T. (1986). J.Pharmac.Exp.Ther., 
239, 554-558.
Jankovic,S. and Beleslin,D.B. (1989) . Iuqoslav.Physiol.Pharmacol.Acta,
25,Suppl.7, 53-54.
Acta P hys io log ies  Hungarica, Volume 75, Supplementum, 1990 155
GYKI-12 743, A NOVEL ANTIHYPERTENSIVE COMPOUND WITH SPECIAL 
ALPHA-ADRENERGIC BLOCKING PROFILE
L.Jaszlits, Gy.Rabloczky, Gy.Csókás, I.Bódi, M.Kürthy, E.Hor­
váth, A.Kovács, A.Jednákovits, P.Arányi, P.Mátyus, E.Kasztreiner
Institute for Drug Research, Budapest, P.O.Box 82, Hungary
Keywords: Antihypertensive, bradycardia, alpha-blocker
Recently, parallel with the development of new selective alpha^ 
àdrenergic blockers in intensive search for selective postsy- 
naptic alpha^-adrenergic antagonists has emerged in the inter­
national drug research (Ruffolo et al., 1987). Predominance of 
postjunctional alpha2-adrenoceptors have been shown in spon­
taneously hypertensive rats (Medgett et al., 1984) and their 
activation should play a role in the maintainance of high 
blood pressure in patients with essential hypertension (Jie et 
al., 1984). It became widely accepted that there is an inter­
action between the change of function of adrenergic nervous 
system and the ion permeability of smooth muscle cell membrane. 
In the course of our studies on pyridazine derivatives with 
potential vasodilating properties, a new group of 2-amino-al- 
kyl-3(2H)-pyridazinonen was synthetized. One member of this 
class of compounds, GYKI-12 743 (Kasztreiner et al., 1989) 
decreased elevated blood pressure in different types of con­
scious experimental hypertensive rats and neurogenic hyperten­
sive cats after acute (3 mg/kg and 0.5 mg/kg respectively)and 
subacute (3-weeks treatment with 10 mg/kg twice daily in 
rats) oral administration. Its antihypertensive action main- 
fested without tachycardia even bradycardia was regularly ob­
served. In canine experiments GYKI-12 743 decreased the total 
peripheral resistance by its strong vasodilator capacity in 
femoral, renal, carotid and vertebral arteries (0.25-1.0 mg/kg 
i.v., i.d.). At a very low dose range (25 and 50yug/kg i.v.) 
GYKI-12 743 could decrease the coronary vascular resistance 
before any marked reduction of systemic blood pressure deve-
1 5 6
loped.
According to our haemodynamic studies and on the base of our 
data on mechanism of action (see posters :Horváth et al., Ba­
konyi et al.( Jednákovits et al.) it might be suggested that 
GYKI-12 743 could be a potent antihypertensive compound in 
human therapy. Besides its significant alpha^-antagonist acti­
vity, GYKI-12 743 exerts predominantly postjunctional (vascu­
lar) alpha2-adrenoceptor blockade and in its vasodilating ac­
tion the opening of К -channels of vascular smooth muscle cells 
could play role.
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336 : 415-418 ( 1 987) .
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VASCULAR AND CARDIAC ELECTROPHYSIOLOGICAL ACTIVITY OF GYKI- 
-12 743 IN ISOLATED TISSUE PREPARATIONS
A.Jednákovits, A.Kovács, I.Bódi, L.Jaszlits, Gy.Rabloczky
Institute for Drug Research, Budapest, P.O.Box 82, Hungary
Keywords: Potassium channel, GYKI-12 743
Potassium conductance is known to be an important regulator of 
membrane potential in cardiac and vascular smooth muscle.
BRL-3491 5 (cromakalim) and pinacidil are two new compounds 
acting at smooth muscles and they are under clinical investi­
gation as antihypertensive and / or bronchodilator agents 
(Ward, 1 984 ; Van den Burg et al., 1 986 ; Arch et al., 1 988) .
The opening of potassium channels leads to hyperpolarization 
of the myocytes. Compounds which initiate relaxation of smooth 
muscle by opening potassium channels may have therapeutic po­
tential as antihypertensives, as well.
The present study has been undertaken in order to characterize 
the action of GYKI-12 743 (a predominantly postjunctional al­
pha-adrenergic blocker) on the potassium conductance in iso­
lated cardiac and vasculr preparations. Intracellular cardiac 
electrophysiological studies was carried out in dog Purkinje 
fiber (DPF)and guinea pig papillary muscle (GPPM).
GYKI-12 743 (10~5M) like BRL-34915 (10~6M), pinacidil (10_6M) 
and nicorandil (5 x 10 ~*M) induces a significant shortening of 
the action potential duration (APD^q and APDgQ) in DPF.
The same effect was demonstrated in case of all compounds tes­
ted in GPPM but only in higher concentrations. The shortening 
of the transmembrane potential was inhibited with TEA but not 
glibenclamide. We have examined the action of GYKI-12 743 on 
mechanical activity in isolated rabbit ear artery (REA) and 
dog coronary artery (DCA). The tissues were precontracted with 
5-hydroxytryptamine (5-HT). The relaxing ED,-q of GYKI-12 743 
was 5 x 10 and in this concentration GYKI-12 743 did not in­
fluence the dose-response curve to 5-HT. We studied the vas-
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cular smooth muscle relaxing activity of GYKI-12 743 in other 
vascular preparation in order to get more information about 
its vasodilating effectiveness against potassium-induced vaso­
constriction .
Our results may provide further evidence that the potassium 
channel opening activity could play an important role in ad­
dition to its predominant postjunctional alpha-adrenergic an­
tagonist character in the vasorelaxing effect of GYKI-12 743.
References :
Ward,J.W., Br. J. Clin. Pharmacol. 18: 223-225 (1984).
Van den Burg,M.J. et al., 11th Scientific Meeting of the Inter­
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THE EFFECT OF NEUROPEPTIDE Y ON FEEDI NG  AND ITS  
ALTERATION BY RECEPTOR ANTAGONISTS IN RATS
T. K a d a r ,  E.V.  B o r i s o v a " ,  G. T e l e g d y
D e p a r t m e n t  o f  P a t h o p h y s i o l o g y ,  A l b e r t  S z e n t - G y ö r g y 1 M e d i c a l  
U n i v e r s i t y ,  Sz e g e d ,  H u n g a r y .  " I n s t i t u t e  o f  N o r m a l  P h y s i o l o ­
gy ,  A c a d e m y  o f  M e d i c a l  S c i e n c e s ,  M osc ow ,  USSR.
K e y w o r d s :  N e u r o p e p t i d e  Y F e e d i n g  B i m o d a l  e f f e c t  A n t a g o n i s t s
I n t r o d u c t i o n
N e u r o p e p t i d e  Y (NPY) i s  a p o l y p e p t i d e  h o r m o n e  f r o m  p o r ­
c i n e  b r a i n  c o n s i s t i n g  o f  36 AA  r e s i d u e s .  I t  was  s h o w n  t h a t  
c e n t r a l  a d m i n i s t r a t i o n  o f  NPY c a u s e d  a r o b u s t  a n d  l o n g - l a s t ­
i n g  s t i m u l a t i o n  o f  f e e d i n g  ( C l a r K  e t  a l . ,  1964).  T h i s  e f f e c t  
i s  s i m i l a r  t o  t h a t  o f  c e n t r a l l y  a d m i n i s t e r e d  n o r a d r e n a l i n e  
( S t a n l e y  a n d  L e i b o w l t z ,  1964) .  I n  t h e  p r e s e n t  s t u d y  t h e  r o l e  
o f  n e u r o t r a n s m i t t e r s  w e r e  i n v e s t i g a t e d  i n  t h e  f o o d  l n t a k e -  
- i n d u c i n g  e f f e c t  o f  NPY, b y  u s i n g  s e v e r a l  r e c e p t o r  b l o c k i n g  
a g e n t s .
M e t h o d
M a l e  W i s t a r  a l b i n o  r a t s  w e i g h i n g  a p p r .  2 0 0  g w e r e  u s e d .  
T h e  i n t r a c e r e b r o v e n t r i c u l a r  ( l e v . )  t r e a t m e n t s  w e r e  c a r r i e d  
o u t  w i t h  100 ng ,  1 pg a n d  5 pg NPY i n  a v o l u m e  o f  2 p l / r a t ,  
a n d  a p r e w e i g h e d  a m o u n t  o f  r a t  c h o w  w a s  p r o v i d e d .  F o o d  i n ­
t a k e  wa s  d e t e r m i n e d  b y  w e i g h i n g  t h e  r e m a i n i n g  f o o d  2 a n d  4 h  
a f t e r  t h e  i n j e c t i o n .  P r e t r e a t m e n t s  w i t h  t h e  a n t a g o n i s t s  w e r e  
c a r r i e d  o u t  l e v .  10 m i n  p r i o r  t o  p e p t i d e  i n j e c t i o n s .  A s  r e ­
c e p t o r  a n t a g o n i s t s  p r a z o s l n e ,  y o h i m b i n e ,  p r o p r a n o l o l  a n d  n a ­
l o x o n e  H C l  ( a l l  S IGMA)  w e r e  u s e d .
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R e s u l t s  a n d  D i s c u s s i o n
NPY e x e r t e d  a  d o s e - d e p e n d e n t  b i p h a s i c  e f f e c t  o n  f e e d i n g ;  t i i e  
lOO n g  d o s e  s i g n i f i c a n t l y  s u p p r e s s e d  4 - h  f o o d  i n t a k e ,  b u t  
h i g h e r ,  1 t ig a n d  5 pg d o s e s  s t i m u l a t e d  f e e d i n g .  I t  i s  p o s s ­
i b l e  t h a t  NPY e x e r t s  i t s  a c t i o n  b y  a l t e r i n g  c a t e c h o l a m l n e r -  
g i c  m e t a b o l i s m  i n  a b i p n a s l c  w a y  i n  t h e  b r a i n ,  s i n c e  a c l o s e  
r e l a t i o n s h i p  b e t w e e n  NPY a n d  t h e  b r a i n  c a t e c h o l a m i n e r g i c  
s y s t e m s  w a s  d e m o n s t r a t e d  ( H a r f  s t r a n d  e t  a l . ,  1966; J a c o b o -  
w i t z  a n d  0 1 s c h o w k a , 1 9 6 2 ) ,  t o g e t h e r  w i t h  t h e  f i n d i n g  t h a t  l o w  
i c v .  d o s e s  d e c r e a s e d  a n d  v e r y  h i g h  d o s e s  i n c r e a s e d  t h e  u t i ­
l i z a t i o n  o f  c a t e c h o l a m i n e s  i n  h y p o t h a l a m i c  s t r u c t u r e s  ( H a r f  -  
s t r a n d  e t  a l . ,  1967) .  F r o m  t h e  a d r e n e r g i c  a n t a g o n i s t s ,  y o ­
h i m b i n e  (4 ii g i c v . )  a n d  p r o p r a n o l o l  (5 pg, i c v . )  s l i g h t l y  
b u t  i n s i g n i f i c a n t l y  i n h i b i t e d  f o o d  I n t a k e  a f t e r  NPY t r e a t ­
m e n t .  P r a z o s i n e  (4 pg i c v . )  e x e r t e d  a p r o n o u n c e d  a n d  s e l e c ­
t i v e  e f f e c t  o n  f e e d i n g  a l t e r e d  b y  NPY:  i t  d i d  n o t  m o d i f y  t h e  
f o o d  i n t a k e - i n h i b i t o r y  e f f e c t  o f  a l o w  NPY d o s e  (100 ng )  b u t  
d e c r e a s e d  t h e  f o o d  i n t a k e  e l e v a t i o n  o f  a h i g h  NPY d o s e  (5 
pg )  t o  t h e  c o n t r o l  l e v e l .  N a l o x o n e  (0 .5  pg,  i c v . ) ,  s i m i l a r l y  
t o  p r a z o s i n e ,  s e l e c t i v e l y  i n h i b i t e d  t h e  f e e d i n g - s t i m u l a t o r y  
e f f e c t  o f  5 pg NPY i c v .  T h e  r e s u l t s  s u g g e s t  t h e  i n v o l v e m e n t  
o f  a l p h a - l - a d r e n e r g i c  a n d  o p i a t e  r e c e p t o r s  i n  t h e  f o o d  i n ­
t a k e - s t i m u l a t o r y  e f f e c t  o f  c e n t r a l l y  a d m i n i s t e r e d  NPY. 
R e f e r e n c e s
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E n d o c r i n o l .  1 1 5 : 4 2 7 - 4 2 9 ,  1 9 6 4 .
H a r f s t r a n d ,  A.,  P. E n e r o t h ,  L.F.  A g n a t i  a n d  K. F u x e .
R e g ü l .  P e p t i d e s  1 7 : 1 6 7 - 1 7 9 ,  1 9 6 7 .
H a r f s t r a n d ,  A.,  K. F u x e ,  L.F.  A g n a t l ,  P. E n e r o t h ,  e t  a l .
N e u r o c h e m .  I n t .  6 : 3 5 5 - 3 6 1 ,  19 66 .
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GASTROPROTECTIVE EFFECT OF MECLOFENAMIC ACID ON [NDOMETHAC IN-INDUCED 
ULCERATION IN RATS
Z. Kapui, I. Cser, I .  Hermecz, I .  R ó z s a Gy. Blasko^
CHINOIN Pharmaceutical and Chemical Works L td ., Budapest, -^Second Department 
of Surgery, and ^F irs t Department of Medicine , Postgraduate Medical 
University, Budapest, Hungary
(Meclofenamic acid, leukotrienes, prostaglandins, gastric ulcer )
Gastric mucosal u lceration and haemorrhage due to nonsteroidal 
antiinflammatory drugs (NSAIDs) has been ascribed, p rinc ipa lly  to a 
prostaglandin "deficiency" created from the in h ib it io n  of the biosynthesis 
of so called "cytoprotective" prostaglandins (PGs), especially PGE2 and 
PGI2.
I t  is  known, however , from studies in nongastric tissues tha t the 
in h ib itio n  of PG cyclooxygenase by NSAIDs can cause diversion of 
arachidonic acid through the 5 -  lipoxygenas pathway with resu ltan t
enhancement in the products derived therefrom. Thus, by analogy with these 
observations i t  is  possible that the consequences of in h ib it in g  PG 
cyclooxygenase might instead of reducing the production of gastro- 
protective PGs, leads to excess synthesis of products of the lipoxygenase 
pathways i.e .  vasoactive leukotrienes (LTs) and hydroperoxy-eicosatetraenoic 
acids (HPETEs). These perturbations by NSAIOs of arachidonic acid metabolism 
could contribute to the pathogenesis of gastric  in ju ry  by NSAIDs. 
Meclofenamic acid (Park-Davis) a well known NSAID, at a high dose range (10 
- 150 mg/kg) did not cause gastric u lcera tion , but inh ib its  indomethacin
induced gastric  lesions in rats ( EDjq = 40 mg/kg p .o .) .
Meclofenamic acid was found to be strong soybean 15 - lipoxygenase in h ib ito r  
(IC50 = 110 /uM), potato tuber 5 - lipoxygenase in h ib ito r ( IC5Q - 50 /uM)
and sheep vesicular gland cyclooxygenase in h ib ito r  (ICjq _ 2.5 yuM).
In human blood p la te le ts  and leukocytes Meclofenamic acid in h ib its  the 
cyclooxygenase and lipoxygenase pahways. The IC5Q values for TxA2 formation 
is about 48 yuM, and for 12 HETE formation is  about 78 yuM in p la te le ts ,
1 6 2
while for 5-HETE, PGE2 and 15-HETE formation in leukocytes are 30 /uM, 8 /uM 
and 147 /uM, respectively.
Meclofenamic acid in h ib its  LTC^  and LTD  ^ induced contractions of iso lated 
guinea pig lung parenchymal s tr ip s , the ICjg value for LTC4 is  1 .1 ./uM and 
fo r LTD4 is  0.8 /uM. Incubation of the parenchymal tissue s tr ip s  w ith 1 /uM 
Meclofenamic acid resulted in s ig n ifica n t s h if t  of the LTC  ^ and LTO^  
concentration response curves to the r ig h t without a ffecting the maximal 
response attained. The e ffec t of Meclofenamic acid appeared to be spec ific  
fo r  the leukotrienes.
Meclofenamic acid in h ib its  TXA2 and IT formation in gastric mucosa in  v itro  
(IC 5Q = 30 /uM for TxÄ2 and 25 /uM for LTC^).
One hour a fte r the indomethacin -  i r r i t a t io n ,  Meclofenamic acid (40 mg/kg 
p .o .)  decreases the LTC^  content of ra t gas tric  mucosa by 50 %.
These results suggest, that Meclofenamic acid has dual e ffe c t on 
arachidonic acid cascade: in h ib its  the cyclooxygenase and lipoxygenase
pathways, and i t  has an antagonistic e ffec t on LT-s receptors.
These effects may play an important ro le  in  the gastroprotective e ffe c t of 
Meclofenamic acid in indomethacin induced u lcer, in h ib its  the overproduction 
o f leukotrienes and other lipoxygenase products a fte r indomethacin
treatm ent.
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ROLE OF ARACHIDONIC ACID METABOLITES IN ACUTE GASTRIC LESIONS INDUCED BY 
INDOMETHACIN IN RATS
Z. Kapui, I .  Cser, I .  Hermecz, I .  Rózsa  ^ and Gy. Blaskó
CHINOIN Pharmaceutical and Chemical Works L td ., Budapest, ^Second Department 
of Surgery, and ^F irs t Department of Medicine, Postgraduate Medical 
University, Budapest, Hungary
(leukotrienes, indomethacin, gastric  ulcerations, lipoxygenase antagonists) 
Gastric mucosa is  capable of synthesizing various products of arachidonate 
metabolism, via cyclooxygenase and lipoxygenase pathways, such as 
prostaglandins (PGs) and leukotrienes (LTs).
A major c lin ic a l problem encountered with the use of nonsteroidal 
antiinflammatory drugs (NSAID) is  the high incidence of gas tro in testina l 
i r r i ta t io n .  The pathogenesis of NSAID - induced u lceration is  s t i l l  not 
completely known, but i t  is  possible that these e ffects  are bound to a 
"cytoprotective" prostaglandin deficiency, especially PGE2 and PGI2 .
In our experiments we observed, that lipoxygenase in h ib ito rs  ( BW - 755 C 
ED5q = 4 mg/kp p .o .; NDGA ED5q = 35 mg/kg p .o .) and leukotriene antagonists 
(FPL - 55712 ED5g = 5 mg/kg p .o .; SKF 88046 ED5g = 4 mg/kg p .o .) protect the 
gastric  mucosa against lesions induced by ora l adm inistration by 
indomethacin.
Ulcerogenic e ffect of the NSAIDs is  bound to the cyclooxygenase in h ib ito ry  
e ffec t of NSAIDs. Those NSAIDs which have a cyclooxygenase and 
lipoxygenase in h ib ito ry  e ffe c t can produce a gastroprotective e ffe c t against 
indomethacin induced gastric  ulcers.
In the control mucosa we observed a balance between TXA2/PGI2 (0 .92), and a 
very low ra tio  of lipoxygenase and cyclooxygenase products (0 .14). After 
indomethacin treatment these ra tios  were sh ifted  toward the d irec tion  of 
TxA2 and lipoxygenase products, and the ra t io  of pro tective  products 
(PGI2+PGE2) contra i r r i t a t io n  products (TxA2+LTs) overturned in  the 
ulcerogenic mucosa towards the d irection of i r r i ta t io n  products:
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TxA2/PGI2 TxA2 + LTs
PGI2 + pge2 TxA2 + pgi2 + pge2
0.14
LTs
Control 0.92 0.778
1 hr 2.7 1.9 0.69
a fte r i r r i ta t io n
4 hr 2.4 2.38 0.65
Table 1
These observations suggest that the overproduction of leukotrienes, 
thromboxane and other lipoxygenase products due to a protective 
prostaglandin synthesis blockade, induced by nonsteroidal anti - 
inflammatory drugs, may play an important ro le  in  the development of acute 
g a s tr ic  mucosal damage induced by these drugs.
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ELECTROPHYSIOLOGICAL EFFECTS OF PLATELET-ACTIVATING 
FACTOR (PAF) IN GUINEA-PIG CARDIAC PREPARATIONS 
Valeria Kecskeméti
Department of Pharmacology, Semmelweis University of Medicine 
Budapest, Nagyvárad tér 4, 1089 Hungary 
Key words: PAF, cardiac action potential
PAF (acetyl glyceryl ether phosphorylcholine) has been 
found to be synthesized by a variety of cell (leukocytes, 
platelets, endothelial cells) and to be implicated in differ­
ent pathophysiological events (Benveniste et al., 1972; Braquet 
et al., 1989). This autacoids has prominent cardiovascular 
actions, including hypotension, decreased coronary flow, 
depressed cardiac contractility. The mechanism by which PAF
induces its negative inotropic effect is not clear. Camussi
2 +et al. (1984) have reported that PAF may decrease slow Ca 
current, whereas Tamargo et al. (1985) have suggested the oppo­
site action. The objective of this study was to examine the 
effects of PAF-acether on the transmembrane action potential 
in auricular and ventricular papillary muscles of guinea-pig. 
Materials and methods. Experiments were carried out on isola­
ted electrically driven (0.3-1.5 Hz) right ventricular papil­
lary muscle and on left auricular muscle of guinea-pig. The 
slow response action potential (APj was elicited with isopré­
naline (5x10 7M) in partially depolarized O40mV, by means of 
25 mM K+Tyrode) atrial and ventricular preparations (Kecske­
méti, 1978). The transmembrane potential was recorded by means 
of conventional microelectrode technique.
PAF-acether (l-0-hexadecyl-2-acetyl-sn-glycero-3-phospho- 
rylcholine) from Sigma was used.
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Results. -The effects of PAF-acether on 
both ventricular and atrial APs at con­
centrations from 1 0 to 10 7M are shown 
in fig. 1 PAF did not cause any signifi­
cant alterations in RP,V . At 10max
it increased the amplitude of atrial and 
ventricular APs and the duration of 
ventricular AP. Its effect on the repol­
arization was not the same in the two 
types of muscle. While the repolarization 
phase was dose-dependently shortened in 
the case of atrium, the duration of vent­
ricular AP was rather increased. PAF log IPAFI (M>
2 +was not able to generate slow Ca -de­
pendent APs in depolarized (by 25 raM K+) 
fibers, when fast Na+channels were inac­
tivated. PAF failed to prevent isopren- 
aline-induced APs in K+-arrested atrial 
fibers. Our data are inconsistent with 
those of Tamargo et al. (1985) and Camussi
et al. (1984) and suggest that PAF does
2+not affect slow inward Ca -current.
Fig.l. Effect of 
PAF-acether on AP1s 
characteristics of guinea-pig atrial (o) 
and ventricular 
papillary muscles (x) 
APA=action potential amplitude ;RP=resting 
[potential ;
Vmax=maximum rate of 
rise of the upstroke; 
APD20 and APD50=AP duration measured at 20% and 50% level of 
repolarization. Each point represents the 
mean values from 6 
experiments; vertical 
bars= S.E.M.References
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PROSTAGLANDIN RELEASING EFFECT OF PVRIDO-PYRIMIDINES IN THE HEART 
Kelemen К. and Marko R.
D ep t .o f  Pharmacology, Semmelweis U n i v e r s i t y  o f  M ed ic ine ,
Budapest,  Hungary
Key words: p y r i d o - p y r i m i d i n e s , p r o s t a g l a n d i n s ,  Na-channel ,  h e a r t  
P ro s ta g la n d in s  have been shown to  i n c re a s e  the r a te  of  r i s e  of  
the ca rd ia c  a c t i o n  p o t e n t i a l  and the am p l i tude  of  the  f a s t  
(sodium) component o f  the inward membrane c u r r e n t  (Kelemen et  
a l . , 1980).  Paracetamol ,  known to reduce the the g a s t r i c  e r o s i v e  
a c t i v i t y  o f  a s p i r i n  by s t i m u l a t i n g  endogeneous p r o s t a g l a n d i n  
p ro d u c t io n  (Seegers e t  a l . , 1979) d i s p la y e d  p r o s t a g l a n d i n - l i k e  
e l e c t r o p h y s i o l o g i c a l  e f f e c t s  in  the hea r t  (Kelemen and
Marko ,1988) . P r o s t a g l a n d i n - l i k e  e f f e c t  o f  paracetamol  was
prevented by indom ethac ine , sugges t in g  the inv o lvem en t  of  
endogeneous p r o s t a g l a n d i n s .
Minor  a n a lg e s ic s  of  p y r i d o - p y r i m i d i n e  s t r u c t u r e  w i t h  p o ten t  
a n t i i n f l a m a t o r y  a c t i v i t y  were developed and found to  decrease the 
mucosal damage caused by a s p i r i n  and o t h e r  agents ( K n o l l  e t  a l . ,  
1987, Gy i res  e t  a l . , 1985) ) .  Aim of  the  presen t  s tudy  was to 
compare the e l e c t r o p h y s i o l o g i c a l  e f f e c t  of  p y r i d o - p y r i m i d i n e s  
w i th  t h a t  o f  pa race tamo l .  Two r e p r e s e n t a t i v e s  of  p y r i d o -  
p y r im id in e s  were s e le c te d :  r im az o l ium  ( 3 - / e t h o x y c a r b o n y 1 / -
6 , 7 , 8 , 9 - t e t r a h y d r o - l , 6 - d i m e t h y l - 4 - o x o - 4 ] i - p y r i d o - / l , 2 a / p y r i m i d i n i -  
um hyd rox ide ) , a c l i n i c a l l y  approved d rug ,  marketed under  the 
t r ade  name o f  Probon ) and CH-127 ( 1 , 6 - d i m e t h y l - 4 - o x o -
1 , 6 , 7 , 8 , 9 , 9 £ - h e x a h y d r o - 4 ^ - p y r i d o / 1,2£ / - p y r im id in e - 3 - c a r b o x a m id e )  
a lso shown to  p r o t e c t  i n t e s t i n a l  damage i n  the r a t .
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Transmembrane io n ic  c u rre n ts  were measured in  the  s in o -  
a u r ic u la r  f ib e r s  o f th e  fro g  h e a rt by a v o lta g e  clamp te ch n iq u e  
based on a double sucrose  gap arrangem en t. Drugs were added to  
th e  p e r fu s io n  f l u i d  in  the fo l lo w in g  m ic rom o la r c o n c e n tra t io n s :  
p ro s ta c y c l in  (P G I^-N a) -  0 .27 ; r im a z o liu m  - 30 .0 ; CH-127 - 3 0 .0 ; 
indom ethac ine  -  2 .0 .  Both r im a zo liu m  and CH-127 induced  a
p ro s ta g la n d in - l ik e  e f f e c t  in  the  vo lta g e -c la m p e d  h e a r t p re p a ra ­
t i o n ,  in c re a s in g  th e  maximal a m p litu d e  o f the  fa s t  inw ard  Na- 
c u r r e n t  by 63 and 6 6 % (fro m  1.64+0.17 uA to  2.59+^0.18 uA and from 
1.83+43.12 uA to  2.78_+0.15 uA, r e s p e c t iv e ly ) .  The changes were 
s t a t i s t i c a l l y  h ig h ly  s ig n i f ic a n t  and were comparable w ith  th a t  
caused by 270 nm ol/1  p ro s ta c y c l in .  P y r id o -p y r im id in e s , s im i la r ly  
to  paracetam ol and p ro s ta g la n d in s ,  had no e f fe c t  on th e  slow 
in w a rd  C a -cu rren t in  the  h e a rt. Indom ethac ine  p re ve n te d  the 
s t im u la to r y  e f fe c t  o f  p y r id o -p y r im id in e s  on the N a -c u r re n t,  
le a v in g  the e f fe c t  o f exogeneous p ro s ta c y c l in  unchanged.
T h is  suggests th a t  the  p r o s ta g la n d in - l ik e  e le c t ro p h y s io -  
l o g ic a l  e f fe c ts  o f p y r id o -p y r im id in e s  a re  due to  endogeneous p ro ­
s ta g la n d in  re lease  in  the  h e a rt.A  s im i la r  e f fe c t  in  th e  g a s tro ­
in t e s t i n a l  t r a c t  may be re s p o n s ib le  fo r  t h e i r  a n t i - u lc e r  e f f e c t .
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EFFECT OF FENOLDOPAM ON ACTION POTENTIAL CHARACTERIST ICS I N  
LEFT A T R I A L  AND RIGHT VENTRICULAR PA PI LL ARY  F IBERS OF GUINEA-PIG 
Z . K e r t é s z  a n d  V . K e c s k e m é t i , D e p t ,  o f  P h a r m a c o l o g y ,  S e m m e l w e i s  
U n i v .  o f  M e d i c i n e ,  B u d a p e s t ,  H u n g a r y
Key words: Fenoldopam, action potential, guinea-pig heart
T he  t y p e  o f  r e c e p t o r s  m e d i a t i n g  t h e  c a r d i a c  a c t i o n  o f  
d o p a m i n e  (DA) i s  n o t  s o  w e l l  d e f i n e d  a s  t h a t  o f  v a s c u l a r  b e d s .
DA caused a hyperpolarizing effect and it enhanced the over­
shoot (OS) but did not change the maximum rate of rise (V ) 
of action potential (AP) on the electrically paced guinea-pig 
left auricular and right ventricular fibers. These effects of 
DA were antagonized by pindolol (Kecskeméti et al.,1985) confir­
ming the significance of 8 adrenoceptors. The aim of this work 
was to analyse the effect of fenoldopam (selective DA^ agonist, 
lack of В agonist activity reported by Hahn et al.) on cardiac 
transmembrane potential.
Material and methods: Transmembrane potentials were recorded 
by glass capillary microelectrodes filled in with 3 M KC1. The 
preparations (left auricules and right ventricular papillary 
muscles of guinea-pig) were placed into Tyrode solution of 34°C, 
pH 7.4 bubbled with 95% О2 - 5% C02, and were stimulated by rec­
tangular pulses (0.3-3 Hz, 0.5 ms at voltage 2 times the stimu­
lus threshold).V of AP was recorded as electronically ob- max
tained differential (dV/dT) of rising phase.
Results : The obtained results are shown in figure 1. Fenoldo­
pam (more or less selective DA-^  agonist, without 6 agonist ac­
tivity) had any effect neither on atrial nor ventricular AP 
parameters, and increased only OS of the ventricular AP at Ю  ~*M.
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It could not generate slow AP in K+-depolarized atrial prepara­
tion. 4xlO-7M pindolol could not modify the above mentioned ac­
tion of fenoldopam. These results suggest that DA^ dopamine re­
ceptors are not involved in the cardiac electrophysiological 
action of dopamine.
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PRECLINICAL STUDIES WITH COMPOUND GYKI-22441 , A NEW LONG-ACTING 
NEUROLEPTIC PHENOTHIAZINE
Ildikó Király, József Borsy, Marianna Tapfer, Sándor Losonczy, 
Klára Rásky, Lajos Toldy and István Tóth
INSTITUTE FOR DRUG RESEARCH, 1325-BUDAPEST, P.O.Box 82, HUNGARY 
Keywords: depot-neuroleptics, new phenothiazine esters
On continuing our earlier research in phenothiazines (Toldy 
et al. 1964; Borsy et al. 1965) the new aim was to develop a 
fluphenazine decanoate-like long-acting antipsychotic drug for 
the therapy of schizophrenic patients.
In order to obtain depot neuroleptic effect several new 
2-trifluoromethyl-phenothiazine esters were synthetized by 
using sterically hindered different acids of lipophyllic char­
acter (Király et al. 1980 and 1988).
Among the new esters of fluphenazine the 4-chloro-phenoxy- 
-isobutyrate (GYKI-22441), which is a cristallic substance and 
readily soluble in sesame oil was selected for preclinical tri­
als .
The specific pharmacological experiments verified the expected 
long-acting neuroleptic effect of this new phenothiazine ester. 
Among the classical neuroleptic methods it seemed to be highly 
active in inhibition of conditioned avoidance reflex (CAR) in 
rats: it showed a good dose-related and long-lasting inhibitory 
effect on learning performance already in low doses.
Similarly to other phenothiazine neuroleptic drugs, it posses­
sed direct dopamine receptor antagonistic effect were measured 
by different methods based on anti-apomorphine activity. In 
these experiments the relative intensity of this inhibitory ef­
fect on different part of central dopaminergic system was de­
termined. We could detected strong effect on nigrostriatal, me- 
solimbic and tuberoinfundibular dopaminergic system.. The dura­
tion of inhibitory effect on intact nigrostriatal and mesolim- 
bic system (measured by apomorphine-induced stereotypy and hy­
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permotility in rats) was relatively short (3-8 days), but after 
the lesion with 6-OHDA the inhibition of supersensitive nigro- 
striatal dopaminergic system (measured by apomorphine-induced 
turning behaviour in rats) was long-lasting (14-28 days).
Its long-lasting (above 28 days) inhibitory effect on tubero- 
infundibular dopaminergic system appeared already in low doses 
(measured by apomorphine-induced vomiting in dogs).
By means of the above listed results in specific pharmacologi­
cal experiments the duration and intensity of its neuroleptic 
effect was equiactive with fluphenazine decanoate.
On the general pharmacological experiments (cardiovascular» 
endocrinological, etc.) this compound did not influence the 
function of other organs of vital importance.
The pharmacokinetic studies supported its long-lasting neuro­
leptic effect already in low plasma concentration (measured by 
radioimmunoassay in dogs).
On the base of toxicological studies (acute tolerability and 
chronic toxicity in rats and dogs, local tissue tolerancy ex­
periments) and terato logical as well as mutagenical studies 
there is no any contraindication of this new drug.
The preclinical studies have already finished and the clini­
cal (phase I and II) trials are in progress now.
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A DEPRENYL-DERIVED NEW SPECTRUM PSYCHOSTIMULANT 
Bertha Knoll, S. Yasar, J. Timár, J. Knoll
Department of Pharmacology, Semmelweis University of Medicine, 
Budapest, P.O.B. 370, 1445 Hungary
Keywords: Amphetamine, MK-306, catecholamine release, uptake
(-)Deprenyl, the only selective inhibitor of В-type mono­
amine oxidase (MAO) in clinical practice is a safe drug be­
cause, in contrast to other MAO inhibitors, it does not po­
tentiate, but inhibits the effect of tyramine, thus it is free 
of the cheese effect (Knoll, J., 1987) . Based on our observa­
tions that MAO and uptake inhibitory effects of (-)deprenyl 
are independent from each other, we developed a new family of 
(-)deprenyl-derived substances which do not inhibit MAO but 
are much more potent than (-)deprenvl in inhibiting the ca­
techolamine releasing effect of indirectly acting amines. As 
a fruit of structure-activity relationship studies, 1-phenyl- 
2-propyl-aminopentane. HC1 (MK-306) was selected as a reference sub­
stance of the family which proved to exert in behavioral tests 
psychostimulant effects reminiscent to amphetamine (Knoll, B. 
et al., 1988). MK-306 and amphetamine were found, however, to 
be essentially different in their mechanisms of action. Amphet­
amine acts via the continuous release of the catecholamine 
transmitters from the neurons, whereas MK-306 is devoid of 
this effect.
For screening of the new derivatives the pulmonary artery 
strip of the rabbit was used. In this test neither low nor 
high doses of MK-306 showed noradrenaline releasing properties,
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on the contrary, it inhibited the releasing effect of amphet­
amine and tyramine. The same effect v/as demonstrated in in vivo 
experiments on the cat nictitating membrane.
We measured on the isolated striatum of the rat the release 
of dopamine using reversed phase HPLC and electrochemical de­
tection. Amphetamine (5-15 umol/1) released dopamine from the 
neurons in a dose-dependent manner, MK-306 (up to 50 umol/1) 
did not change the release of the transmitter.
Whereas MK-306 was much less potent than amphetamine in 
increasing motility and basal metabolic rate, it v/as highly 
active in enhancing learning and retention in behavioral tests. 
MK-306 (1-10 mg/kg, s.c.) facilitated the acquisition of a con­
ditioned avoidance response in the shuttle box in a dose-de- 
pendent manner and completely antagonized tetrabenazine-induced 
depression. Amphetamine facilitated the acquisition of a con­
ditioned avoidance response in small doses (1-2 mg/kg, s.c.) 
but inhibited it in higher doses. In contrast to amphetamines 
with catecholamine releasing properties the psychostimulant 
effect of MK-306 was not antagonized by a-methylparatyrosine. 
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THE ROLE OF HYPOGLYCEMIC SULPHONYLUREAS IN ARRHYTHMIAS CON­
TRIBUTING TO THE MORTALITY IN ACUTE MYOCARDIAL ISCHEMIA.
M.Zs. K o lta i, Z. Aranyi, G. Ballagi-Podány and G. Pogátsa 
National In s titu te  of Cardiology, Budapest 1450 P.O.B. 9-88, Hungary 
Keywords: diabetes m e llitus , cardiac arrhythmias, sulphonylureas
Sulphonylureas of the two generations are known to exert d if fe re n t ca r­
diac e ffects . To analyse th is  phenomenon, on one hand the incidence and 
m orta lity  o f acute myocardial in fa rc tion  have been compared in 775 d iabetic 
patients according to the d iffe re n t therapies. On the other hand the e ffec t 
o f d iffe re n t sulphonylurea compounds have been studied on arrhythm ias in ­
duced by coronary a rte ry  ligation in rats.
Acute myocardial in fa rc tion  occured in 20% and w ith lethal outcome in 
13% among the diabetic patients. 10% (le tha l: 7%) o f diabetics treated w ith  
su lphonylureas, 7% ( letha 1:5% ) o f those on insu lin  and 3% (le thal: 1.5%) o f 
all w ith  d ie t controlled patients su ffered from acute myocardial lesion. A - 
mong the diabetic patients treated w ith hypoglycemic sulphonylurea com­
pounds, those w ith glibenclamide therapy showed the lowest (p<0.001) 
incidence o f acute myocardial in fa rc tion . From all diabetics w ith acute 
myocardial infarction 36% (le tha l: 25%) have been on insu lin , 52% (le th a l: 
34%) on sulphonylurea therapies and 12% (le tha l: 6%) were contro lled  w ith  
regime alone. Acute myocardial in farction  had a lethal outcome in all those 
treated w ith glibenclamide in 8%, while in 24% among diabetics on ca rb u ta - 
mide and tolbutamide therapies (p<D.001).
In o rder to support th is  c lin ical observation about the h igher incidence 
and m orta lity  of acute myocardial in farction  in d iabetic patients treated 
w ith  f ir s t  generation su lphonylurea compounds (carbutamide, to lbutam ide) 
the e ffects of these compounds have been investigated and compared w ith  
tha t o f second generation sulphonylureas (glibenclam ide, g lip iz id e ), on the 
incidence o f ven tricu la r ectopic beats and on the duration o f trans itiona l
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v e n tr ic u la r f ib r illa tio n  in ischemic ra t hae rts . Tolbutamide, carbutamide 
and gliclaside (doses: 0.1-1-2-5-10-100-1000 jjm o l/k g ) increased in 105, 
w hile  glibenclamide and g lip iz ide  (doses: 0 .1 .1 .2 .5 .1  0 ,umol/kg) decrea­
sed in 50 rats the number o f ven tricu la r ectopic beats and the duration 
o f transitional v e n tr ic u la r  fib rilla tio n  d u rin g  the f ir s t  30 minutes a fte r 
liga tion  of the le ft a n te rio r descending co rona ry  a rte ry  in a dose-depen­
den t manner.
These results seem to support the hypothesis tha t the f ir s t  generation 
su lphonylurea compounds in the antid iabetic therapy may contribu te  or 
even provoke a rrhythm ias in the case o f acute myocardial ischemia. 
Therefo re  in all those cases, when myocardial ischemia is e x is tin g , g li­
benclamide or g lip iz ide  must be p re fe rred , i f  the good metabolic contro l 
can not be achieved by d ie t or regime on ly .
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P O S S I B I L I T I E S  OF PHARMACOLOGICAL PREVENTION OF THROMBIN-INDUCED
CORONARY VASOSPASM
A.Kovács, P.Arányi, J.Singer, Gy.Rabloczky
Institute for Drug Research, Budapest, P.O.Box 82, Hungary
Keywords: Vasospasm, thrombin, thrombin-inhibitor, cromakalim
Besides its well known role in blood clotting, thrombin (T) 
possesses a modulatory role in the regulation of the vascular 
tone, as well. It can induce either relaxation or contraction 
of the vascular smooth muscle, depending on the type of blood 
vessel, and the actual state of the endothelial cells (Hauste­
in et al., 1966; DeMey et al., 1981; White et al., 1984). In 
dog coronary arteries T elicits a biphasic vascular effect: a 
transient, dose-dependent relaxation, followed by a slow and 
irreversible contraction (Ku, 1982). T-induced vasodilatory 
response is endothelium dependent, while vasoconstrictory ef­
fect is endothelium independent and both of the vascular ef­
fects are blocked when proteolytic activity of T is inhibited 
(Ku, 1986). This vascular effects of T could not be inhibited 
by phospholipase or cyclooxygenase inhibitors, or Ca ^antago­
nists (Haver et al., 1984). Their experiments demonstrated that 
the T evoked contractions are linked neither to the synthesis 
of prostaglandins, nor to the extracellular Ca2+level. Low 
concentrations of alpha-T were shown to be present even in the 
plasma of healthy males. Because of its potent effects,alpha- 
T is supposed to be involved in the etiology of myocardial 
ischemia (Haver et al., 1983).
In our experiments the influence of T-inhibitors and K+- 
channel openers was studied on T evoked vascular responses.
1. Inhibitors of the coagulant and catalytic activity of T
were effective in blocking the T evoked contractile respon­
ses .
a./ GYKI-14 766 (N-methy1-D-pheny1 alany1-proline-L-arginine
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sulphate) is a specific tripeptide aldehyde type T- 
inhibitor (Bajusz et al., 1987) . Our experiments de­
monstrated that dog coronary arteries,pretreated with 
GYKI-14 766 (0.5, 1.0, 5.0, 10.0yUg/ml) caused reduction
of vasoconstrictory response to the effect of T. 
b./ Making a T-inhibitor complex previously to the addition 
to the vascular tissue, this preformed complex elicited 
vasoconstrictions, which did not significantly differ 
from the control.
2. In our experiments BRL-34915, a specific K+-channel opener
was tested against T-induced vasoconstriction in concentra- 
“ V — 6tions of 10 , 10 M/l. Dog coronary arteries pretreated
with BRL-34915 showed decreased responsiveness to T.
Conclusively, GYKI-14 766, a specific T-inhibitor, seems to 
be effective in preventing T-induced vasospasm. On the other 
hand, using T-GYKI-14 766 complex vasoconstrictory activity of 
T remained at least partially preserved in the absence of its 
proteolytic activity.
Thus, we found two different newer pharmacological means to 
attenuate T-induced vasospasm.
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THE SELECTIVITY OF HIGHLY PURIFIED BOVINE LIVER ANGIOHYPOTENSIN 
TOWARDS RESISTANCE VESSELS 
I. Kovács, I. Miklya, J. Knoll
Department of Pharmacology, Semmelweis University of Medicine, 
Budapest, P.O.B. 370, 1445 Hungary
Keywords: angiohypotensin, capacitance vessels, resistance ves­
sels, vas deferens preparations
The substance, named angiohypotensin (AH), capable of block­
ing the release of noradrenaline to nerve stimulation in a do­
se-dependent manner was detected in human and mammalian blood 
and was found to exert its effect on resistance arteries with 
high selectivity (Knoll, 1987, 1988). Recently highly purified 
angiohypotensin preparations containing 3000-3500 units/mg were 
produced from pig and bovine liver. Bovine liver AH prepara­
tions bioassayed on the central ear artery of the rabbit were 
used in our experiments aiming to check the selectivity of this 
substance to vascular smooth muscle.
The isolated organs prepared from rabbits, rats and guinea 
pigs were used in our study. From the rabbit samples of the 
central ear artery, the saphenous artery, the pulmonal artery 
and the vas deferens; from the rat samples of the aorta, the 
rectococcygeal muscle and the vas deferens; from the guinea pig 
samples of the vas deferens and the longitudinal muscle of the 
ileum were prepared.
The strips of the organs were mounted in an organ bath 
(5 ml) and a series of contractions of the smooth muscle were 
elicited by field stimulation with appropriate time intervals
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before and after the presence of AH in the organ bath. The dose 
of AH was raised up to 50 units, according to the needs. The 
organ was classified to be insensitive to AH if there was no 
change in the nerve stimulation induced réponse at the 50 unit/ 
bath level of the substance.
Out of the organs used in this study only the two resistance 
artery preparations (the central ear artery and the saphenous 
artery) proved to be sensitive towards AH. In these preparations 
AH inhibited with a rapid onset the stimulation-induced vaso­
constriction in a dose-dependent manner. The effect could always 
be washed out rapidly and completely, no tolerance to the ef­
fect of AH was observed.
In some of the rectococcygeal muscle preparations the con­
traction of the smooth muscle to field stimulation was transi­
ently inhibited, but the effect was never dose-dependent and 
reproducible. The capacitance vessels (pulmonal artery, aorta), 
as well as the vas deferens preparations, used in our study, 
proved to be insensitive towards AH.
Studying the selectivity of AH we inevitably selected smooth 
muscle organs with noradrenergic transmitter machinery. As an 
example, however, we checked the effect of our highly purified 
AH preparations on the longitudinal muscle strip of the guinea 
pig ileum, because of the extremely high sensitivity of this 
preparation to different types of smooth muscle active peptides. 
This organ, too, was found to be insensitive towards AH. 
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CHANGES IN MONOAMINE OXIDASE (MAO) ACTIVITY IN MIGRAINE
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Key words: p la te le t MAO a c t iv ity ,  migraine, sex differences in  
MAO a c t iv ity ,  brain aging
P la te le t MAO a c t iv i t y  in  m igraine was w ide ly studied during the las t 
decades. The in te re s t  was stim u la ted  by the observation th a t "cheese 
re a c tio n " to certa in  foodstuffs in patients treated with поп-se lec tive  MAO 
in h ib ito rs , was s im ila r to dietary migraine (Glover et a l. 1977).
Seventy female and 44 male pa tien ts  (average: 42.4 years of age) with 
common or c lassica l migraine were included in to  our studies. Blood samples 
were taken from the cub ita l vein and p la te le t preparation fo r  measuring MAO 
a c t iv i t y  was carried out by the method of W illberg and Oreland (1976). The 
p la t e le t  MAO a c t iv i t y  compared to age-matched c o n tro ls  was measured 
ra d io m e tr ic a lly  based on the method of Wurtman and Axelrod (1963) and 
modified by Magyar (1980), both during and between headache attacks. In the 
incubation media ^C-phenylethylamine was used as a substrate.
The MAO a c tiv ity  in  migraine was s ig n if ic a n tly  lower between attacks both 
in  male and female compared to controls, but enzyme a c t iv ity  of the males 
was more expressed in  both groups. In th is  re rspect we d id  not fin d  
s ig n ifica n t differences between patients with common or c lass ica l migraine. 
The MAO a c tiv it ie s  of the same patient did not change s ig n if ic a n tly  during 
the  a tta cks  and the symptoms-free periods, while  in  some p a tie n ts  a 
remarkable decrease was observed in the a c tiv ity  during migraine headache. 
The p la te le t MAO a c t iv ity  of 20 patients with migraine was determined every 
4 weeks over a period  of 36 weeks. Remarkable changes of enzyme a c tiv ity
182
were re g is te red  in  patients with migraine, while in  contro ls a re la tiv e ly  
c o n s ta n t le v e l was fo u n d . The f lu c tu a t io n  in  enzyme a c t iv i t y  was 
independent of p la te le t functions (counts, serotonin content, aggregability 
o f p la te le ts ) ,  hormonal changes and the registered c l in ic a l parameters. 
Th is observation re fle c ts  the in s ta b ility  of p la te le t MAO in  migraine and 
th is  f in d in g  can throw same l ig h t  on the co n tra d ic to ry  data which were 
re g is te re d  in  these p a tie n ts  by d iffe ren t investiga to rs. We did not find  
age dependent s ig n if ic a n t  changes in the enzyme a c t iv ity  in  our patients 
w ith  migraine, but th e ir  age was re la tive ly  low.
The MAG enzyme produces NH3 , aldehydes and H2O2 , agents with established 
or p o te n t ia l to x ic i ty .  The lower leve l of MAO a c t iv i ty  in  migraine may 
p ro v id e  lower risk  to the harmful effects of these neurotoxic metabolites. 
I t  is  known from the l i t e r a tu r e  tha t the MAO a c t iv ity  of the smokers is  
a lso  low er, compared to non-smokers and the Parkinsonism is  rarer in  these 
p o p u la tio n . By analogy, we studied the frequency of Parkinson’ s disease in 
the  m igrainous p a tien ts  who were registered in  our c l in ic  and we did not 
found Parkinsonism among them. This finding supports the above mentioned 
hypo thes is  but in  order to  ob ta in  convincing evidence fu r th e r  careful 
s tud ies are needed in th is  l in e .
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EARLY REGENERATION OF COLONY FORMING UNITS IN CULTURE (CFUc) OF MURINE BONE
MARROW AFTER MODERATE DOSES OF DIBROMOMANNITOL
1 1 2 1 Kovács, P. , Hernádi, F. , In s t itó r is  L. , Вепкб, I .
1 Dept, of Chemotherapy, In s t, of Pharmacol., Univ. Med. School, Debrecen,
2 Chinoin Pharmaceutical Works, Budapest, Hungary
Key words: Colony Forming Unit in culture, Dibromomannitol
To study the re lationship between the dose of a cytosta tic  drug and the 
surv iva l of "Granulocyte-Macrophage Colony Forming Units in culture" (CFUc), 
mice are usually k ille d  24 h a fter treatment in order to estimate CFUc. The 
importance of the "time in te rva l between drug administration and removal of 
the target tissue under study" was emphasized, among others, by Lohrmann and 
Schreml (1982). Our data show that the shape of such a dose-response curve 
may be influenced s ig n ific a n tly  by a change in th is  in te rva l. In the case of 
l , 6-d ideoxy-l,6-dibromomannitol (DBM, Eckhardt & Horváth 1980), th is  is  per­
haps due to an early regenera­
tion  of the CFUc-population in 
the bone marrow a fte r moderate 
doses of DBM.
DBM, suspended in saline with 
5% Tween 80, was given ip . to 
(BALB/c X CBA)F1 mice. Four or 
24 h la te r, so ft agar cultures 
of marrow ce lls  were prepared 
with L -c e ll conditioned medium 
as source of colony stim ulating 
a c t iv ity .  Colonies (groups of 
3-50 c e lls )  were counted a fte r 7 
days of incubation.
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Fig. 1. Frequency of CFUc in bone marrow 
ce lls  of mice 4 h ( o )  or 24 h ( r j )  a fte r 
the ip. adm inistration of dibromomannitol.
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The frequency of CFUc in bone marrow ce lls  (colonies growing from 105 c e lls )
was not reduced by >500 mg/kg of DBM (D  ^ = 551 mg/kg) but decreased expo-
2
n e n tia lly  at higher doses with a Do of 173 _+ 21 mg/kg when estimated 24 h 
a f te r  treatment (Fig. 1 ). I f  mice were k il le d  e a rlie r, namely 4 h a fte r the 
adm inistration DBM, the "shoulder" of the dose-response curve was less wide 
(D = 199 mg/kg) and the exponential portion was s ig n ifica n tly  (p<0.01) 
less steep with a Dq of 315 _+ 35 mg/kg.
FLizy et a l. (1975) estimated the number of p ro life ra tin g  p luripo ten t stem 
c e lls  16 h after treatment with DBM, and found a Dq of 237 mg/kg, which is  
between the Devalues found in  our studies on granulocyte-macrophage progen­
i to r s  (CFUc) at 4 and 24 h. Our data are at variance with those of Számos- 
vö lg y i et a l. (1989), who reported a Dq of 651 mg/kg and a of ~ 0  mg/kg 
fo r  GM-CFU 24 h a fte r treatment with DBM. This might be due to the d i f fe r ­
ent s tra in  of mice, vehic le , and source of colony stimulating a c t iv ity .
The changes in the dose-response curve between 4 and 24 h a fte r treatment 
(F ig . 1) were probably due to the regeneration of the CFUc-population in  the 
bone marrow during th is  period, which was more pronounced at doses of é600 
mg/kg. After larger doses of DBM, the regeneration may s ta rt la te r than 24 
h, s im ila r ly  to that reported by Gulya et a l. (1977), who studied the regen­
e ra tion  of p luripotent stem ce lls  a fte r 1600 mg/kg of DBM.
1 Do is  the dose-increment reducing the number of CFUc to e~ ~0.37 at 
the exponential portion of the curve
2 Dq: "shoulder width" or "quasi-threshold" dose, i .  e. the in tercept of the 
exponential portion of the curve with the abscissa
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THE GASTROPROTECTIVE EFFECT OF CHINOIN - 127 ON INDOMETHACIN INDUCED GASTRIC 
ULCER IN RATS
Z. Kovács, Z. Kapui, I .  Cser, I .  Hermecz, I .  Rózsa^ and Gy. Blaskó^
CHINOIN Pharmaceutical and Chemical Works Ltd, Budapest, ^Second Department 
of Surgery, and ^F irs t Department of Medicine , Postgraduate Medical
U niversity, Budapest, Hungary
(CHINOIN - 127, cytoprotective drugs, indomethacin induced gastric  u lce r) 
CHINOIN - 127 (1 ,6-d im ethyl-4-oxo-l,6 ,7 ,8 ,9 ,9a-hexahydro-4H-pyrido-(l ,1a)-
pyrimidine - 3 -carboxamide) is  a potent non - narcotic analgesic and
antiinflammatory agent, possessing a remarkable protective e ffe c t on
ulcerations caused by nonsteroidal antiinflammatory drugs.
CHGINOIN -  127 has a protective e ffec t on indomethacin induced u lcer (EÜ5q= 
25 mg/kg p .o .) and on ac id ified  ethanol -  induced ulcer (EDjg = 26 mg/kg 
p .o .)
In th is  study we studied the mechanism of gastroprotective e ffec t o f CHINOIN 
-  127 on indomethacin induced ulcer in  ra ts .
In the mucosa of contro l animals we observed a balance between TXA2/PGI2 
( TXA2/PGI2 = 0.92 ). Indomethacin treatment causes d is in tegra tion  of th is
balance, sh ift in g  the synthesis towaerds TxA2 production (TXA2/PGI2 = 1.92). 
Increase in the loca l thromboxane concentration causes contraction in  the 
ca p illa ry  network of gastric  mucosa leading to local ischaemia followed by
tissue necrosis and ulcer formation. CHINOIN - 127 (50 mg/kg p .o .)
pretreatment improves the deranged TXA2/PGI2 balance ( TXA2/PGI2 = 0.77 ).
We also determined the a c tiv it ie s  of the prostaglandin synthesizing enzymes 
in  indomethacin induced ulcer model.In the control mucosa the a c t iv ity  of 
TxA2 and PGI2 synthesizing enzymes is  15 pg/mg p ro t./m in . A fter 
indomethacin treatment the a c t iv ity  o f PGI2 synthetase is  decreased (10 
pg/mg. prot/m in) and the a c t iv ity  of TxÄ2 synthetase shows a remarkable 
increase (27 pg/mg. p ro t./m in ). Indomethacin sh ifts  the arachidonic acid 
metabolism towards the production of TxA2 > the balance between the a c t iv ity  
of TxA2 and PGI2 synthetases overturned. Pretreatment of CHINOIN - 127 
restores the overturned balance of TxA2 and PGI2 synthetases.
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PGI2 synthetase TxA2 synthetase ra tio  
pg/mg p ro t./m in
Control 15 15 1
Indomethacin (50 mg/kg) 9 27 3
Indomethacin (50 mg/kg) +
CHINOIN - 127 (50 mg/kg) 19 15 1.3
Table 1.
CHINOIN - 127 pretreatment restores the changed TXA2/PGI2 ra tio  and the
changed a c tiv ity  o f TxA2 and PGI2 synthetases, and these effects could be 
an explanation for th e ir  cytoprotective e ffe c t.
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THE EFFECT OF NEDOCROMIL AND DEXAMETHASONE ON THE ANTIGEN INDUCED CHANGES 
OF SHEEP TRACHEAL SMOOTH MUSCLE RESPONSIVENESS
P.Sz.Körmöczy and W.M.Abraham
Chinoin Pharmaceutical and Chemical Works Co.Ltd..Budapest,Hungary,and Mt. 
Sinai Medical Center,Miami Beach,FL 331A0
(tracheal smooth muscle.antigen.sensitization.dexamethasone,Nedocromil-Na) 
Airway hyperresponsiveness is  a characteris tic  of asthma, however the 
mechanism responsible is  s t i l l  unclear.The purpose of our experiments was: 
1/ To determine i f  low doses of antigen ( i.e .  concentrations that do not 
cause tracheal smooth muscle contraction in v itro )  increase smooth muscle 
responsiveness to acetylcholine (Ach).
2/ To determine i f  the increased responsiveness can be blocked by 
pretreatment with compounds that lack anti-mediator or smooth muscle 
relaxant effect:dexamethasone and nedocromil sodium.
We tested th is  hypothesis in v itro  using the tracheal smooth muscle (TSM) 
from a lle rg ic  sheep.TSM s tr ip s  were hung under 2g tension in separate organ 
bath (40ml) containing Krebs-Henseleit solution (39° C) equ ilib ra ted  with 
95% 02 ,and 5% CO2.Isometric forces generated in response to increasing 
concentrations of Ach were measured to determine the concentrations 
required to produce 25% (EC25) and 50% (EC50) of the maximum
contraction.Two Ach dose-response curves (ORC) were performed.Between the 
DRC-s,the tissues were washed to return to baseline tension and then 
d iffe re n t s trips  were subjected to one of the following treatments:
a) buffer (contro l)
b) Ascaris suum antigen between 0.007-1.06 PNU (subthreshold dose that did 
not cause contraction)
c) Dexamethasone (9.7x10-7 M) was added 40 min before antigen
d) Nedocromil sodium (3x10-6 M) was added 20 min before antigen
(The tissue which previously served to determine the subthreshold dose of 
antigen was no longer used in the experiments).
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Before adding antigen EC25 and EC50 for Ach in  TSM (n=20)(expressed as mean 
SD,-log M) were 6.60+0.60 and 5.80+0.50, respective ly .In  the control tissues 
(no antigen added) tachyphylaxis developed during the second ORC to Ach. 
However,this was not the case with antigen treated tissues.A fter antigen 
EC25 and EC50 values were sh ifted  to the le f t  indicating an increased 
s e n s it iv ity  to Ach:
Delta EC25 Delta EC50
Control (n=20) +0.30+0.20 +0.20+0.30
Antigen (n=24) -0.50^0.40 § -0.30+0.30 §
§=p^.0.05 vs respective co n tro l; -leftward s h if t ;  +rightward s h if t .
Both nedocromil sodium and dexamethasone prevented the antigen induced 
increase in TSM responsiveness:
Ascaris suum +nedocromil n EC25 EC50 Emax (G)
DRC-1 10 6 .110.6 5.310.6 43117
DRC-2 10 6.110.5 5.410.5 44116
SHIFT 0 .010.2 § 0 . 1+0.1  § 1
Ascaris suum+dexamethasone n EC25 EC50 Emax (G)
DRC-1 11 6.510.3 5.810.2 40l4
DRC-2 11 6.510.2 5.810.1 4116
SHIFT - 0 .1+0.1 § 0 .010.1 § 1
(Values are mean SD; + s h i f t  to the right (less responsive); -  s h if t  to the
le f t  (more responsive) ;§=p ^-0.05 vs A.suum alone)
Thus,sub-threshold doses o f antigen increase the s e n s it iv ity  of airway 
smooth muscle.This may be one mechanism that contributes to chronic airway 
hyperresponsiveness in asthma.
Glucocorticoids and nedocromil in h ib it th is  increase in responsiveness.
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TRANSMEMBRANE POTENTIALS OF CANINE CARDIAC PURKINJE FIBRES 
AS AFFECTED BY PRAJMALINE
Irén Krassói, J.Gy. Papp, L. Szekeres
Department of Pharmacology, A lbert Szent-Györgyi Medical University, Szeged,
Hungary
K_e^_wordsj_ P urk in je  f ib e rs ,  p ra jm a line , transmembrane p o te n t ia l,  
e ffe c tive  re fractory period.
Knowledge of the ca rd iac  m ic ro e le c tro p h ys io lo g ica l p ro p e rtie s  of 
p ra jm a line  (N-propyl ajmaline hydrogen ta rta ra te ), a Class 1 antiarrhythm ic 
drug, is  ra th e r lim ite d  (Späth, 1983). The present study was therefore 
designed to obtain quantita tive  data on the effectiveness and mode of action 
o f the drug in  canine P u rk in je  f ib re s ,  when app lied  in  the rapeu tica lly  
meaningful concentrations (Handler et a l . ,  1985).
R ight v e n tr ic u la r  d is ta l  P u rk in je  f ib re s  were isolated from canine 
hearts  and transmembrane p o te n tia ls  were recorded, u t i l iz in g  a microelec­
trode technique, as described e a r lie r  (Papp, 1978; Papp et a l . ,  1980).
Prajmaline (0.1-0.5 mg/1) caused a prolongation in  the conduction time 
and a decrease in the action po ten tia l amplitude and the maximum ra te  of de­
po la riza tion  without a s ig n ifica n t e ffe c t on the resting  membrane p o te n tia l. 
The a c tio n  p o te n t ia l du ra tion  (APDjg.gg) and the e ffective  re fra c to ry  pe­
r io d  (ERP) were shortened considerably. The ra t io  of ERP/APD9Q was not s ig ­
n if ic a n t ly  affected (Table I ) .
Since prajmaline is  thus able to diminish the normally long action po­
te n t ia l  duration in  Purkinje fib re s  and does not seem to a lte r considerably 
the r e la t iv e ly  sho rte r a c tio n  po ten tia l duration in  the 'working' myocar­
dium (V irág  e t a l . ,  unpublished), i t  might be able to decrease the inhomo­
gene ity  in  reg iona l re p o la r iz a tio n  w ith in  the ven tric le , thereby reducing 
the l i a b i l i t y  to arrhythm ias. To te s t the v a lid ity  of such a suggestion, 
fu r th e r  studies of the microelectropharmacological effects of prajmaline in
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ischaemic ven tricu la r muscle and Purkinje fib re s  would be well worthwhile.
Table I
E ffe c t of prajmaline on the parameters of transmembrane potentia ls recorded 
from ce lls  of canine r ig h t ventricu lar d is ta l Purkinje fib re  strands
CT
(msec)
•
Чпах 
(V /sec)
RP
(mV)
APA
(mV)
apd50
(msec)
apd90
(msec)
ERP
(msec) erp/ apd90
CONTROL
(n=14)
3.5
+0.3
344.6
+24.1
-81.6
+1.2
101.6
+1.9
270.2
+22.8
371.3
+23.7
337.5
+18.4
0.89
+0.01
PRAJMALINE
0 .1  mg/1  
(n=3)
4.5
+1.4
282.0
+27.0
-80.7
+5.5
91.3
+5.2
++
183.5
+6.5
++
293.0
+12.0
++
283.5
+4.5
0.95
+0.04
0 .2  mg/1  
(n=5)
+
5.4
+0.9
++
202.0
+26.4
-77.3
+3.0
+++
80.0
+1.5
++
153.6
+21.6
++
252.6
+21.9
+++
243.8
+2.7
0.95
+0.04
0.5 mg/1
(n=6 )
++
8.0
+1.4
+++
168.3
+15.6
-78.5
+2.3
+++
81.2
+2.2
+++
156.5
+12.5
+++
262.0
+13.6
++
244.0
+21.8
0.97
+0.04
Mean values are given +_ S.E. n = number of preparations.
CT = conduction tim e ; Vmax = maximum rate of depolarization; RP = resting  
p o te n t ia l;  APA = action po ten tia l amplitude; APDjq and APDgg = time fo r re - 
po la riza tion  to 50 and 90%.
S ta t is t ic a l s ign ificance : + P<0.05; ++ PcO .O l; +++ PcO.OOl.
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POSITIVE INOTROPIC EFFECTS OF GYKI-52 713 IN CONSCIOUS AND
ANAESTHETIZED ANIMALS
M.Kürthy, Gy.Rabloczky, J.Körösy, T.Hámori
Insitute for Drug Research, Budapest, P.O.Box 82, Hungary
Keywords: GYKI-52 713, positive inotrop, in vivo and in vitro
Major group of newer positive inotropic compounds block the 
phosphodiesterase enzyme activiy. Recently it became evident 
that almost all of them had a very limited therapeutic value in 
patients with cardiac failure. This fact could be explained by 
(1) the risk of arrhythmias, (2)tachycardiac effect, (3) (4) re­
lative or absolute lumen uneffectiveness, (5)development of to­
lerance during the longterm treatment. Therapeutically more 
succesful member of that group remained the compounds which 
possess some other mode of action (e.g.:calcium sensitizing ef-
9feet) lack of former undesirable side-effects. Therefore our 
aim was to develop an experimental schedule for testing and in­
vestigating new molecules and thereby select the most effective 
ones with the hope of the most probable therapeutic usefulness. 
GYKI-52 713 is a 5H,2,3-benzodiazepine compound with strong 
positive inotropic and coronary vasodilatory effects.
1. In anaesthetized open-chest cats this compound produced in 
situ positive inotropic effect after either i.v. or i.d. ad­
ministrations of 5 mg/kg dose: cardiac effect was equieffec- 
tive in peak and duration with that of amrinone.
2. In anaesthetized open-chest dogs of intact heart it caused 
marked increase of the myocardial contractile force already 
after 0.25, 0.5, 1.0 and 2.0 mg/kg i.v. doses; heart muscle 
effect was accompained by moderate fall of blood pressure 
and heart rate.
3. In anaesthetized dogs of intact chest and heart GYKI-52 713 
elicited the same positive inotropic effect but, heart rate 
and blood pressure remained unchanged.
4. In dog experiments the interrelationship of positive inotro-
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pic and coronary dilatory effects was shifted to the myo­
cardial effect in the course of the total effective period, 
while the coronary vascular effect showed predominance in 
the case of reference compounds (amrinone, forskolin, ino- 
sin) .
5. 6 weeks after acute myocardial infarction provoked by LAD 
artery occlusion GYKI-52 713 remained active after 0.25 and 
0.5 mg/kg i.v. doses, as well. The predominance of positive 
inotropic component in relation with coronary vascular ef­
fect was achieved in these postinfarcted heart dogs, too.
6 . Positive inotropic effect could be demonstrated in chroni­
cally catheterized cats of either intact or infarcted heart 
In these experiments blood pressure and heart rate never 
changed.
7. GYKI-52 713 was active in isolated cardiac preparations,too
8 . Studies on the biochemical mode of action and toxicity stud 
ies are in progress in the Drug Research Institute,Budapest.
DOPAMINE, DOPEXAMINE AND DOBUTAMINE AS INOTROPIC AND AUTOMATOTROPIC AGENTS
Cs. Lengyel, 0. Hála, J.Gy. Papp, L. Szekeres
Department of Pharmacology, Albert  Szent-Györgyi Medical Universi ty,  Szeged,
Hungary
Ke^words^_ dopamine, dopexamine, dobutamine, inotropy, automat ic i ty .
Dopamine and dobutamine have long been known as posit ive ino t rop ic  and 
chronotropic agents (Tut t le and M i l l s ,  1975). Dopexamine, a novel s t ruc tu ra l  
analogue of dopamine, has also been shown to increase cardiac c o n t r a c t i l i t y  
and s i n o - a t r i a l  automaticity (Brown et a l . ,  1985; Smith et a l . ,  1987). How­
ever, a comparison of the i n o t r o p i c  and chronotrop ic e f f i c a c y  of these 
drugs, in  order to determine t h e i r  automatot ropic potency at equivalent 
inot ropic  concentrations, has not yet been made.
The present study therefore compares the inotropic and automatotropic 
(arrhythmogenic) ac t i v i ty  of dopamine, dopexamine and dobutamine in  isolated 
r a b b i t  cardiac preparations. Right ventr icu lar papi l lary muscles, the spon­
taneously f i r i n g  s ino -a t r ia l ,  A-V junct ional  and r ight  ventr icu lar Purkinje 
f i b r e  areas were dissected and placed in an organ bath containing modified 
Locke's s o lu t i on ,  as described e a r l i e r  (Papp and Vaughan Wil l iams, 1969; 
Szekeres and Papp, 1986). The muscle preparations were e le c t r i c a l l y  driven 
(1 msec duration, 100 per min frequency, twice threshold strength) and the i r  
c o n t r a c t i l i t y  was recorded. The e lec t r ica l  a c t i v i t y  of the three pacemaker 
areas was fol lowed by recording surface potent ials.  The preparations were 
exposed to  i n c r e a s in g  drug concentrat ions,  pÛ2 values and i n t r i n s i c  
a c t i v i t i e s  relat ive to dobutamine were determined.
A l l  three drugs exer t  a concentration-dependent posi t ive inot ropic  
e f f e c t ,  g iv ing a pÜ2 value of 6.59 fo r  dobutamine, 6.67 for  dopamine and 
7.11 for dopexamine. The in t r i n s i c  inotropic ac t i v i ty  relat ive to dobutamine 
i s  0.498 fo r  dopamine and 0.324 fo r  dopexamine. Dopamine, dopexamine and 
dobutamine are able to increase automaticity not only in the s in o - a t r i a l ,  
but also in the A-V junct ional  and ventr icu lar (Purkinje f ibre )  regions. The 
e f f e c t  of the drugs on the re la t i o n s h ip  between the maximum cont ract i l e  
force and pacemaker a c t i v i t y  is  shown in Table I .  The automatotropic potency 
re la t i ve  to dobutamine is  s ign i f i can t l y  larger  for  dopamine than fo r  dopexa­
mine. The order of the 'arrhythmogenic' potent ia l  of the drugs determined in 
th is  way is  dopamine >  dobutamine >  dopexamine.
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Table I
E ffec t of dobutamine, dopamine and dopexamine on the re lationship between 
maximum c o n tra c tile  force and autom aticity in  pacemaker areas of
the rabbit heart
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O'Connor,S.E., Simpson,W.T., Smith,G.W.: Br. J. Pharmac. £5: 599 (1985). 
Papp,J.Gy., Vaughan Williams,E.M. : Br. J. Pharmac. Yh. 380 (1969).
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Szekeres,L., Papp,J.Gy.: Arch. lox ico l. 5Э_: 188 (1986).
T u tt le ,R.R., M ills , J . :  C ire . Res. 36: 185 (1975).
Mean values of the slopes of regression lin e s  obtained from five  experiments 
are given +_ S.O.
R = automatoropic a c t iv i ty  re la tive  to dobutamine. 
p = leve l of s ign ificance  re la tive  to dobutamine; x p<0.05.
SA-NODE AV-JUNCTI0N PURKINJE FIBRES
DOBUTAMINE R=1.000 R=1.000 R=1.000
1.0997 1.3168 1.0545
+0.1521 +0.1227 +0.1909
DOPAMINE R=1.1372 R=2.0080 R=2.3941
1.2506 2.6441 2.5246
+0.1545 +0.0563 +0.0522
(p=0.4150) (p=0.0001х) (p=0.0003х)
DOPEXAMINE R=0.9333 R=1.3262 R=1.5607
1.0263 1.7464 1.6458
+0.1708 +0.0934 +0.0797
(p=0.6395) (p=0.0806) (p=0.0119х)
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EFFECT OF DIFFERENT VEGETABLE OILS ON ARRHYTHMIAS INDUCED BY 
MYOCARDIAL ISCHEMIA IN HYPERCHOLESTEROLEMIC RATS
I s t v á n  Leprán,  András Kékes-Szabó+ , Lász ló  Szekeres 
Depar tment of Pharmacology,  A . Szen t-György i  Medica l  U n i v e r s i t y ,  
H-6701 Szeged, Р .0 .В .115 ,  KÖJÁL, Szekszárd,  Hungary
KEY WORDS: d i e t  - f a t t y  ac id  -  m yocard ia l  i n f a r c t i o n  -  r a t
Feeding p o ly u n s a tu r a te d  f a t t y  ac id  r i c h  d i e t s  has been shown 
to  p r o t e c t  the development of  a r rhy thm ias  and sudden ca rd iac  
death du r ing  the acute phase of  m yocard ia l  i n f a r c t i o n  i n  e x p e r i ­
menta l  animals (Leprán e t  a l .  1981, 1988; McLennan e t  a l .  1985, 
1988) .  Human e p id e m io lo g i c  s t u d ie s  show p o s i t i v e  c o r r e l a t i o n  
between the plasma c h o l e s t e r o l  l e v e l  and the i n c id e n c e  of  co ro ­
nary hea r t  d i sease .  The p resen t  exper iments  were devoted to 
s tudy in  expe r im en ta l  c o n d i t i o n s  the e f f e c t  o f  d i f f e r e n t  vege­
t a b l e  o i l  d i e t s ,  r i c h  in  p o ly u n s a tu r a te d  f a t t y  a c i d s ,  on the 
s e v e r i t y  of  co ronary  a r t e r y  l i g a t i o n  induced a r r h y t h m ia s  in 
h y p e r c h o le s te r o le m ic  r a t s .
Male Sprague-Dawley CFY r a t s ,  weigh ing 220-250 g were fed 
w i t h  a s tandard l a b o r a t o r y  chaw, supplemented by 12 % o f  e i t h e r  
pork  f a t  (as s a t u r a t e d  f a t t y  ac id  r i c h  d i e t ,  SF),  l i n s e e d  o i l  
(LSO),  walnut  o i l  (WNO), or s a f f l o w e r  seed o i l  (SFO). The 
an imals  were a lso  g iven  1 % c h o l e s t e r o l  i n  the d i e t  (+CH) .
A f t e r  4 week- long d i e t  du r ing  e the r  anes thes ia  a loose  s i l k  
loop  (E th i c o n ,  5-0)  w i t h  a smal l  p o l y e th y le n e  t u b i n g  was app l ied  
around the l e f t  main coronary  a r t e r y  about 2 mm from i t s  o r i g i n  
(Leprán et  a l .  1983) .  One week a f t e r  t h i s  p r e l i m i n a r y  op e ra t io n  
acute myocard ia l  i n f a r c t i o n  was produced by t i g h t e n i n g  the loose 
l i g a t u r e .  Cont inuous r e c o rd in g  of  b i p o l a r  chest  e le c t r o g r a m  was 
per formed f o r  15 min or u n t i l  the death of  the a n im a ls .  The 
inc idenc e  of  a r r h y t h m ia s ,  e .g .  v e n t r i c u l a r  t a c h y c a r d i a  (VT),  
f i b r i l l a t i o n  (VF) ,  was r e g i s t e r e d .
Table 1. S u r v i v a l  r a t e  (SR), in c id e n c e  of  v e n t r i c u l a r  f i b r i l l a t -  
ion  ( VF) and t a c h y c a r d i a ,  and animals  showing no a r r h y t h m ia s  (N) 
d u r i n g  the acute phase of  m yocard ia l  i n f a r c t i o n  i n  conscious 
r a t s .
Group n SR ( % ) VF ( % ) VT(%) N ( % )
SF + CH 12 25 75 83 8
LSO + CH 11 73 + 27 + 45 + 36
WNO + CH 11 91 + 18 + 36 + 45 +
SFO + CH 14 64 + 43 57 43 +
+ p < 0.05 , compared to the SF +CH group.
Coronary a r t e r y  l i g a t i o n  in consc ious ,  f r e e l y  moving ra t s  
produce severe a r rh y th m ia s  w i t h i n  4-6 min and o n l y  25% of  the 
c o n t r o l ,  sa tu ra te d  f a t t y  a c i d + c h o l e s t e r o l  fed r a t s  s u r v i v e d  the 
most severe 15 min o f  myocard ia l  i schemia.
Linseed o i l ,  t h a t  con ta ins  44% l i n o l e n i c  ac id  (C 18 :3 ,  n-3)
and 30% l i n o l e i c  ac id  ( С18 :2 , n - 6 ) ,  s i g n i f i c a n t l y  decreased the
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i n c i d e n c e  of VF and i n c r e a s e d  the s u r v i v a l  r a t e  du r ing  the acute 
phase of  myocard ia l  i n f a r c t i o n .
Walnut  o i l  and s a f f l o w e r  seed o i l  -  c o n t a i n i n g  l i n o l e i c  ac id  
i n  73% and 70%, r e s p e c t i v e l y  -  produced s i m i l a r  p r o t e c t i v e  
e f f e c t .  The inc id e n c e  o f  ar rhy thmias  was decreased and s i g n i f i ­
c a n t l y  more an imals  s u rv i v e d  the acute phase of  myocard ia l  
i n f a r c t i o n  w i thou t  d e v e lo p in g  a r rh y th m ia s .
The present  r e s u l t s  show tha t  feed ing  a po ly u n s a tu ra te d  f a t t y  
a c i d  r i c h  d i e t ,  c o n t a i n i n g  e i t h e r  n -6  or  n-3 f a t t y  a c ids ,  s i g n i ­
f i c a n t l y  reduce the in c id e n c e  of l i f e  t h r e a t e n i n g  a r rhy thm ias  
and inc rease the chance to  su rv ive  the most c r i t i c a l  phase of  
m y o c a r d ia l  i n f a r c t i o n  i n  consc ious,  h y p e r c h o le s t e r o le m ic  r a t s .  
T h e r e f o r e  the p r o t e c t i v e  e f f e c t  presumable man i fes ted not  on ly  
i n  decreas ing  a t h e r o s c l e r o t i c  a l t e r a t i o n s ,  bu t  a d i r e c t  p r o t e c t ­
i o n  a g a in s t  ischemic changes may be i n v o l v e d ,  as w e l l .
Re fe rences  :
Leprán  I . ,  Nemecz G y . ,  K o l t a i  M., Szekeres L . :  3. Card iovasc.  
Pharmacol.  3: 847 -853 .  1981.
Leprán  I . ,  K o l t a i  M. , Szekeres L . :  3. Pharmacol .  Meth. 9: 219- 
230. 1983.
Leprán  I . ,  Szekeres L . ,  Kékes-Szabó A . :  Pharmacol .  Res. Commun. 
20 (S u p p l . 1) :  8 1 -8 2 .  1988.
McLennan P .L . ,  Abeywardena M.Y.,  Charnock J . S . :  Can. 3. P h y s i o l .  
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THE RELEVANCE OF THE CALCIUM CHANNEL BLOCKER NIMODIPINE IN THE 
THERAPY OF CEREBRAL ANEURYSMS
K. M a ie r -H au f f  and P. S t a h l ,  Depar t ,  o f  Neurosurgery,  UKRV, FU 
B e r l i n ,  Germany
I n t r o d u c t i o n  : S i g n i f i c a n t  improvement o f  m ic rosurge ry t e c h n i ­
que in  the t rea tm en t  o f  rup tu red  i n t r a c r a n i a l  aneurysms d id  
not  show the suspected s a t i s f a y i n g  e f f e c t s  on the n e u r o l o g i c a l  
d y s f u n c t i o n  and m o r t a l i t y  r a t e  a f t e r  s u r g e r y .  An improvement 
o f  the outcome was expected using Calc ium an tago n is ts  in  the 
p re -  and p o s t o p e ra t i v e  aneurysm t h e r a p y .  Methods : 100 p a t i e n t s  
in  the age of  13-75 years underwent aneurysm surgery .  A l l  pa­
t i e n t s  rece ived  the Calcium channel  b lo c k e r  Nimodipine i n  a 
dosage of  2-3 mg/h i . v .  before the o p e r a t i o n  a l ready .  In  the 
past  16 month we per formed t r a n s c r a n i a l  doppler  sonography 
(TDC) be fo re  and a f t e r  su rge ry .  The t i m i n g  of  the o p e r a t i o n  
date depended on the c l i n i c a l  c l a s s i f i c a t i o n  in  grades 
Hunt/Hess. P a t i e n t s  w i t h  grade I to I I I  were operated w i t h i n  
72 hours i f  they had no s igns  of  vasospasm in  TCD or a n g io ­
graphy.  Resu l ts  : In s p i t e  o f  N imod ip ine a d m i n i s t r a t i o n  we 
found i n  50 % o f  the H/H group I - 111 inc reased  blood f l o w  v e l o ­
c i t i e s  o f  120-200 cm/sec. and in H/H group IV-V in  80 4 s igns  
o f  vasospasm. The r e s u l t s  of  surge ry  show e x c e l l e n t  and good 
outcome w i th  f u l l  recovery in  70 % a f t e r  e a r l y  surgery and in  
90 % a f t e r  l a t e  s u rg e ry .  The m o r t a l i t y  r a t e  was 9 % in  f i r s t  
group and 3 % i n  the o the r  group.  P a t i e n t s  o ld e r  than 65 years 
of  age had a s i g n i f i c a n t  h igher  m o r t a l i t y  r a t e .  Delayed c e r e b ­
r a l  ischemia from vasospasm f o l l o w i n g  SAH and surgery was in
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t he  p r e s e n t  study a lso r a r e  as re p o r te d  in  o the r  s e r ie s  ( 1 ) .  
C on c lu s io n s  : Our s tudy  demonstrated t h a t  the r e s u l t s  o f  e a r l y  
and l a t e  aneurysm s u r g e r y  w i th  n im od ip ine  med icat ion were 
good.  Nimodip ine cannot  preven t  the in c id e n c e  of  vasospasm in  
a l l  cases but e v e n t u a l l y  reduce the i n f a r c t i o n  s ize im prov ing  
th e  outcome. Other f a c t o r s  may be r e s p o n s ib le  f o r  vasospasm e. 
g. th e  amount of  i n i t i a l  hemorrhage, chemica l  media tors  and 
th e  s u r g i c a l  t rauma. F u r t h e r  i n v e s t i g a t i o n s  are to be made in  
o r d e r  to  answer a l l  the ques t i ons  in  d e a l i n g  w i th  the vaso­
spasm .
Re fe rences : (1)  Pet ruk КС et  a l  (1988) ,  J Neurosurg 6 8 : 505-
517
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INFLUENCE OF THROMBOXANE ON ADRENERGIC NEUROTRANSMISSION IN  
ISO LATE D G UINEA P IG  A T R IA
L a u r a  M a n t e l l i ,  S a n d ra  A m e r in i ,  A n n a l i s a  R u b in o ,  F a b r i z i o  
L e d d a
D e p a r tm e n t  o f  P h a r m a c o lo g y ,  U n i v e r s i t y  o f  F lo r e n c e ,  V i a l e  G . B .  
M o r g a g n i 65 - F lo r e n c e  -  I t a l y
Key words : heart, adrenergic neurotransmission, thromboxane
Conflicting results have been obtained in studies on the 
thromboxane effects on adrenergic neurotransmission in periphe­
ral preparations. In fact it has been demonstrated that nora­
drenaline release is potentiated by a thromboxane analogue in 
preparations obtained from the rabbit (Trachte, 1986; Trachte 
and Stein, 1989), but that this release is unaffected or redu­
ced in peripheral preparations obtained from other animal spe­
cies, such as the dog, rat and guinea pig (Makita, 1983, Naka­
jima and Toda, 1986).
In this study we have evaluated the effect of thromboxane 
analogues on the cardiac response to adrenergic nerve stimula­
tion in isolated guinea-pig atria. The preparations were 
stimulated at 4 Hz by point stimulation; the stimulation of 
sympathetic nerves was obtained by field stimulation applied 
during the functional refractory period, in the presence of 
atropine (1 pM) . The effect of field stimulation consisted of a 
transient increase in cardiac contractility, due to noradrena­
line release.
The natural substance thromboxane B 2 (0.1-10 pM), and two 
stable thromboxane mimetics, cTxA2 (1-100 nM) and U46619 (0.1-
10 nM) have been studied. All these substances dose-dependen-
2 0 0
tly reduced the cardiac response to adrenergic nerve stimula­
tion, with the following order of potency: U46619 > cTxA2>
thromboxane B2. The inhibitory effect of U46619 was antagonized 
by two thromboxane receptor antagonists, namely АН 23848B (0.1- 
10 nM) and sulotroban (0.1-1 pM), but was unaffected by the 
prostaglandin receptor antagonist AH 6809 (lpM). The effect of 
U46619 was not due to interference with postsynaptic noradrena­
line receptors, since the agonist was not able to modify the 
positive inotropic effect induced by exogenous noradrenaline. 
These findings seem to suggest that thromboxane mimetics are 
able to reduce the stimulation-induced noradrenaline release. 
However, in guinea-pig atria loaded with [3 H ]-noradrenaline, 
U46619 was not able to modify the stimulation-induced overflow 
of tritium, although it did reduce the positive inotropic 
effect of field stimulation.
These findings indicate that the effects of thromboxane mime­
tics on adrenergic neurotransmission in the guinea-pig heart 
are mediated by still unexplained mechanisms more complicated 
than the simple interaction with prejunctional and/or 
postjunctional cardiac receptors.
Makita,. Y.: Br. J. Pharmacol. 78, 517-527 (1983).
Nakajima, M. and Toda, N.: Europ. J. Pharmacol. 120, 309-318 
(1986).
Trachte, G.J.: J. Pharmacol. Exp. Ther. 237, 473-477 (1986). 
Trachte, G.J. and Stein, E.A.: J. Pharmacol. Exp. Ther. 249, 
216-220 (1989).
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DIFFERENTIAL BINDING OF AGONISTS AND ANTAGONISTS 
TO gabaa AND GLYCINE RECEPTORS 
Gábor Maksay
Central Res. Inst, for Chemistry,
Hung. Acad. Sei., H-1025 Budapest POB 17
Gamma-aminobutyric acid (GABA) and glycine are major inhi­
bitory neurotransmitters in mammalian brain and spinal cord, 
respectively. GABAft and glycine receptors are coupled to chlo­
ride channels. GABA receptors were classified by selective 
antagonists. Bicuculline-sensitive GABA^ binding sites have 
subpopulations of different affinities. This study seeks dif­
ferent binding modes of agonists and antagonists to these sub­
populations. It also attempts to reveal similarities between 
GABAft and glycine receptor complexes.
Extensively washed synaptosomal membranes were prepared 
from rat whole brains and spinal cords (Maksay, 1990) and used 
for radioligand binding.
Tyrosine-specific reagents such as p-diazobenzenesulfonic 
acid (DSA) and tetranitromethane were found to decrease selec­
tively the number of the low affinity GABAft sites (Maksay and 
Ticku, 1984a), while Eccles'anions (Cl, SCN ) mask the high 
affinity population. DSA pretreatment and the presence of Ecc-3les' anions shifted the H-GABA-displacing potencies of GABAft
agonists and antagonists in the opposite direction (Maksay and
Ticku, 1984b). The super-low affinity GABA receptors were
A 3characterized by the enhancing effect of GABA on H-diazepam
binding (Maksay, 1988). GABA antagonists SR 95103 and R 5135
shifted and suppressed the dose-response curve of GABA. It
contradicts to a pure competitive binding of antagonists to
the lower affinity GABA sites.
a  2Dissociation of the antagonist H-SR 95531 binding was 
polyphasic. The rapid and slow phases were separated kineti- 
cally (Maksay, 1988). The displacing potencies of Table 1 
show that the slower phase corresponded to higher affinity 
SR 95531 binding. This high affinity population for SR 95531 
corresponds to the super-low affinity sites of GABA (Table 1).
2 0 2
Table 1. Displacing potencies of SR 955 31 and GABA on the
rapid and slow phases of JH-SR 95531 dissociation.
Displacer . jC5° rapid (nM)slow
SR 95531 2 9±11 12±4
GABA 580 ±14 0 2620H230
The chiral GABA agonist dihydromuscimol displaced high3affinity H-muscimol binding with great potency and stereo-3selectivity. In contrast, it displaced the antagonist H-SR 
95531 binding with low potency and stereoselectivity. The 
above findings can be explained by a preferential binding of 
antagonists to hydrophobic accessory sites around low affini­
ty GABA receptors.
A 3 3Dissociation of H-muscimol and H-SR 95531 binding elici
ted by dilution was accelerated by excess GABA or SR 95531 ,
suggesting cooperativity in binding (Maksay, 1990). The rapid
first phase of dissociation was preferentially accelerated by
the agent in antagonistic relationship to the radioligand.
Modification of the receptors by DSA selectively decreased3the accelerating effect of GABA on the dissociation of H-SR 
95531 (Maksay, 1990) . It suggests that the low affinity GABA^ 
sites are (partly) due to negative cooperativity in binding.
The dissociation of the antagonist ^H-strychnine binding 
from spinal cord membranes elicited by dilution was prefe­
rentially accelerated by glycine (Maksay, 1990). Similarly, 
pretreatment with DSA decreased selectively this negative 
heterotrop (i.e. allosteric) interaction.
In conclusion, "direct" antagonists do not bind to their 
respective receptors in a pure competitive manner with GABAft 
and glycine agonists. Tyrosine residues might be involved in
these allosteric interactions similar for the GABA,- andAglycine-gated chloride channels.
References
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A DUAL MEMBRANE STABILZING AND CALCIUM BLOCKING EFFECT OF 
KHL-8430 (CHINOIN) , A FENDILIN ANALOG ON THE HEART 
R. Marko and K. Kelemen, Department o f  Pharmacology, Semmelweis 
U n i v e r s i t y  o f  Med ic ine,  Budapest,  Hungary
Key words:  KHL-8430, Class I  and Class IV a n t i a r r h y t h m i c s
The a n t i a r r h y t h m i c  mode of a c t i o n  o f  the compound KHL-8430 
( C h i n o i n ) ,  a f e n d i l i n  analog of  d ip h e n y l -p r o p y la m in e  s t r u c t u r e  
has been analyzed by a v o l t a g e  clamp te c h n iq u e ,  based on a double 
sucrose gap ar rangement ,  on the s i n o - a u r i c u l a r  f i b e r s  of  the 
f r o g .  Sodium and ca lc ium  b l o c k in g  p r o p e r t i e s  were i d e n t i f i e d  by a 
pha rm aco log ica l  approach (Kelemen and Marko, 1985 .) .  Calc ium- 
dependent slow inward c u r r e n t  was a c t i v a t e d  by a d r e n a l i n e  (4 .6  
umol /1)  or by h is ta m in e  (5 .4  umol /1)  i n  sodium f r e e  s o l u t i o n  or 
i n  the presence of  t e t r o d o t o x i n  (4 .5  u m o l /1 ) .  Sodium-dependent 
f a s t  inward c u r r e n t  was enhanced by p r o s t a c y c l i n  (P G ^-N a ,  
C h ino in ,  0.27 u m o l /1 ) ,  a p h y s i o l o g i c a l  s t i m u l a t o r  of  the f a s t  
sodium channel  in  the h e a r t  (Kelemen and Marko, 1988) , i n  ca lc ium 
f r e e  s o l u t i o n  or  i n  the presence of  D-600 (4.1  u m o l /1 ) .  Calcium 
b l o c k e r s ,  l i k e  v e ra p a m i l ,  p reven t  the a c t i v a t i n g  e f f e c t  of  both 
a d r e n a l i n e  and h is ta m in e  on the slow ( c a l c i u m )  inward c u r r e n t  but 
leave  the s t i m u l a t o r y  e f f e c t  o f  PG^-Na on the f a s t  (sodium) 
inward c u r r e n t  unchanged. Use of  both a d r e n a l i n e  and h i s tam ine  
he lps  to  d i f f e r e n t i a t e  b e ta - a d r e n e r g i c  b lo c k e r s  and h i s ta m in e  H^  
r e c e p t o r  b lo c k e rs ,  r e s p e c t i v e l y ,  from ca lc ium b l o c k e r s .  On the 
o th e r  hand, sodium b l o c k e r s ,  l i k e  l i d o c a i n e ,  p rev en t  the 
s t i m u l a t o r y  e f f e c t  o f  p r o s t a c y c l i n  on the f a s t  sodium c u r r e n t ,  
w i t h o u t  a f f e c t i n g  the a c t i o n  of a d r e n a l i n e  or h i s tam ine  on the
slow ca lc ium c u r r e n t .
E f fe c t  o f  KHL-8430 was checked i n  a c o n c e n t r a t i o n  range of 
5 t o  20 umol /1.  T h res ho ld  c o n c e n t r a t i o n  was 7 umol /1 and maximal 
e f f e c t  was reached a t  14 umol /1.  KHL-8430 had a b l o c k i n g  e f f e c t  
on both components o f  the ca rd iac  inward  c u r r e n t .  I t  preven ted ,  
l i k e  l i d o c a i n ,  the p r o s t a c y c l i n - i n d u c e d  inc rease  of  the ampl i tude 
o f  the f a s t  sodium c u r r e n t  and, l i k e  v e ra p a m i l ,  the a d r e n a l i n e -  
and h is ta m ine - induced  a c t i v a t i o n  of  the slow c a lc ium  c u r r e n t .  
Maximal  ampl i tude o f  th e  f a s t  inward c u r r e n t  ( a t  a d e p o l a r i z a t i o n  
s t e p  of  +40 to +50 mV ag a in s t  the h o ld in g  p o t e n t i a l )  was 1. l j+0 .6 
nA i n  20 c o n t r o l  p r e p a r a t i o n s ,  i t  was in c reased  to  1. 9^+0.8  nA by 
0 .27  umol/1 p r o s t a c y c l i n  ( p < 0 . 0 0 1 ) ,  w h i l e  in  the presence of  the 
same conc en t ra t i o n  o f  p r o s t a c y c l i n  + 14 umol /1 KHL-8430 the mean 
v a lu e  of the maximal ampl i tude  of  the  f a s t  inward  c u r r e n t  was 
0 . 4 +^0.2 nA (p < 0.001 compared to  the p r o s t a c y c l i n  v a l u e ) .  Slow 
inw ard  c u r ren t  at  d e p o l a r i z a t i o n  s teps  of  +70 to  +80 mV aga ins t  
t h e  ho ld ing  p o t e n t i a l  cou ld  be r a r e l y  de te c te d  under c o n t r o l  
c o n d i t i o n s  but a t y p i c a l  slow inward c u r r e n t  o f  0.1 t o  0 .3 nA was 
c o n s i s t e n t l y  a c t i v a t e d  by e i t h e r  a d r e n a l i n e  or  h i s tam ine  (8 
p r e p a r a t i o n s  each) which was c om p le te l y  a b o l i s h e d  in  a l l  
p r e p a r a t i o n s  by 14 umo l /1  o f  KHL-8430.
The r e s u l t s  i n d i c a t e  t h a t  KHL-8430 combines the p r o p e r t i e s  of 
C lass  I  and Class IV a n t i a r r h t h m i c s , i . e .  the p r o p e r t i e s  of 
membrane s t a b i l i z e r s  and ca lc ium t r a n s p o r t  i n h i b i t o r s .
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PHARMACOLOGICAL CHARACTERIZATION OF BENZOTRIAZOLE DERIVATIVES ACTIVE 
ON THE MUSCARINIC RECEPTOR.
R.Meli. G.Muccioli*. E.Perissutti0, V.Santagada0. C.Silipo0. A.Vittoria0 and R.Di Carlo 
Department of Experimental Pharmacology, University of Naples. 'Institute of Pharmacology, 
University of Turin and °Department of Pharmaceutical and Toxicological Chemistry, University 
of Naples, Italy
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In order to explore the stereoelectronic requirement of muscarinic receptor attachment 
points, a series of benzotriazole derivatives was synthetized (La Rotonda et al., 1989) and 
investigated by radioligand (3H-N-methylscopolamine) binding experiments for their affinity to 
the different muscarinic receptors in the cerebral cortex, atria and ileum of the rat according to 
the method of Yamamura and Snyder (1974), Moreover, the antimuscarinic activity of the more 
interesting compounds was also investigated in vitro on guinea-pig atria and ileum. The 
results obtained are summarized in table I.
The affinities to the three muscarinic receptor subtypes differed generally, showing an 
interesting selectivity toward M2 receptor (atrium). In vitro pharmacological tests seem to
confirm this finding. Among the different benzotriazoles tested, compound III appeared the 
most active whereas the highest selectivity both on binding and in pharmacological tests was 
displayed by compound II. It seems that the 2-substituted isomers are more active than the 
corresponding 1-substituted isomers; moreover, polar effects of the substituents on the 
ammonium moiety seem to play a role in the capability to differentiate among M-subtype 
receptors. AF-DX 116, a classical antimuscarinic drug, with high affinity for M2 receptors
(Micheletti et al.. 1987), exhibited similar selectivity but higher potency.
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Table I -  Affinities of some benzotriazole derivatives for the muscarinic binding sites present in 
cerebral cortex, atrium and ileum of the rat (radioligand binding studies) and antagonist activity 
evaluated in vitro on isolated right atrium and ileum of guinea-pig.
К, = binding affinity determined as the capacity to induce 50% inhibition in the 3H-NMS 
binding calculated by the method of Cheng and Prusoff (1973). Values are the mean of 3-4 
determinations.
ICgo = concentration of drug causing 50% inhibition of the submaximal contractions induced 
by acetylcholine 5x1 O'7 M (atrium) or 1x10-9 M (ileum).
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HOW MAITOTOXIN INCREASES CYTOSOLIC CALCIUM LEVELS?
O.Meucci, M.Grimaldi, E.Landolfi, A.Scorziello, A.Marino and 
G.Schettini.Inst, of Pharmacology, II School of Medicine, University of 
Naples, Via S. Pansini 5, 80131 Naples.
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Maitotoxin (MTX), a potent marine toxin, is able to increase 
intracellular calcium levels by a still unknown mechanism. A 
direct action both on voltage sensitive calcium channels 
(VSCC) (Freedman et al; 1984) and phospholipids breakdown 
(Bernard et al; 1988) has been suggested to explain MTX effect 
on calcium homeostasis. Conversely, MTX was recently supposed 
to simply act as a pore-forming agent (Sladeczek et al; 1988). 
We observed that MTX dose-dependently enhances free cytosolic 
calcium levels, measured by fura 2 and quin 2 fluorescent 
probes, in different cell types such as normal anterior 
pituitary cells (Schettini et al; 1984), PRL-secreting cell 
line 235-1 (Schettini et al; 1988; Meucci et al; 1988) and PC12 
cells, while in EGTA containing medium MTX did not cause this 
stimulatory effect. In order to study the mechanism of MTX 
action on VSCC, we tested the effect of MTX in presence of 
organic calcium channel antagonists (verapamil, nicardipine), 
which specifically block L-type calcium channels. Nicardipine 
clearly inhibited MTX-induced calcium levels (Table I), and 
pertussis toxin pretreatment significantly reduced nicardipine 
inhibition of MTX-induced calcium rise. Furthermore, the
addition of Bay-k 8644, a dihydropyridine derivative agonist, 
one minute before MTX caused a twofold increase of
MTX-induced calcium rise. These results support the hypothesis
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that MTX could act at L-type calcium channels level.
We also studied the possible involvement of N-type calcium 
channels in MTX action, by using omega-conotoxin (GVIA 
fraction), a toxin which blocks N-type calcium channels. In 
omega-conotoxin treated PC12 cells the effect of MTX was 
reduced by 48%, thus also suggesting a possible activation of 
N-type calcium channels by MTX (Table I).
Table I: Nicardipine (Nic)(luM) and omega-conotoxin ( Ctx)
(luM)inhibition of MTX-induced intracellular calcium levels.
Control Nie Ctx Nic+ Ctx
BASAL 80 -- 75 --
MTX (lng/ml) 299 114 183 99
values represent intracellular calcium level (nM)
Finally, the effect of MTX was evaluated on inositol phosphate 
production in PC12 cells. We found that MTX caused a dose- 
dependent enhancement of inositol phosphate production. 
Nicardipine reduced, and a calcium-free medium containing EGTA 
abolished, the MTX-stimulation of phosphoinositides hydrolysis. 
In conclusion, our data suggest that MTX-induced increase of 
intracellular calcium levels could be ascribed to an 
enhancement of calcium mobilization that occurs through VSCC. 
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EFFECTS OF BISPHOSPHONATES ON CELLS OF THE MONONUCLEAR PHAGOCYTE SYSTEM
M.Mianl,L.Giovannini1,D.Benetti^,A.Bertelli^
^Department of Pharmacology.University of Pisa,Pisa
^Gentili Institute Research Centre,Pisa
^Department of Pharmacology .University of Milan,Milan
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Bisphosphonates (BPs) are inhibitors of bone resorption and several studies 
have shown that they impart potent inhibitory effects on either osteoclasts 
or their (probably hematopoeitic) precursor cells. We tested the effects of 
three BPs,dichloromethylenebisphosphonate (CL2 MBP),6 -amino-1-hydroxyexylide 
ne-1,1-bisphosphonic acid (AHHexBP) and 4-amino-l-hydroxybutylidene-l,1- 
bisphosphonate (AHBuBP) on the formation of bone marrow derived osteoclast­
like multinucleated cells(MNC). The cells were obtained from the mononuclear 
fraction of the bone marrow aspirates of rabbits. They were cultivated for a 
period of three weeks in 16 mm tissue culture wells containing 0,5 ml of me 
dium + test substances. At the end of the incubation period the cells were 
fixed and stained (Wright's Giemsa). MNC formation was stimulated with 10 nM 
of 1,25-dihydroxyvitamin D3 and measured by counting the total number of 
cells/well containing three or more nuclei using an inverted stage phase nú 
croscope.The results obtained show that AHBuBP inhibits the MNC formation 
at lower concentrations than CL2 MBP and AHHexBP. The results are dose-depen 
dent and statistically significant .For instance,at a concentration of 10 ^M 
of BPs the number of MNC per well were reduced from 210 (mean control value) 
to 110,70 and 50 with CL2MBP,AHHexBP and AHBuBP respectively. Increasing 
the BPs concentration to 10~^M,the number of MNC per well fell progressive 
ly to almost null.
Since osteoclasts probably originate from hematopoeitic precursors (a member 
of the monocyte-macrophage system) various authors have suggested that macro 
phages(Mó) could act as substitutes in "in vitro" model systems.whereby 
the action of BPs on osteoclast function could be reproduced and easily inter 
preted (Stevenson,1980).
The three BPs employed on the bone marrow culture system were used to study
2 1 0
some aspects of Mó function (phagocytosis,superoxide production,cell viabiH 
ty). The cells were removed from the peritoneal cavity of the rat with hepa 
rinized Hank's balanced salt solution. The Mó were either resident or elic.i 
ted by initially injecting thioglycollate intraperitoneally (Gallily,1967).
Cell viability was determined by using the Trypan blue exclusion test. All 
three substances displayed a dose-dependent increase in cell toxicity,althou
_ Tgh this effect became significant only at a concentration of 10 ’M even with 
AHBuBP.the most potent of the three: this determined a 10 and 5% mortality
_ Оrate in the resident and elicited Mó,respectively. CL2MBP and AHBuBP at 10 M 
concentration caused respectively a 10 and 15% mortality rate in resident Mó.
The phagocytic activity was measured by counting the number of Mó that inje 
sted opsonised S. Cerevisiae spores. The inhibitory activity was not signify
_ Пcant for all the tested BPs up to 10 ^M concentration. At this concentration, 
the number of cells with phagocytosed spores (with respect to 100 cells coun 
ted) were drastically reduced from 60 to 20 in the elicited Mó and from 50 to 
10 for the resident Mó. The results were similar for all the BPs.
Superoxide radical production from zymosan stimulated Mó was evaluated spectro 
photometrically by the ferricytochrome-c reduction technique. Resident cells, 
cultivated in dishes for 2A hours prior to incubating them with BPs (30 & 60 
min.) showed a dose-dependent reduction in 0“ production but only in the pre 
sence of very high concentrations of the compounds. For example,AHBuBP,the 
most potent of all three,inhibited 20 to 30% of O2 release at 1 mM and 5 mM 
respectively.
The results of our study point out that BPs are only weak inhibitors of Mó 
function or at least they are active only at very high concentrations,not 
comparable with those that are renowned for osteoclast function inhibition 
or recruitment. Moreover,the relative potencies of the BPs on Mó function 
inhibition do not correspond to their bone-resorbing capacity.
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A NEW SPECTRUM ANXIOLYTIC: 3-AMINO-4-ETHYLTHIO-7-C1-QUINOLINE.
HCl (EGIS 5278).
I. Miklya, D. Berényi, J. Knoll
Department of Pharmacology, Semmelweis University of Medicine, 
Budapest, P.O.B. 370, 1445 Hungary
Keywords: Benzodiazepine receptors, chlordiazepoxide, tofisopam 
EGIS 5278, Miklya-Knoll test.
Tofisopam, a 3,4-benzodiazepine derivative used for its 
anxiolytic activity in man, is known to be completely ineffec­
tive in animal tests, like the Vogel test (Pellow and File,
1986). We described recently (Miklya and Knoll, 1988a,b) a con­
flict situation by the aid of which we were able to measure the 
anxiolytic effect of tofisopam and demonstrate that this effect 
can be antagonized by Ro 15-1788, the selective benzodiazepine 
receptor antagonist.
The results of a comparison of the effects of chlordiazepoxi­
de and tofisopam in our test suggested that two subtypes of 
benzodiazepine receptors one with a higher and one with a lower 
affinity to chlordiazepoxide (named for sake of brevity BRI and 
BR2 receptors) were involved in the effect of this drug,whereas 
tofisopam acts selectively on BRI receptors.
The way was open for the search of new derivatives acting 
selectively on BRI receptors and being much more potent than 
tofisopam. Structure-activity relationship studies during a 
5-year period revealed that some quinoline-derivatives meet 
the requirements. Out of 63 compounds with essentially similar 
pharmacological spectrum the thioaminoquinoline derivative
2 1 2
3-amino-4-ethylthio-7-Cl-quinoline.HCl (EGIS 5278), was select­
ed as the reference substance, representing the new spectrum 
anxiolytic activity.
The analysis of the anxiolytic activity of EGIS 5278 in com­
parison to reference substances revealed, that Ro 15-1788 left 
the effect of phénobarbital unchanged and antagonized the an­
xiolytic activity of chlordiazepoxide, tofisopam and EGIS 5278 
which proved to be 20 time more potent than chlordiazepoxide 
and 3000 times more potent then tofisopam in the Miklya-Knoll 
test. The ratio between the sedative and anxiolytic dose was 
found to be 2.5 for diazepam, 8 for phénobarbital 26.6 for to­
fisopam, 100 for chlordiazepoxide and 500 for EGIS 5278. EGIS 
5278 did not exert any significant anticonvulsant activity in 
mice treated with penthylentetrazol or picrotoxin.
The working hypothesis is forwarded that EGIS 5278 is selec­
tively acting on a subtype of central benzodiazepine receptors 
and by this mechanism we have a benzodiazepine-receptor-related 
anxiolytic activity without significant sedative, hypnotic and 
anticonvulsant effect.
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ONE-DAY KINETICS OF CaCl? ARRHYTMOGENICITY FOLLOWING ACUTE ISOPRENALINE 
TREATMENT
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Ltd..Budapest,HUNGARY
(arrhythmia, isoprénaline,desensitization.CaCL, )
I t  is well known that those compounds which raise intracel lular  cAMP level 
in the myocardium, increase the suscept ib i l i ty  of the heart to arrhythmias 
(Lubbe et a l . ,  1987).This par t ia l l y  explains the arrhythmia inducing ef fect  
of isoprénaline, too. On the other hand, i t  has been found that chronic 
administration of isoprénaline reduces the severi ty of adrenaline induced 
ventr icular arrhythmias (Das et a l . ,  1986). I t  has however, not been 
studied how single large doses of isoprénaline (1.0-2.5-5.0 mg/kg) 
influence the arrhythmic tendency to CaCL,. The objectives of our 
investigations in that connection were therfore the following:
1/ Does isoprénaline pretreatment influence the development of 
CaC^-induced arrhythmia?
2/ I f  so, what is the kinetics of th is ef fect  ?
Experiments were perfomed in male Wistar rats of 250-300 g body-weight. 
Isoprénaline pretreatment was carried out with di f ferent doses (1.0-2.5 and
5.0 mg/kg) 30 min-1-2-3-6 and 24 hours before e l i c i t i n g  CaC^ arrhythmia. 
The CaCl^ solution (200 mg/ml) was injected into the r ight jugular vein of 
anaesthetized (40 mg/kg petobarbital-Na, i . p . )  rats through a cannula, at a 
rate of 0.4 ml/min un t i l  the appearance of ventr icular tachycardia. In the 
untreated (control) group we compared the dose of CaC^ required for 
inducing ventr icular tachycardia to that of CaCl^ e l i c i t ing  tachycardia in 
the isoprénaline pretreated group. The dif ference found between the two 
groups was expressed in percentage form (mean - S.E.M.), signif icance was 
calculated by Student's t  test. The results are presented in the fol lowing
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table:
( The negative sign before the percentual changes indicate the percent 
di fference between the quantit ies of СаС1„ required for e l i c i t i n g  
tachycardia compared to control  group)
PERCENT OF DIFFERENCES BETWEEN THE CONTROL AND ISOPRENALINE-TREATED GROOPS 
DOSE n 30 min n l h  n 2 h  n 3 h  n 6 h n 24 h
mg/kg
1.0  16 -43.2XXX 29 35.0XXX 27 43.2xxx 28 35.2xxx 16 7 . lx 23 6.5xx
2.5  18 -44.8XXX 27 -З.Зххх 28 48.3xxx 25 107.3xxx 24 28.8xxx 19 3.3n.s.
5.0 27 -40-lxxx 18 -14.8xxx 16 -4.3n.s. 16 78.1xxx 16 67.6xxx 15 9.6 xx
xxx=p^0.001;xx=p<0.01;x=p<0.05;n.s.= not s ign i f icant;n= number of animal
At the begining we found increased arrhythmic tendency towards CaC^ at 
each dose level. With elevat ion of the doses the duration of the developed 
arrhythmia also prolonged. This enhancement of the suscept ib i l i ty to 
arrhythmias was followed by signi f icant desensit ization, so that 
arrhythmia could be induced only with considerably higher doses of CaC^. 
The arrhytmic tendency, character ist ic to the control  group, returned to 
the base level within 24 hours in a l l  cases, independently of isoprénaline 
dose applied. The early (0.5-1.0 h.) increase in the tendency for 
arrhythmia may probably be conected with the increase of cAMP level, while 
the subsequent decrease in arrhytmic tendency (1-3 h) may be related to 
reduced cAMP formation, meaning that we are faced with a desenzitation 
process (Blaiklock at a l . ,  1978).
Blaiklock, R.G., E.M. Hirsh, D. Lehr, 1978, 0.Mol.Cell .Cardiol.  10,499. 
Dash, P.K., S. Bhowmik, 1986, 0.Mol .Cel l .Cardiol . 18(suppl.3.),21.
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Acta P hys io log ica  H ungarica, Volume 75, Supplementum, 1990 215
PHARMACOTHERAPY OF OPIATE AUD I CT I ON IN MARCHE REGION.
V . M o r e t t i ,  A . B r u n i ( x ) ,  C . B u f a r i n i ,  A . C a s a d i d i o ( + ) ,  l . G a o n i ,  
M .M arcucc i ( + ) ,  N .S c o la ( S ) ,  L.Re, L .R o s s in i
I . M . S . C . ,  L a b o r a t o r y  o f  P h a r m a c o l o g y , U n i v e r s i t y  o f  Ancona,  
Medical  School ;  ( x )  C.T. “ Ber ta 80“ , S. Sever ino Marche; (+)  U .S .L .  
9, Marche Region, ($)  Department of  H e a l t h ,  Marche Region, I t a l y .  
Key words: A d d i c t i o n  Treatment  - F o l l ow -up  Study - Opioids
The t h e r a p e u t i c  approach to  d rug  a d d i c t i o n  s h o u l d  be
com p re h e n s iv e  o f  s e v e r a l  t r e a t m e n t s .  M o d a l i t y  s e t t i n g s  o f
i n d i v i d u a l  p l a n  o f  a d d i c t i o n  t r e a t m e n t s  t o g e t h e r  w i t h
s i m u l t a n e o u s  r e s o r t  to  s e v e r a l  c o m p le m e n ta ry  i n t e r v e n t i o n s ,
somet imes s y n e r g i s t i c ,  had been s u b j e c t e d  to an i n t e g r a t e d
e v a lu a t i o n  rev iew .
The e p i d e m i o l o g i c a l  r e s e a r c h  s t a r t e d  Janua ry  1989 ,  a 
c o l l a b o r a t i v e  e f f o r t  o f  the Regional  Depar tment of Heal th and the 
U n i v e r s i t y  and H o s p i t a l  U n i t s ,  focused on the s tudy and f o l l o w - u p  
o f  the v a r i o u s  t r e a t m e n t  p rog ram s ,  i n  use both at  p u b l i c  and 
p r i v a t e  Regional  Cen te rs .
In  t h i s  n o t e  th e  r e s u l t s  o f  t h e  f i r s t  s t e p  o f  the  
overv iew are r e p o r t e d .  The goal to reach d e t a i l e d  knowledge of 
the th e r a p e u t i c  p lans o f  the 23 p u b l i c  Cen ters ,  p a r t i c u l a r l y  in 
r e f e r e n c e  to the p h a r m a c o l o g i c a l  t h e r a p y ,  has been h i t ,  as 
dep ic ted  in Table 1.
Tab. I :  Pha rmacolog ica l  t reatments  adopted by 23 p u b l i c  Centers 
(750 p a t i e n t s  f o r  1989; Marche Region: 1 ,500,000 of  i n h a b i t a n t s ) .
Only s u b s t i t u t i v e  drugs 8.7% 
Only n o n - s u b s t i t u t i v e  drugs 21.7% 
S u b s t i t u t i v e  and /o r  n o n - s u b s t i t u t i v e  drugs 56.5% 
D rug - f ree  Centers (n .  3) 13.0%
Among the no n -s ub st i t иt i v e  d r u g s , the mos t ly  preeminent
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use i s  o f  s e d a t i v e - h y p n o t i c s  and t r a n q u i l l i s e r s ,  n o n - n a r c o t i c  
a n a l g e s i c s ,  c l o n i d i n e ,  na l t r e x o n e  ( a f t e r  d e t o x i f i c a t i o n ) ;  muscle 
r e l a x a n t s ,  t razodone ,  n e u r o l e p t i c s  and c o r t i c o s t e r o i d s  are less 
f r e q u e n t l y  employed.
The t r e a t m e n t s  w i t h  s u b s t i t u t i v e  drugs i n c l u d e  the 
o u t p a t i e n t s  ( a m b u l a t o r y )  d e t o x i f i c a t i o n  by s c a l a r  doses over  
t h r e e  weeks, the maintenance on methadone ( e x c e p t i o n a l l y ) ,  the 
h o s p i t a l i z a t i o n  and r a p i d  d e t o x i f i c a t i o n  w i th  methadone, and the 
s low  s c a l a r  d e t o x i f i c a t i o n  w i th  methadone or b u p r e n o r f i n e .
In the  96% o f  cases the p h a r m a c o th e r a p y  i s  a s s o c i a t e d  
w i t h  n o n - p h a r m a c o l o g i c a l  methods ( f u l l  p s y c h o t h e r a p y  c y c l e s ,  
f a m i l y  t h e r a p y ,  c o u n s e l i n g ,  s o c i a l  r e h a b i l i t a t i o n ,  g e n e r i c  
p s y c h o l o g i c a l  s u p p o r t ) .
The s t u d y  o f  t r e a t m e n t  e f f e c t i v e n e s s  i n c l u d e s  th e  
s p e c i f i c a t i o n  of  the t r e a tm e n t  paradigms,  the ta k in g  i n t o  account 
o f  the problems of  compar ison across t r ea tm en ts ,  the p e r i o d i c  
e v a l u a t i o n  of  ten parameters  du r ing  t r e a tm e n ts  and p o s t r e a t m e n t s , 
th e  cho ic e  of  minimal  p e r io d s  of  o b s e r v a t i o n ,  the e v a l u a t i o n  of 
v a l i d i t y  o f  i n t e r v i e w  d a t a  and t h e  c h a r a c t e r i z a t i o n  o f  
c o n s i s t e n c y  of  samp l ings .
At the p resen t  s te p ,  emergent problems r e s u l t  f rom the 
i n a d e g u a t e  o r g a n i z a t i o n  and the poor  c o o r d i n a t i o n  i n s i d e  and 
between Centers ;  a r e l e v a n t  programme managers in the t h e r a p e u t i c  
g r o u p  s t a f f i n g s  and a b e t t e r  and permanen t  t r a i n i n g  to w a rd s  
p r e v e n t i o n  are u r g e n t l y  reques ted .
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CHEMICAL (ALCUMUL,NaUH,NaCl ANU HC1)-INDUCED CHANCES IN 1HE GASTRIC 
MIJCUSAL ML MURÄNE-BUUNU AIP-UEPENUENI ENERGY SYSTEMS
Gy.Mózsik,M.Garamszegi,T.Jávor,L .Nagy,M.Németh,G.Sütő & Ä.Vincze
F irs t  department of medicine,Medical University of Pécs,H-7643 Pécs,Hungary
Key-words:chemicaIs, gastr ic mucosal lesions, energy systems
Gastric mucosal lesions could be produced by in tragastr ic administrat ion 
of d i f f e ren t  necrot izing agents,such as 0,6 M HC1,0.2 M Na0H,25% NaCl or 
96% alcohol (Robert et a l . , 1979). These necrot iz ing agents produce about 
the same number and severi ty of gastr ic mucosal lesions in rats, at 1 hour 
a f ter  administrat ion of necrot izing agents,however, the developmental 
mechanisms of mucosal lesions remained unknown (Mózsik & Jávor,1988).
The aim of th i s  study was to evaluate the possible changes in the gastr ic 
mucosal membrane-bound ATP-dependent energy systems during the development of 
gast r ic  mucosal lesions produced by alcohol,NaDH,Nacl and HC1.
Sprague-Dawley ( L a t i ,Gödöllő,Hungary)-strain rats,weighing 18D-21G g, 
were used for  th is  study. The animals were fasted for 24 hours before the 
experiments. The gast r ic mucosal lesions were produced by in t ragast r ic  
administrat ion of U,6 M HCl, U,2 M NaUH, 25% NaCl or 96% ethanol (1 ml).
The animals were sacr i f iced at 1 hour a f ter  administrat ion of necrot iz ing 
agents,when the number and severi ty of gas t r ic  mucosal lesions was noted.
The tissue levels of ATP,ADP,AMP and lactate were enzymatically, whi le cAMP 
by RIA, and the i r  quant i t ies were expressed as means - SEM per one 1 mg 
mucosal protein.
The t issue levels of ATP and cAMP were decreased,while ADP increased 
at 1 hour a f ter  administrat ion of necrot izing agents (F ig . l ) .  The extents 
of ATP-ADP transformations were increased in assot iat ion to the decreased 
ATP-cAMP and cAMP-AMP transformations (F ig .2).
I t  has been concluded that:  l .The development of gastr ic mucosal damage 
associated with an increased energy l i b e r a t i o n ,obtained by the increased 
extent of ATP-ADP transformation; 2 .The increased ATP-ADP transformation 
associated with the decreased extents of ATP-cAMP and cAMP-AMP transform
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a t ions ;  3.The simi lar  changes were obtained in the gastr ic mucosal membrane- 
bound ATP-dependent energy systems,during the development of mucosal in jury  
produced by d i f ferent  necrot iz ing agents.
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Fig.l .Chemicals-induced changes in the c e l l u l a r  energy systems in the ra t  
g a s t r i c  mucosa (numbers are 14-16, and sever i t ies  are about 50 per one ra t  
stomach in a l l  groups of animals).
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F ig .2 .Changes in the 
feedback between the 
membrane-bound ATP- 
dependent energy systems, 
during the development of 
gastr ic mucosal damage 
produced by d i f fe ren t  
necrotizing agents.
References
Mózsik Gy.,Jávor T.Dig.Dis.
Sei .33,92-105(1988). 
Robert A.,Nemazis J .E . ,  
Lanchaster,C. ,Hanchar A.J. 
Gastroenterology 77, 
433-443(1979).
Acta P hys io log ica  Hungarica, Volume 75, Supplementum, 1990 2 1 9
GASTRIC CYTOPROTECTION MEDIATING IN SH-GROUPS IS FALIED 
BY SURGICAL VAGOTOMY:
Gy.M ó z s ik ,A .K irá ly .M .Garamszegi,T.Já vo r,L .Nagy,M .Németh,G.Sütő & A .Vincze 
F ir s t  Department o f  M ed ic ine,M edica l U n iv e rs ity  o f  Pécs,H-7643 Pécs,Hungary
Key-words:gastric cytoprotection,SH-groups,L-cysteine,NEM,vagotomy.
I t  has been observed that the gastr ic cytoprotect ion,at least par t ly ,  
mediates via SH-groups of mucosal proteins (Szabó et al .  ,1981).SH-group 
(L-cysteine) has gastr ic mucosal protect ing,whi le SH-blocker compound 
(N-ethylmaleimide,NEM) has aggravating ef fect  on the development of gas­
t r i c  mucosal damage produced by di f ferent  necrot izing agents.
The aims of th is  study were:l.To evaluate the gastr ic cytoprotective 
ef fect  of L-cysteine on the number and severi ty of gastr ic mucosal lesions 
produced by int ragastr ic administration of ethanol(ETOH); 2.To study the 
extent of aggravation of N-ethylmaleimide (NEM) on the ETOH-induced gastr ic 
mucosal damage in rats with intact  vagal nerve and af ter  acute surgical 
vagotomy.
The observations were carried out on Sprague-Dawley (LATI,Gödöllő,Hun­
g a r y ) -  s train rats,weighing 180-210 g.The animals were fasted for 24 hours 
before the experiments.The gastr ic mucosal damage was produced by in t r a ­
gastr ic administration of 96% ethanol(ETOH) ( 1 ml ). L-cysteine and NEM 
( in  d i f fe ren t  doses ) were given at 30 min before administration of ETOH.
The animals were sacri f iced at 1 hour af ter  ETOH administration,when the 
number and severi ty of gastr ic mucosal lesions was noted.The resul ts were 
expressed as means _+ SEM per one rat  stomach.
L-cysteine dose-dependently prevented,while the NEM aggravated the 
number (Fig. 1 ) and severi ty of ETOH-induced gastr ic mucosal lesions in 
rats with intact  vagal nerve, but thei r  e f fects  disappeared af ter  acute 
surgical vagotomy.
I t  has been concluded that:  l.The gastr ic cytoprotective ef fect of SH-
2 2 0
]  sham-operated rats У ///Л  surgically vaqotomized rats
L-cysteine ( mq/kq sc ) N-ethylmaleimide INEMHmq/kq sc )
NS not significant ж P—0 05 «ж-P—0.01 »«ж P—0001
Fi g . 1 . E f f e c t s  of  L - c y s t e i n e  and N -e thy lm a le im ide  (NEM) on the 
number o f  e thanol  (ETOH) - induced g a s t r i c  mucosal damage i n  r a t s  
w i t h  i n t a c t  vagal nerve and i n  r a t s  a f t e r  acute s u r g i c a l  vagotomy.
group  disappeared a f t e r  s u r g i c a l  vagotomy ; 2 . The agg rava t i ng  
e f f e c t  o f  SH-blocker  f a i l e d  by s u r g i c a l  vagotomy; 3.The acute 
s u r g i c a l  vagotomy m o d i f i e d  the f u n c t i o n a l  p r o p e r t i e s  of  SH- 
p r o t e i n s  in  the g a s t r i c  mucosa.
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THE SHORT TERM COMPARATIVE STUÜY OF AN TIOLCER ORUGS WITH 
DIFFERENT MODES OF ACTION IN DUODENAL ULCER PATIENTS
A.Németh, M. Garam szegi, I . P a t t y ,  F . Tárnok, L.Nagy  
Gy.Mózsik & T. Jávor
F i r s t  Departm ent o f  M e d ic in e , M e d ic a l  U n iv e r s i ty  o f  Pécs,
H-7643 P é c s ,Hungary
Key-words: duodenal  u l c e r ,  u l c e r  p l a n i m e t r y ,  p r o t e c t i v e  agents
Pharmacodynamic s t u d i e s  were c a r r i e d  out  w i t h  d i f f e r e n t  
a n t i s e c r e t o r y , a n t a c i d  and c y t o p r o t e c t i v  compounds on duodenal  
u l c e r  p a t i e n t s .  P a t i e n t s  were randomly s e le c te d  in  d i f f e r e n t  
t r e a tm e n t  g roups .  Duodenal u l c e r  was e n d o s c o p i c a l l y  v e r i f i e d  
and f o l l o w e d .  A d e t a i l e d  case r e p o r t ,  d i f f e r e n t  l a b o r a t o r y  t e s t s  
were per formed a t  the beginn ing and the  end of  t r e a t m e n t .  Every 
p a t i e n t  had a d i a r y  card to r e g i s t e r  the s i z e  of  u l c e r ,  the 
c o m p l a i n t s ,  a n t a c i d  consumpt ion,  and p o s s i b l e  s ide e f f e c t s .
Autho rs  i n v e s t i g a t e d  the u l c e r  h e a l i n g  e f f e c t  of  Cimet id ine/ lOOOmt 
R a n i t i d i n /ЗООтд / , Gast r o z e p i n e / 150m g/ , Sucra 1f a t / 1OOOrng/, T i s a c i d  
/ A l -Мд a n t a c i d /  g iv en  in  d i f f e r e n t  doses ,  the com b ina t i on  of  
A t r o p i n e / 1 . 8mg/ w i t h  P e r i t o l / c y p r o h e p t a d i n u m  c h lo ra tum ,  12mg/ 
s u p p l i e d  w i t h  a n t a c i d  as r e q u i r e d ,  and a comb inat ion o f  A t r o p i n e  
/ 1 . 8 m g / ,  Carbenoxolon/500mg/  p lu s  cyp rohep tadinum c h l o r a t u m / 1 2 m g / . 
By the m a th em at i ca l  a n a l y s i s  o f  the  r e s u l t s  on the h e a l i n g  r a t e s  
produced by d i f f e r e n t  compounds no s i g n i f i c a n t  d i f f e r e n c e  was 
o b t a in e d .  The p l a n i m e t r i c a l l y  measured u l c e r  s izes  were decreased 
s i g n i f i c a n t l y  d u r i n g  the f i r s t  two weeks p e r i o d ,  meanwhi le t h i s  
decrease was s m a l l e r  in  the second two weeks p e r i o d .  I t  can be 
supposed t h a t  f rom the p o i n t  o f  pharmacodynamic a c t i o n  the 
s t u d i i n g  o f  the uncomp le te ly  hea led u l c e r s  can g ive more i n f o r -
2 2 2
m a t i o n s .  The u l c e r  s i z e  s i g n i f i c a n t l y  decreased d u r in g  th e  f i r s t  
two week p e r iod  - l i k e  i n  the summarized u l c e r  s i z e  c h a n g in g ,  - b u t  
no s i g n i f i c a n t  d i f f e r e n c e  was o b ta in e d  among the groups.  
Compar ison of  the u l c e r  s i z e s  to  t h e i r  bas ic  s izes  in  p a t i e n t s  
who were not  healed d u r i n g  the f o u r  week p e r i o d ,  showed t h a t  
t h e  u l c e r  s i z e  were e x p r e s s i v e l y  d i f f e r e n t  at  the b e g in n in g  of  
t h e  t r e a t m e n t ,  and the r e d u c t i o n  i n  them were found to  be s i g ­
n i f i c a n t .
I t  has been conc luded based on our  data t h a t  th e re  i s  no 
e v a l u a b l e  d i f f e r e n c e  among the u l c e r  h e a l i n g  ra te s  produced by 
a n t i s e c r e t o r y  drugs,  a n t a c i d s  and c y t o p r o t e c t i v  drugs or  by t h e i r  
c o m b i n a t i o n  in  duodenal  u l c e r  p a t i e n t s .
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DIFFERENTIAL RESPONSIVENESS TO ANTIARRHYTHMIC DRUGS IN THE RABBIT 
ATR10-VENTRICULAR CONDUCTING SYSTEM
M. Németh, O.Gy. Papp, L. Szekeres
Department of Pharmacology, A lbert Szent-Györgyi Medical University, Szeged,
Hungary
]<e^w£r^sj_ a tr io -v e n tr ic u la r conduction, calcium antagonists, 
fast sodium channel blocking antiarrhythm ics.
Pharmacological 'mapping' o f the re g io n a l e ffe c ts  of drugs in  the 
heart have revealed im portan t d iffe rences  (Papp e t a l . ,  1989; Winslow,
1984). I t  was, th e re fo re , of in terest to study the responsiveness of d is ­
t in c t  po rtions  o f the a t r io - v e n t r ic u la r  conducting system to some of the 
representatives of Class 1 (mexiletine, prajmaline) and Class IV (d iltiazem , 
verapam il) a n tia rrh y th m ics . Results have also been obtained with a mixed- 
-type (Class 1+4) antiarrhythm ic drug, propafenone.
Hearts of young rabb its  were removed and a complex cardiac preparation 
was made which consisted of the in te r -a tr ia l septum with the A-V node, the 
in te r -v e n tr ic u la r  septum containing the His-bundle, the r ig h t bundle branch 
and p a p illa ry  muscles and the righ t d is ta l Purkinje network with attached 
v e n tr ic u la r  muscle. The prepara tion  was put in  an organ bath containing 
m odified Locke's s o lu t io n . Atrium-His bundle (А-H), atrium-Purkinje f ib re  
(А-P), His bundle-Purkinje fib re  (H-P) and His bundle-papillary muscle (H-V) 
in te rv a ls  as w e ll as А-H, H-P and H-V e f fe c t iv e  re fracto ry  periods were 
determined in  the absence and presence of the drugs, as described e a r lie r  
(Németh et a l ., 1986).
Exposure of the p repara tion  fo r  60 min to drugs with Class 4 a n t i­
arrhythm ic p ro p e rtie s  (d ilt ia z e m , 0.2 mg/1 ; verapamil, 0.1 mg/1 ; propafe­
none, 1 mg/1) usually resulted in a prolongation of the А-H and А-P conduc­
t io n  tim es, and an increase in the А-H e ffe c tive  re fracto ry  period. On the 
o ther hand, agents known to block fast sodium channels i.e .  Class 1 a n t i-
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arrhy thm ics  (m e x ile tin e , 2 mg/1; prajmaline 0.5 mg/1; propafenone, 1 mg/1) 
exert a marked and, fo r the most part, predominant e ffec t on the H-P and H-V 
in te rv a ls  and the respective e ffe c tive  re fracto ry  periods (Table I ) .
I t  is  thus apparent th a t, as regards th e ir  action the a tr io -ve n tr icu - 
la r  conducting system, antiarrhythm ics c la ss ifie d  in the same group of drugs 
may have a d is tin c tive  electropharmacological p ro file .
Table I
E ffect of antiarrhythm ic drugs on the rabb it a tr io -v e n tr ic u la r 
conducting system
Parameter Control
(n=40)
Diltiazem 
0.2  mg/1  
(n=6 )
Verapamil 
0.1  mg/1  
(n=10)
Mexiletine 
2 mg/1
(n=5)
Prajmaline 
0.5 mg/1  
(n=5)
Propafenone 
1 mg/1  
(n=8)
CONDUCTION
A-H 62.9 107.0+ 93.5+ 71.0 64.6 68.8
+5.3 +9.5 +9.5 +4.0 +3.6 +1.6
A-P 88.2 118.0+ 121.2+ 91.0 105.2 115.0+
+5.6 +8 .6 +10.5 +6.9 +11.7 +12.4
H-P 24.4 27.6 26.7 27.6 46.0+ 46.3+
+2.5 +4.5 +2.7 +8.4 +6.8 +5.2
H-V 38.4 39.2 41.8 61.2+ 50.6+ 58.6+
+2.7 +3.1 +2.3 +4.9 +9.8 +6.1
ERP
A-H 208.6 342.0+ 346.3+ 232.0 225.0 242.5+
+6.9 +9.2 +11.1 +12.4 +21.8
H-P 193.5 193.3 171.0 238.0+ 223.0+ 246.0+
+6.8 +8.1 +5.5 +17.2 +7.9 +21.3
H-V 181.2 180.0 162.5 258.0+ 217.0+ 252.5+
+5.1 +10.0 +5.4 +19.6 +12.4 +17.9
Mean values are given +_ S.E. n = number of preparations. + P<0.05 
ERP = e ffec tive  re fracto ry  period. See te x t fo r abbreviations.
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INHIBITION OF SARCOLEMMAL ATPase ANO pNPPase BY CH-103
K. Nosztray, 0. Szabó, E. Varga and J. Szegi. Department of Pharmacology, 
Medical University of Debrecen, H-4012 Debrecen, Hungary 
Key words: Beta blocking drugs, Na+,K+-ATPase, K+-pNPPase 
Beta adrenoceptor blockers, -  in  addition to th e ir  spec ific  drug-receptor 
in te rac tion , -  possess a wide range of sp e c ific  membrane a c tiv ity  (SMITH, 
1982). The beta blocker CH-103 (4-cyclohexilam ino /-l-/l-naphto lenyloxy/-2 - 
butanol maleate) has also inh ib ited  the plasma membrane Na+,K+-ATPase (SZA­
BÓ et a l . ,  1988). Because the basic ATPase a c t iv ity  in  ra t myocardium re la ­
t iv e ly  high, i t  seemed worth studying the e ffe c t of CH-103 on the in d ire c t 
enzymatic manifestation of Na+ ,K+- ATPase, i . e .  the K+-stimulated p -n itro -  
phenylphosphatase (K+-pNPPase), where a more favourable per cent d is tr ib u ­
tion  of enzyme a c t iv ity  could be detected.
Pooled ra t heart ven tric les  were homogenized in  10 volumes of 20 mM Tris-HCl 
containing 1 mM EDTA and 0.1 mM phenylmethanesulfonyl fluo ride  /pH 7 .0 / (VE- 
LEMA and ZAAGSMA, 1981). Protein content was determined according to LOWRY 
et a l.  (1951). The ATP and pNPP hydrolysing a c t iv i t ie s  of crude cardiac ho­
mogenate were studied w ith and without beta blockers (AKERA, 1984).
In crude cardiac homogenate only 20% of the to ta l ATPase was the Na+,K+- 
stimulated portion , while the K+-stimulated portion  of pNPPase was higher 
(35%). CH-103 s ig n if ic a n tly  inh ib ited  the to ta l ATPase and pNPPase a c t iv it ie s  
at concentrations 5xlO- ^M and 1x10 ^M, respective ly . To in h ib it  s ig n if ic a n tly  
the basic ATPase, higher concentrations of CH-103 were necessary (2x10 ^M).
In the case of basic pNPPase a c t iv ity  we could not achieve a s ig n if ic a n t 
in h ib it io n  at a l l .  Linewaver-Burk p lo t of the data by employing d iffe re n t 
substrate concentrations revealed that in h ib ito ry  e ffec t of CH-103 on to ta l 
ATPase and pNPPase a c t iv it ie s  was mainly due to a decrease in Vmgx values.
In the case of to ta l ATPase the did not change s ig n if ic a n tly , but a s ig -
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Table I .  K inetic parameters of ATPase and pNPPase a c tiv it ie s  in  the 
presence and in  the absence of 2 mM CH-103
Enzyme
a c t iv i ty
V*max
contro l CH-103 control
К**m
CH-103
ATPase
to ta l
basic
14.41-0.94 
13.34-0.59
6.18-0.23x 
8.00-0.57х
0.441-0.044
0.364^0.016
0.384-0.004 
0.425-0.007х
pNPPase
to ta l
basic
0.98-0.09 
0.78-0.05
0.49-0.02х 
0.64^0.03
0.746-0.094
0.732-0.061
0.274-0.027х 
0.580-0.039
 ^ ^
Vmax values of ATPasg and pNPPase are expressed in  10 mol Р./mg p ro te in /
hour and in  10 mol pNP/mg pro te in /hour, respectively 1
**K values od ATPase and pNPPase are expressed in  10 "W l ATP and in  10 
m M/l pNPP, respective ly
p <  0.001 (s ig n if ic a n tly  d iffe re n t from con tro l)
n if ic a n t  decrease of Km fo r  to ta l pNPPase a c t iv ity  may indicate an increase
in  substrate a f f in i ty .  The basic ATPase a c t iv ity  was also depressed by CH-103
w ith  a decrease in  V and an increase in  К ( Table I ) .max m
In sp ite  of the more favourable per cent d is tr ib u tio n  of to ta l pNPPase, CH- 
103 has inh ib ited the Na+ ,K+-ATPase to a higher extent than the ^ - s t im u la t ­
ed pNPPase. This e ffe c t may orig inate from the d iffe re n t intramembranal 
lo c a liz a tio n  of the active  s ites  of enzyme.
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PRESYNAPTIC CONTROL OF STRIATAL TYROSINE HYDROXYLASE ACTIVITY BY 
CORTICOTROPIN - RELEASING FACTOR.
Maria C. Olianas and Pierluigi Onali, Department of Neurosciences, 
University of Cagliari, via Porcell 4, 09124 Cagliari, Italy.
key words : CRF ; Tyrosine hydroxylase; striatum.
Corticotropin-releasing factor (CRF), originally identified as a 
hypophysiotropic peptide, has subsequently been found to affect a variety 
of brain functions (Aguilera et al., 1987). Recently, we have observed 
that in vitro CRF causes stimulation of synaptosomal dopamine (DA) 
synthesis which is associated with an increase of tyrosine hydroxylase 
(TH) activity in rat and mouse striatum (Olianas and Onali, 1988; 1989). 
In mouse striatum, CRF maximally increases the enzyme activity by 60 %  
and this effect appears to consist in an increase of the app. Vmax of 
the enzyme form with high affinity (Km 80 pM) for the cofactor. The CRF 
response occurs at nanomolar concentrations of the peptide (EC 50 15 n M ) , 
is significantly antagonized by the CRF receptor antagonist «-helical CRF 
9-41 (Ki 120 nM) and withstands gel filtration treatment of the 
synaptosomal extract. Sauvagine and urotensin I, two peptides displaying 
sequence homology to CRF, mimick the CRF effect with EC 50 values of 5 
and 10 nM, respectively. An important property of the CRF stimulation of 
TH activity is the strict dependence on the concentration of
extracellular Ca+. In a Ca+4-free medium, the stimulatory effect of the 
peptide is minimal and is maximal at about 0.5 mM extracellular Ca+ t 
Moreover, polymyxin B, a relatively selective protein kinase C inhibitor, 
antagonizes the CRF effect (IC 50 30 pM), suggesting a possible role of 
the second messengers generated by phospholipids hydrolysis in the action
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o f  CRF. To test this hypothesis, we investigated the effect of neomycin, 
a n  aminoglycoside which binds to phosphoinositides and inhibits their 
hydrolysis.
Table 1
Inhibitory Effect of Neomycin on CRF Stimulation of Synaptosomal TH 
Activity in Mouse Striatum.
TH activity 
(pmol C 0 2/min/mg prot) 
basal CRF-stimulated*
vehicle
neomycin 0.1 mM 
0.3 
0.6 
1.2
20.5 ± 0.5 
20.2 ± 0.6 
19.1 ± 0.4
15.5 ± 0.2a 
14.8 ± 0.4a
12.5 ± 1.0 
9.1 ± 0.8 
7.7 ± 0.6b
5.4 ± 0.3b
5.5 ± 0.2b
*  net increase of TH activity above basal produced by 0.5 pM CRF 
a P < 0 . 0 5  vs vehicle ; b < 0 . 0 5  vs CRF alone.
As shown in Table 1, neomycin causes a concentration-dependent inhibition 
of both basal and CRF stimulated TH activities with maximal effects
corresponding to 28 % and 60 % reductions, respectively. The IC 50 value 
of neomycin in inhibiting the CRF effect is about 0.15 mM. These results 
indicate that in striatal dopaminergic terminals CRF receptors control 
the state of activation of TH by a mechanism that requires both C a +and 
inositol phospholipids hydrolysis.
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POSITIVE CORRELATION OF CALCIOM CONCENTRATION IN CEREBROSPINAL FLUID AND 
RECTAL TEMPERATURE IN RABBITS.
M. Palmi and G.P. Sgaragli
In s titu to  di Scienze Farmacologiche, Via E.S. Piccolomini, 170, 53100 
Siena, I ta ly
Keywords: Thermoregulation, CSF calcium.
Experiments performed by Feldberg et a l.  (1970) and Myers and Veale 
(1971) led to formulate the theory that the chemical composition of the 
cerebrospinal f lu id  (CSF) in  the 3rd ve n tr ic le  adjacent to the temperature 
centres in  the hypothalamus exerts an influence on body temperature. I t  was 
also postulated that the "set point" of the thermoregulatory system is  de­
termined by the balance between Na and Ca ions in  CSF. A recent study 
carried out in our laboratory, showed that in  rabb its  neurones responsible 
fo r temperature contro l are a target of organic calcium antagonists or 
agonists. In fa c t, intracerebroventricu lar in je c tio n  of Verapamil, N ifed ip ine 
and Cinnarizine caused a dose-related hyperthermic response, while the 
in je c tio n  of BAY-K-8644, resulted in  a dose-dependent hypothermic response 
(Palmi and Sgaragli, 1989). These findings led us to hypothesize tha t 
calcium concentration in CSF might have a re levant ro le  in thermoregulation. 
I f  th is  was the case, when body temperature increases as i t  happens in  
fever, there should be a change in  (Ca ) o f the f lu id  bathing the b ra in .
To test th is  hypothesis, in the present study, we checked whether a possible 
co rre la tion  exists between CSF (Ca ) and re c ta l temperatue in rabb its  f o l ­
lowing recovery from surgical implantation o f a cannula into the cisterna 
magna. Conscious, restrained animals (n=29), 2-3 days a fte r surgery had 
been performed under nembutal anaesthesia, were kept at constant ambient 
temperature of 20 °C throughout the experimental session and, one hr a fte r  
th e ir rec ta l temperature was s tab ilized , samples of CSF were withdrawn 
during a 2 hrs period at 24 min in te rva ls  and at a flow rate of 5 u l/m in . 
Total CSF calcium concentration was determined by the methç^ of Stern and 
Lewis (1957), using ortho-cresolphthalein complexone as Ca +complexing 
agent and 8-hydroxyquinoline-5-sulfonic-acid to elim inate Mg in te rfe rence . 
CSF prote in content was also determined according to the coomassie-blue 
binding method. Animals exhibited a wide range o f+recta l temperatures, 
from normothermia to fever and also th e ir  CSF (Ca ) showed a large va ria ­
b i l i t y .  These two parameters, as shown in  f ig .  1, were positive ly  and high­
ly  s ig n if ic a n tly  correlated. On the contrary, CSF protein concentration 
(64 +_ 4.3 mg x 100 ml , mean value +_ s.e.m ., n=18|+did not seem to be 
related e ither to rec ta l temperature of to CSF (Ca ). Even though a 
previous study carried out in  men fa ile d  to +evidentia te any co rre la tion  
between body temperature and lumbal CSF (Ca ) (Nielsen et a l. 1973), our 
findings give support to the hypothesis tha t brain calcium metabolism plays 
a ro le  in  thermoregulation.
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Fig. 1. CSF^Ca**) in 29 rabbits plotted against rectal tempera­
ture (Tr). (Ca ) value of each animal is the mean of 5 fractions 
analysed in quadruplicate. Coefficients of variation of the 5 deter­
minations ranged between 1.4 and 6.7 per cent.
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AN EXPERIMENTAL _ MODEL. TO. SELECT DRUGS AGAINST HEAD
TRAUMA
M . Parocгаi . К Сеоm o r . E. Kárpáti
Pharmacol. Pee. Centre of Chemical Wirke of Gedeon 
Richter, Ltd., Budepest, Hungary
Key words: head trauma, lipid peroxidation, free radical 
scavenger, Ca- ionophore. Ca-ari tagon ist
Brain ischaemia, aberrant Ca-fluxes and lipid peroxidation
are sought to be the most important events after CMS
injury (Hall and Wolf, 19861. There are lot of evidences
showing the protective effect of antioxidants against
cerebral ischaemia (Suzuki et al. 1984; Misoi e* al .
1986). Ca-antagoniste were found to be effective in
posttraumatic spinal cord i schaemia-model (Hall arid Wolf,
1986). We present some experimental evidences proving the
role of free radical reactions and intracellular Ca-
accumulatione in the consequences of head injury in mice.
Our acute head trauma modell was also suitable to follow
up the effect of drugs on the mortality and neurological
statue of mice during 3 days of the observartion period.
1. Mortality arid neurological deficits following 
acute head injury were decreased by antioxidants (Selen, 
Vitamin-E, Mannitol, D-penicillamin)
2. Endogen free radical production can be increased 
by Paraquat or Fenilhidrasin (Oroszlán et al. 1981). A 
moderate head injury combining with the administration of 
a free radical inductors resulted in the neurological 
status similar to the consequences of serious head trauma. 
In this way, the selectivity of the antioxidants can be
e s t i m a t e d .
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3. A Ca-ionophore (A 23187) к as able to evoke higher 
mortality and mere serious damage than the acute trauma 
a l o n e .
4 . Prugs h a V in g p г о tective effect again s t cell
damage (membrane stabilizers. Ca-a n t a g o n i s t e ) were able to 
его eliorete neurologies 1 deficits .
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ORAL ZINC SULPHATE TREATMENT IN WILSON’S DISEASE.
Pasqualicchio M .. Marrella M., Moretti U., Velo  G .P ., Deganello A.*, Tom elleri G .**  
and Milanino R.
Institute of Pharmacology, 'C lin ical Pediatric, “ Clinical Neurology, University of 
Verona, Verona, Italy.
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W ilson’s disease is a  inborn error of copper metabolism which prom otes an 
excessive copper accumulation that is fatal if untreated. Most patients with this 
disease are treated with a  highly toxic cupriuretic agent D-penicillam ine (D-pen) 
(B rew er et al., 1987). It has been recently shown that the oral administration of zinc 
sulphate may well substitute D-pen at least in those patients which have been  
previously decoppered by chelation therapy (Cossack, 1988; Sanstead, 1987 ).
W e present the results obtained in three patients affected by W ilson’s d isease and 
submitted to a  zinc sulphate treatm ent. In the first moment and then periodically the 
efficacy of zinc sulphate, orally administered at the dose of 200 mg 3 tim es daily, was 
verified by m eans of copper balance study. Furthermore the patients w ere controlled 
by measuring copper and zinc plasm a concentrations, 24  h copper and zinc urinary 
excretion and serum ceruloplasmin (S -Ср) levels.
O ne patient, a 29 year old fem ale with serious neurological symptoms, a fte r 10 years  
of D -pen therapy was shifted to oral zinc and manteined on this regimen since three  
years. After the beginning of the substitutive treatm ent the patient was subm itted to a 
two copper balance studies: the first, after three months, was negative for 0 .09  
m g/day; the second, after 30 months, was negative for 0 .2 4  mg/day.
The second patient, a 25 year old man, presenting a  neurological form of the
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d is ea se , was treated from the start with zinc sulphate and he has been on this 
th e ra p y  for two years. T h e  copper balances under zinc sulphate have shown a 
n eg ative  copper balance for 1.16 mg/day after one month and 0.59 m g/day after 12 
m onths.
D uring zinc treatment, in both patients, the clinical conditions and S -Ср levels 
rem ain ed  unchanged, while a  significant decrease of the cupruria and cuprem ia was 
observed .
T h e  third case was a 11 y e a r old child in seem ingly good health with no symptoms of 
neurological disorders but showing a remarkable increase of serum transam inases. 
H e received oral zinc sulphate as the primary and sole therapy for W ilson’s disease. 
T h e  basal copper balance w as found positive (0 .0 4  mg/day); on the contrary the 
co p p e r balance im m ediatly after the beginning of zinc sulphate therapy resulted 
neg ative  (-0.56 mg/day). T h e  results obtained during two years of treatm ent have 
show n a decrease of S G O T , S G P T  and S G G T , a  progressive decrease of total 
co p p e r in both 24 h urine and plasm a and stationary S -С р concentrations. 
Considering that the only side effect seen during the therapy of the three patients 
w as an  initial mild gastric irritation, which d isappeared  after few days, in the first 
patient, these data may suggest the convenience to use oral zinc as both primary 
and  m anteinance therapy in W ilson’s disease.
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SYSTEM1CALLY APPLIED RUTHENIUM RED IN H IB IT S  THE STIMULATION OF 
SENSORY RECEPTORS BY CAPSAICIN
Gábor Pethö and János Szolcsànyi 
Department of Pharmacology, University Medical School of Pécs 
H-7643 Pécs, Szigeti ùt 12.
Key words: capsaicin, ruthenium red, Bezold-Jarisch reflex 
Introduction
The inorganic dye ruthenium red (RR) selectively inhibits 
the effects of capsaicin in vitro (Maggi et al., 1988) and 
prevents capsaicin-induced nociceptor stimulation in the 
perfused rabbit ear (Amann and Lembeck, 1989). Topically 
administered RR inhibits both reflex and local efferent 
responses evoked by capsaicin (Maggi et al., 1989). Since 
there are no data available about in vivo administration of 
this dye, the aim of the present study was to examine the 
effect of systemically applied ruthenium red on reflex 
responses evoked by capsaicin.
Meth o ds
Female albino rats of the Wistar strain weighing 230-320 g 
were anaeshetized with urethane (1.0-1.2 g/kg i.p.). The 
trachea, the right carotid artery and the right jugular vein 
were cannulated. Arterial blood pressure, myocardial 
contractility (dp/dt) and breathing movements were recorded 
by a Beckman dynograph. Rectal temperature was kept at 38°C 
by means of a heating pad. Capsaicin and veratridine were 
administered by intravenous bolus injections of 0.1 ml.
Results and discussion
Intravenous injection of capsaicin excites the pulmonary J 
receptors and evokes the Bezold-Jarisch reflex of bradycardia, 
fall in arterial blood pressure and apnoe (Paintal, 1973). The 
threshold dose of capsaicin was 0.8-1.6 p g / k g .  RR (0.5, 1.0
and 2.0 mg/kg), injected intravenously within 10 to 30 seconds 
inhibited the triple response evoked by capsaicin in a dose- 
-dependent manner. The respective dose ratios were: 2.0 (n=7),
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2.2 (n=4) and 6.8 (n=4) by calculating the identical effects 
of capsaicin on the heart rate before and after the treatment. 
Slow intravenous injections of RR (0.5, 1.0, and 2.0 mg/kg) 
produced no significant cardiovascular changes. In some cases, 
particularly after the highest dose apnoe or tachypnoe was 
o b s e r v e d .
Capsaicin excites the endings of vagal sensory C-fibres 
and the efferent fibres to the heart run also in the vagus 
nerve (Saolcsànyi, 1982). The RR-induced inhibition of the 
reflex is not due to an effect on parasympathetic fibres and 
neurotransmission. Bradycardia induced by electrical 
stimulation of the peripheral stump of the cut vagal nerve was 
not inhibited by RR (0.5-2.0 mg/kg, n=4-4).
Evidence against a site of action in the central nervous 
system was also obtained. Stimulation of the preterminal part 
of vagal afferents by veratridine also elicits the Bezold- 
-Jarisch reflex (Paintal, 1973). In contrast to the capsaicin- 
-induced response the vagal reflex evoked by veratridine (8, 
16 p . g / k g  i.v . ) was not abolished by RR  (0.5-2.0 mg/kg, n=4-4).
It is concluded that RR inhibits the effect of 
capsaicin at the level of sensory nerve endings in vivo. Our 
paper is the first report on systemic application and 
effectivness of RR as an antagonist of capsaicin at sensory 
nerve e n d i n g s .
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ACTIVE REPORTING SCHEME: AN EXAMPLE TO EVALUATE SPECIFIC
ADVERSE DRUG REACTIONS
LUIGI-ALBERTO PINI, EMILIO STERNIERI
CLINICAL PHARMACOLOGY DEPT. UNIVERSITY OF MODENA - ITALY 
Key words: post-marketing surveillance, NSAID.
Spontaneous reporting schemes for acquiring information on
suspected Adverse Drug Reactions (ADRs) are generally well
accepted as valuable alerting systems, and have proved to be of
greatest benefit when signalling rare events. The increasing
amount and availability of data depending on computerised
international systems has stressed both the relevance of
"quality" of type of information, so that it is possible to
compare data originating from different countries, and the need
for "denominator" data to evaluate and validate the 'rate' of
estimated risk (Lawson,1988).
Since in Italy about 8% of all prescriptions are NSAIDs, and a 
quarter of all spontaneous reports in England concerns these 
drugs, we started in 1987 in Modena a program of post-marketing 
drug surveillance to evidence type and incidence of ADRs during 
NSAIDs outpatients' treatment.
We selected 12 physicians belonging to the National Health 
Service with care of 15000 patients in Modena. We knew all drug 
prescriptions made by physicians by means of the Health Service 
computerized system and demographic data of patients; moreover 
in a parallel study we evaluated the number of OTC products 
sold in Modena to define the possible relevance of this factor 
in ADRs related to these drugs. All reports were collected by 
the Clinical Pharmacology Dept. and every month doctors would 
meet to discuss the causality of ADRs reports and to verify 
the accuracy of the reporting and the treatment.
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Within 4 months we collected 56 ADRs,33% of them "certainly" 
and 54% "probably" related to NSAIDs use. The quality of 
reports was verified comparing fully-compiled forms. In this 
group we noted 4 cases of oral ulcers and decided to begin a 
cohort study to evaluate the incidence of this unwanted effect 
in our population. During a two-month period we recorded 23 
cases of oral ulcerations: in 10 cases they were associated
with NSAID assumption. The incidence of oral ulcerations was 
0.21% for DDD ; ulcerations were related to Naproxen, 
Ketoprofen, Proglumetacine, Diclofenac and Fenprofen use. In 4 
cases we did a positive rechallenge; the other 6 cases did not 
show any elements which could impute the oral ulceration to 
other causes apart from the drug. The width of the ulcerations 
ranged between 2 and 20 mm, and they were located on cheek 
(80%), gums (20%) and tongue (20%). Clinically the lesions did 
not differ from ulcerations unrelated to NSAID use. In all 
patients drug withdrawal resolved the clinical picture.
The small number of observations does not allow us to eviden- 
tiate differences between NSAIDs, but we can draw some 
conclusions: a) the high compliance of family doctors to this
scheme spurs us to continue in this educational effort to 
improve spontaneous reporting; b) the active reporting scheme 
has shown itself to be able to evoke evidence of uncommon side 
effects; c) oral ulcerations seem to be a frequent, even if 
minor,side effect which should be taken into account in long- 
treatment with NSAIDs.
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NEW DIHYDROPYRIDINE COMPOUND (GYKI-46 544) WITH BRADYCARDIAC 
AND VASODILATORY EFFECTS
G.Rabloczky, L.Jaszlits, I.Bódi, G.Szilágyi, A.Jednákovits,
A.Kovács, E.Horváth, É.Bozó
Institute for Drug Research, Budapest, P.O.Box 82, Hungary
Keywords: Antihypertensive action, lack of tachycardia
Since the early 60's great number of dihydropyridines have 
been investigated and introduced into the therapy of cardio­
vascular diseases. Almost all of them however may elicit ref- 
lexogenic tachycardia at least at the start of the treatment 
and have some negative inotropic effect, as well. Recently 
GYKI-46 544 has been selected for further investigation in 
our laboratory. This compound could produce marked antihyper­
tensive effect in SH-rats, renal hypertensive and DOCA + salt 
hypertensive ones without causing significant tachycardia. 
After single administration (2.5 mg/kg p.o.) it elicited bra­
dycardia and blood pressure decrease in SH-rats.
In the course of a 3-week oral treatment period GYKI-46 544 
produced consistent decrease of both blood pressure and heart 
rate in the SH-rats. This new GYKI-compound was able to exert 
strong vasodilatory or antivasoconstrictory actions in in vivo 
and isolated vessel preparations. Its negative inotropic effect, 
appeared only after 2 or 3 order of magnitude higher concent­
rations above the vasodilatory effective ones. GYKI-46 54 4 had
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fourtimes stronger antianginal effect than that of nifedipine 
measured by the inhibition of vasopressin-induced ST-elevation 
in the EKG of the rats. On the base of its favourable heart 
rate effect and longlasting vasodilatory effect GYKI-46 544 
m a y  compete with some very new dihydropyridine c o m pounds,t o o .
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ELABORATION OF HIGHLY PURIFIED ANGIOHYPOTENSIN PREPARATIONS 
FROM MAMMALIAN LIVER
D. Rácz, I. Miklya, J. Knoll
Department of Pharmacology, Semmelweis University of Medicine, 
Budapest, P.O.B. 370, 1445 Hungary
Keywords: Angiohypotensin, rabbit ear artery, gel chromatogra­
phy
Angiohypotensin (AH), extracted from human serum by the aid 
of gel chromatography on Sephadex G-15 column, was found to in­
hibit neuromuscular transmission in the perfused rabbit ear ar­
tery in a dose-dependent manner, leaving the sensitivity of the 
vascular smooth muscle to endogenous and exogenous noradrenali­
ne unchanged (Knoll, 1978). It was further proved that semi- 
purified human serum angiohypotensin inhibited with high selec­
tivity the release of noradrenaline from the nerve terminals of 
vascular smooth muscle (Knoll, 1979). AH was detected in trace 
amounts in human and mammalian blood, but liver was found to 
contain significantly higher amount of the substance (Knoll, 
1978) .
Highly purified AH preparations from pig and bovine liver 
were prepared. The fractions were assayed on the central por­
tion of the rabbit ear artery. vasoconstriction was elicited 
by field stimulation (100 V) and the resulting increase in 
intravasal pressure was measured with an electromanometer and 
recorded. The content of AH in the preparation that inhibited 
the vasoconstriction of the rabbit ear artery to nerve stimula­
tion was taken to contain 1 unit.
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The flow sheet for the elaboration of highly purified angio- 
hypotensin preparations from pig or bovine liver is shown below:
[ Pig or bovine liver tissue I
n 0.05 M ammonium acetate and 
3000 * g for 30 min )
homogenized
centrifuged
Supernatant filtered through 
Amicon UM-2 membrane
filtrate concentrated and centrifuged 
(20 000 * g for 30 m.n )
Supernatant fractionated on 
Sephadex G-15 column
Í fractions bioassayed, active fractions concentrated
Active fractions chromatographed 
on Bio-Gel P-2 column
I fractions bioassayed, active 
I fractions concentrated
Active fractions chromatographed 
on carboxymefhylcellulose column
fractions bioassayed,active 
I fractions freeze dried
Final product yellowish white powder 
of which 250-A00 ng contains 1 unit of 
angiohypotensm activity
Using this method we succeeded to extract up to 100,000 
units/kg of AH from bovine liver. The most active preparations 
contained 3000-3500 units AH/mg.
References
Knoll, J. Pol. J. Pharmacol. Pharm. 30, 269, 1978.
Knoll, J. in: Modulation in Neurochemical Transmission, ed:
Vizi, E.S., Akadémiai Kiadó, Budapest, pp. 97-125, 1979. 
Knoll, J. in: Cardiovascular Pharmacology187. Results, Concepts 
and Prespectives, ed: Papp, J.Gy., Akadémiai Kiadó, Budapest, pp. 245-252, 1987.
Acta P hys io log ica  Hungarica, Volume' 75, Supplementum, 1990 243
LEU-ENKEPHALIN EFFECTS AT THE MOUSE NEUROMUSCULAR JUNCTION
L. Re, L. Rossini, M. Bernardi, B. Di Sarra, C. Concettoni . V. 
Moretti, I.M.S.C., Laboratory of Pharmacology, University of 
Ancona, via Ranieri 2, 60100 Ancona, Italy.
Key Words : Leu-enkephalin - Acetylcholine Release - Mouse End 
Plate
Opiate peptides have been reported to affect neurosecretion in 
different preparations (Haynes and Smith, 1982; Bixby and 
Spitzer, 19831. In particular, Met-enkephalin reduced the amount 
of acetylcholine (ACh) released (Bixby and Spitzer, 1983! from 
frog muscle by nerve stimulation. This effect suggested that 
enkephalin might interact with presynaptic Ca'T channels reducing 
the quantal content of transmitter release. Furthermore, a 
postsynaptic effect of opiate peptides related to a possible 
inhibition of acetylcholinesterase is also reported (Haynes and 
Smith, 19821. Here we study the effects of leu-enkephalin at the 
mouse neuromuscular junction.
The method used was previously described (Re et al, 1989! and led 
to the acquisition of the most significant parameters related to 
the spontaneous and evoked release of transmitter at the end- 
plate level. Stock solutions of Leu-enkephalin (acetate salt, 
Sigma lot. 84F-5805) dissolved in distilled water were stored at 
-35 °C and diluted immediately before use.
Table I shows the results obtained on five parameters related to 
the ACh release at the mouse diaphragm in the presence of 
different Leu-enkephalin concentrations. Values are expressed as
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Non statistically significant.
This results show that Leu-enkephalin reduces in a significant 
manner only the parameter related with the evoked ACh release. 
Indeed the means of the percent changes from the control values 
induced in all the other parameters are not significant. The 
decrease in the size of the evoked release averages from 13t 
ÍLeu-enkephal in 15 uM; n=5l to 21% (Leu-enkephalin 60 uM; n=4) . 
The results obtained in this preparation do not indicate any 
post-synaptic effect of Leu-enkephalin. Indeed, both the
amplitude and the time constant of the quantal conductance change 
are not modified by Leu—enkephal in treatment. These experimental 
data seem to exlude any interference with the postsynapt ical ly 
located acetylcholinesterase which, if inhibited, would produce 
an increase of the rate of the ACh-receptor complex 
conformational change.
Bixby J.L., Spitzer N.C. Nature 1983; 301. 431.
Haynes L.W. , Smith M.E. Neuroscience 1982: 7, 1007.
Re L, Giusti P, Concettoni C, Di Sarra B. J. Pharmacol.Methods 1989: 22 (4! .
the mean of the fractional percent variations from the control 
values with the respective standard errors of the mean; p values, 
where not indicated, were always less than 0.05 by Student t 
test .
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IN VIVO AND IN VITRO EFFECTS OF CYTOKINES ON THE GENERATION OF NK 
CELL-MEDIATED ANTITUMOR ACTIVITY.
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Key words: Cytokines, Natural k i l le r  c e lls , In te rleuk in -2 .
Natural re a c tiv ity  mediated by Natural K i l le r  (NK) ce lls  is an inborn and 
autonomous function of bone marrow CBM) involved in resistance against 
in fectious agents as well as in the contro l of tumor cell growth and 
dissemination. BM transplants have been used fo r treatments of patien ts 
with systemic or metastatic malignancies. As shown by recent studies of 
autologous BM transplantation, although very high doses of chemotherapy 
and/or le tha l irra d ia tio n  have resulted in complete remission, the major 
problem has been recurrence of tumor a fte r  a short period of tim e. One 
strategy to address th is  problem could be to augment the host's  
immunological e ffec to r mechanisms a fte r the BM transplantation, to  help to 
elim inate small numbers of residual tumor c e lls .  Treatments to acce lle ra te  
reconstitu tion  of NK a c tiv ity  during the post-transplant period might 
help to elim inate metastatic tumor ce lls . We have evaluated the e ffe c ts  of 
various cytokines (CKs), used alone or in  combination, on the in  v it ro  
generation of NK ce lls  from BM precursors and on the in vivo recons titu tion  
of NK ce ll a c t iv ity  and resistance to métastasés from B16 melanoma in 
le th a lly  irrad ia ted  (9 Gy) mice transplanted with syngeneic BM. In th is  
regard, i t  is  of note that NK a c t iv ity  is  usually absent or s trong ly  
depressed a fte r le tha l irra d ia tio n  and BM transplanta tion, re turn ing only
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a fte r  2 weeks. In vivo treatment from day zero trough day 5 a fte r  BM 
transp lanta tion  with the fo llow ing combinations o f interleukin 2 ( IL -2 ) and 
other cytokines: IL-2 + IL-1 + tumor necrosis fa c to r (TNF) or IL-2 + IL— 1 + 
lymphotoxin (LT) induced appreciably greater and more rapid augmentation of 
NK c e ll regeneration than IL -2  alone as evaluated 14 days a fte r  BM 
transp lan t. Generated e ffe c to r ce lls have the characteristics of fresh NK 
c e lls  in  that are asialoGMl+, Thy.l+, CD4 , CD8 and lyse tumor ta rge ts . 
The same treatments induced s ign ifican t augmentation of in vivo resistance 
against pulmonary métastasés in C57BL/6 mice injected with B16 melanoma 
c e lls  (200.000 cells/mouse iv ) .  To analyze the mechanism(s) responsible of 
the above described in  vivo effects we also performed in v itro  experiments 
by cu ltu ring  BM c e lls  w ith IL-2 alone or in  combination with other CKs. Our 
resu lts  show that IL -1 , TNF and LT were able to  augment the IL-2-dependent 
NK c e ll generation as evaluated at the end o f the 7 days culture period. 
A fte r th is  time both cyto tox ic  a c tiv ity  against NK sensitive ta rge ts  and 
number of generated c e lls  were s ig n if ic a n tly  higher in the group o f BM 
c e lls  cultured with IL-2 plus IL-1, TNF or LT as compared to the group with 
IL -2  alone. IL-1, TNF or LT were also able to  augment the mRNA expression 
fo r  the a chain (p55) o f IL-2 receptor ( IL -2 / r )  in BM ce lls , as evaluated 
by the northern b lo t analysis, as well as the number of IL -2 /r  pos itive  
c e lls  in  the cu lture as evaluated by FACS analysis using antibodies against 
the a  chain of the IL -2 /r  (clone AMT13). These data show that treatment 
w ith CKs can stimulate the generation o f NK c e lls  from BM precursors and 
tha t th is  e ffect may be o f value in the contro l o f metastatic disease.
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CHRONIC EXPOSURE TO OPIOID AGONISTS AND ANTAGONISTS AFFECTS PRODYNORPHIN
GENE EXPRESSION
P. Romualdi, G. Lesa and S. Ferri
Dept. Pharmacology, University of Bologna, Irne rio  48, 40126 Bologna, I ta ly  
Pioaynorphin - Gene expression - Chronic opiates - Tolerance
The neurochemical a lte ra tions related to the development of a tolerance to 
the e ffects o f opiates are s t i l l  fa r to be c lea rly  understood.
The neuronal pathways u t i l iz in g  opioid peptides have been proposed as 
candidate fo r an involvement in the modifications induced by chronic 
exposure to opiate drugs (Adler, 1986). Since expression o f several 
neuropeptide genes may change in response to drug-induced a lte ra tions  in 
neuronal function, the aim of our study was to examine the influence of 
chronic treatment with opioid agonists and antagonists on the gene 
expression o f the opioid peptide prodynorphin.
I t  has been shown that a tolerance to antinociceptive and motor e ffec ts  of 
dynorphin A, purported endogenous ligand fo r the < opioid receptor, 
develops a fte r i ts  chronic in tra thecal infusion (Spampinato and Candeletti,
1985); moreover dynorphin A is  s t i l l  e ffec tive  in rats made to le ra n t to 
morphine, whereas i t  is  in e ffe c tive  in rats made to le ra n t to 
ethylketocyclazocine (EKC), a synthetic compound, mainly к -opio id agonist, 
thus supporting the hypothesis of a s p e c if ic ity  of dynorphin A fo r the < - 
opioid receptor (Chavkin, 1982).
Sprague-Dawley rats were treated with morphine, EKC (10 mg/kg, i .p .  twice 
da ily  fo r 7 days) and naloxone (3 pg /p l/h , icv infused via minipumps fo r 7 
days); brains were rapid ly removed, tissue dissected and frozen a t -80°C. 
Total RNAs from hypothalamus and hippocampus were extracted by cesium 
chloride gradient and subjected to Northern analysis. Blots were hybridized 
with a cDNA probe, the BgBa fragment of the genomic DNA complementary to 
the prodynorphin mRNA (k ind ly  provided by Drs. J.Douglass and O .C iv e lli,  
1985), labelled by nick trans la tion  to a spec ific  a c t iv ity  of 7-9 x 10  ^
cpm/ng. Hybridization was performed overnight at +42°C and, a fte r  washing, 
b lo ts were exposed to x-ray f ilm  fo r 7 days.
Under the adopted conditions, the chronic treatment with morphine reduced
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prodynorphin mRNA leve ls  in hippocampus (approximately twofold) and in 
hypothalamus; at the same way the chronic treatment with EKC markedly 
reduced prodynorphin mRNA levels in hippocampus and hypothalamus
(approximately fo u rfo ld ), compared with control ra ts.
On the contrary, a marked increase (twofold) in the levels of prodynorphin 
mRNA was observed in the same tissues a fte r chronic exposure to naloxone. 
Our resu lts indicate tha t prodynorphin gene expression is  affected by 
chronic treatment to both opioid agonists and antagonists, with opposite 
e ffe c ts  on the biosynthesis of the opioid neuronal system. These data are 
in  agreement with those o f other Authors (Uhl, 1988) showing a decrease of 
proenkephalin mRNA, a fte r  chronic morphine in ra t striatum.
In conclusion the hypothesis is  supported tha t chronic exposure to agonists 
and antagonists fo r opio id receptors (premise necessary to the development 
o f a tolerance) induces a lterations in function of neuronal systems 
invo lv ing opioid peptides and th e ir  gene expression.
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D IHYD RO PYRID INE CALCIUM  ANTAGO NISTS P R E V E N T CO CAINE-, B U T  N O T  
AM P H E TA M IN E -, IN D U C E D  DO PAM INE RELEASE A N D  M O TO R ACTIVITY IN RATS.
Z.L. ROSSETTI, L. PANI, A. K U ZM IN ’ , S. CA R B O N I AND G.L. GESSA
"B.B. Brodie" Department of Neuroscience,
University of Cagliari, Italy 
and ’ Pavlov Medical Institute, Leningrad, U.S.S.R.
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Cocaine abuse has grown rapidly during the past several years. Therefore, the 
search for a therapeutical control of cocaine intoxication and abuse is a m ajor public 
health issue. Cocaine is thought to elicit its locom otor and rewarding effects by inhi­
biting dopam ine (DA) reuptake in the central nervous system. By using the brain 
microdialysis technique it has been shown that cocaine increases DA release both in 
the rat striatum and in the nucleus accum bens and that, unlike am phetam ine, 
cocaine releases DA via a calcium -dependent m echanism  (Hurd and Ungerstedt, 
1989; Im perato and Di Chiara, 1988). W e report that dihydropyridine (D H P ), L-type 
calcium channel antagonists, nimodipine, nifedipine and isradipine, prevent both 
cocaine-induced DA output in the striatum, as m easured by microdialysis in awake  
rats, and the locomotor stimulant effects of the drug. Brain dialysis w as perform ed  
as already described (Pani et al., 1990), using cyanoacrylate-methallylsulphonate  
m em branes (220 д т  o.d.) implanted transversely through the caudate (coordinates: 
A, 2.0; V, 6 .0 from bregma) of male, 220-250g Sprague Dawley rats, using a Krebs 
buffer, pH 7.2, as perfusing solution. DA and metabolites were measured by HPLC- 
EC in 50д1/20 min fractions. Cocaine, 15 m g /k g  i.p., increased the DA output in the 
striatum to a maximum of 360%  of baseline, 90  min after treatment. Pretreatm ent
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(12 0  min beforehand) with nimodipine (10 m g /k g  s.c.) markedly reduced (-250% ) 
co ca in e  effect on DA outflow. Isradipine (2.5 m g /k g  s.c.) and nifedipine (10 m g /kg  
s .c .) pre-treatm ent produced similar inhibition of cocaine-stimulated DA release. In 
contrast, DHP calcium antagonists were completely ineffective against am phetam ine- 
ind u ced  (1.5 m g /kg  i,p.) DA release. DHP calcium-antagonists prevented also 
cocaine-induced locomotor stimulation. M otor activity was measured in individual 
motility cages for 3 min periods at different intervals following treatments in different 
g ro up s of rats. Nimodipine and isradipine produced a  dose-related inhibition of the 
m o to r response to cocaine, and completely suppressed cocaine-induced motor 
stim ulation at the doses of 20 m g /kg  and 2 .5  m g /k g , respectively. How ever, these 
drugs failed to antagonize the stimulatory effect of amphetamine. In contrast, three 
n o n -D H P  calcium antagonists, verapamil, diltiazem and flunarizine, had little or no 
effect both on DA release and on locomotor stimulation induced both by cocaine or 
by am phetam ine. These results indicate that calcium influx through the L-type chan­
nel is essential for DA release by cocaine and suggest that DHP calcium antagonists 
m ay be clinically useful in the treatm ent of cocaine abuse.
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CHARACTERIZATION OF OPIOID RECEPTORS INVOLVED IN THE
MODULATION OF NANC NEUROTRANSMISSION IN THE MAMMALIAN HEART
Annalisa Rubino, Laura Mantelli, Sandra Amerini, Fabrizio 
Ledda.
Department of Pharmacology, University of Florence, Viale 
G.B. Morgagni, 65 - Florence - Italy
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Non-adrenergic, non-cholinergic (NANC), capsaicin-sensitive 
neurons are present in the mammalian heart (Saito et al., 
1986a). The antidromic stimulation of these sensory nerves 
produces an excitatory response, mainly due to the release of 
calcitonin gene-related peptide (Saito et al., 1986b). We have 
described a simple method for the selective stimulation of NANC 
cardiac nerves, and have previously demonstrated that opioid 
peptides are able to reduce NANC transmission in isolated 
guinea-pig atria (Mantelli et al., 1989). In this study we have 
attempted to obtain a characterization of the subtype of opioid 
receptors involved in the inhibitory action of opioid peptides. 
Isolated guinea-pig atria, obtained from animals pretreated 
with reserpine 5 mg/Kg, and incubated in the presence of 1 pM 
atropine and 0.3 pM CGP 20712A (a selective beta ^ -blocker), 
were electrically stimulated at 4 Hz. Transmural nerve stimula­
tion ( TNS) was applied during the refractory period by two 
platinum plates parallel to the preparations; the effect of TNS 
mainly consisted of a transient increase in cardiac contracti­
lity, as previously described (Mantelli et al., 1989).
The p agonist [D-Ala2,-N-Me-Phe,Gly5-ol] enkephalin (DAGO), at 
concentrations ranging from 0.01 to 3 pM, dose-dependently 
reduced the cardiac response to TNS; also the mixed é-p agonist
2 5 2
[D-Ala 2, D-Leu 5] enkephalin (DADLE), induced a similar inhibitory 
effect at the same range of concentrations: the IC50 values for 
the two agonists were respectively 0.09 and 0.19 pM. On the 
other hand, the cardiac response to TNS was less affected by 
morphine and dynorphin, at concentrations ranging from 0 . 1  to 
10 pM; the IC 5Q values for the two agonists were 0.4 and 20 
pM respectively. The inhibitory effects of DAGO, DADLE and 
morphine were competitively antagonized by 0 .0 1-0 . 1  pM nalo­
xone. The effect of dynorphin was antagonized by 0.1 pM nalo­
xone but was unaffected by 0.5 pM of the к receptor antagonist 
MR 2266. Finally, the ^-selective agonist [D-Pen2 ,D-Pen5]enke­
phalin (0.01-10 pM) was unable to modify the cardiac response 
to TNS; moreover, a 6 -selective antagonist, ICI 174864 at a 
concentration of 0.3 pM, did not antagonize the inhibitory 
effect of DADLE.
These results confirm that inhibitory prejunctional opioid 
receptors are present on NANC cardiac sensory nerves; moreover 
the activities displayed by the different agonists and antago­
nists of opioid receptors employed in the present study suggest 
that these receptors belong to the px subtype.
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BETA-ENDORPHIN-INDUCED BEHAVIOURAL EFFECTS: ENDORPHIN-CATECHOL- 
AMINES INTERACTIONS
Ranka Samardzic ,Danica Jovanovic-Micic ,Nina Japindzic and D.B.Beleslin
Department of Pharmacology,Medical Faculty,P.O.Box 662,11000 Beograd, 
Yugoslavia
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An interaction of endogenous opioid peptides and catecholamines in the ge­
nesis of some behavioural phenomena has been suggested. For instance, Sti- 
nus et al. (1980) reported that the increase in the locomotor activity evoked 
by infusion of beta-endorphin into the ventral tegmental area depends on the 
integrity of dopaminergic neurones in the n. accumbens of the rat. On the o- 
ther hand, there is little information on the neurochemical mechanisms sub­
serving the symptoms of psychomotor excitation induced by beta-endorphin 
in cats (Beleslin et al., 1982). Therefore, the aim of the present experiments 
was to study the behavioural symptoms evoked by intracerebroventricular (i. 
c.v. ) administration of beta-endorphin in cats with destroyed catecholamin- 
ergic neurones by 6-hydroxydopamine (6-OHDA).
In an aseptic operation under pentobarbital sodium (35-40 mg/kg,i.p. ) 
anaesthesia, an infusion cannula was implanted into the left lateral cerebral 
ventricle of cats of either sex (2-3.5 kg), so that i.c.v. injections of drugs 
could later be made without anaesthesia. On the day of testing, animals were 
acclimated to the test environment for 1 hour before the injection of drugs.
The solutions of drugs were injected i.c.v. manually from a 1 ml syringe, in 
a volume of 0.1 or 0.2 ml, and washed with 0.1 ml of saline under the same 
conditions as the drugs. The behaviour of cats was observed continuously for 
4 hours and intermittently for 24 hours. In order to avoid tolerance, each 
cats was used only once for these experiments.
Beta-endorphin (0.03 - 0.04 mg) injected i.c.v. in unanaesthetized cats, 
(n=16) induced dose-related and longlasting (up to 4 hours) psychomotor ex­
citation (restlessness, apprehension, vacant staring, stereotyped movements 
of the head, impelling locomotion) accompanied with autonomic (mydriasis) 
and motor (tremor) phenomena. The most prominent symptoms were im­
pelling locomotion, stereotyped movements of the head, mydriasis and tre­
mor. In cats treated with i.c.v. beta-endorphin in a dose of 0.05 mg, im­
pelling locomotion, stereotyped movements of the head and tremor appeared 
in 100 %, whereas mydriasis was observed in 50 % of these animals. The du­
ration of these symptoms after a single i.c.v. injection of beta-endorphin 
(0.05 mg) in cats (n=4) is shown in the Table 1.
Another group of cats (n=7) was treated with i.c.v. 6-OHDA twice at 24 h 
intervals. Ten days after the last dose of 6-OHDA, these animals received 
beta-endorphin i.c.v. in a dose of 0.05 mg. The behavioural effects of beta- 
-endorphin in 6-OHDA-treated cats were depressed or completely abolished, 
as shown on the Table 1.
Beta-endorphin, injected i.c.v., induces longlasting and dose-related psy­
chomotor excitation. These behavioural effects are mediated via opioid rece­
ptors, since they can be blocked with opiate antagonists (Stinus et al., 1980;
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Table 1.
Behavioural effect of beta-endorphin in 6-OHDA-treated cats
symptom betaendorphin
6-OHDA
beta-endorphin
statistical
significance
NaCl 0.9% 
0.2 ml
minutes minutes t-test minutes
locomotion 65.0 +13.9 14.0 + 6.5 p C 0.01 0
stereotyped move­
ment of head 111.2 + 3.4 0 p < 0.001 0
mydriasis 66.2 +39.3 4.2 + 3.9 p > 0.05 0
tremor 152.5 +35.3 44.5 +15.2 p <  0.05 0
Beleslin et al., 1982). In the present experiments, the behavioural effects of 
beta-endorphin in cats (locomotor activity, stereotyped movements of the 
head and tremor ) have also been significantly reduced or completely abolished 
in cats pretreated with 6-OHDA. Similarly, in rats, 6-OHDA inhibited the lo­
comotor activity induced by intracerebral administration of beta- endorphin 
(Stinus et al., 1980). These findings suggest that intact catecholaminergic ne­
urones are necessary for the expression of the behavioural effects of beta- 
endorphin. There is solid evidence that dopamine, but not noradrenaline,plays 
a major role in the locomotor activation and stereotyped behaviour, whereas 
5-hydroxytryptamine may act as a modulator (Korsgaard et al., 1985; Samar- 
dzic et al. , 1988). Moreover, opioid receptors have been found upon the do­
paminergic nerve terminals (Hökfelt et al., 1980). Our results support the 
view that beta -endorphin induces, at least some of the behavioural effects by 
activating dopaminergic mechanisms in the brain. The finding that 6-OHDA 
completely prevents the appearance of the stereotyped movements of the head, 
whereas the locomotor activity and tremor are only reduced, and mydriasis 
remains unaffected, suggests that besides dopamine, other neurotransmitters 
may also be involved in the appearance of the behavioural phenomena evoked 
by beta-endorphin in cats.
This work has been supported by a grant from the Serbian Republic Fund, Beo­
grad, Yugoslavia.
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EFFECTS OF NEUROHYPOPHYSEAL HORMONES ON COCAINE-INDUCED
BEHAVIORAL SENSITISATION
Z. S a rn y a i, G. S^abó, M. K r iv á n , G.L. Kovács and G. Telegdy 
I n s t i t u t e  o f P a th o p h ys io lo g y , A. S zen t-G yö rgy i  M edica l U n i­
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p re ss in  
In t r o d u c t io n
S ubchron ic  a d m in is t ra t io n  o f coca ine  induces s e n s i t is a t io n  
to  the  locom oto r response o f a c h a lle n g e  dose o f the  d rug upon 
c e s s a tio n  o f tre a tm e n t (P o s t e t a l .  1981). The b io lo g ic a l  b a s is  
o f the  s e n s it is a t io n  to  co ca ine  is  an a d a p tive  change in  the  
dopam ine rg ic  n e u ro tra n s m is s io n  w ith in  the c e n tra l nervous s y s ­
tem (D ack is  and Gold 1985). E a r l ie r  data suggest th a t  the  
neurohypophysea l hormones o x y to c in  (OXT) and a rg in in e -v a s o ­
p re s s in  (AVP) p lay  an im p o r ta n t re g u la to ry  ro le  in  the adap­
t iv e  processes induced by n a rc o t ic  drugs v ia  the  dopam ine rg ic  
mechanisms (Kovács and Telegdy 1987). The aim o f the  p re s e n t 
expe rim en t was to  s tudy  the  e f fe c ts  o f OXT and AVP on th e  de­
ve lopm ent o f c o ca in e -in d u ce d  b e h a v io ra l s e n s i t is a t io n  in  m ice . 
Methods
Male a lb in o  CFLP mice w e igh ing  20-30 g were used. Locomo­
to r  a c t i v i t y  was measured by o p e n - f ie ld  methods. Mice were 
t re a te d  s u b c h ro n ic a lly  w ith  e i th e r  s a lin e  or coca ine  (7 .5  
mg/kg s . c . )  tw ice  a day fo r  5 days. The an im a ls were te s te d  
fo r  locom o to r a c t i v i t y  w ith  a ch a lle n g e  dose o f coca ine  7 .5  
mg/kg s . c . )  3 days a f t e r  c e s s a tio n  o f the  su b ch ro n ic  t re a tm e n t.
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QXT and AVP were a d m in is te re d  1 hour p r io r  to  coca ine  o r sa­
l i n e  in je c t io n s ,  e xce p t on the te s t  day. The data were sub­
je c te d  to  a n a ly s is  o f va r ia n ce  and p o s t hoc D unnett te s ts .  
R e s u lts  and D is c u s s io n
T a b le  1. E f fe c ts  o f neurohypophysea l hormones on b e h a v io ra l 
s e n s i t is a t io n  to  cocaine
TREATMENT No . o f anim als LOCOMOTOR ACTIVITY SIGN
S a l + Sal 4 2 1 5 9 . 0 + 1 0 . 9
Sal+Coc 4 8 2 1 8 . 4 + 1 1 . 4 +
0 . 0 0 5 -  u  g OXT+Coc 1 0 2 3 2 . 4 + 3 3 . 8 NS
0 . 0 5  u g OXT + Coc 2 0 2 3 6  . 1 + 1 4 . 8 NS
0 . 5  u g OXT+Coc 1 1 2 9 0 . 4 + 4 0 . 4 + +
0 . 0 0 5  u g AVP+Coc 17 1 3 8 . 3 + 1 6 . 8 + +
0 . 0 5  u g AVP+Coc 1 6 1 6 0  . 8 + 1 8 . 8 + +
0 . 5  p g AVP+Coc 1 6 1 5 2 . 6 + 1 9 . 3 + +
The locom oto r a c t i v i t y  is  the  e f f e c t  o f the  c h a lle n g e  dose 
o f coca ine  on mice t r e a te d  s u b c h ro n ic a lly  w ith  coca ine  or sa­
l i n e  and p re tre a te d  w ith  DXT and AVP, t h is  e f f e c t  be ing ex­
p ressed  as a p e rcen tag e  o f the basa l a c t i v i t y  le v e l o f na ive  
m ice . +: P< 0.05 vs . S a l+ S a l; ++: p< 0 .05  vs . Sal+Coc
N e ith e r  OXT nor AVP tre a tm e n t a lone in te r fe r e d  w ith  the e f ­
f e c t  o f the c h a lle n g e  dose o f coca ine  (d a ta  no t shown). The 
d a ta  (T ab le  1) in d ic a te d  th a t  co c a in e -in d u c e d  s e n s i t is a t io n  
was p o te n t ia te d  by th e  h ig h e s t dose o f OXT. In  c o n t ra s t ,  a l l  
doses o f AVP used in h ib i t e d  the deve lopm ent o f c o c a in e - in ­
duced b e h a v io ra l s e n s i t is a t io n .  The r e s u l t s  suggest th a t  
th e  b e h a v io ra l s e n s i t is a t io n  induced by coca ine  can be mo­
d u la te d  in  the o p p o s ite  d ir e c t io n  by neurohypophysea l h o r­
mones.
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INOTROPIC RESPONSE OF "STUNNED" MYOCARDIUM INDUCED BY DOPAMINE IN DOGS 
T. Seres, G. Fehérx, ЕЛ . Takácsx ,
I l l r d  In te rna l Med., Debrecen Medical School, xDept. of Pharmacology, 
BIOGAL Pharmaceutical Works, Hungary
Key words: inotropic response, stunned myocardium, dopamine, dog
Transient coronary occlusion (15 minutes) does not resu lt in  
irre ve rs ib le  myocardial in ju ry  but is  associated with a depression of 
co n tra c tile  function sustained fo r several hours to days ("stunned 
myocardium"). The defect in  the con trac tile  process responsible fo r th is  
phenomenon has been suggested to be causally releated to a reduced 
energetic state, altered exc ita tion  or excita tion-contraction coupling, 
or damaged con tractile  filam ents (Mercier et a l . ,  1982; E ll is  et a l . ,  
1904; Heusch et a l. ,  1900).
The purpose of our study was to evaluate the con trac tile  reserve of 
postischemic myocardium early a fte r reperfusion in  open chest dogs. 
Global and segmental co n tra c tile  function was measured as pos itive  
LVdP/dtmax and con trac tile  force (CF), respectively using s tra in  gauges 
in  the basal (nonischemic) and apical (ischemic) region of the le f t  
ve n tr ic le . We compared ino trop ic  responses 15 minutes before and 20,40 
and 60 minutes a fte r ischemic in su lt (15 minutes LAO lig a t io n ) .  
Ino trop ic response was induced by 50 jjg/kg dopamine intravenously.
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TABLE I
Ino trop ic  responses induced by dopamine
Parameters of Preischemia 
c o n tra c t il i ty 20 min.
Postischemia 
40 min. 60 min.
+dP/dt:
CF: (base) 
CF: (apex)
166.3+7.2 171.3+24.8 166.0+62.0 142.8+58.7 
52.0+21.9 57.7+29.0 51.7+20.3 55.0+11.7 
100.3+41.0 95.2+28.9 89.8+34.3 105.3+45.9
Comment: n :6 , mean+SD, values are % of change (max. increase of 
c o n tra c t ility )
There was no s ig n if ic a n t difference between ino trop ic  responses before 
and a fte r transient ischemic insu lt, although CF of the postischemic 
segment was s ig n if ic a n tly  depressed, about 50% of preischemic value. 
Dopamine could tra n s ie n tly  improve segmental co n tra c tile  function and i t  
seems that e ffic iency  increases with the duration of reperfusion. These 
find ings imply that the "stunned" myocardium can generate ATP and 
suggest that postischemic dysfunction in  humans may be e ffe c tive ly  
reversed by ino trop ic therapy.
References:
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BIOCHEMICAL BACKGROUND OF CIMETIOINE-INÜUCED GASTRIC MUCOSAL PREVENTION
IN RATS TREA1EO WITH HCL
(ACTIONS OF CYTOPROTECTIVE AND ANTISECREIÜRY OOSES).
G.Sütő,M.Garamszegi,T.Jávor,L.Nagy,A.Németh & Á.Vincze 
F irs t  Department o f Medicine,Medical U n ive rs ity  o f Pécs,H-7643 Pécs,Hungary
Key-words:cimetidine, gas tric  mucosal b iochem istry,SOD,energy systems;
The H2-blocking compounds are able to prevent the development o f g a s tr ic  
mucosal damage by th e ir  antisecretory and cytoprotective properties. The 
phenomenon of "gas tric  cytoprotection" d if fe r s  from the in h ib it io n  o f gas tric  
acid secretion (Robert et a l . , 1979). The dose o f 2.5 mg/kg was found to be 
cytoprotective agent in  case of Cimetidine (Moron et a l . , 1983).
The aim of th is  study was to compare the changes in the g a s tr ic  mucosal 
biochemical parameters produced by cy topro tective  and antisecretory doses 
of c im etid ine.
The observations were carried out in  Sprague-Dawley (LATI,Gödöllő, 
Hungary)-strain ra ts ,weighing 180-210g.The g a s tr ic  mucosal lesions were 
produced by the in tra g a s tr ic  adm inistration o f 0.6 M HC1 ( 1 ml ) ,  and the 
animals were sacrificed  at 1 hour a fte r adm in istra tion of 0.6 M HC1. 
Cimetidine (used in  cytoprotective and an tisecre to ry doses) was given ip . 
at 30 min before adm inistration of necro tiz ing  agent. After s a c r if ic e  of 
animals the number and severity of g as tric  mucosal lesions was noted. 
D iffe re n t biochemical compounds such as ATP,ADP,AMP enzymatically,cAMP by 
RIA were measured, from the to ta l homogenate o f gastric mucosa. From the 
same homogenate, the superoxide dismutase a c t iv i ty  was measured (Misra 
& Fridovich,1972).
I t  has been found tha t: 1 .Cimetidine dose-dependently prevented the 
development of 0.6 M HCl-induced gastric  mucosal damage; 2 .The extent of 
ATP-ADP transformation was increased by c im etid ine adm inistration, while 
the transformations of ATP-cAMP and cAMP-AMP decreased in that tim e; 3.The 
SOD a c t iv ity  returned back to i t s  normal value by administration of
cim etid ine.
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C Y T O P R O T E C T IV E  A N D  A N T IS E C R E T O R Y  DO SES OF 
C IM E T ID IN E - IN D U C E D  B IO C H E M IC A L  C H A N G E S  IN  T H E  
0 .6  M H C l- IN D U C E D  G A S T R IC  M U C O S A  IN R A T S ( m e a n s i  
S E M  )( n  =10)
* -----X mucosal AOP
F ig . 1 .Cimetidine-induced biochemical changes in  the ra t gastric mucosa. 
The re su lts  were expressed as means +_ SEM.Abbreviations: T ,sa line-trea ted  
groups (normal con tro l animals); NS,not s ig n if ic a n t;+ , P <  0,05;++,
P < 0 .0 1  and +++, P <  0.001.Cimetidine was given in  cytoprotective ( 2.5 
mg/kg ip . )  and an tisecre to ry ( 50 mg/kg ip . )  doses at 30 min before admi­
n is tra t io n  of 0.6 M HCl.
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EFFECT OF CH-103, A BETA ADRENERGIC RECEPTOR ANTAGONIST ON THE ACTIVITY 
OF Ca2+,Mg2+-ATPase IN RAT CARDIAC SARCOLEMMA
3. Szabó, К. Nosztray, E. Varga and 3. Szegi. Department of Pharmacology, 
Medical University of Debrecen, H-4012 Debrecen, Hungary 
Key words: sarcolemmal Ca2+,Mg2+-ATPase, beta adrenergic antagonists,
membrane perturbation
CH-103 (4-cyclohexylam ino/-l-/l-naphtolenyloxy/-2-butanol maleate), a newly 
developed beta antagonist with qu in id in e -like  membrane s ta b iliz in g  property 
has produced a marked in h ib ito ry  e ffe c t on sarcolemmal Na+,K+-ATPase in  ra t 
myocardium (SZABÚ et a l. ,  1988). Because th is  in h ib itio n  presumably is  not 
the only manifestation of membrane perturbation caused by th is  compound, the 
e ffe c t on Ca2+,Mg2+-ATPase a c t iv ity  was also studied in comparison with 
propranolol and p racto lo l.
Pooled ra t heart ventric les were homogenizated in  10 volumes of 20 mM T ris - 
HC1 containing 1 mM ethylene-diamine-N,N,N’ N’ -te traace tic  acid and 0.1 mM 
phenylmethanesulfonyl fluo ride  (pH 7 .0 ). Iso la tion  of cardiac ve n tr icu la r
sarcolemma was performed at 4°C as described 
(VELEMA and ZAAGSMA, 1981). Protein was deter­
mined by the method of LOWRY et a l. (1951). The 
sarcolemmal ATPase a c t iv ity  was determined at 
37°C according to RUDINGER et a l.  (1984) by 
measuring the inorganic phosphate produced 
during the ATPase reaction by the method of 
TAUSSKY and SH0RR (1953). To characterize the 
physicochemical property of CH-103 and other 
beta adrenergic antagonists the octanol :water 
p a r t it io n  co e ffic ie n t was measured.
Sarcolemmal Ca2+,Mg2+-ATPase a c t iv ity  was s ig -
ъ
0 20 40
F ig . l .  E ffect of 
exogenous calmodulin on 
sarcolemmal Caz -ATPase 
(ord inate: ATPase a c ti­
v ity  in  percent of cont- 
ro l-lS E ; abscisse: ng
calmodulin/ug membrane 
pro te in)
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Table I . Effect of beta antagonists on Ca^+,Mg^+-ATPase in ra t cardiac 
sarcolemma
Each value is  a mean-SE. xs ig n ifica n tly  d if fe re n t from control (p <  0.05), 
* in  the presence of 40 ng calmodulin/ug membrane protein
n if ic a n t ly  stimulated by exogenous calmodulin ( F ig . l ) .  CH-103 and proprano­
lo l  have d ra s tica lly  decreased the basic and to ta l Ca^+,Mg^+-ATPase a c t iv i-  
?+
t ie s ;  the C a -s tim u la te d  portion, however -  remained nearly unchanged. At 
the same time p rac to lo l has increased both basic and to ta l ATPases (Table I ) .  
The octanol:water p a r t it io n  coeffic ien ts were as fo llow : propranolol: 26.03,
CH-103: 65.09, p ra c to lo l: 0.0107.
Conclusion: CH-103, -  s im ila r ly  to other membrane active beta blockers, e.g. 
propranolol, -  possesses some specific membrane a c t iv ity  which may be re la t­
ed to the physicochemical nature of the drug.
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EFFECTS OF INHIBITION OF CARDIAC POTASSIUM AND CALCIUM CHANNELS 
ON THE DIGOXIN-INDUCED CARDIOTONIC ARRHYTHMOGENIC AND TOXIC ACTIONS 
J. Szegi, Á. Cseppentő and A.J. Szentmiklósi. Department of Pharmacology, 
Medical University of Debrecen, H-4012 Debrecen, Hungary 
Key words: digoxin, 4-aminopyridine, verapamil, cardiotonic action, v e n tr i­
cular arrhythmias
Although d ig ita l is  has a benefical action in  treatment of congestive heart 
fa ilu re , i t s  arrhythmogenic action causes many problems fo r c lin ic ia n s . 
In the present experiments the influence of in h ib ito rs  of cardiac potassium 
channels (4-aminopyridine: 4-AP) and of slow calcium channels (verapamil) 
was investigated on the digoxin-induced ve n tricu la r arrhythmias (in fu s io n  
rate of digoxin: 17 ug/kg/min) and to x ic ity  in  anaesthetized (1.5 g/kg ure­
thane i . p . )  guinea pigs. In v itro  experiments were made to analyse the po­
s it iv e  ino trop ic  action in  isolated e le c tr ic a lly  stimulated (3 Hz, 1 ms 
voltage twice of threshold) le f t  a t r ia l myocardium of guinea pigs.
Table 1: E ffe c ts  o f 4 -a m in o p y rid in c  and ve rapam il on the d igo x in -in d uce d  
v e n t r ic u la r  a rrh y tlim ia s  (A ) and c a rd io to n ic  a c tio n  (B)
A Dose o f d ig o x in  (u g /k g )  in du c in g
V e n tr ic u la r V e n tr ic u la r V e n tr ic u la r E le c tr ic
1reatm ent e x tra s y s to le tach yca rd ia
f i b r i l l a t i o n s ta n d s ti 11
in a na es th e tize d  gu inea  p ig s
C o n tro l
(n=6)
430-46.4 676-73.3 790-95.6 018-19.9
4-AP (n=6) 317-24.7 390-29.2 430 -33 .9 517-40.1
(4  mg/kg) n .s . p <  0 .05 p <  0.01 p <  0.01
Verapam il 
(1 mg/kg) 
(n=6)
500-106.1
n .s .
713-85.1
n .s .
1063-51.5  
p <  0 .05
1042-56.9 
p <  0.05
В Increase  in  c o n t r a c t i le  fo rc e o f a t r i a l  myocardium
in  the  absence in  the  presence
Treatment
o f 0 .3  umol/1 d ig o x in
4-AP (n=5) 
(40 um o l/1)
2 .1 -0 .2 7 mN 4 .5 -0 ,.68 mN o.oi
Verapam il 
( 1 um o l/1) 3 .4 -0 .5 1 mN 1 .3 -0 .25 mN <  0.01
(n=5)
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In in  vivo experiments on guinea pigs, both the dose requiring the p re c ip i­
ta t io n  of d iffe re n t ve n tr icu la r arrhythmias and the le tha l dose of digoxin 
decreased a fte r addition o f 4 mg/kg 4-AP (Table 1, Part A). In the case of
verapamil (1 mg/kg) the reverse was true (Table 1, Part A).
Digoxin (0.3 umol/1) increased the co n tra c tile  tension of myocardium by
53.6^4.46% (n=10). In the presence of 40 umol/1 4-AP the cardiotonic action
increased by 114%, whereas a fte r addition of 1 umol/1 verapamil th is  e ffe c t 
reduced by 62% (Table 1, Part B).
The find ings obtained w ith verapamil are in  good corre la tion  with the c l in i ­
cal observations, namel1', d ig ita l is  to x ic ity  may be precipitated by elevated 
calcium levels (GUBNER and KALLMANN, 1957) i t  could be reduced by using 
che la ting  agents.
□n the other part, i t  is  w e ll known that cardiac manifestations of to x ic ity  
occur when in tra c e llu la r  potassium concentration is  reduced (LOWN and LEVI­
NE, 1958). Paradoxycally, in h ib it io n  of potassium channels by 4-AP did not 
prevent, even enhance, the to x ic  reactions of d igoxin. I t  is  supposed that 
voltage-dependent opening o f slow calcium channels in  the presence of 4-AP 
could increase the in flu x  o f calcium to the in tra c e llu la r  space, therefore 
synergetic in teraction  of calcium and d ig ita l is  might be manifested. In 
a dd ition , an ind irec t action mediated by releasing various transm itters 
from nerve va ricos itie s  could also be proposed.
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CONCENTRATION-DEPENDENT ACTION OF 4-AMINOPYRIDINE ON THE ADENOSINE-INDOCED 
SINOS SLOWING AND VASORELAXATION
A.J. Szentmiklósi, Á. Cseppentő, A. Gajdos, 3. Szegi, V. Kékesi* and A.
ЖJuhász-Nagy . Department of Pharmacology, Medical Oniversity of Debrecen, 
Debrecen and C lin ic  of Cardiovascular Surgery, Semmelweis University Medical
School, Budapest , Hungary
Key words: adenosine, 4-aminopyridine, pulmonary artery, sinus node 
The c e llu la r  action of adenosine has been generally thought to be connected 
with the m odification of transmembrane Ca^+ and K+ fluxes. 4-aminopyridine 
(4-AP), a K+ channel blocker, has been recently shown to have a dose-depend­
ent biphasic action on the adenosine-induced coronary vasodilatation in 
anaesthetized dogs (KÉKESI et a l. ,  1985; JUHÁSZ-NAGY et a l . ,  1989). In the 
present experiments the action of d iffe re n t concentrations of 4-AP was stud­
ied on the suppressing e ffec t of adenosine in  the s in u -a tr ia l node (tissue 
containing A1 adenosine receptors) and vascular smooth muscle ( tissue con­
ta in ing A2 adenosine receptors). In spontaneously beating r ig h t a tr ia  of 
guinea pigs (technique: ex trace llu la r recording by b ipolar platinum elec­
trodes from the nodal area), adenosine (1-300 pmol/1) exerted sinus slowing, 
which was s ig n if ic a n tly  potentiated in  the presence of low concentration 
(2 pmol/1) of 4-AP (Fig 1A). Higher concentrations of 4-AP (1-10 mmol/1), 
however, antagonized the adenosine-induced reduction in  the s in u -a tr ia l 
pacemaker a c t iv ity  (Fig 1A).
S im ilar findings have been obtained from experiments on isolated pulmonary 
a r te r ia l s tr ip s  of rabbits (technique: vessels precontracted with 0.3 jjmol/1 
noradrenaline; recording by isometric mechano-electric transducer). The re­
laxing e ffec t of adenosine was enhanced in  the presence of 2 pmol/1 4-AP, 
but i t  was antagonized by exposure to 50 pmol/1 4-AP (Fig IB and 1C).
These results are in  accord with previous find ings in  anaesthetized dogs
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F ig . l :  Modification of the adenosine-induced suppression in s in u -a tr ia l
pacemaker a c tiv ity  in  the presence of 2 pmol/1  (o-----o), 1 mmol/1
( • -----•)  and 10 mmol/1 (o------ o) 4-aminopyridine (Fig. 1 A ; • ------■ :
before exposure to 4-aminopyridine). E ffect of 4-aminopyridine on 
the a rte r ia l vasorelaxation e lic ite d  by adenosine (Fig. IB and 1C). 
Vasorelaxation (% Relaxation) is  expressed as percent of re laxing 
action of 100 pmol/1  papaverine in  vessels precontracted by 0.3 
jumol/1 noradrenaline. Results are expressed as means-S.E.M.
(KÉKESI e t a l. ,  1985; 0UHÁSZ-NAGY et a l. ,  1989), in  isolated dog coronary 
a r te r ie s  (ŰUHÁSZ-NAGY et a l . ,  1989) and in  iso la ted, e le c tr ic a lly  paced 
a t r ia l  myocardium of guinea pigs (SZENTMIKLÓSI et a l . ,  1983). I t  is  sup­
posed th a t 4-AP low concentrations might in h ib it  the adenosine tu rn o ve r(i.e . 
d ipyridam ole-like  action: in h ib it io n  of c e llu la r  adenosine uptake or co fo r- 
m yc in -like  e ffect: in h ib it io n  of in tra c e llu la r ly  localized enzyme adenosine 
deaminase). The antagonistic e ffe c t of 4-AP could probably be due to i t s  
K+ channel blocking property.
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EFFECT OF CAPSAICIN, RESINIFERATOXIN AND PIFER IN E ON 
ETHANOL-INDUCED GASTRIC ULCER OF THE RAT
János Szolcsànyi
Department of Pharmacology, University Medical School of Pécs 
H-7643 Pécs, Szigeti ùt 12.
Key words: capsaicin; piperine, resiniferatoxin, gastric ulcer 
Introduction
Impaired defense mechanism to experimental ulcer formation 
after systemic pretreatment of rats with high, desensitizing 
doses of capsaicin has been demonstrated (Szolcsànyi, Barthô 
1981). On the other hand intragastric capsaicin in lower dose 
range elicited local mucosal protection (Szolcsànyi, Barthô, 
1981, Holser, Lippe 1988, Holzer et a l . 1989). These effects 
are not due to cytoprotection or direct mucosal action 
(Szolcsànyi, Môzsik 1984, Holzer et al. 1989). A hypothesis 
has been put forward (Szolcsànyi, Barthô 1981), that capsaicin 
enhances mucosal microcirculation by releasing vasodilator 
mediators from local sensory receptors. This protective 
mechanism operates also in untreated animals and an impaired 
defense ensues when the nerve endings are blocked in capsaicin 
desensitized rats. In the light of these considerations other 
stimulants of capsaicin-sensitive receptors could also protect 
against experimental gastric ulcer. Furthermore, gastric 
application of capsaicin in desensitizing concentrations 
should aggravate ulcer formation. In the present paper 
piperine (PIP),the pungent ingredient of black pepper and 
resiniferatoxin (RTX), an ultrapotent capsaicin type agent 
(Szállási et al. 1989) were used besides capsaicin (CAP) in 
the ethanol-induced ulcer model.
Methods
Female Wistar rats (250-310g) deprived of food for 24 h 
before the experiment, received through a stomach tube 50% 
ethanol in water v/v in 3 ml/kg volume for gastric ulcer 
production. The rats were killed 1 h later, and the number and 
area of mucosal lesions were determined under an operating 
microscope. Mann-Whitney U-test and X2 statistics were used.
2 6 8
287-291 (1984).
Results and discussion
The experiments with different pungent agents support our 
hypothesis outlined above. Table 1 shows that 1 h after 
intragastric application the incidence of lesions is 
significantly decreased when piperine, and low concentration 
of capsaicin or RTX were used. Piperine is a weak local 
stimulant and desensitizing agent (Szolcsànyi, Barthô 1981). 
Desensitisation with high local concentrations of capsaicin 
aggravated the ulcer formation 24 h after the treatment.
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INHIBITION OF LIPID PEROXIDATION BY MONOAMINE OXIDASE ENZYME INHIBITORS 
Éva Szökő, Gábor Báthory and Kálmán Magyar
Department of Pharmacodynamics, Semmelweis Oniversity of Medicine,Budapest, 
Hungary
Key words: l ip id  peroxidation, MAO in h ib ito rs
The peroxidation of unsaturated l ip id  components of biomembranes is  a 
degradative free rad ica l process. I t  has been considered to be involved in 
basic deteriorative mechanisms which are responsible fo r various pathologi­
cal and tox ico log ica l states. Free radicals can be produced by enzymatic as 
w e ll as non-enzymatic reactions in the organism. Monoamine oxidase enzyme 
(MAO) is  also capable to generate hydrogen peroxide, one of the reactive 
oxygen species th a t may be invo lved in  the in i t ia t io n  of l ip id  peroxi­
dation.
We stud ied the e ffec t of two irreve rs ib le  MAO in h ib ito rs  in  v it ro  on l ip id  
pe rox ida tion  in ra t brain homogenate. The two compounds were 1-deprenyl, a 
s e le c tiv e  in h ib ito r  of MAO type В and 3-512 (/1 ,2 ,3 ,4-te trahydro-a lpha- 
naphthyl/-methyl-propargylam ine), a поп-se lective  in h ib ito r of MAO enzyme. 
L ip id  peroxidation was induced by NADPH or ascorbic acid in the presence of 
ADP and FeC^. T h iobarb itu ric  acid (TBA) test was performed by the method 
o f Buege and Aust (1978). In both systems 1-deprenyl and 3-512 in h ib ite d  
l ip id  peroxidation in  a concentration-dependent manner as shown in  Figure 1. 
The concentrations of 1-deprenyl producing 50% in h ib itio n  were 680 yumol/1 
(inducer: NADPH) and 310 ^imol/1 (inducer: ascorbic acid) and those of 3-512 
were 120 /jmol/1 and 160 ^umol/1, re s p e c tiv e ly . Both in the abscence and 
presence of the in h ib ito rs  the formation of TBA-reactive products was time- 
-dependent: over an experimental period of 90 min the amounts of these me­
tabo lites  were continuously increased with time; nevertheless th e ir  produc-
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t io n  remained suppressed (as compared with con tro l) by 1-deprenyl or J-512 
throughout the experiment. Ihe inh ib ito ry  e ffe c t was tested in the concen­
t r a t io n  range of 0.5-1 mmol/1 for the former and 0.05-0.5 mmol/1 fo r the 
la t te r  substance.
100-1
5 0 -
4 3
l - d e p r e n y l  ( - l o g  m o l / l ) J - 5 1 2  ( - l o g  m o l / l )
Figure 1 Effect of l-deprenyl А/ and J-512 В/ on NADPH (—A - 4 and ascorbic 
acid (—• —) stim ulated lip id  peroxidation in ra t brain homogenate. 
TBA-reactive products were tes ted  a f te r  45 minutes incubation. 
Results are presented as percent of con tro l. Each point represents 
the mean of three determinations.
The regional d is tr ib u tio n  of TBA-reactive products was also estimated a fte r 
a four-week l-d e p re n y l treatm ent of ra ts  (d a i ly  dose: 0.25 mg/kg s .c .)  
S ig n ifica n t changes were observed in two of seven brain areas. The leve l of 
l i p i d  peroxides was decreased in  striatum, whereas i t  was elevated in  the 
white matter.
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ROLE OF BIOCHEMICAL CHANGES IN THE DEVELOPMENT OF EARLY ISCHEMIC AND 
REPERFUSION ARRHYTHMIAS
E .I. Takács, T. Seres* and G. Fehér
Dept, of Pharmacology, BIOGAL Pharmaceutical Works, xI I I r d  In te rna l 
Med., Debrecen Medical School, Hungary
Key words: ischemia,reperfusion,arrhythmias,prostaglandins
One of the most serious consequences of the in te rrup tion  of blood flow
to the myocardium is  the development of ven tricu la r arrhythmias.
Ventricu lar ectopic a c tiv ity  appears w ith in  minutes of the onset of
myocardial ischemia in  experimental animals and probably also in  the
c lin ic a l s itua tion  of an acute coronary attack (Parratt and Coker,
1985). There seems to be a close re la tionsh ip  between the development of
these arrhythmias and the biochemical consequences of ischemia (Coker
and P arra tt, 1984). The purpose of our work is  to study th is  problem.
In our previous experiments 15 min occlusion and 60 min reperfusion
were induced by liga tu re  of the le f t  an te rio r descending coronary a rte ry
(LAD) in anesthetized open-chest dogs. The in ju ry  of the myocardium was
investigated by measuring the hemodynamic, global and segmental function
and electrophysio logical parameters of the heart (Takács et a l . ,  1988).
In the present study we determined thromboxane (TXB2 ) and
prostacycline (6-keto PGF^) release and free-rad ica l production (MDA)
of the heart during the occlusion and reperfusion period.
The normal TxB0/ 6-keto PGF, ra tio  (n=6 mean * SE): 0.69+0.13 increased 
Z ic<
to 2.0±0.7 during occlusion when ectopic a c tiv ity  was high or 
ven tricu la r f ib r i l la t io n  occured.
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We found that treatment with an in h ib ito r  of thromboxane synthesis and 
several scavenger drugs exerted a protective e ffe c t against ven tricu la r 
ectopic a c tiv ity .
We suppose that the increase in the ra t io  o f thromboxane/prostacycline 
and in  the production of free radicals, in  addition to other biochemical 
fac to rs , play an important role in  the development of the arrhythmias 
resu lting  from both myocardial ischemia and subsequent reperfusion.
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ANTI - AMNESIC EFFECT OF A THIAZOLIDINE COMPOUND, GYKI - 20 238
M. TAPFER, J. BORSY, B. VITÁLIS, E. BAGDY, L. TOLDY 
INSTITUTE f'OR DRUG RESEARCH, BUDAPEST , HUNGARY
Keywords: GYKI-20 238, anti-amnesic effect, muscarinic agonist
It was shown earlier that a thiazolidine derivative, 2-methyl- 
imino - 3 - (2,6-dichloro-phenyl)-4-methyl-thiazolidine (GYKI -
20 238) facilitated the learning performance of mice in a 
simple one-trial passive avoidance test (Borsy et al., 1971).
Recently the growing interest in the possible application of 
cholinergic agents for the treatment of Alzheimer's disease has 
prompted us to find out whether the memory improving ability of 
GYKI - 20 238 is related to the central cholinergic system.
In this study we employed in vitro radioligand binding assay 
using 3H-quinuclidinyl benzylate (3H-QNB) (Yamamura and Snyder, 
1974). Specific 3H-QNB binding in rat cortical membranes was 
inhibited by GYKI-20 238 with an IC^ 0 value of 0.4 yuM, showing 
that the compound has affinity to central muscarinic receptors.
In an attempt to prove a possible central muscarinic agonis­
tic effect, we used the potentiation of oxotremorine evoked 
tremor and salivation in mice (Ôgren et al., 1 985). It was 
found that the compound (1 mg/kg ip. or 3 mg/kg p.o.) enhanced 
the tremorigenic response of oxotremorine without exerting any 
effect on peripheral cholinergic signs, such as salivation.
In order to study the anti-amnesic effect of GYKI - 20 238 we 
applied two rat behavioural models (Cumin et al., 1983).
We used the scopolamine - induced memory deficit in a passive 
avoidance test. The amnesic agent scopolamine (0.5 mg/kg ip.) 
and GYKI-20 238 were administered simultaneously after the last 
passive avoidance training. The other behavioural model we em­
ployed was the electroconvulsive shock - induced amnesic test. 
Electroshock (ESC; 45 mA, 2s) or sham ECS was applied after the 
avoidance acquisition. The training method and the administra­
tion of GYKI-20 238 were similar to those used in the scopol­
amine behavioural test.
Our results show (Fig. 1.) that GYKI-20 238 at a dose of 0.5 
mg/kg p.o. significantly antagonized the memory deficit induced 
by both scopolamine and an electroconvulsive shock, giving an
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inverted U-shaped dose response function.
SCO + GYKI -  20 238 ECS + GVKI -  20 238
Fig. 1. Anti-amnesic effect of GYKI - 20 238 (1.25, 2.5 and 5 
mg/kg p.o.) on memory deficit induced by scopolamine (A) or an 
electroconvulsive shock (B) in rats (N = 12). SCO = scopolamine 
hydrobromide (0.5 mg/kg ip.) VEH + VEH = vehicle ip. (distilled 
water) and vehicle p.o. (0 . 1 % carboxymethylcellulose in dist­illed water). Sham ECS + VEH = sham electroconvulsive shock and 
vehicle p.o. Ordinate = per cent of rats remaining on the plat­
form for 60s in the retention test, x = p<0.05 vs SCO + VEH or ECS + VEH controls, XZ test.
For studying the putative selectivity to muscarinic re­
ceptors, the assessement of purposeless chewing behaviour was 
carried out in rats (Stewart et al., 1989). Administration of 
GYKI-20 238 (1-4 mg/kg ip.) didn't produce a marked increase in 
purposeless chewing behaviour mediated via muscarinic recep­
tors .
In summary, the results indicate that this compound has a mar­
ked anti-amnesic effect through the central muscarinic recep­
tors of type.
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PRESYNAPTIC EFFECT OF DEXMEDETOMIDINE ON CHOLINERGIC 
CHEMICAL TRANSMISSION
Tarkovács, G., Rakovska, A., Romics, L.+ and Vizi E.S.
Institute of Experimental Medicine, Hungarian Academy of 
ij>c iences
3rd Department of Medicine, Semmelweis University, Medical 
School, Budapest, Hungary
Key words: cholinergic system, dexmedetomidine
Alpha-2 adrenoceptor agonists (xylazine, clonidine) 
have been used in clinical practice, in a variety of medical 
treatments, including those of hypertension, opiate, alcohol 
and tobacco withdrawal, chronic pain. Very recently 
dexmedetomidine (4(5)-(l-(2,3-dimethylphenyl)e t h y l )-
imidazole) , a novel alpha-2 adrenoceptor agonist has been 
shown to reduce anesthetic requirements during surgery (Doze 
et. al., 1989). Alpha-2 adrenoceptor agonists prolong 
barbiturate sleep time (Hársing et al., 1989). The site of 
action of these effects is supposed to be on the peripheral 
and central noradrenergic system. Since the work of Paton 
and Vizi (1969) it is also known that cholinergic axon 
terminals are equipped with presynaptic inhibitory alpha-2 
adrenoceptors (Beani et al., 1978 , Vizi and Pásztor, 1981) 
whose stimulation results in an inhibition of ACh release. 
In order to study the effect of 1-dexmedetomidine HC1 (MPV- 
1441,Far m o s ,Finland) on cholinergic transmission, on the 
intestinal motility ,isolated longitudinal muscle strip with 
Auerbach plexus attached was set up in Krebs solution and 
stimulated with 0.1Hz (1 msec).The contractions were
isometrically recorded (1.24^+0.08 mN, n = 16).
Dexmedetomidine (1 uM) reduced the force of contraction by 
23%. CH-38083, a selective alpha-2 adrenoceptor antagonist, 
completely prevented the inhibitory effect of 
dexmedetomidine (Table 1.)
Table 1. Effect of dexmedetomidine on the contraction 
of guinea-pig ileal longitudinal muscle strip evoked by 
stimulation (0.1 Hz, 1 msec ) and by neurotensin (0.03 u M )
Contraction
stimulation
(%) evoked by
neurotensin
control 100+6,1 100+16
dexmedetomidine ( 1 uM ) 71,3+4,4 36,2+3,4
CH-38083 (0.8uM) 
+dexmedetomidine (luM)
- 92,8+1.8
The contraction produced by neurotensin was completely 
reduced by dexmedetomidine.
It is suggested that dexmedetomidine inhibits ACh release 
from the myenteric plexus, reduces gastrointestinal 
m o t i l i t y .
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REFLEX INHIBITORY ACTION OF A NON-NMDA TYPE EXCITATORY AMINO 
ACID ANTAGON 1ST, GYKI 52466
I.Tarnawa, *S.Farkas, P.Berzsenyi, M.Pátfalusi and 
Institute for Drug Research, Budapest, and 'Chemical 
Gedeon Richter Ltd., Pharmaco1ogica 1 Research Centre,
key words: spinal reflexes, excitatory amino acids
Excitatory amino acids glutamate and aspartate are 
regar-ded as major excitatory transmitters all over the 
mammalian central nervous system. Receptors mediating their 
actions are subdivided into NMDA and non-NMDA (kainate and 
quisqualate) receptors. Under physiological conditions, the 
role of NMDA receptors in mediation of fast synaptic events is 
a guestion of debate. They definitely play a role, however, in 
some so called plastic phenomena in the central nervous system. 
Although glutamate is the main transmitter candidate which 
mediates segmental spinal reflexes, only the polysynaptic 
component of them seems to be affected by NMDA antagonists 
(Davies and Watkins, 19B3). The role of non-NMDA receptors in 
these processes has been difficult to investigate because of 
the lack of any in vivo effective specific antagonist.
GYKI 52466 is a 2,3-benzodiazepine compound which shows 
muscle relaxant and anticonvulsant properties in several animal 
models (Berzsenyi et al., 1988; Tarnawa et al., 1989). Recently 
it has been shown to selectively inhibit neuronal 
depolarization evoked by iontophoretic application of 
guisgualate and kainate in rat neocortex slices (Tarnawa et 
al., 1990). Our present data demonstrate the role of non-NMDA 
type excitatory amino acid receptors in both poly- and 
monosynaptic spinal reflexes.
Flexor reflex was investigated in intact, chloralose 
anesthetized cats. The hind paw was stimulated and the response 
was recorded from the anterior tibial muscle using a 
quantitative electromyographic method (Farkas et al., 1988). 
GYKI 52466 (1.0 mg/kg i.v.) inhibited the flexor reflex to
about 50'/.. Patellar reflex was studied in chloralose 
anesthetized cats. ED 5Q values of GYKI 52466 were about 1.5 
mg/kg i.v. both in intact and in Cl spinal cats.
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intraduodena 1 application, 4-8 mg/kr) caused a 50'/. inhibition 
which lasted tor several hours. Atter l.v. application maximum 
effect: developed quickly. A two phase kinetics was observed in 
the recovery: a fast but only partial decrease in the drug
effect was followed by a second phase of slow, gradual 
recovery. Spinal root reflexes evoked by stimulation of the 
tibial nerve were examined by recording reflex potentials 
directly from the L6 , L7 and SI spinal roots in spinal, 
unanestheti 2ed cats. GYKÏ 52466 (2 mg/kg i.v.) inhibited both 
the mono- and ttre polysynaptic ventral root reflexes by about 
507.. In contrast to the classical benzodiazepines like 
midazolam or diazepam, GYKI 52466 did not enhanced the dorsal 
root reflex and the dorsal root potential.
The fast onset and the characteristics of the recovery 
correlate with pharmacokinetic findings: 2 minutes after an 
i.v. dose of 4 mg/kg ^^C-GYKI 52466, a 20-30 pM concentration 
of the drug could be detected in the rat brain. The
concentration quickly decreased down to about 5 pM, but a level 
of a few pM was still detectable even after several hours.
The fact that GYKI 52466 at the concentration of 10-50 pM 
considerably attenuated Quisqualate responses in vitro suggets 
that inhibition of the non-NMDA type receptor mediated 
excitatory amino acid transmission is responsible for spinal 
reflex inhibition. Our results support the suggestions on the 
involvement of glutamate or other excitatory amino acids in 
mediation of the spinal monosynaptic reflex.
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COMPARISON OF THE EFFECTS OF (-)DEPRENYL, 1-PHENYL-2-PROPYL- 
AMI NOPENTANE (MK-306) AND AMPHETAMINE ON THE STRIATAL AND LIMBIC 
DOPAMINERGIC SYSTEM
J. Timár, S. Yasar, B. Knoll and J. Knoll
Department of Pharmacology, Semmelweis University of Medicine 
Budapest, P.O.B. 370, 1445 Hungary
Key words: MK-306, (-)deprenyl, striatal DA, mesolimbic DA
The stimulation of the nigrostriatal and the mesolimbic dop­
amine (DA)-ergic systems is known to have different behavioral 
consequences. The DA agonists-provoked stereotyped behavior is 
connected mainly to the nigrostriatal machinery, whereas hyper­
motility and rearing are related to the mesolimbic DA-ergic sys­
tem (Costall et al., 1977). (-)Deprenyl, up to now the only 
selective monoamine-oxidase (MAO) В-type inhibitor used in cli­
nical practice, facilitates the activity of the nigrostriatal 
dopaminergic neurons with peculiar selectivity (Knoll, 1987).
It strongly potentiates the phenylethylamine-induced stereo­
typed behavior without inducing hypermotility or rearing (Timár 
et al., 1908) .
(-)Deprenyl is known to inhibit the reuptake of catechol­
amine (CA) which makes this drug unique in beeing free from 
the cheese effect. On the base of this observation a series of 
deprenyl-derived compound were developed which inhibited the 
DA-reuptake, but have neither MAO-inhibitory nor noradrenaline 
releasing action. One of the most characteristic representati­
ves of these substances is MK-306 (Knoll B. et al., 1988).
In this study the action of MK-306 on DA-stimulated activity 
was analysed in comparison to that of (-)deprenyl and amphet-
2 8 0
amine. The locomotion (LM), the rearing and the stereotyped 
head movements (STHMV) were simultaneously measured in a 30 
min observation period. (-)Deprenyl following either single 
administration of as high dose as 20 mg/kg sc, or following a 
repeated administration of the selective MAO-B inhibitory dose 
(0.25 mg/kg sc) failed to induce any type of hyperactivity. 
MK-306 increased the activity of the rats, however, as Table 1. 
shows it, stereotypy was induced only with a higher dose.
Table 1, MK-306-and amphetamine-induced hyperactivity in rats 
Dose _____Time (min) spend with_______
mg/kg_______ LM___________ rearing________STHMV
Saline 2.82 3.32 0.48
MK-306 1.0 4.94 3.71 0.775.0 5,48х 6.70х 0.78
20.0 2.51 1 2.12х 0.9325.0 6 .53х 5.53 5.01х
Amphetamine
1.29х0.5 4.48 4.245.0 7.12х 6.85 3.09х
mathematically significant compared to saline
MK-306, influences learning behavior in smaller doses (1-2 
mg/kg, sc) (see Knoll B. et al., in this volume), which speaks 
in favor of the assumption that this compound has a stronger 
effect on the mesolimbic system than on the striatal DA-ergic 
neurons.
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SODIUM-AZIDE-EVOKED NORADRENALINE RELEASE FROM PERIPHERAL NERVES OF RABBIT 
PULMONARY ARTERY
P. T. Tóth, A. M. Azzidani, T. L. Török and K. Magyar
Department of Pharmacodynamics, Semmelweis University of Medicine, H-1445 
Budapest, Nagyvárad tér 4, P.O.Box 370, Hungary
Key Words: t r i t ia te d  noradrenaline release, sodium-pump, sodium-azide
The spontaneous release of /-^H/noradrenaline (/^H/NA) has been 
measured from the iso la te d  main pulmonary a rte ry  of the ra b b it in the 
presence of uptake b lockers (cocaine, 30/uM; corticosterone, 50/uM). The 
tone o f the smooth muscle was sim ultaneously recorded. The Na+-pump 
in h ib i to r  sodium-azide (NaNj, 2mM) moderately increased the /^H/NA release 
and relaxed the smooth muscle. K+-removal from the Krebs solution increased 
the  release of /-^H/NA and the tone of pulmonary a rte ry . NaN  ^ fu r th e r  
increased the tra n sm itte r re lease in  "К-free " solution, but relaxed the 
muscle. External K+-readmission was e ffec tive  in in h ib itin g  the transm itte r 
re leas ing  action of NaNj. In another series of experiments the transm itte r 
re leas ing  action  of ouabain (10- i,M) was also measured. Ouabain fu rthe r 
increased the /^H/NA re lease in  the absence of ex te rna l K+ and in  the 
presence o f azide, but fa i le d  to  produce post-synap tic  response. In 
conc lus ion , we found th a t in  p e riphe ra l sympathetic nerves sodium-azide 
a lso  in h ib ite d  the Na+-pump in  a s im ila r  manner, l ik e  in  motor nerve 
te rm ina ls  (Elmqvist and Feldman, 1965). The elevated /^H/NA release, which 
was a consequence of Na+-pump in h ib itio n  was abolished during reactiva tion  
of Na+-pump by readmission of K+ to Na+-loaded ce lls .
Elmqvist, D. and Feldman, D. S ., (1965) J. Physiol., Lond. 181, 498-505.
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DIFFERENT SENSITIVITY OF CHOLINERGIC AND DOPAMINERGIC NEURONS
TO SULPIRIDE
András Törőcsik and E. Sylvester Vizi
Institute of Experimental Medicine, Hungarian Academy of 
Sciences, Budapest, Hungary
Cholinergic and dopaminergic neurotransmission are strongly 
interrelated in the striatum. The release of acetylcholine (ACh) 
is modulated by presynaptic muscarinic autoreceptors (Szerb, 
1977) and by dopaminergic heteroceptors of the D-2 subtype (Vizi 
et a l ., 1977). The release of dopamine (DA) is inhibited by
dopaminergic D-2 autoreceptors (Groves et al., 1975). However, 
the physiological significance of these interactions is still 
debated. The existence of a presynaptic receptor does not 
necessarily indicate that the presynaptic modulation operates 
under physiological conditions. If the biophase concentration of 
the neurotransmitter is not high enough in the vicinity of the 
axon terminal, presynaptic receptors are not functioning.
The aim of this study was to determine, whether or not 
presynaptic DA-2 receptors, which inhibit neurotransmitter 
release from cholinergic and dopaminergic neurons in the striatum 
are tonically stimulated by endogenous DA in an in vitro slice 
preparation.
Rat striatal slices (450 urn thickness) were loaded with
3 3H-choline or H-DA, superfused with Krebs solution and
stimulated with electrical field stimulation (20 V/cm, 2 Hz 1 ms,
3 3240 pulses). H-ACh or H-DA release into the superfusate was 
determined with scintillation spectrometry. Alteration of 
neurotransmitter release was characterized by the Sg/S^ ratio.
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Sulpiride, a selective antagonist of DA-2 receptors,
3
increased the release of H-DA in a concentration— dependent 
mannner, probably by interrupting the negative feed-back 
inhibition of endogenous DA. On the other hand sulpiride had no
3
effect on the release of H-ACh. Evidence was presented, that 
cholinergic terminals were equipped with presynaptic DA-2 
receptors as well as dopaminergic terminals, since P P H T , a
3
selective DA-2 receptor agonist, was able to decrease H-ACh 
release, an effect, which could be antagonized with sulpiride.
Transmitter Sulpiride cone. V s i n Signi f icance
oH-DA
^H-DA 1 uM
0.98
1.10
+
4-
0.06
0.05
3
3 p > 0.05
^H-DA
JH-DA
10 uM 1 .33 + 0.05 3 p < 0.05
100 uM 2.03 4 0.07 4 p < 0.001
^H-ACh 1 .02 + 0.06 4
•%-ACh 10 uM 0.95 + 0.04 4 p > 0.05
Our results suggest, that although in the striatum 
cholinergic nerve terminals are equipped with presynaptic DA-2 
receptors, the biophase concentration of endogenous DA at the 
cholinergic terminals is not high enough to inhibit ACh release. 
An other possibility is, that due to different intracellular 
signalling pathways, presynaptic DA-2 receptors of cholinergic 
and dopaminergic neurons are not similarly sensitive to 
endogenous DA.
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1MMUNM0DULAT0RY ACTIVITY OF 
D-M et2-  Pro -ENKEPHALINAMIDE
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I n s t i t u t e  fo r  Drug Research, Budapest
KEY WORDS: D-Me t 2-P rtf’- enkepha 1 i  nam i  de , 
immunmodulator
2 5D-Met -P ro -e n kepha linam ide  (EA) is  an o p io id  p e p tid e  
analogue having a n a lg e s ic  a c t i v i t y  in  an im a ls  more p o te n t 
than morphine a f t e r  in tra ve n o u s  a d m in is t r a t io n .  C l in ic a l  
s tu d ie s  re ve a le d  th a t  EA has a n a lg e s ic  e f fe c t  in  human, 
as w e l l .
R ecen tly  i t  has become c le a r  th a t ,  in  a d d it io n  to  t h e i r  
r o le  in  nervous system , o p io id  p e p tid e s  have p le io t r o p ic  
e f fe c t  on s e v e ra l body system, in c lu d in g  the  immune system .
In s p ire d  by these f in d in g s  we s tu d ie d  the  e f fe c ts  o f EA 
on v a r io u s  immune fu n c t io n s .
M a te r ia ls  and methods
A n im a ls : CBA mice and Long Evans r a ts  were used th ro u g h o u t 
the e xp e rim e n t.
Spleen c e l ls  were s t im u la te d  in  v i t r o  w ith  
P h y to h e m a g g lu tin in  and C oncanavalin  A in  the absence and 
presence o f the  te s t  compound. A f te r  48 h in c u b a tio n  a t^
37 °C in  5 % CO2 a tm osphere, c u ltu re s  were pu lsed w ith  H- 
- th y m id in e  fo r  fu r th e r  16 hou rs . C e lls  were ha rves ted  on 
Whatman GF/c f i l t e r  and the r a d io a c t iv i t y  in c o rp o ra te d  to  
the c e l ls  was counted in  a l iq u id  s c i n t i l l a t i o n  s p e c tro ­
photom eter .
M a c rophag ephagocy tos is
Macrophages were o b ta in e d  by p e r ito n e a l lavage and a llow ed  
to  adhere to  c u ltu r e  p la te .  IgG coa ted  sheep e ry th ro c y te s  
were used as the  in d ic a to r  o f p h a g o c y tic  a c t i v i t y .  The 
r a t io  o f p h a g o cy tic  c e l ls  was q u a n t ita te d  m ic ro s c o p ic a lly .
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^GÏibody_formation
M ice were immunized w ith  sheep red b lood c e l ls  (SRBC) and 
t r e a te d  w ith  the te s t  compound or v e h ic le .  At d i f f e r e n t  
t im e s  a f t e r  im m un iza tion  mice were b led  and the  le v e ls  o f 
l y s in g  a n tib o d ie s  a g a in s t SRBC were te s te d .
Qülüyedtype !]yP§EP?GPÍÍiyiíy_Í^ It!2_E§§EÍÍ2D
M ice were immunized in t ra v e n o u s ly  w ith  10g SRBC. F ive  days 
l a t e r  an im a ls  were re s t im u la te d  w ith  10° SRBC in t r a -  
p la n t a r l y .  Footpad s w e ll in g  was measured 24 h la t e r .
A d ju v a n t a r t h r i t i s  was induced  by CFA. The p rog ress  o f the  
d is e a s e  was m onitored by m easuring the  volume o f both h ind  
fe e t  by a p le thysm ograph .
The e f f e c t  on the p r im a ry  in fla m m a tio n  (0 -1 0  days) and on 
th e  im m u n e -a r th r it is  phase (10-21  days) was te s te d  
s e p a ra te ly .  The te s t  compound was a p p lie d  sc . in  
0 .1 -1 .0 -1 0  mg/kg/day doses.
R e s u lts
EA tre a tm e n t s l ig h t ly  m o d if ie d  sp leen c e l l  m ito g e n e s is . I t  
had no e f f e c t  on in  v iv o  a n tib o d y  fo rm a tio n . Macrophage 
p h a g o c y to s is  was in h ib i t e d  by 25-30 % a t the  10-30 mg/kg 
dose range when 1 day ip .  p re tre a tm e n t was a p p lie d .
EA in h ib i t e d  the DTH re a c t io n  by 25 % in  5x100 mg/kg d a i ly  
doses i f  the  tre a tm e n t was a p p lie d  a f te r  im m u n iza tio n .
EA r e s u l te d  in  more seve re  in fla m m a tio n  bo th  on the 
im m unized (+70 %) and on th e  o th e r fo o t  (+40 %), when the 
compound was a p p lie d  in  th e  f i r s t  and second phase o f the  
a d ju v a n t a r t h r i t i s ,  r e s p e c t iv e ly .
2 5These f in d in g s  in d ic a te  th a t  D-Met -P ro  -enkepha linam ide  
in  h ig h  doses has im m unm odulatory p ro p e r ty .
R e fe re n ce s
J. I .  S z é k e ly : P o l. J. P harm aco l. Pharm ., 3_9> 641 (1987)
В . В . Newf o u ld  : B r i t .  J . P harm ., 2J^ , 127 (1963)
D . I . S c h r ie r :  0. Immunopharmacology, ]_, 313 (1985)
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INTERNAL SODIUM-DEPENDENT /3H/NORADRENALINE RELEASING ACTION 
OF MANGANESE FROM THE ISOLATED MAIN PULMONARY ARTERY OF THE 
RABBIT
T.L. Török, P.T. Tóth, A.M. Azzidani and K. Magyar 
Department of Pharmacodynamics, Semmelweis University of Me­
dicine, H-1089 Budapest, Nagyvárad-tér 4, P.O.Box: 370,
Hungary
3 2 +key words: rabbit pulmonary artery, / H/NA-release, Mn ,
Na+-pump, Na+/Ca2+-exchange 
3 3Spontaneous / H/noradrenaline (/ H/NA) release from the 
isolated main pulmonary artery of the rabbit has been measu­
red in the presence of uptake blockers (cocaine, 3x10 3M; 
corticosterone, 5x10 3M) and after blocking the MAO enzyme 
(pargyline, 1 .2x10 ^M).
The Na+-pump was inhibited by removal of K+ from the exter­
nal medium (Na+-loading) in the absence of external Ca2 + (+
1 mM EGTA). In K+-, and Ca2+-free medium manganese (Mn2+, 2 
mM) increased the release of /3H/NA from the arteries and 
the rate of release was directly proportional to Na+-loading 
being bigger if longer exposure time was used to K+-free 
solution. Without Na+-loading (Ca2+-free, EGTA alone), Mn2+
failed to produce transmitter release. Using constant Na+-
+ 2+ 3loading (120 min К -free perfusion) the Mn -evoked / H/NA-
release was also directly proportional to the concentration
of Mn2+ used (1.2, 1.6, 2.0 mil). When most of the external
Na+ (113 mM) was substituted for Li+ during Na+-loading, Mn2+
2 +was ineffective in producing transmitter release. Mn was al­
so ineffective in releasing neurotransmitter if the Na+-pump
2 8 8
was previously reactivated by readmission of K+ to Na+-loaded 
nerves.
2 +It is concluded that under reversed Ca -gradient, the tran- 
2 +sition metal Mn , the well known blocker of Ca-channel and 
+ 2+Na /Ca -exchange, releases neurotransmitter by an internal 
Na+-dependent manner from peripheral sympathetic nerves.
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A N  A L G O R I T H M  F O R  E V A L U A T I N G  T H E  A B S O R P T I O N  R A T E  C O N S T A N T  F R OM
U R I N A R Y  E X C R E T I O N  D A T A .
P e t e r  V a r k o n y i  , D e p a r t m e n t  o f  M a t h e m a t i c a l  M o d e l i n g ,  C H I N O I N  
P h a r m a c e u t i c a l  W o r k s  L T D ,  B u d a p e s t  T o  u .  1 - 5 .  
H u n g a r y  1 0 4 5
S i m p l e  c a l c u l a t i o n s  p r o v i d i n g  t h e  p a r a m e t e r  e s t i m a t e s  o f  t h e  
L i n e a r  C o m p a r t m e n t  O p e n  M o d e l s  w i t h  f i r s t  o r d e r  a b s o r p t i o n ,  f r o m  
c u m u l a t i v e  u r i n a r y  e x c r e t i o n  d a t a  a r e  d e s c r i b e d  i n  t h i s  p a p e r .  
T h e  e s t i m a t i o n  o f  t h e  p a r a m e t e r  c h a r a c t e r i z i n g  t h e  a b s o r p t i o n  c a n  
b e  v e r y  d i f f i c u l t  f r o m  u r i n a r y  e x c r e t i o n  d a t a  b e c a u s e  t h e  
f r e q u e n t l y  a p p l i e d  m e t h o d s  o f  m e a s u r e m e n t  g i v e  t h e  f i r s t  r e l e v a n t  
d a t a  a t  s e v e r a l  h o u r s  a f t e r  a d m i n i s t r a t i o n ,  t h u s  t h e  f i r s t  r e g i o n  
o f  t h e  e x p e c t e d  c u r v e  d i r e c t l y  r e l a t e d  t o  t h e  a b s o r p t i o n  i s  l o s t  
( F i g .  1 ) .  T h e  s u g g e s t e d  a l g o r i t h m  i s  a b l e  e s t i m a t e  t h e  a b s o r p t i o n  
c o n s t a n t  a n d  t h e  o t h e r  p a r a m e t e r s  o f  t h e  m o d e l s  i n  t h e  c a s e  o f  
t h e  a b o v e  c o n d i t i o n s .  I t  i s  b a s e d  o n  t h e  s i g m a  m i n u s  p l o t  w i t h  
l i n e a r  r e g r e s s i o n  o r  " s t r i p p i n g  t e c h n i q u e "  a c c o m p l i s h e d  w i t h  s o m e
2 9 0
s i m p l e  c a l c u l a t i o n s .  O f  c o u r s e  a m o r e  r e l i a b l e  s o l u t i o n  c a n  b e  
o b t a i n e d  b y  a c o m p l i c a t e d  c o m p u t e r  p r o g r a m  f o r  n o n l i n e a r  
e s t i m a t i o n ,  b u t  e v e n  s o ,  t h e  a l g o r i t h m  c a n  p r o v i d e  a g o o d  s e t  o f  
p r e l  i m i n a r y  e s t i m a t e s .
M E T H O D
T h e  e q u a t i o n  o f  t h e  c u m u l a t i v e  a m o u n t  e x c r e t e d  t o  t h e  u r i n e  i n  
t h e  c a s e  o f  t h e  g e n e r a l  m o d e l  c o n t a i n i n g  n  c o m p a r t m e n t s  i s  a s  
f о  1 1 o w s :
f o l l o w i n g  c a n  b e  o b t a i n e d :
n
. 2  A j «  i
I - 1
n
. 2 1 A j -
T o  o b t a i n  k a , A j -  s , o i j - s  a n d  X M h a v e  t o  b e  p r o v i d e d .  F o r  t h e  O n e  
a n d  t h e  T w o  C o m p a r t m e n t  M o d e l  t h e s e  p a r a m e t e r s  c a n  b e  o b t a i n e d  b y  
e m p l o y i n g  t h e  s i g m a  m i n u s  p l o t .
R E F E R E N C E S
G i b a l d i ,  M i l o  a n d  P e r r i e r ,  D o n a l d  " P h a r m a c o k i n e t i c s " ;  M a r c e l
D e k k e r ,  I n c . :  N e w  Y o r k ,  1 9 8 2 ,  3 7 - 4 0 ,  8 1 - 1 0 3 ,  4 3 3 - 4 4 4 .
V a r k o n y i ,  P .  : M e d U S A  v e r s i o n  1 . 3  -  M e d i c a l  U s a g e  o f  S c i e n t i f i c
A l g o r i t h m s .  C o m p u t e r s  i n  B i o l o g y  a n d  M e d i c i n e  V o l .  1 8  ( 5 ) ,
1 9 8 8 ,  S o f t w a r e  S u r v e y  S e c t i o n  I I .
W a g n e r ,  J o h n  G .  " F u n d a m e n t a l s  o f  P h a r m a c o k i n e t i c s " ;  D r u g
I n t e l l i g e n c e  P u b l i c a t i o n s ,  I n c . :  H a m i l t o n ,  I l l i n o i s ,  1 9 7 5 ,  5  7 -  
6 3 ,  7 4 - 8 2 ,  1 0 2 - 1 0 6 .
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EFFECT OF NITROGLYCERIN AND A NITROGLYCERIN-LIKE SUBSTANCE 
IN ISOPRENALINE (ISO) NECROSIS AND HYPOXIA
Cs. Vértesi, E. Knopf and P.Sz. Körmöczy
CHINOIN Pham. Chem. Works Co. Ltd, Budapest -  HUNGARY
(cardioprotection, hypoxia, n itrog lycer in , molsidomine, SIN-1)
Molsidomine is  new antianginal agent with effects  on hemodynamics, F iedler 
and Scholthols (1978). The drug has been shown to be effective in the 
treatment of angina pectoris by a n i t ro g lyce r in - l ike  mode of action but of 
substantia lly  longer duration, Majid (1980).A number of sympathomimetic 
amines can cause cardiac damage. The cardiotoxic e ffect of ISO, which 
induced an in fa rc t - l ik e  necrosis, has been of part icu lar in terest since 
standard dosages consistently produce myocardial lesions of reproducible 
severity. ISO induced cardiac necrosis has been widely used for studying 
the potentia l protective e ffec t of pharmacological interventions on the 
morphological evaluation of the size of myocardial in farction.
We tested the re la t ive  cardioprotective potencies of n it rog lyce r in ,  
molsidomine and SIN-1 in the ra t  ISO model according to Körmöczy et al
(1987).ISO was injected in 5 mg/kg i .p .  doses, daily for 5 consecutive 
days. We evaluated the developed hypoxia (HP) and necrosis (NC) 
quantita t ive ly  by h is to log ica l methods.To follow the time course of 
cardioprotection the drugs were injected da ily  i . p .  60, 120 and 240 min 
before ISO.Cardioprotection was defined as the re la tive reduction of 
percentually expressed necrotic (NC) and hypoxic (HP) areas, respectively 
from corresponding values in the o ra l ly  treated physiological saline and 
ISO control group.The comparative cardioprotective e f fe c t  of 
n itrog lycer in , molsidomine and SIN-1:
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hour nitrog lycerin  
1 mg/kg i .p .
molsidomine 
1 mg/kg i .p .
SIN-1
0.25 mg/kg i .v .
NC% HP% NP% HP% NC% HP%
1 70.3XX 68.4XX 58.2XX 65.5XX 95.l xx 95,4XX
2 59.9XX 59.4XX 69.l xx 77.7XX
3 37.7X 39.2X 50.l xx 57,4XX
Values represent percentage difference in hypoxic and necrotic
areas compared to control: X  = p < 0 .01 , X X  = p < 0.001
The e ffec t of molsidomine is  more prolonged than that of 
n i t ro g ly c e r in .
The pretreatment with SIN-1 prevents cardiac necrosis and 
hypoxia.
F ied ler, V.B., Scholtholf, J . :  Arzneim. Forsch. 28, 1605 (1978). 
Majid, P.A., De Feyten, P. S.F., Van der Wall, E.E., Wandeh, R., 
Roos, Л.Р.: Engl. 3. Med. 302, 1 (1980).
Körmöczy Sz., P., Vértesi, Cs., Mikus, E., Tardos, L., Kovács, 
G.: Prostaglandins 33, 505 (1987).
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BIOCHEMICAL BACKGROUND OF ß -CAROTENE-INDUCED GASTRIC CYTOPROTECTION 
IN RATS TREATED WITH HC1.
A.Vincze,M.Garamszegi,T.Jávor,L.Nagy,A.Németh,G. Sütő,Gy Л óth & gy.Mózsik 
F irs t Department of Medicine,Medical University of Pécs,H-7643 Pécs,Hungary
Key-words:gastric cytoprotection,carotene,mucosal biochemistry.
Vitamin A and other carotenoids prevent the development of gastr ic  
mucosal damage produced by in tragastr ic  administration of d if fe ren t necro­
t iz in g  agents (such as 96% ethanol, 0.6 M HC1) without presence of any 
inh ib i t ion  of gastric acid secretion (Jávor et a l . , 1983).
The aim of th is  study was to compare the ß  -carotene-induced changes 
in the gastric mucosal biochemistry,during the development of gastr ic  cyto­
protection produced by i t s  d if fe ren t doses.
The observations were carried out on Sprague-Dawley(LATI,Gödöllő, 
Hungary)-£train rats,weighing 180-210 g. The animals were fasted fo r  24 
hours befure the experiments. The gastric mucosal damage was produced by 
in trgas tr ic  administration of 0.6 M HC1. The animals were treated with 
/3 -carotene at 30 min before administration of HCl.The d iffe rent doses 
of /3 -carotenewere dissolved in sunflower o i l  and given in t ra g a s t r ic a l ly . 
The animals were sacrificed at 1 hour a fte r  the administration of HC1, 
when the number and severity of gastric mucosal lesions was noted.The 
tissue levels of ATP,A0P,AMP and lactate were enzymatically measured, 
while cAMP by RIA.The values of ATP/ADP,adenylate pool (ATP+ADP+AMP) 
and "energy charge " f  (ATP+0.5 ADP)/(ATP+ADP+AMP)7 were calculated. A l l  
biochemical parameters were calculated in re la t ion  to 1.0 mg mucosal 
protein, and the ir  results expressed as mean _+ SEM.
I t  has been found that: l.The extent of ATP-ADP transformation
decreased in association with the increased extent of ATP-cAMP transform­
ations and of cAMP-AMP transformations; 2 .The changes in membrane-bound 
ATP-dependent energy systems depended on doses of /3 -carotene; 3.The value 
of energy charge was unchanged.
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B IO C H E M IC A L  B A C K G R O U N D  O F  G A S T R IC  M U C O S A L  
P R O T E C T IO N  O F  0 .6 M H C l- IN D U C E D  G A S T R IC  M U C O S A L  
L E S IO N S  B Y  D IF F E R E N T  C Y T O P R O T E C T IV E  D O S E S  O F  
p - C A R O T E N E  ( m e a n s ± S E M ) ( n = 1 0 )
( in  c o m p a r is o n  w i t h  r e s u l t s  o f  d a m a g e d  m u c o s a )  
d o s e s  o f [ 3 - c a r o te n e  ( m g  k g -1 ig  )
001 01 10 10.0
U lc e r  num ber 0 + 0 NS -6 .0 ± 0 5 * * * - 6 .5 * 0 5 * * * -9.0 ± 0 .6 ***
U lc e r  s e v e r ity 0+0 NS -1 0 0 *1 .0 ** -1 5 0  ± 0 .6 *** 20 0± 0 6 * * *
ATP -2 .0±07NS - o .o ± o o NS + 2 0 ± 0 5 ns + 2 .1 ± 0 5 n s
AD P 0+0 NS - 1 7±0  8 NS -4 .0  ± 0 .5 ** * -5  0±06 * * *
ATP A D P ~ 1 -0  09 ±0 01 NS - 0 0 9 i0  0 2 NS + 0 2 2 * 0 0 2 * * * ♦ 0.24±0.03***
AMP +2.0±08 NS +2.8* 0.7 NS + A 2 * 0 7 * * + 80±0.1 * * *
c A M P +0 3 ± 0 0 1 NS + 0 5 ± 0 0 4 NS + 1 .0 *0 .0 2 *** +1.1 ± 0.02 * * *
A d e n y la te  pool +10 ±09 NS + 1 0 ± 0 8 ns +1.2 ± 0 7 NS ♦ 20±09 NS
„e n e rg y  charge ’ -0  07 ± 001NS -0 0 8 *0 .0 1 NS -0 0 9  ±001NS -010±0.01NS
L a c ta te  - 3 0 i1 0 NS 
N S = n o t s ig n if ic a n t , ++ = P - 0 0 1
-20 ± 10 NS 
, +++=P «0.001
-15 ±15 NS -20±10 NS
F i g . 1 . Changes in  the g a s t r i c  mucosal b io c h e m is t r y , d u r ing  the 
deve lopm ent o f  g a s t r i c  c y t o p r o t e c t i o n , produced by d i f f e r e n t  
doses o f  / 3 -c a ro te n e .  The r e s u l t s  were c a lc u la te d  as d i f f e r e n c e s  
between the  r e s u l t s  o b ta ine d  w i th o u t  and w i th  a p p l ic a t io n  o f  
/Ь - c a r o te n e  .
I t  has been concluded t h a t :  l .A  m o d i f i c a t i o n , between the 
d i f f e r e n t  membrane-bound ATP-dependent energy systems, co u ld  be 
produced by a p p l i c a t io n  o f  ß  -ca ro te n e  in  the  u lc e ra te d  g a s t r i c  
mucosa o f  r a ts  t re a te d  w i th  HCl; 2. The e x te n t  o f phosphory­
l a t i o n  a n d /o r  d é p h o s p h o ry la t io n  of c e l l s ,  in  both cases o f  
w i t h o u t  and w ith  t re a tm e n t  o f  /Ъ - c a ro te n e ,  was unchanged; 3.
The e x te n ts  o f  b io ch e m ica l changes depended on the dosage o f  
/3  - c a r o te n e  .
R eference
Jávo r T . jB a ta  M . ,Lovász L .,M oron  F .,N agy L . ,P a t t y  I . , Szabo lcs J . ,  
Tárnok F . , Tóth G y .,M ózs ik  Gy. I n t . J . T i s s . Reac. 5,289-296 
(1 9 8 3 ) .
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MICRÜELECTROPHARMACOLOGICAL STUDY OF PRAJMALINE IN RABBIT PAPILLARY MUSCLE
L. Virág, J.Gy. Papp, L. Szekeres
Department of Pharmacology, Albert Szent-Györgyi Medical University, Szeged,
Hungary
Keywordsj_ prajmaline, papillary muscle, transmembrane potentia l,  use- 
-dependence.
L i t t l e  in fo rm a t ion  is  ava ilab le  on the microelectropharmacological 
p rope rt ies  of prajmaline, a widely used Class 1 antiarrhythmic drug (Späth, 
1983). A systematic study to subclassify th is  agent has not yet been carried 
out. The present experiments were therefore performed to gain more ins igh t 
into the mechanism of action of prajmaline at the ce l lu la r  level.
Right ventr icu lar pap il la ry  muscles were prepared from hearts of young 
ra b b its  and placed in  an organ bath containing modified Locke's so lu tion. 
Transmembrane potentia ls were recorded by u t i l i z in g  a microelectrode techni­
que, as described e a r l ie r  (Freedberg et a l . ,  1970; Szekeres and Papp, 1986; 
Virág et a l . ,  1987). The preparations were exposed to increasing concentra­
tions of prajmaline; each concentration was allowed to act for 60 min.
The resu lts  have been summarized in Table I .  Prajmaline (0.1, 0.2 and 
0.5 mg/1) diminished the maximum rate of depolarization CJmax). The action 
p o te n t ia l  amplitude (APA) was also depressed considerably (at 0.5 mg/1), 
wh ile  the other c h a ra c te r is t ic  parameters of the transmembrane potentia l 
remained una lte red , i . e .  the action potentia l duration (APD) at 50 or 90 % 
re p o la r iza t io n s  was not prolonged or shortened to any s ign if ican t extent, 
and the re s t in g  p o te n t ia l  (RP) and the e f fec t ive  ref-ractory period (ERP) 
did not change e ither.
In the presence of prajmaline (0.5 mg/1) the blockade of Vmax occurred 
in  a use-dependent manner, but a considerable resting block was also obser­
ved. The drug-induced use-dependent block was f i t t e d  by using the following
formula:
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dV/dtmax = P(l) + P(2) exp(P(3)t)
where P(1) is  the s teady -s ta te  le ve l  o f  Vmax block, - P(2) is  the use- 
dependent block, P(3) is  the k ine t ic  constant. At an interstimulus in te rva l 
of 300 ms, exposure to 0.5 mg/1 prajmaline resulted in (mean ^  S.D.)
-  64.3 + 2.7 V/s for P(l) , 34.3 + 3.7 V/s fo r  P(2) and
-  0.051 + 0.012 s_1 for P(3).
Table I
Changes in action po ten t ia l parameters in the presence of prajmaline
Drug
RP
(mV)
APA
(mV) A(ms5
APD9n
(ms) h h
ERP
(ms)
Control -78.5 104.3 152.3 200.8 129.3 198.2
(n=10) +2.0 +3.8 +20.4 +23.9 +19.3 +18.0
Prajmaline
0.1 mg/1 -78.3 102.5 157.0 202.2 110.7 211.8
(n=3) +0.4 +4.2 +25.1 +25.5 +17.5 +21.6
0.2 mg/1 -78.2 102.8 140.4 194.0 99.5+ 189.2
(n=3) +2.6 +4.3 +20.3 +21.9 +13.8 +21.3
0.5 mg/1 -77.3 93.7+ 159.9 210.4 57.3+ 220.0
(n=4) +1.1 +3.5 +17.0 +20.4 +18.8 +18.4
Means _+ S.D. n = number of preparations. + P<0.05. 
See te x t  fo r abbreviations.
In  conclusion, prajmaline appears to belong to that subgroup of Class 
1 an t ia r rh y th m ics  which is  characterized by a marked blockade of Vmax, in ­
e f fe c t iv e n e s s  on the APD o r ERP and also by a slow rate of onset of Vmax 
in h ib i t io n .
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HETEROGENEITY OF PRESYNAPTIC ALPHA-2-ADREN0CEPT0RS
V i z i ,  E .S . ,  Kapocs i,  J . ,  H á rs ing , G.L. J r  and Mario Del Tacca
I n s t i t u t e  o f  E x p e r im e n ta l M ed ic ine , Hungarian Academy o f  Sciences, 
Budapest, Hungary and Dept, o f  M o lecu la r  Pharmacology, U n iv e r s i t y  
o f  Pisa , P is a , I t a l y
Key words :a lp h a -2 -a d re n o c e p to rs ,  p re s y n a p t ic  m odu la t ion
P resynap t ic  a lp h a -2 -a d re n o c e p to rs ,  which modulate t r a n s m i t t e r  
re le a s e  from d i f f e r e n t  nerve te rm in a ls  have been found in  numerous 
anim al t is s u e s  as w e l l  as in  v a r io u s  human b lood  vesse ls . 
R e ce n t ly ,  we have shown th a t  p re s y n a p t ic  a lp h a -2 -a d re n o c e p to rs  are 
a ls o  p resent in  the  human c y s t i c  a r t e r y  (Kapocsi e t  a l . ,  1987a). 
A lso r e c e n t ly ,  s tu d ie s  performed by a number o f l a b o r a t o r ie s  have 
in d ic a te d  the p o s s i b i l i t y  o f the h e te ro g e n e i ty  o f  a lpha -2 -  
a d re n o ce p to rs . H e te ro g e n e i ty  o f a lp h a 2 -a d re n e rg ic  re c e p to rs  has 
been noted in  many la b o r a to r ie s  both on the b a s is  o f  fu n c t io n a l  
and ra d io l ig a n d  b in d in g  s tu d ie s .  More r e c e n t ly  t h i s  h e te ro g e n e i ty  
has been in te r p r e te d  to  r e s u l t  from p h a rm aco lo g ica l subtypes of 
the re c e p to r .
I s o la te d  vas d e fe re n s  o f  the r a t  and l o n g i t u d in a l  muscle s t r i p  of 
g u in e a -p ig  i leum  were used to  study the  p re s y n a p t ic  e f f e c t  of 
a lp h a -2 -a d re n o ce p to r  a g o n is ts  and a n ta g o n is ts  on chemical 
n e u ro tra n sm iss io n  ( f o r  methods see Kapocsi e t a l . ,  1987b). In 
a d d i t io n  the e f f e c t  o f  d i f f e r e n t  a lp h a - 2 - a n ta g o n is ts  on the 
re le a se  o f ЗН-n o ra d re n a l in e  from c e re b ra l  c o r te x  was also 
measured. There was a s i g n i f i c a n t  d i f f e r e n c e  in  the  p re syn a p t ic  
i n h i b i t o r y  a c t i v i t y  (IC50 in  uM) o f  1-NA and X y la z in e  on r a t  vas
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d e fe re n s  and long . m. s t r i p  o f guinea p ig  o f  i leum  (T ab le  1 ) .  CH-
38083, a s e le c t i v e  a lp h a -2 -a d re n o c e p to r  a n ta g o n is t  w ith
a l lo b e r b a n e  s t r u c tu r e  ( V i z i  e t a l . ,  1986) enhanced the  re le a se  of
3H-NE from the c e re b ra l  c o r te x  s l i c e .  However the s te re o iso m e rs  of
CH-38083 antagonized th e  i n h i b i t o r y  e f f e c t  o f  exogenous NE w ith
d i f f e r e n t  po tenc ies :  Kg va lu e s  fo r  ( - ) - i s o m e r  and f o r  (+ ) - is o m e r
were 14 .3  and 97. 2 n m o l /1 .  In  a d d i t i o n ,  d i f f e r e n c e  was found
between recep to rs  lo c a te d  in  the CNS and in  the  p e r ip h e ry .
Tab le  1. P resynap tic  i n h i b i t o r y  e f f e c t  o f  1 -n o ra d re n a l in e  and 
x y la z in e  (IC^g in  uM) on chemical n e u ro t ra n s m is s io n  in  r a t  vas 
d e fe re n s  and3 g u in e a -p ig  i l e a l  l o n g i t u d in a l  muscle s t r i p  a ttached 
w i th  Auerbach p lexus 0 .1  HZ s t im u la t io n  (1 msec).
r a t  vas d e f(a )______Auerbach p l . ( b )  b/a
1 -n o ra d re n a l in e  1 .67  2 .5  1.5
x y la z in e  0 .0 5  3 .7  74.0
Our f i n d in g s  do not s u p p o r t  the u n i f i e d  h yp o th e s is  o f  feedback 
m o d u la t io n  o f NE r e le a s e .  I t  is  conc luded th a t  two d i f f e r e n t  
s u b ty p e s  o f  p re s y n a p t ic  a lp h a -2 -a d re n o c e p to rs  are in v o lv e d  in  the 
m o d u la t io n  o f NE re le a s e  in  the CNS and in  the  p e r ip h e ry .
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COMPARISON OF THE DEPENDENCE CAPACITY OF AMPHETAMINE, MK-306 
and (-)DEPRENYL
S. Yasar, J. Timár, В. Knoll, J. Knoll
Department of Pharmacology, Semmelweis University of Medicine 
Budapest, P.O.B. 370, 1445 Hungary
Key words: (-)deprenyl, Mk-306, amphetamine, dependence capaci­
ty
(-)Deprenyl is a methamphetamine derivative, free of cate­
cholamine releasing properties. It was the first described se­
lective inhibitor of В-type MAO, is still the only one used in 
clinical practice, being free of the cheese effect. The safe­
ness of the drug is due to its ability to inhibit the uptake 
of indirectly acting amines. This spectrum of the drug initi­
ated the development of (-)deprenyl-derived compounds which 
are devoid of MAO inhibitory potency but are more potent than 
the parent drug in inhibiting the uptake of tvramine. MK-306 
is one of these derivatives possessing a peculiar psychostimu­
lant effect without having either MAO inhibitory or catechol­
amine releasing properties (Knoll, B. et al., 1988).
We analyzed the physiological dependence capacity of (-)dep­
renyl and MK-306 in comparison to amphetamine in rats using 
the method'of Nickel and Aledter (1987). Rats were treated 
either with drug or salihe daily for 8 weeks and treatment 
was withdrawn on every seventh day. Body weight was measured 
daily four hours after the administration of the drug or sali­
ne. As a sign of physical dependence in amphetamine-treated 
rats body weight was significantly increased on the day of drug 
with-drawal and to end of the experiment the amphetamine-
зоо
treated rats has a significantly lower body weight than their 
saline treated peers. No sign of physical dependence was ob­
served in (-)deprenyl treated rats (4 mg/kg/day, orally).
MK-306, which was as potent as amphetamine in facilitating 
learning in the shuttle box, was in a series of experiments 
completely free of showing signs of physical dependence. Even 
in the series of experiments in which a high dose of MK-306 
(20 mg/kg/day) was given, inconsistent sign of withdrawal only 
were observed, without any loss of body weight compared to the 
saline-treated controls. In the parallel group treated with 
5 mg/kg/day amphetamine physical dependence developed uniquivo- 
cally and the loss of body weight was highly significant. 
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THE EFFECT OF DINH LANG AND (-) DEPRENYL ON THE SURVIVAL RATE 
OF MALE RATS
Yen, T.T., Dalló, J., Knoll, J.
Department of Pharmacology, Semmelweis University of Medicine 
Budapest, P.O.B. 370, 1445 Hungary
Key words: sexual activity, motility, Dinh lang, deprenyl, 
longevity.
Dinh lang root extract (DLRE) was found to exert an aphrodi­
siac effect (Yen, 1981). It was known from previous experiments 
that (-)deprenyl, the first selective inhibitor of MAO-B and 
still the only one in clinical practice, facilitates both sex­
ual activity and learning performance in rats, because it fa­
cilitates with high selectivity the activity of the striatal 
dopaminergic system (Knoll, 1987). Long term treatment with 
(-)deprenyl extended lifespan of the rats well over the known 
maximum age of rats (Knoll, 1988, Knoll et al., 1989).
We studied the effect of a combination of (-)deprenyl and 
DLRE on male rats' behavioral performance and survival.
195 aged sexually inexperienced Wistar male rats (24 months 
old) which did not display ejaculation were tested. 66 rats 
were given saline, 65 were treated with DLRE (10 mg/kg, per os) 
and 64 with the combination of DLRE (10 mg/kg) and (-)deprenyl 
(0.25 mg/kg, s.c.) three times a week.
Sexual activity was tested once a week, motility once a 
month and body weight was measured twice in a mounth.
DLRE and the combination of DLRE and (-)deprenyl restored 
full scale of sexual activity (around 96% of rats in both
3 0 2
groups ejaculated in at least one test during the experimental 
period) . The age-related motor function is known to be decreas­
ed with advanced age. But the treatment of DLRE and (-) deprenyl 
slowed down this phenomenon. The mean activity in open field 
behavior in drug-treated groups was significantly higher than 
that of controls. The body weight loss of aged rats was common­
ly observed. The control body weight loss was about 40% but 
there were only 15-30% in the drug treated groups.
The changes of behavioral activities may have a possible 
correlation with the survival time in rats. The longest living 
rat in control group lived 164 weeks. The average lifespan of 
the group was 147.05+1.56 weeks. The average of surviving time 
of DLRE and its combination of (-)deprenyl treated groups were 
179.98+1.87 weeks and 206.33+3.40 weeks, respectively. The 
longest living animal in the DLRE treated group lived 194 weeks, 
whereas in the group treated with DLRE + deprenyl the last ani­
mal completed 239 weeks.
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THE EFFECT OF ANGIOTENSIN I AND I I I  ON THE ARACHIDONATE 
CASCADE OF BRAIN MICROVESSELS 
J. Z á d o r i ,  Á. Geese, Zs. Mezei, G. Telegdy 
Department of P a th o p h ys io lo g y  A lb e r t  S z e n t-G yd rg y i Medical 
U n iv e r s i t y ,  Szeged, Hungary
Key words: a n g io te n s in  I  and I I I ,  a ra ch id o n a te  cascade 
b ra in  m ic rovesse ls  
In t r o d u c t io n
Exper im en ta l ev idence  supports the  h yp o th e s is  t h a t  p ro s ta ­
g la n d in s  and l ip o xyg e n a se  m e ta b o l i te s  have p h y s io lo g ic a l  and/ 
o r  p a th o lo g ic a l  r o le  in  c e n t r a l  b lood p ressu re  c o n t r o l .  The 
c e re b ra l  c o r t i c a l  m ic ro ve sse ls  have been s tu d ie d  s p e c i f i c a l l y ,  
because a ra ch id o n a te  in t e r a c t io n s  m ight occur w i t h  o the r  c e l l s  
( c i r c u l a t i n g  b lood  c e l l ,  p l a t e le t s  or n e u ra l e lem en ts )  and 
pep t ide s  - a n g io te n s in  I  and a n g io te n s in  I I I  -  t h a t  come i n ­
to  con tac t  w i th  the  e n d o th e l ia l  l i n i n g  o f the  m ic ro v e s s e ls .
The l o c a l l y  s y n th e s iz e d  and re leased  a ra c h id o n a te  m e ta b o l i te s  
m igh t modify th e  e n d o th e l ia l  c e l l  f u n c t io n s ,  r e s u l t i n g  in  an 
a l te r e d  c e r e b ra l  m ic r o c i r c u la t io n  and b lo o d - b r a in - b a r r i e r  
f u n c t io n ,  w i th  consequences. E n d o th e l ia l  c e l l s  are r ic h  in  
a n g io te n s in  - c o n v e r t in g  enzyme, and i t  t h e r e fo r e  seemed w o r th ­
w h i le  to de te rm ine  whether a n g io te n s in  I  a n d /o r  a n g io te n s in  I I I  
have any e f f e c t  on the a rach idon a te  cascade o f  b ra in  m ic ro ­
vesse ls  .
Methods
B lo o d - f re e  c e r e b r a l  c o r te x  m ic ro ve sse ls  were i s o la t e d  from 
male ra ts  of CFY s t r a i n ,  we igh ing  160-180 g, by a micrometod 
o f  Hwang e t a l .  (1980) w i th  m o d i f i c a t io n s .
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The is o la t e d  m ic ro ve sse ls  were p re in cu b a te d  in  TC Medium
199 a t  37 °C f o r  10 min and then  a n g io te n s in  I  o r  a n g io te n -  
-9 -5s in  I I I  (10 M - to  10 M) was g iv e n  to  the in c u b a t io n  m ix­
t u r e ,  ten  m inutes l a t e r  the  enzyme re a c t io n  was s t a r t e d  by 
th e  a d d i t i o n  o f ^ C - a r a c h id o n ic  a c id  (3 .7  kBq) as t r a c e r  
s u b s t r a t e  to  the  in c u b a t io n  m ix tu r e .  R ad ioac t ive  a ra c h id o -  
n a te  m e ta b o l i te s  were separa ted  and q u a n t i t a t i v e l y  d e te rm i­
ned in  a Beckman LS l i q u i d  s c i n t i l l a t i o n  c o u n te r .
R e s u l ts  and D iscuss ion
A n g io te n s in  I  (10 M to  10 M) s i g n i f i c a n t l y  i n h i b i t e d  the 
r e le a s e  o f  the t o t a l  a ra ch id o n a te  m e ta b o l i te s  from b r a in  m ic ­
r o v e s s e ls .  The cyc looxygenase pathway was a t te n u a te d  by the
_9
the  o n ly  c o n c e n t ra t io n  (10 M) o f  a n g io te n s in  I .  The pep­
t i d e  was more e f f e c t i v e  on the l ipoxygen ase  pathway r e s u l t ­
in g  in  an i n h i b i t i o n  (10 ^ M to  10 ^ M). This e f f e c t  m ight 
be i n d i r e c t ,  because the e n d o t h e l ia l  c e l l s  are r i c h  sources 
o f  a n g io te n s in  c o n v e r t in g  enzyme (Johnson and Erdős 1979). 
A n g io te n s in  I I I  was less  e f f e c t i v e  on the a ra c h id o n a te  cas­
cade o f  b ra in  m ic ro ve sse ls  than a n g io te n s in  I .  The re le a s e  
o f  t o t a l  a rach idon a te  p roduc ts  was in h ib i t e d  by two concen t-  
r a t i o n s  o f  a n g io te n s in  I I I  (10 M and 10 M). The r a t i o
o f  l ip o xyg e n a se  and cyc looxygenase p roduc ts  was n o t  m o d if ie d  
by any c o n c e n t ra t io n  o f a n g io te n s in  I I I .
Acknowledgement : This work was part ly  supported by the S c ie n t i f ic  Rese­
arch Council, Ministry of Social Welfare and Health.
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SANTO  V A N A S IA , Via M M acch i 58 
2 0 1 2 4  M ila n o
JAPAN
K IN O K U N IY A  C O M P A N Y  LTD 
Jo urna l D epartm ent. P.O. Box 55 
Chitose, Tokyo 156
M A R U ZEN  C O M P A N Y  LTD . Book Departm ent 
P.O. Box 5 0 5 0  Tokyo  In te rnationa l, Tokyo 100-31  
N A U K A  LTD., Im port D epartm ent 
2 -3 0 -1 9  M in a m i Ikebukuro, Tosh im a-ku, Tokyo 171
KOREA
C H U L P A N M U L . P henjan  
NO RW A Y
TA N U M -T ID S K R IF T -S E N T R A L E N  A  S.
Karl Johansga ta  43, 1000 Oslo
POLAND
W ijG IE R S K I IN S TYTU T KULTURY
M arsza lkow ska  80, 0 0 -5 1 7  Warszawa
CKP I W, ul. T ow arow a  28, 0 0 -9 5 8  Warszawa
R O U M A N IA
D. E. P., B u cu re s ti
ILE X IM . Calea G riv ite i 6 4 -6 6 . B ucu re s ti 
SOVIET U N IO N
SO YU ZP E C H A T —  IM P O R T. M o s c o w  
and the  post o ffices in each to w n  
M E Z H D U N A R O D N A Y A  KNIG A , M o s c o w  G -2 00
SPAIN
D IA Z  DE S AN TO S  Lagasca 95, M a d rid  6 
SWEDEN
ESSELTE TIDSKR IFTSC EN TR ALE N  
Box 62, 101 2 0  S to ckh o lm
SWITZERLAND
KARGER L IB R I AG, Petersgraben 31, 4011  Base! 
USA
EBSCO S U B S C R IP T IO N  SERVICES 
P.O. B ox 1943 , B irm ingham . A labam a 35201  
F. W . FAXO N C O M P A N Y . INC.
15 S ou thw es t Park, W e stw o od  Mass. 0 20 90  
M A JO R  S C IE N TIF IC  S U B SC R IPTIO N S  
1851 D ip lom a t, P.O. Box 819074 ,
Pallas. Tx. 7 5 3 8 1 -9 0 7 4  
R E A D -M O R E  P U B LIC A T IO N S . INC.
140  Cedar Street, N e w  York. N. Y. 10006  **
YUGOSLAVIA
JU G O S LO V E N S K A  K N JIG A . Terazije 27. B eograd  
FO R U M , V o jvod e  M ièica 1, 2 1 0 0 0  N o v i Sad
In d e x : 26.023
